run:
Finally the specific silencing or inhibition of BRAF V600E  expression in the NM176 and ME1042 melanoma cells decreased Tbx3 protein expression and this correlated with the concomitant increased E-cadherin  Figure 2c  
Mutation Word : V600E @Position : 8
Function Word : inhibit @Position : 5
Impact Word : decrease @Position : 18
Finally the researchers identified a new TKI resistance mutation L747S substitution of serine for leucine at position 747 in a patient whose TKI-sensitive NSCLC had become resistant to gefitinib and showed that this resistance mutation also reduced TKI-induced apoptosis in cells growing in dishes by interfering with BIM up-regulation 
Mutation Word : L747S @Position : 9
Function Word : apoptosis @Position : 38
Impact Word : reduce @Position : 36
As expected we found that the combination of both reduced ATP and V600E BRAF levels caused activation of AMPK as seen from increased phosphorylation at Thr172 of the alpha subunit of AMPK in doxycycline treated samples Figure  6F  
Mutation Word : V600E @Position : 12
Function Word : phosphorylation @Position : 23
Impact Word : increase @Position : 22
Ki67 labeling revealed an enhanced proliferation index in JoMa1-ALK-F1174L-derived tumors 48% compared to JoMa1-ALK-R1275Q- 40% and JoMa1-ALK-wt-derived tumors 38% Figure  3b  suggesting that the accelerated tumor growth of JoMa1-ALK-F1174L tumors may partly result from their increased proliferation capacity 
Mutation Word : R1275Q @Position : 13
Function Word : proliferation @Position : 38
Impact Word : enhance @Position : 4
Consistent with published data   PLX4032 abolished the ERK1/2 activating phosphorylation in BRAF V600E/K  melanoma cells  Figure 2  pERK YULAC YURIF YUMAC and YUGEN8 
Mutation Word : V600K @Position : 14
Function Word : activity @Position : 10
Impact Word : abolish @Position : 7
In some cases AKT itself is constitutively active because of a mutation in the PH domain E17K   or as in the case of the v-AKT of murine thymoma virus fusion to viral Gag sequences that mediate membrane attachment   
Mutation Word : E17K @Position : 16
Function Word : activity @Position : 7
Impact Word : constitutive @Position : 6
Immunoblot analysis revealed that this inhibition was caused by reduced phosphorylation of BCR-ABL and Crk-L and increased activation of PARP in Ba/F3 BCR-ABL T315I cells after treatment with ponatinib  Figure 1D  
Mutation Word : T315I @Position : 23
Function Word : activity @Position : 17
Impact Word : increase @Position : 16
The NS1 mutants D2N †  and V226I bound F2F3-FLAG with comparable affinity to HK-wt NS1 but NS1 mutants V23A and R227K †  demonstrated a 2-fold increase in binding affinity p<0.05 and p<0 01 two-tailed students t-test 
Mutation Word : V226I @Position : 7
Function Word : binding @Position : 29
Impact Word : increase @Position : 27
The data suggest that low BRCA1 level may neutralize the negative effects of the EGFR T790M mutation on erlotinib sensitivity and that high BRCA1 expression may lead to de novo EGFR TKI resistance potentially through increased DNA damage repair capacity   
Mutation Word : T790M @Position : 15
Function Word : effect @Position : 11
Impact Word : negative @Position : 10
However cells expressing the Y375C mutation responded to FGF1 treatment with a small increase in ERK1/2 activation while phosphorylation levels of FRS2α and PLCγ1 remained unchanged 
Mutation Word : Y375C @Position : 4
Function Word : activity @Position : 16
Impact Word : increase @Position : 13
The most characterized resistance mutation is the T790M-point mutation in exon 20 which increases the affinity of the EGFR for ATP thus reducing the binding of EGFR TKIs to the ATP pocket 
Mutation Word : T790M @Position : 7
Function Word : binding @Position : 24
Impact Word : increase @Position : 13
The  BRAF-V600E  mutation in particular impairs the therapeutic effects of cetuximab and panitumumab 
Mutation Word : V600E @Position : 2
Function Word : effect @Position : 10
Impact Word : impair @Position : 7
Here we provide the first evidence that  V600E BRAF causes the upregulation of genes involved in glycolysis whereas knock-down of  V600E BRAF in melanoma cells conversely reduces the expression of these genes lowers the rate of glycolysis and causes the reversal of the Warburg phenotype 
Mutation Word : V600E @Position : 22
Function Word : expression @Position : 30
Impact Word : reduce @Position : 28
At a later time point in pancreas development S33Y mutant β-cat expression enhanced islet cell proliferation and increased the size of pancreas [ 49 ] 
Mutation Word : S33Y @Position : 8
Function Word : expression @Position : 11
Impact Word : enhance @Position : 12
Comparing the efficiency between PNAcqPCR and DS for the detection of the  BRAF  V600E  mutation the sensitivity and accuracy of PNAcqPCR method were both higher than those of DS 
Mutation Word : V600E @Position : 15
Function Word : sensitivity @Position : 19
Impact Word : higher @Position : 27
Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
Mutation Word : T315I @Position : 14
Function Word : inhibit @Position : 1
Impact Word : enhance @Position : 2
The cobas test showed a very high sensitivity >99% and specificity 88% for the detection of the  BRAF  V600E mutation 
Mutation Word : V600E @Position : 20
Function Word : sensitivity @Position : 7
Impact Word : high @Position : 6
In terms of EGFR-TKI sensitivity Kancha et al  have identified 4 sets of mutations based on their drug sensitivity profiles a mutations that are very sensitive to all 3 drugs tested with IC50 values in the low nanomolar range L858R and Del 747-753insS b mutations that are less sensitive to gefitinib IC50 >100 nmol/l but sensitive to both erlotinib and AEE788 G719S V742A and R776C IC50 < 100 nmol/l c mutations that are less sensitive to both gefitinib and erlotinib but sensitive to AEE788 D761N S768I S784F L838V and L861Q and d mutations that are resistant to all three drugs tested N826S and T790M   
Mutation Word : T790M @Position : 104
Function Word : sensitivity @Position : 82
Impact Word : less @Position : 74
On the other hand YFP-EGFR-ICD proteins bearing the uncommon exon 21 mutation P848L and A859T showed markedly lower autophosphorylation levels than YFP-EGFR-ICD L858R Figure  4C  
Mutation Word : P848L @Position : 12
Function Word : autophosphorylation @Position : 18
Impact Word : lower @Position : 17
BRAF  belongs to the RAF family of serine/threonine kinases and the V600E mutation results in constitutive activation in 45% of papillary thyroid carcinomas in adults 
Mutation Word : V600E @Position : 12
Function Word : activity @Position : 17
Impact Word : constitutive @Position : 16
BRAF V600E   mutations are found in 60% of benign nevi and are thought to result in the initial increase in proliferation of melanocytic cells followed by induction of cell cycle arrest and senescence   
Mutation Word : V600E @Position : 1
Function Word : result @Position : 16
Impact Word : increase @Position : 20
Further elevated CDK4 levels in the embryonic pancreas through the CDK4 R24C  mutant showed increased proliferation of early mesenchymal endocrine precursors   
Mutation Word : R24C @Position : 11
Function Word : proliferation @Position : 16
Impact Word : increase @Position : 15
Furthermore they demonstrated an enhanced anti-tumor effect against a subcutaneously implanted mouse-derived V600E BRAF melanoma line using vemurafenib in combination with adoptively transferred splenocytes designed to target the melanocyte marker gp100 
Mutation Word : V600E @Position : 12
Function Word : effect @Position : 6
Impact Word : enhance @Position : 4
The V600E mutant expresses a 10-fold increased kinase activity compared to the wild-type BRAF   
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 8
Impact Word : increase @Position : 6
Complete abrogation of EphA3 function was achieved by the mutation of both Y602 and Y779 similar to that of the kinase inactive mutants K653R and Y596F  Fig  7  
Mutation Word : K653R @Position : 23
Function Word : function @Position : 4
Impact Word : abrogate @Position : 1
In a panel of human kinases TAK-285 showed weak inhibition 0‒50% against 88 of 96 kinases tested moderate inhibition 50-80% against EGFR L858R and alkaline phosphatase and strong inhibition 80‒100% against HER family kinases including EGFRL861Q as well as against CDK3/cyclin E and Flt3 Figure  1  
Mutation Word : L858R @Position : 22
Function Word : inhibit @Position : 28
Impact Word : weak @Position : 8
Expression of BRAF V600E  in BRAF mutant naïve cells resulted in increased expression and activation of Usp5 suggesting that pathway activation or phospho-regulation underlie Usp5 activation 
Mutation Word : V600E @Position : 3
Function Word : activity @Position : 26
Impact Word : increase @Position : 12
The M918T mutation appears to increase the stability of monomeric active forms of RET but activation of these mutants can also be further enhanced by binding of GDNF–GFRα complexes suggesting that these mutant RET forms may induce signal transduction from both within and outside the lipid rafts perhaps via distinct signaling complexes  Figure 2B  
Mutation Word : M918T @Position : 1
Function Word : activity @Position : 15
Impact Word : increase @Position : 5
Our previous study also demonstrated that the COS-7 cell expressing c-Met-N375S  mutation was less sensitive to specific MET kinase inhibitors such as SU11274 compared to cell expressing  c-Met  wild-type  
Mutation Word : N375S @Position : 10
Function Word : sensitivity @Position : 15
Impact Word : less @Position : 14
In a panel of human kinases TAK-285 showed weak inhibition 0‒50% against 88 of 96 kinases tested moderate inhibition 50-80% against EGFR L858R and alkaline phosphatase and strong inhibition 80‒100% against HER family kinases including EGFRL861Q as well as against CDK3/cyclin E and Flt3 Figure  1  
Mutation Word : L861Q @Position : 35
Function Word : inhibit @Position : 28
Impact Word : weak @Position : 8
T790M may increase the GTP affinity in the tyrosine kinase domain of the EGFR or hindrance to TKI binding to the tyrosine kinase domain   
Mutation Word : T790M @Position : 0
Function Word : affinity @Position : 5
Impact Word : increase @Position : 2
Upon FGF2 stimulation S252W fibroblasts significantly altered expression of 55 DEGs up-regulating 21 genes and down regulating 34 genes  Table S3  
Mutation Word : S252W @Position : 3
Function Word : regulation @Position : 16
Impact Word : alter @Position : 6
In M17 neuroblastoma cell line G2019S mutation decreased the average length of neurites and G2019S/G2385R double mutants counteract the neurite shortening effect of G2019S suggesting that the impact of G2385R is strong enough to overcome the kinase-activating effect of the G2019S   
Mutation Word : G2385R @Position : 29
Function Word : effect @Position : 37
Impact Word : decrease @Position : 7
In addition the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
Mutation Word : V617F @Position : 39
Function Word : resistance @Position : 20
Impact Word : increase @Position : 33
The up-regulation of BIM was also attenuated in a similar dose–response manner as seen in the apoptosis assay  Figure 6 A bottom with L858R-T790M completely abrogating the induction of BIM and L858R-L747S attenuating both the up-regulation of BIM and apoptosis 
Mutation Word : L858R @Position : 32
Function Word : apoptosis @Position : 40
Impact Word : attenuate @Position : 33
Consistent with the observed transcription profile melanocytes expressing B-RAF V600E  show rounded cell morphology and diminished substrate and cell adhesion as reported previously   
Mutation Word : V600E @Position : 9
Function Word : substrate @Position : 17
Impact Word : diminish @Position : 16
Two of these missense mutants V689M and L703F are constitutively active possibly because they stabilize acceptor/donor interactions   
Mutation Word : L703F @Position : 7
Function Word : activity @Position : 10
Impact Word : constitutive @Position : 9
PLX4720 is a potent inhibitor of migration significantly decreasing cellular migration and invasion of human BRAF V600E -positive thyroid cancer lines  in vitro  [ 6 ] 
Mutation Word : V600E @Position : 16
Function Word : migration @Position : 10
Impact Word : decrease @Position : 8
The coexistent mutations of  AKT3  and  PIK3CA  in one sample suggest that some types of  AKT  mutations non-E17K might coexist with  PIK3CA  mutations to enhance the activation of the PI3 kinase–AKT pathway 
Mutation Word : E17K @Position : 23
Function Word : activity @Position : 34
Impact Word : enhance @Position : 32
On the other hand Y375C and K652E FGFR3 showed increased levels of phosphorylation in response to ligand stimulation  Figure 4a  
Mutation Word : Y375C @Position : 4
Function Word : phosphorylation @Position : 12
Impact Word : increase @Position : 9
In that context we demonstrate that inhibition of SIRT1 with genetic or pharmacological approaches additively enhances the efficacy of PLX4032 of melanoma cells but more importantly that it rescues the sensitivity to PLX4032 of the resistant BRAF V600E -mutated melanoma cells 
Mutation Word : V600E @Position : 37
Function Word : inhibit @Position : 6
Impact Word : enhance @Position : 15
In a dose-response experiment  Figure 3 B left panel the best inhibitor D4 was effective at a concentration of 200 nM to inhibit RET C634Y  autophosphorylation up to 70% and to drastically reduce ERK phosphorylation 
Mutation Word : C634Y @Position : 25
Function Word : effect @Position : 15
Impact Word : reduce @Position : 34
In our models MEK inhibitors produced a much stronger effect than WZ4002 which targets the EGFR[T790M] mutation   Fig  4C  
Mutation Word : T790M @Position : 15
Function Word : effect @Position : 9
Impact Word : stronger @Position : 8
We show that low levels of wild-type MITF activity are oncogenic with BRAF V600E  to promote melanoma  in vivo  and that abrogating MITF activity in melanoma leads to rapid tumor regression 
Mutation Word : V600E @Position : 13
Function Word : activity @Position : 26
Impact Word : abrogate @Position : 24
PLX4032 was recently demonstrated to reduce the uptake of 218Ffluoro-2-deoxy-D-glucose 18F-FDG in melanoma cells whereas inducible expression of V600E BRAF increased the glucose uptake rate and decreased O 2  consumption in thyroid cancer cells   
Mutation Word : V600E @Position : 18
Function Word : induce @Position : 15
Impact Word : increase @Position : 20
This is proposed to drop anti-apoptotic activity in JAK2 V617F  mutant cells below a critical threshold unleashing Bak and Bax to drive mitochondrial cell death 
Mutation Word : V617F @Position : 9
Function Word : activity @Position : 6
Impact Word : drop @Position : 4
The putative relationships between  MLH1  expression and BRAF V600E RET/PTC and IDH1 genetic alterations were evaluated 
Mutation Word : V600E @Position : 10
Function Word : expression @Position : 7
Impact Word : alter @Position : 15
Graph shows that the common L858R mutation confers higher autophosphorylation levels to YFP-EGFR-ICD than P848L and A859T 
Mutation Word : A859T @Position : 16
Function Word : autophosphorylation @Position : 9
Impact Word : higher @Position : 8
Some of these mutations alter specifically the configuration of the ATP-binding kinase pocket V654A and T670I inhibiting imatinib binding 
Mutation Word : V654A @Position : 13
Function Word : binding @Position : 18
Impact Word : alter @Position : 4
Leukocytes from ET patients harboring the JAK2 V617F mutation showed higher expression of PRV1  median = 4.88 in comparison to those negative for the JAK2 V617F mutation 1.91 p = 0.0074 Figure  6A  and consequently a positive correlation between  PRV1  expression and JAK2 V617F allele burden was observed in ET patient leukocytes r = 0.4785 p = 0 0067 Figure  6B  
Mutation Word : V617F @Position : 48
Function Word : expression @Position : 45
Impact Word : higher @Position : 10
Strikingly we also observed that the number of EPO-independent endogenous erythroid colonies a clinical criterion of JAK2 V617F -induced PV  29   was markedly reduced after macrophage depletion  Fig. 6j  and  Supplementary Fig  12g  
Mutation Word : V617F @Position : 17
Function Word : induce @Position : 18
Impact Word : reduce @Position : 26
It appears that PtdIns binding is enhanced in the E416A mutant for two reasons i the Arg 380 –Glu 416  salt bridge which otherwise blocks the entrance to the binding pocket is broken and ii the sentry glutamate residue Glu 416  is replaced by an alanine in this open state which further increases the accessibility of the binding site for negatively charged lipid headgroups 
Mutation Word : E416A @Position : 9
Function Word : binding @Position : 59
Impact Word : increase @Position : 54
9   Preclinical studies have shown superior activity of afatinib over first-generation TKIs mainly due to 1 irreversible binding which confers stronger binding affinity and potency 2 ability to circumvent first-generation TKI resistance mechanism T790M mutation in exon 20 and 3 effectiveness against multiple HER-endothelial growth factor receptors   10  
Mutation Word : T790M @Position : 35
Function Word : affinity @Position : 24
Impact Word : stronger @Position : 22
Only recently there were a few reports of methylation of the negative regulators of the JAK-STAT signaling pathway SOCS1 SOCS2  and  SOCS3  in Ph-ve MPN regardless of the JAK2 V617F mutation status   
Mutation Word : V617F @Position : 32
Function Word : regulation @Position : 12
Impact Word : negative @Position : 11
An acquired T790M mutation was found in a NSLCL patient resistant to the drug Gefitnib by increasing the affinity to ATP   
Mutation Word : T790M @Position : 2
Function Word : affinity @Position : 18
Impact Word : increase @Position : 16
This study finds that the two most common EGFR mutations in non-small cell lung cancer L858R and Δ746–750 result in EGF–independent tEGFR activities comparable to or greater than the activity of EGF–stimulated WT EGFR and that tEGFR activation resulting from these mutations remains strongly coupled to asymmetric kinase dimer formation  Fig  3d  
Mutation Word : L858R @Position : 15
Function Word : result @Position : 38
Impact Word : remain @Position : 42
It is striking that several of the variants with reduced activity had altered evolutionarily conserved glycine residues that is G220V G401S and G465R suggesting that these residues may be particularly important for OCT1 function   
Mutation Word : G465R @Position : 22
Function Word : activity @Position : 10
Impact Word : alter @Position : 12
In this study we used functional mutagenesis to investigate the involvement of the JH2 αC helix in the constitutive activation of JAK2 V617F 
Mutation Word : V617F @Position : 22
Function Word : activity @Position : 19
Impact Word : constitutive @Position : 18
Hence the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT down-regulated CBL and MAPK-ERK1/2 phosphorylation up-regulated 
Mutation Word : L858R @Position : 4
Function Word : effect @Position : 15
Impact Word : modulates @Position : 5
Tyrosine phosphorylation of MIG6 appears to be increased in cancer cell lines containing Δ746–750 or L858R EGFRs suggesting that in addition to inhibiting EGFR MIG6 may also be a direct substrate of these mutant receptor EGFRs  
Mutation Word : L858R @Position : 15
Function Word : substrate @Position : 30
Impact Word : increase @Position : 7
27   Cells expressing G719X were less resistant to erlotinib than gefitinib in vitro however L861Q was resistant to both erlotinib and gefitinib 
Mutation Word : L861Q @Position : 16
Function Word : resistance @Position : 18
Impact Word : less @Position : 7
In the cases of mutation M918T constitutive RET activation probably results from disruption of an auto-inhibited head-to-tail RET tyrosine kinase homodimer   
Mutation Word : M918T @Position : 5
Function Word : activity @Position : 8
Impact Word : constitutive @Position : 6
Importantly the wild type protein formed fibrils only at 10 μM erlotinib whereas the TKI-sensitive mutants relocated to fibrils in the presence of 10–100 nM erlotinib and this effect was fully abrogated by the erlotinib-resistant T790M mutation 
Mutation Word : T790M @Position : 35
Function Word : effect @Position : 28
Impact Word : abrogate @Position : 31
In an overlay assay using ERK4 peptides with wild-type sequence or single amino-acid substitutions bound to cellulose membrane the authors showed that D336N but not E331D reduced  in vitro  binding of recombinant MK5 
Mutation Word : E331D @Position : 25
Function Word : binding @Position : 31
Impact Word : reduce @Position : 26
One includes ERK signaling reactivation caused by point mutations in MEK1[ 10   15 ] amplification of mutant BRAFV600E[ 16 ] elevated CRAF activity[ 17 ] activating NRAS mutations [ 11 ] increased levels of COT/Tpl2[ 12 ] and/or aberrantly spliced BRAFV600E[ 13 ] 
Mutation Word : V600E @Position : 42
Function Word : activity @Position : 27
Impact Word : elevate @Position : 22
These data suggest that Lyn is constitutively activated in PVTL-1 cells and activates signaling pathways involving the SHP2/Gab2 and CrkL/c-Cbl complexes as well as SHP1 among others while Jak2-V617F uniquely activates STAT5 and is partly involved in phosphorylation of SHP2 
Mutation Word : V617F @Position : 28
Function Word : activity @Position : 30
Impact Word : constitutive @Position : 6
Firstly exon 19 deletions might be more efficiently inhibited by EGFR-TKIs than exon 21 L858R mutations [8]  Mutant forms of exon 19 deletion and L858R mutation had a reduced affinity for its natural substrate ATP but equivalent or increased affinity for reversible EGFR-TKIs which explained why tumors with these EGFR mutations had higher sensitivity to TKIs  [30]   [31]  
Mutation Word : L858R @Position : 25
Function Word : substrate @Position : 34
Impact Word : reduce @Position : 29
Herein we show that inhibition of PI3K/AKT signaling by MK-2206 affected the growth of both  JAK2 V617F or  MPL W515L-expressing cells via reduced phosphorylation of AKT and inhibition of its downstream signaling molecules 
Mutation Word : V617F @Position : 17
Function Word : phosphorylation @Position : 25
Impact Word : reduce @Position : 24
We employed the human mast cell leukemia cell line -1 HMC-1 model which harbors KIT D816V and V560G mutations and depends on signaling from these constitutively active KIT receptors for growth and survival [ 4 ] 
Mutation Word : D816V @Position : 15
Function Word : activity @Position : 26
Impact Word : constitutive @Position : 25
Deletion of exon 19 occurs just downstream from a lysine residue at a critical position for ATP binding and L858R mutations occur adjacent to the DFG motif which stabilizes the A-loop 
Mutation Word : L858R @Position : 19
Function Word : stability @Position : 28
Impact Word : stability @Position : 28
For 4557W reversible dual TKI of EGFR/ERBB2 the E884K mutation modulated the L858R mutation in- cis  again in a dominant fashion rendering the double mutant receptor more sensitive to the dual inhibitor  Figure 2  
Mutation Word : E884K @Position : 8
Function Word : sensitivity @Position : 28
Impact Word : modulates @Position : 10
The phosphorylation of Akt induced by S768I was abrogated by 100 nM erlotinib and fibril formation was noted upon treatment with 1 μM or higher concentration of the drug 
Mutation Word : S768I @Position : 6
Function Word : phosphorylation @Position : 1
Impact Word : abrogate @Position : 8
Finally we observed that expression of the murine  Mycn  gene was significantly higher in  MYCN / Alk  tumors compared with  MYCN  tumors as previously described in transgenic  ALK   F1174L   mice [ 22 ] 
Mutation Word : F1174L @Position : 37
Function Word : expression @Position : 4
Impact Word : higher @Position : 14
Consistent with published data   PLX4032 abolished the ERK1/2 activating phosphorylation in BRAF V600E/K  melanoma cells  Figure 2  pERK YULAC YURIF YUMAC and YUGEN8 
Mutation Word : V600E @Position : 14
Function Word : activity @Position : 10
Impact Word : abolish @Position : 7
Enhancement by PDGFRα-I of the signaling pathway inhibition by BRAF-I in BRAF-I sensitive and resistant melanoma cell lines harboring BRAFV600E
Mutation Word : V600E @Position : 19
Function Word : inhibit @Position : 7
Impact Word : enhance @Position : 0
Here we applied a genome-wide expression profiling approach to identify downstream B-RAF V600E  signaling changes that modulate melanocyte morphology and migration 
Mutation Word : V600E @Position : 12
Function Word : migration @Position : 21
Impact Word : modulates @Position : 17
In the present study FGFR2 S252W  mutation leads to increased proliferation migration and osteogenic potential of both fibroblasts and MSCs 
Mutation Word : S252W @Position : 5
Function Word : proliferation @Position : 11
Impact Word : increase @Position : 10
BRAF V600E   enhances the migrating and invasive capacity of colon adenocarcinoma cells through RhoA activation  
Mutation Word : V600E @Position : 1
Function Word : migration @Position : 6
Impact Word : enhance @Position : 4
A mutated BRAF gene with a single amino acid substitution BRAF V600E results in higher kinase activity 
Mutation Word : V600E @Position : 11
Function Word : activity @Position : 16
Impact Word : higher @Position : 14
Substitution of S252W and P253R alter the ligand binding specificities of FGFR2b and FGFR2c but retain the ligand-dependent activation properties   whereas K659N causes receptor hyperactivation   
Mutation Word : S252W @Position : 2
Function Word : activity @Position : 18
Impact Word : retain @Position : 15
The data suggest that low BRCA1 level may neutralize the negative effects of the EGFR T790M mutation on erlotinib sensitivity and that high BRCA1 expression may lead to de novo EGFR TKI resistance potentially through increased DNA damage repair capacity   
Mutation Word : T790M @Position : 15
Function Word : effect @Position : 11
Impact Word : neutral @Position : 8
Enhancement by PDGFRα-I of the anti-tumor activity of BRAF-I in human BRAFV600E melanoma cells grafted in immunodeficient mice
Mutation Word : V600E @Position : 11
Function Word : activity @Position : 6
Impact Word : enhance @Position : 0
Vemurafenib treatment results in deletion mutant p61B-RAF V600E  with enhanced dimerization and activity through a similar allosteric mechanism 
Mutation Word : V600E @Position : 7
Function Word : dimerization @Position : 11
Impact Word : enhance @Position : 10
In vitro studies by Guo and colleagues suggested that Nilotinib in cell lines transfected with a KIT gene containing an exon 9 or 11 mutation with an exon 17 mutation D820Y and N822 K demonstrated significant kinase inhibition as well as decreased cell proliferation The Japanese study also documented a partial response in patients whose GIST contained a KIT exon 11 dup 567–576 and exon 17 D820G mutation   
Mutation Word : D820G @Position : 65
Function Word : proliferation @Position : 42
Impact Word : decrease @Position : 40
The patient remained on this regimen for 7 mo with an excellent performance status exceeding the expected survival of a patient expressing B-RAF V600E colon cancer 
Mutation Word : V600E @Position : 23
Function Word : expression @Position : 21
Impact Word : remain @Position : 2
All mutations experience variations in electrostatic interactions ranging from −4.95 to −6 71 kcal/mol with Glu286 in particular Q252H Y253H T315I and F317L experience increased electrostatic interactions with Glu286 
Mutation Word : T315I @Position : 20
Function Word : interaction @Position : 26
Impact Word : increase @Position : 24
H606Q disrupts the interactions between the residue 606 sidechain and the L604/L609 backbones affecting the conformation of the loop 604 to 609 connecting the JH2 C-helix and the β-4 sheet and thus changing the position of V617 relative to the C-helix 
Mutation Word : H606Q @Position : 0
Function Word : interaction @Position : 3
Impact Word : disrupt @Position : 1
The mutants T316A K323A and R326A which were engineered to abrogate the hydrophilic interactions also moderately impaired the kinase activity 
Mutation Word : T316A @Position : 2
Function Word : activity @Position : 19
Impact Word : impair @Position : 16
Of note a decreased steady-state expression of the R728L variant was detected in both cell lines and the T933M variant in hTERT-RPE1 cells   Fig  S6A and B   
Mutation Word : R728L @Position : 8
Function Word : expression @Position : 5
Impact Word : decrease @Position : 3
Furthermore our results show that both insertions confer higher kinase activity than T790M thus underscoring an important difference between these two types of exon 20 alterations 
Mutation Word : T790M @Position : 12
Function Word : activity @Position : 10
Impact Word : higher @Position : 8
Hence the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT down-regulated CBL and MAPK-ERK1/2 phosphorylation up-regulated 
Mutation Word : L858R @Position : 4
Function Word : phosphorylation @Position : 23
Impact Word : modulates @Position : 5
All mutations experience variations in electrostatic interactions ranging from −4.95 to −6 71 kcal/mol with Glu286 in particular Q252H Y253H T315I and F317L experience increased electrostatic interactions with Glu286 
Mutation Word : Q252H @Position : 18
Function Word : interaction @Position : 26
Impact Word : increase @Position : 24
In addition the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
Mutation Word : V617F @Position : 39
Function Word : result @Position : 31
Impact Word : increase @Position : 33
Meclozine also ameliorated abnormally suppressed proliferation of human chondrosarcoma HCS-2/8 cells that were infected with lentivirus expressing constitutively active mutants of FGFR3-K650E causing thanatophoric dysplasia FGFR3-K650M causing SADDAN and FGFR3-G380R causing ACH 
Mutation Word : K650E @Position : 25
Function Word : activity @Position : 18
Impact Word : constitutive @Position : 17
Recent studies show that EGFR expression occurs in a significant percentage of BRAF resistant melanomas and receptor activation though disadvantageous under normal conditions becomes beneficial when the MAPK pathway is blocked in BRAF V600E  positive melanomas [ 40 ] 
Mutation Word : V600E @Position : 33
Function Word : activity @Position : 17
Impact Word : beneficial @Position : 24
The Y931C mutation may disrupt hydrophobic interactions between Y931 and the ring structures of the inhibitor along with other hydrophobic interactions which are likely required to hold the inhibitor in the binding pocket eventually weakening the inhibitor binding 
Mutation Word : Y931C @Position : 8
Function Word : binding @Position : 37
Impact Word : disrupt @Position : 4
Moreover E884K had a dominant effect over L858R when in- cis  in these signaling modulatory effects 
Mutation Word : E884K @Position : 1
Function Word : effect @Position : 16
Impact Word : dominant @Position : 4
Expression of AKT3 E17K in A375 cells increased AKT phosphorylation as compared to transfection with the control vectors or wild-type AKT3 under normal tissue culture conditions  Figure 1  Panel C 
Mutation Word : E17K @Position : 3
Function Word : expression @Position : 0
Impact Word : increase @Position : 7
The effect on the downstream signal mediators p-AKT [S473] and p-STAT3 [Y705] correlated well with the inhibition of EGFR phosphorylation  Figure 1A  E884K in- cis  with L858R decreased erlotinib inhibition of AKT and STAT3 phosphorylation but increased inhibition by gefitinib 
Mutation Word : E884K @Position : 24
Function Word : inhibit @Position : 40
Impact Word : decrease @Position : 30
The substitution of a thymidine to adenine in exon 15 results in an amino acid sequence change of valine to glutamate V600E this alteration makes  BRAF  constitutively active   with a higher affinity for MEK1 and MEK2 and with a potent activating effect on MAPK pathway 
Mutation Word : V600E @Position : 21
Function Word : activity @Position : 44
Impact Word : constitutive @Position : 28
These cases uniformly harbored a monoallelic  BRAF  V600E mutation which associates with constitutive activation of ERK1/2 reported in HCL  [19]   [20]  
Mutation Word : V600E @Position : 9
Function Word : activity @Position : 15
Impact Word : constitutive @Position : 14
It was noted that PLX4720 also reduced pRB protein phosphorylation increased p27 expression suppressed cyclin D1 expression and induced cleavage of PARP only in melanoma cell lines harbouring the  BRAF -V600E mutation  Figure 1D  
Mutation Word : V600E @Position : 31
Function Word : induce @Position : 18
Impact Word : reduce @Position : 6
Both effects were readily abrogated by the TKI-resistant mutation T790M 
Mutation Word : T790M @Position : 9
Function Word : effect @Position : 1
Impact Word : abrogate @Position : 4
In conclusion the auto-inhibitory activity of JAK2 was disrupted by the presence of this V617F mutation 
Mutation Word : V617F @Position : 14
Function Word : activity @Position : 4
Impact Word : disrupt @Position : 8
Ki67 staining showed that the proportion of proliferating cells was significantly increased within the midline mesenchyme separating premaxillary bones in  Fgfr2 +/S252W   mice compared with unaffected littermates 
Mutation Word : S252W @Position : 22
Function Word : proliferation @Position : 7
Impact Word : increase @Position : 11
While many JAK2 inhibitors are able to achieve normalization of leukocytosis and thrombocytosis as well as improve symptoms in cancer patients [ 15   16 ] they are less effective in achieving consistent hematologic remissions and reducing JAK2V617F allelic burden [ 15   17 - 20 ] 
Mutation Word : V617F @Position : 38
Function Word : effect @Position : 30
Impact Word : less @Position : 29
Compared to L858R alone the L858R+E884K dual mutant was less sensitive to erlotinib in the inhibition of tyrosine phosphorylation of EGFR 
Mutation Word : L858R @Position : 5
Function Word : sensitivity @Position : 10
Impact Word : less @Position : 9
In addition MITF mutations have been identified in BRAF V600E  melanomas including somatic mutations with either hypomorphic or increased activity   and a germline SUMOylation E318K mutation that is a melanoma risk factor and confers differential gene expression of MITF target genes   
Mutation Word : V600E @Position : 9
Function Word : activity @Position : 20
Impact Word : increase @Position : 19
Mcl-1 depletion in JAK2 V617F  mutant SET-2 cells increases apoptosis and sensitizes the cells to NVP-BSK805-induced cell death  
Mutation Word : V617F @Position : 4
Function Word : sensitivity @Position : 12
Impact Word : increase @Position : 9
Hence E884K in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 1
Function Word : associated @Position : 27
Impact Word : alter @Position : 29
The BRAF  mutations found in CFC can confer either weakly elevated kinase activity mutations of Q257R S467A L485F K499E or impaired kinase activity versus wild-type  BRAF  E501G and G596V     
Mutation Word : L485F @Position : 18
Function Word : activity @Position : 23
Impact Word : elevate @Position : 11
For example crizotinib maintains activity against the R1275Q mutant but drastically loses activity against F1174L another frequently occurring mutant Wood et al.  Sakamoto et al.  Schönherr et al   
Mutation Word : F1174L @Position : 14
Function Word : activity @Position : 12
Impact Word : maintain @Position : 3
In western blot experiments we observed that IM was unable to decrease the expression of the mature form of T670I c-Kit mutant while the  wt  form of the receptor decreased in UT-7/Epo or in  wt -c-Kit BaF3 cells  Figure 7B  
Mutation Word : T670I @Position : 19
Function Word : expression @Position : 13
Impact Word : decrease @Position : 31
Studying how BRAF V600E  altered kinase activity in patients with PTC creates alterations in the already complex tumor cell–ECM interactions has been a logical next step for our laboratory 
Mutation Word : V600E @Position : 3
Function Word : interaction @Position : 20
Impact Word : alter @Position : 13
Overall H2A values were greater than H2A.Z and that A2B1 H2A > H2A.Z was lesser than A2C12 H2A > H2A Z   Figure S12C   in agreement with nucleosome depletion associated with gene expression 
Mutation Word : S12C @Position : 24
Function Word : expression @Position : 35
Impact Word : greater @Position : 4
Immunoblotting for phospho-AKT was performed after successful transfection and weaning of IL3-dependent growth true autoactivating TK mutations result in IL3-independent growth and found that AKT activation increases after transfection of plasmid vectors encoding for a  FLT3  ITD  FLT3  D835V  KIT  D816Y or  BCR-ABL1  isoform 
Mutation Word : D835V @Position : 42
Function Word : activity @Position : 25
Impact Word : increase @Position : 26
9   Preclinical studies have shown superior activity of afatinib over first-generation TKIs mainly due to 1 irreversible binding which confers stronger binding affinity and potency 2 ability to circumvent first-generation TKI resistance mechanism T790M mutation in exon 20 and 3 effectiveness against multiple HER-endothelial growth factor receptors   10  
Mutation Word : T790M @Position : 35
Function Word : ability @Position : 28
Impact Word : stronger @Position : 22
Insertion mutant autophosphorylation is less sensitive to inhibition by gefitinib than that of L858R but CL-387785 is more effective than gefitinib at inhibiting insertion mutant and L858R autophosphorylation 
Mutation Word : L858R @Position : 26
Function Word : sensitivity @Position : 5
Impact Word : less @Position : 4
Tyrosine phosphorylation of PECAM-1 is enhanced by the E255K or T315I imatinib-resistant mutation in BCR/ABL
Mutation Word : E255K @Position : 8
Function Word : phosphorylation @Position : 1
Impact Word : enhance @Position : 5
These data suggest that binding to PtsInsP species is enhanced by the E416A mutation in agreement with the MD results reported above 
Mutation Word : E416A @Position : 12
Function Word : result @Position : 19
Impact Word : enhance @Position : 9
This analysis revealed that the GST–JNK2 mutants D162N or D326N residing within the ED and CD domains respectively had reduced association with Myc-1018-C  Figure 6 B lanes 3–5 
Mutation Word : D162N @Position : 7
Function Word : associated @Position : 20
Impact Word : reduce @Position : 19
However both ET- and PMF-like disease are also induced in mice by experimental manipulation of the JAK2 V617F allele burden and mutant allele burden in PMF is often as high as that seen in PV and its level increases further during fibrotic transformation 
Mutation Word : V617F @Position : 17
Function Word : induce @Position : 8
Impact Word : high @Position : 29
BRAF  V600E mutation is associated with reduced survival overall survival disease-free survival or cancer-specific survival especially in MSS tumors Table  1    
Mutation Word : V600E @Position : 2
Function Word : survival @Position : 15
Impact Word : reduce @Position : 7
The former is the case of the S492R mutant which confers resistance to cetuximab since the mutation is located in its binding epitope on the EGFR external domain   whereas the later is the case of the T790M mutant mutation in the kinase domain which confers resistance to gefitinib or erlotinib in lung adenocarcinomas   by stabilizing the active tyrosine kinase conformation and enhancing aTP binding   
Mutation Word : T790M @Position : 38
Function Word : atp @Position : 66
Impact Word : enhance @Position : 65
The effect on the downstream signal mediators p-AKT [S473] and p-STAT3 [Y705] correlated well with the inhibition of EGFR phosphorylation  Figure 1A  E884K in- cis  with L858R decreased erlotinib inhibition of AKT and STAT3 phosphorylation but increased inhibition by gefitinib 
Mutation Word : L858R @Position : 29
Function Word : inhibit @Position : 40
Impact Word : decrease @Position : 30
CNP and meclozine increased the Alcian blue staining of ATDC5 cells expressing FGFR3-G380R and –K650E in micromass culture 
Mutation Word : G380R @Position : 12
Function Word : expression @Position : 11
Impact Word : increase @Position : 3
In a study of four categories of imatinib- and dasatinib-treated patients imatinib resistant/dasatinib-responsive dasatinib-resistant blast crisis or CML progression and T315I or F317L mutated patient receiving omacetaxine treatment   transcriptional and translational levels of HCK LYN and another SFK-related gene BTK were elevated in more than 50% of resistant CML patients 
Mutation Word : F317L @Position : 22
Function Word : resistance @Position : 49
Impact Word : elevate @Position : 43
Knockdown or inhibition of FGFR3 signalling in the FGFR3-mutant UC cell lines MGHU3 Y375C 97-7 S249C and UMUC14 S249C is accompanied by diminished cell proliferation and/or anchorage dependent growth  in vitro  in all although with different efficacy   
Mutation Word : S249C @Position : 18
Function Word : proliferation @Position : 24
Impact Word : diminish @Position : 22
Tyrosine phosphorylation of PECAM-1 is enhanced by the E255K or T315I imatinib-resistant mutation in BCR/ABL
Mutation Word : T315I @Position : 10
Function Word : phosphorylation @Position : 1
Impact Word : enhance @Position : 5
MST1 expression significantly increased apoptosis which is reduced by expression of BRAF V600E  
Mutation Word : V600E @Position : 12
Function Word : expression @Position : 9
Impact Word : increase @Position : 3
Immuno-precipitation data showed that curcumin induced EGFR protein degradation by accelerating ubiquitin-proteasome ability in wide type EGFR CL1-5 and A549 and also in the mutated EGFR with T790M H1975 
Mutation Word : T790M @Position : 27
Function Word : induce @Position : 5
Impact Word : degrade @Position : 8
The mutations E255K and T315A experience increased vdW interactions with Leu354 
Mutation Word : E255K @Position : 2
Function Word : interaction @Position : 8
Impact Word : increase @Position : 6
Coincident with the inability to produce conidiospores on Aspergillus Minimal Medium  Figure 3  the G70R mutation results in a remarkable decrease in the capability of the FlbB bZip to bind previously defined DNA targets compared to the wild type protein    
Mutation Word : G70R @Position : 16
Function Word : result @Position : 18
Impact Word : decrease @Position : 22
Therefore  BRAF  V600E increases the kinase activity that provides cancer cells with both proliferation and survival signals and promotes them to become tumors in the model system 
Mutation Word : V600E @Position : 4
Function Word : survival @Position : 17
Impact Word : increase @Position : 5
Expression of stereocilin is increased in Fgfr2 S252W/+  mice brains
Mutation Word : S252W @Position : 7
Function Word : expression @Position : 0
Impact Word : increase @Position : 4
Furthermore transfection of another activated mutant L858R EGFR cDNA also induced enhanced expression  Figure 7C  and restored drug sensitivity to erlotinib in 11–18/ER1-7 cells  Figure 7D  
Mutation Word : L858R @Position : 6
Function Word : sensitivity @Position : 20
Impact Word : enhance @Position : 11
As seen in  Fig  4E  the expression of BRAF V600E  completely abolished MST1 kinase activity 
Mutation Word : V600E @Position : 12
Function Word : expression @Position : 9
Impact Word : abolish @Position : 15
Studying how BRAF V600E  altered kinase activity in patients with PTC creates alterations in the already complex tumor cell–ECM interactions has been a logical next step for our laboratory 
Mutation Word : V600E @Position : 3
Function Word : activity @Position : 7
Impact Word : alter @Position : 13
In agreement with the effects on EGFR phosphorylation and AKT/ERK signaling cells expressing the T790M form of L858R EGFR had less apoptosis when exposed to dasatinib  Figure 5C  
Mutation Word : L858R @Position : 17
Function Word : apoptosis @Position : 21
Impact Word : less @Position : 20
Solid double-headed arrow placed near the R683G mutation suggests increased flexibility induced by this JH2 hinge mutant 
Mutation Word : R683G @Position : 6
Function Word : induce @Position : 11
Impact Word : increase @Position : 9
Notably inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
Mutation Word : D816F @Position : 16
Function Word : phosphorylation @Position : 3
Impact Word : reduce @Position : 10
Tyrosine phosphorylation of STAT5 was also enhanced though not as significantly as that of PECAM-1 in cells expressing the E255K or T315I mutant  Fig  4C  
Mutation Word : T315I @Position : 21
Function Word : expression @Position : 17
Impact Word : enhance @Position : 6
The mutations Y253F E255V and H396P experience decreased vdW interactions with Phe382 
Mutation Word : H396P @Position : 5
Function Word : interaction @Position : 9
Impact Word : decrease @Position : 7
However an active form of  β -catenin increases the penetrance and incidence of melanoma in mice expressing oncogenic NRAS Q61K  or BRAF V600E  specifically in melanocytes [ 131   216 ] 
Mutation Word : V600E @Position : 24
Function Word : activity @Position : 2
Impact Word : increase @Position : 8
As summarized in Table  II  five nsSNPs ERCC5-S311C OGG1-S326C XRCC3-T241M CCND3-S259A and CDKN1A-S31R were predicted to abolish putative phosphorylation sites whereas four nsSNPs were predicted to create putative phosphorylation sites in the proteins ERCC2-H201Y ERCC4-P379S LIG4-P231S and XRCC1-P309S 
Mutation Word : P231S @Position : 37
Function Word : phosphorylation @Position : 30
Impact Word : abolish @Position : 18
Several resistance mechanisms such as EGFR T790M secondary mutation that leads to a higher ATP binding capacity and MET amplification resulting in an aberrantly activated alternative pathway that bypasses the inhibited EGF receptors had been discovered 
Mutation Word : T790M @Position : 6
Function Word : result @Position : 20
Impact Word : higher @Position : 13
Interestingly SIRT1 level and activity are enhanced in the PLX4032-resistant BRAF V600E -mutated melanoma cells compared with their sensitive counterpart 
Mutation Word : V600E @Position : 11
Function Word : activity @Position : 4
Impact Word : enhance @Position : 6
At high cell densities  BRAF   V600E  -HEK293A cells showed increased  ITGB2  expression compared with  BRAF   WT  -HEK293A cells  Figure 2c  
Mutation Word : V600E @Position : 8
Function Word : expression @Position : 17
Impact Word : increase @Position : 13
In BRAF V600E  mutated cells inhibition of BRAF pathway lead to a decrease in ERK1/2 phosphorylation and cyclin D1 levels and an increase in p27 Kip1  
Mutation Word : V600E @Position : 2
Function Word : phosphorylation @Position : 16
Impact Word : decrease @Position : 13
Enhancement by PDGFRα-I of the signaling pathway inhibition by BRAF-I in BRAF-I sensitive and resistant melanoma cell lines harboring BRAFV600E
Mutation Word : V600E @Position : 19
Function Word : resistance @Position : 14
Impact Word : enhance @Position : 0
Enhancement by PDGFRα-I of the  in vitro  anti-proliferative and pro-apoptotic activity of BRAF-I in BRAF-I sensitive and resistant melanoma cell lines harboring BRAFV600E
Mutation Word : V600E @Position : 24
Function Word : sensitivity @Position : 17
Impact Word : enhance @Position : 0
Restoration of PP2A activity inhibits BCR-ABL expression and activity hence impairing wild-type and T315I BCR-ABL  leukemogenesis 
Mutation Word : T315I @Position : 13
Function Word : inhibit @Position : 4
Impact Word : impair @Position : 10
The addition of c-MET siRNA to either EGFR wild type or T790M-specific siRNAs resulted in an increased effect on cell growth inhibition and caspase−3/7 activity induction 
Mutation Word : T790M @Position : 11
Function Word : effect @Position : 17
Impact Word : increase @Position : 16
These studies demonstrate that by targeting the switch pocket this class of KIT inhibitors possesses a novel mechanism of inhibition whose dual suppression of KIT D816V neoplastic proliferation and SCF enhanced mast cell activation advocate future clinical development 
Mutation Word : D816V @Position : 25
Function Word : inhibit @Position : 19
Impact Word : enhance @Position : 30
We hypothesized that the R958D substitution would disrupt the ion pair with E884 through electrostatic repulsion in a way similar to the effect of the E884K substitution 
Mutation Word : E884K @Position : 25
Function Word : effect @Position : 22
Impact Word : disrupt @Position : 7
In BRAF V600E  human melanoma xenograft BRAFi + MEKi showed enhanced antitumor activity with more sustained tumor control than that seen either single agent 
Mutation Word : V600E @Position : 2
Function Word : activity @Position : 13
Impact Word : enhance @Position : 11
Dasatinib synergizes with PLX4720 to reduce proliferation in PTC and ATC BRAF V600E  cell lines
Mutation Word : V600E @Position : 12
Function Word : proliferation @Position : 6
Impact Word : reduce @Position : 5
Our results indicated that CIMP-H status was significantly associated with serrated polyps proximal location  BRAF  V600E mutations and increase in polyp size 
Mutation Word : V600E @Position : 17
Function Word : associated @Position : 8
Impact Word : increase @Position : 20
Consistent with the results of Y27632 treatments knockdown of ROCK1/2 greatly reduced the GLUT1 translocation and the Warburg effect in cells and furthermore largely abolished the stimulating effects of mutp53 on GLUT1 translocation and the Warburg effect in H1299  Fig. 6c & d   p53  R172H/R172H   MEF  Fig. 6e & f  and MDA-MB468 cells  Supplementary Fig  S6c & e  
Mutation Word : R172H @Position : 48
Function Word : effect @Position : 36
Impact Word : abolish @Position : 24
Since RKO cells harbor a V600E BRAF mutation  resulting in constitutive ERK activation it was of interest to determine whether km23-1 knockdown could inhibit the constitutive ERK activity in this model system 
Mutation Word : V600E @Position : 5
Function Word : activity @Position : 28
Impact Word : constitutive @Position : 26
Conversely E884K worked in concert with L858R in- cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition  Fig  1A B  
Mutation Word : E884K @Position : 1
Function Word : sensitivity @Position : 14
Impact Word : enhance @Position : 12
The mutations Y253F E255V and H396P experience decreased vdW interactions with Phe382 
Mutation Word : Y253F @Position : 2
Function Word : interaction @Position : 9
Impact Word : decrease @Position : 7
The high potency of afatinib to inhibit the tyrosine kinase activity of wild-type EGFR was fully maintained on EGFR with the activating L858R mutation Solca et al.  Sos et al   
Mutation Word : L858R @Position : 22
Function Word : activity @Position : 21
Impact Word : maintain @Position : 16
In addition the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
Mutation Word : V617F @Position : 39
Function Word : effect @Position : 23
Impact Word : increase @Position : 33
Immune-complexes kinase assays showed as expected high BRAF activity in YULAC-BRAF V600E  and YUMAC-BRAF V600K  cells that was suppressed after treatment with PLX4032 for 30 min  Figure 3A  YULAC and YUMAC 
Mutation Word : V600K @Position : 15
Function Word : activity @Position : 8
Impact Word : high @Position : 6
The pan-BCR-ABL kinase inhibitor ponatinib exhibits potent activity against native T315I and all other clinically relevant mutants and showed better inhibition than the previously known inhibitors 
Mutation Word : T315I @Position : 10
Function Word : inhibit @Position : 20
Impact Word : better @Position : 19
Among the 30  BRAF  V600E positive tumors detected with ARMS-PCR assay direct sequencing identified the mutation in 27 tumors but failed to identify 3 tumors that had  BRAF  V600E mutation possibly due to the lower sensitivity of detection of automated dideoxy sequencing 
Mutation Word : V600E @Position : 32
Function Word : sensitivity @Position : 39
Impact Word : lower @Position : 38
Among the investigated melanoma cell lines three display constitutive activation of the Ras/Raf/MEK/ERK pathway through activating V600E BRAF mutation or NRAS mutations Colo-679 BRAF V600E mut Nras wt IGR-39 BRAF V600E mut Nras wt IPC298 Braf wt Nras Q61K mut  
Mutation Word : V600E @Position : 30
Function Word : activity @Position : 15
Impact Word : constitutive @Position : 8
The E17K mutation constitutively activates Akt1 by altering the kinetics and specificity of phospholipid binding increasing the binding to PIP2 the more abundant plasma membrane phospholipid in the absence of PI3-kinase activation  
Mutation Word : E17K @Position : 1
Function Word : activity @Position : 31
Impact Word : constitutive @Position : 3
Hence E884K in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 1
Function Word : sensitivity @Position : 10
Impact Word : alter @Position : 29
In this work we explore the role of the pseudokinase domain helix C in the constitutive activation of JAK2 V617F by focusing on residue F595 predicted to be located in the middle of the helix 
Mutation Word : V617F @Position : 19
Function Word : activity @Position : 16
Impact Word : constitutive @Position : 15
Our study revealed that the BRAF V600E  mutation was significantly associated with several molecular alterations 
Mutation Word : V600E @Position : 6
Function Word : associated @Position : 11
Impact Word : alter @Position : 15
Surprisingly we found that expression of each activated KRAS ED  lead to a substantial decrease in Braf V600E  induced tumors relative to the EGFP control suggesting the existence of a KRAS activated negative regulator of tumorigenesis 
Mutation Word : V600E @Position : 18
Function Word : regulation @Position : 35
Impact Word : decrease @Position : 15
Our studies here using COS-7 transfection model system show that E884K works in concert with L858R in- cis  in a dominant fashion to change downstream signaling differentially induce MAPK-ERK1/2 signaling and associated cell proliferation and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor-specific fashion 
Mutation Word : L858R @Position : 15
Function Word : sensitivity @Position : 38
Impact Word : alter @Position : 37
Mutations to this protein such as G469A E586K V600E and K601E can increase BRAF catalytic activity  
Mutation Word : K601E @Position : 10
Function Word : activity @Position : 15
Impact Word : increase @Position : 12
Potentially the increased TGFβ2 expression resulting from SF-1 knockdown could pose a problem for such a therapy if childhood tumors have dysregulated TGFβ signaling like the NCI-H295R cells and this needs to be explored further 
Mutation Word : H295R @Position : 26
Function Word : expression @Position : 4
Impact Word : increase @Position : 2
Consistent with this differential signaling effect the L858R+E884K-COS-7 cells had a significantly higher cell proliferation rate than that of the L858R-COS-7 cells in the MTS cell proliferation assay for 5 days  Figure 3B  
Mutation Word : E884K @Position : 7
Function Word : proliferation @Position : 26
Impact Word : higher @Position : 12
Structurally this residue lies in the substrate-binding pocket of the kinase and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP-bound form effectively making RET more active more of the time  48 – 51  
Mutation Word : M918T @Position : 13
Function Word : binding @Position : 19
Impact Word : increase @Position : 17
PACSIN1 shows significantly increased phosphorylation when co-transfected with the P52L mutant compared to the wild-type PAK6 * indicates p<0 05 ** indicates p<0 01
Mutation Word : P52L @Position : 9
Function Word : phosphorylation @Position : 4
Impact Word : increase @Position : 3
TRAIL dependence on the constitutive activation of BRAF V600E  is emphasised through the overexpression of BRAF V600E  in the permissive genetic background of colon adenocarcinoma Caco-2 cells 
Mutation Word : V600E @Position : 17
Function Word : activity @Position : 5
Impact Word : constitutive @Position : 4
62  Mutated ALK at F1174L led to increased proliferation and decreased apoptosis of neuroblastoma cell lines 
Mutation Word : F1174L @Position : 5
Function Word : proliferation @Position : 9
Impact Word : increase @Position : 8
The mutations T315I E255V F317L and F317V contribute to decreased vdW interactions with Ala269 
Mutation Word : E255V @Position : 3
Function Word : interaction @Position : 11
Impact Word : decrease @Position : 9
As previously reported   levels of phosphorylated RET and ERK were constitutively high in untreated PC12/MEN2A cells due to the presence of the active RET C634Y  allele 
Mutation Word : C634Y @Position : 26
Function Word : activity @Position : 24
Impact Word : high @Position : 13
NFAT transcriptional activity was approximately 10-fold higher in A375 cells and approximately 70-fold higher in WM266-4 cells compared with  BRAF  wild-type CHL-1 cells  Figure 1A  consistent with increased B-RAF activity of BRAF V600D  compared with BRAF V600E   Wan  et al  2004  
Mutation Word : V600D @Position : 41
Function Word : activity @Position : 33
Impact Word : higher @Position : 13
According to the Ki67 positive cells  BRaf  V600E  expression increased lung cell proliferation index from 33.51% ±2.389% n = 8 20X fields from 3 different mice in 10-days-old WT to 42.56% ±2.861% n = 11 20X fields from 3 different mice in age-matched  Braf  CA  mice each 20X field quantified contained between 2500–5000 nucleus  P  = 0 0345  Figure 1E  
Mutation Word : V600E @Position : 9
Function Word : proliferation @Position : 15
Impact Word : increase @Position : 12
The imatinib-resistant cell line DA1-3b/M1 referred to as M1 hereafter which was derived from M0 cells after prolonged selection with imatinib and carries an E255K BCR-ABL mutation and the DA1-3b/d365 cell line referred to as d365 hereafter which was derived from M0 cells injected in mice and isolated after 1 year of tumor dormancy and harbors partial resistance to imatinib also exhibited decreased GILZ expression  Figure 1a    
Mutation Word : E255K @Position : 24
Function Word : expression @Position : 64
Impact Word : decrease @Position : 62
These observations suggested that the increased nuclear expression of YAP1 might promote the invasion of  BRAF   V600E   + PTC into adjacent tissues 
Mutation Word : V600E @Position : 19
Function Word : expression @Position : 7
Impact Word : increase @Position : 5
The FGFR2 S252W  mutation has a positive effect on both proliferation and migration of fibroblasts and a negative effect on MSC proliferation 
Mutation Word : S252W @Position : 2
Function Word : effect @Position : 19
Impact Word : negative @Position : 18
These two mutations resulting in L1198F and G1201E amino acid changes respectively both reside within the ALK tyrosine kinase domain where they dramatically increased tyrosine kinase activities 
Mutation Word : G1201E @Position : 7
Function Word : activity @Position : 26
Impact Word : increase @Position : 23
Furthermore in wild-type cells overexpression of BRAF V600E  increased NFAT activity which was blocked by the MEK inhibitor PD98059 
Mutation Word : V600E @Position : 7
Function Word : activity @Position : 11
Impact Word : increase @Position : 9
In addition in PMF JAK2 V617F-positive patients compared to their mutation-negative counterparts were more likely to display higher plasma levels of IL-1RA IL-2R IL-6 IL-12 hepatocyte growth factor HGF CXCL10 and monokine induced by interferon IFN-γ other phenotypic correlates included increased levels of i IL-6 and IL-8 with constitutional symptoms ii HGF with marked splenomegaly iii IL-2R IL-8 IL-10 macrophage inflammatory protein MIP-1α and monocyte chemotactic protein-1 with red cell transfusion dependency iv IL-2R HGF and CXCL10 with leukocytosis and v CXCL10 with thrombocytopenia 
Mutation Word : V617F @Position : 5
Function Word : phenotype @Position : 37
Impact Word : higher @Position : 17
Four cases with increased  JAK2  V617F  RNA expression levels outliers are indicated 
Mutation Word : V617F @Position : 7
Function Word : expression @Position : 10
Impact Word : increase @Position : 3
Hence the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT down-regulated CBL and MAPK-ERK1/2 phosphorylation up-regulated 
Mutation Word : E884K @Position : 4
Function Word : effect @Position : 15
Impact Word : modulates @Position : 5
This mutation  E17K  increases recruitment of AKT1 to the membrane increases AKT1 phosphorylation and activity transforms Rat1 fibroblasts and induces leukaemia in transgenic mice  Carpten  et al  2007  
Mutation Word : E17K @Position : 3
Function Word : activity @Position : 16
Impact Word : increase @Position : 12
We found that the expression of TGF-β1 TGF-β2R and TGF-β3 were all increased in BRAF V600E  mice thyroid tumors compared to wild type normal thyroid tissue Figure  3 B 
Mutation Word : V600E @Position : 15
Function Word : expression @Position : 4
Impact Word : increase @Position : 12
These experiments also indicated that HEL cells that display multiple copies of  JAK2 V617F resulted significantly less sensitive than the  JAK2 V617F heterozygous SET2 cells 
Mutation Word : V617F @Position : 23
Function Word : sensitivity @Position : 18
Impact Word : less @Position : 17
Intriguingly the imatinib-resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM-1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells  Fig  4  
Mutation Word : T315I @Position : 7
Function Word : phosphorylation @Position : 19
Impact Word : increase @Position : 9
Melanomas with  V600E   BRAF  mutations frequently accumulate nuclear β-catenin and interestingly GSK3A and GSK3B were recently shown to be negatively regulated by  V600E Braf/Mek/Erk signalling in a phosphoproteomic screen of human melanoma cells following MEK inhibition Old et al  
Mutation Word : V600E @Position : 27
Function Word : regulation @Position : 24
Impact Word : negative @Position : 23
Previous  in vivo  analyses of the Fgfr2 P253R/+  and Fgfr2 S252W/+  mouse models of Apert syndrome revealed increased osteoblastic gene expression around the coronal suture   
Mutation Word : S252W @Position : 13
Function Word : expression @Position : 24
Impact Word : increase @Position : 21
Furthermore high levels of CXCR4 expression were found in  BRAF  V600E -positive PTCs and CXCR4 expression was associated with thyroid capsule infiltration and extrathyroidal extension Torregrossa et al   2011  
Mutation Word : V600E @Position : 12
Function Word : expression @Position : 17
Impact Word : high @Position : 1
CL-387785 had an even greater effect on colony formation by cells expressing L858R  EGFR  completely inhibiting transformation at 0 003 μM unpublished data 
Mutation Word : L858R @Position : 12
Function Word : effect @Position : 5
Impact Word : greater @Position : 4
Our observation that NFAT activity was higher in V600D-mutated WM266-4 cells compared with V600E-mutated A375 cells which correlated with the amount of BRAF kinase activity evoked by each mutant is particularly noteworthy 
Mutation Word : V600D @Position : 13
Function Word : activity @Position : 24
Impact Word : higher @Position : 6
Overall SP inhibitors represent an innovative mechanism of KIT inhibition whose dual suppression of KIT D816V neoplastic mast cell proliferation and SCF enhanced mast cell activation may provide significant therapeutic benefits 
Mutation Word : D816V @Position : 15
Function Word : proliferation @Position : 19
Impact Word : enhance @Position : 22
Since the companion assay COBAS used in the phase 3 vemurafenib study has a high sensitivity for V600E with partial cross-reactivity to V600K  http//www.accessdata.fda.gov/cdrh_docs/pdf11/P110020b pdf  10 patients who were later found to have the BRAF V600K mutation were included in the vemurafenib group 
Mutation Word : V600E @Position : 37
Function Word : sensitivity @Position : 15
Impact Word : high @Position : 14
Increased activation of Akt1 by E17K L52R C77F and Q79K mutants led as expected to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
Mutation Word : E17K @Position : 5
Function Word : phosphorylation @Position : 16
Impact Word : increase @Position : 15
These studies also described a correlation between PRV1  expression and the JAK2 V617F allele burden as well as between  PRV1  overexpression and elevated JAK2 tyrosine kinase activity   
Mutation Word : V617F @Position : 13
Function Word : activity @Position : 29
Impact Word : elevate @Position : 25
The authors reported that increased ATP affinity is the primary mechanism by which the T790M mutation confers drug resistance 
Mutation Word : T790M @Position : 14
Function Word : atp @Position : 5
Impact Word : increase @Position : 4
Moreover mutations L755S L755P V777L T798M and T862A displayed enhanced activation of JNK/SAPK and to a lesser extent of ERK1/2 compared to wt-ERBB2  Figure 2A  
Mutation Word : T862A @Position : 7
Function Word : activity @Position : 10
Impact Word : enhance @Position : 9
Although not significant our data showed a decrease in  MLH1  expression in samples harbouring BRAF V600E mutations Figure  1 A RET/PTC rearrangements Figure  1 B or transitions Figure  1 C 
Mutation Word : V600E @Position : 17
Function Word : expression @Position : 12
Impact Word : decrease @Position : 7
With the aim of selecting the best assays for the tracking of MRD % JAK2 -V617F <1 in QC5 two further in-house assays were evaluated Assays 8 and 9 but were eliminated because they exhibited poorer specificity when tested on serial dilutions of HEL in K562 cells 
Mutation Word : V617F @Position : 15
Function Word : exhibit @Position : 34
Impact Word : eliminate @Position : 31
Mutations to this protein such as G469A E586K V600E and K601E can increase BRAF catalytic activity  
Mutation Word : E586K @Position : 7
Function Word : activity @Position : 15
Impact Word : increase @Position : 12
In particular it inhibited MET signalling induced cellular apoptosis and abrogated cytoskeletal functions key controlling step in tumour invasion and metastasis  in vitro   Birchmeier  et al  2003  and was effective  in vivo  leading to cytoreduction of murine tumour xenografts of the T790M-EGFR expressing erlotinib-resistant H1975 cells 
Mutation Word : T790M @Position : 49
Function Word : function @Position : 12
Impact Word : abrogate @Position : 10
It was noted that PLX4720 also reduced pRB protein phosphorylation increased p27 expression suppressed cyclin D1 expression and induced cleavage of PARP only in melanoma cell lines harbouring the  BRAF -V600E mutation  Figure 1D  
Mutation Word : V600E @Position : 31
Function Word : expression @Position : 16
Impact Word : increase @Position : 10
The mutations E255K F317L and F317V experience increased electrostatic interactions with Tyr253 
Mutation Word : E255K @Position : 2
Function Word : interaction @Position : 9
Impact Word : increase @Position : 7
In C618R   R618 moves toward E543/D544 and forms strong salt bridges with them disrupting the interaction between R564 and E543 
Mutation Word : C618R @Position : 1
Function Word : interaction @Position : 17
Impact Word : disrupt @Position : 15
Introduction  of a melanoma-associated mutation P52L into this peptide reduces pseudosubstrate autoinhibition of PAK6 and increases phosphorylation of its substrate PACSIN1 Syndapin I in cells 
Mutation Word : P52L @Position : 6
Function Word : substrate @Position : 20
Impact Word : increase @Position : 16
The former is the case of the S492R mutant which confers resistance to cetuximab since the mutation is located in its binding epitope on the EGFR external domain   whereas the later is the case of the T790M mutant mutation in the kinase domain which confers resistance to gefitinib or erlotinib in lung adenocarcinomas   by stabilizing the active tyrosine kinase conformation and enhancing aTP binding   
Mutation Word : S492R @Position : 7
Function Word : activity @Position : 60
Impact Word : stability @Position : 58
Indeed Shi et al    demonstrated that 20% of melanoma patients treated with BRAF inhibitors Vemurafenib and Dabrafenib showed an increase in genomic copy number of BRAF V600E  and BRAF V600E  amplification resulted in BRAF V600E  overexpression in tumors of melanoma patients whose cancer had progressed after initial response 
Mutation Word : V600E @Position : 39
Function Word : result @Position : 36
Impact Word : increase @Position : 22
This analysis revealed that the GST–JNK2 mutants D162N or D326N residing within the ED and CD domains respectively had reduced association with Myc-1018-C  Figure 6 B lanes 3–5 
Mutation Word : D162N @Position : 7
Function Word : associated @Position : 20
Impact Word : reduce @Position : 19
As expected BRAF V600E  inhibited MST1-induced 3XIRS reporter activation in a dose-dependent manner and MST1 abolished the inhibitory effect of BRAF V600E  on FoxO3 transactivation  Fig  3B & 3C  
Mutation Word : V600E @Position : 22
Function Word : activity @Position : 9
Impact Word : abolish @Position : 16
Depletion of PKN1 increases apoptosis initiated by a BRAF-V600E inhibitor 
Mutation Word : V600E @Position : 8
Function Word : apoptosis @Position : 4
Impact Word : increase @Position : 3
The persistence of the  V600E  mutation in all samples of our patient is consistent with the reported molecular analyses from the pivotal vemurafenib studies which showed that tumours that developed acquired resistance maintained their V600 mutations  14  
Mutation Word : V600E @Position : 36
Function Word : resistance @Position : 33
Impact Word : maintain @Position : 34
Conversely E884K worked in concert with L858R in- cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition  Fig  1A B  
Mutation Word : E884K @Position : 1
Function Word : sensitivity @Position : 14
Impact Word : enhance @Position : 12
These studies demonstrate that by targeting the switch pocket this class of KIT inhibitors possesses a novel mechanism of inhibition whose dual suppression of KIT D816V neoplastic proliferation and SCF enhanced mast cell activation advocate future clinical development 
Mutation Word : D816V @Position : 25
Function Word : proliferation @Position : 27
Impact Word : enhance @Position : 30
Our results reveal that SIRT1 activity is higher in PLX4032-resistant BRAF V600E -mutated melanoma cells compared with their sensitive counterpart 
Mutation Word : V600E @Position : 11
Function Word : sensitivity @Position : 18
Impact Word : higher @Position : 7
All mutations experience variations in electrostatic interactions ranging from −4.95 to −6 71 kcal/mol with Glu286 in particular Q252H Y253H T315I and F317L experience increased electrostatic interactions with Glu286 
Mutation Word : F317L @Position : 22
Function Word : interaction @Position : 26
Impact Word : increase @Position : 24
V617F that lead to constitutive kinase activation  
Mutation Word : V617F @Position : 0
Function Word : activity @Position : 6
Impact Word : constitutive @Position : 4
Second Mps1 KD  displayed much stronger kinetochore staining than Mps1 WT  and even the less active Mps1 mutants Mps1 T676A  Mps1 T676E  exhibited stronger kinetochore staining than Mps1 WT   Fig  2A  
Mutation Word : T676A @Position : 24
Function Word : activity @Position : 17
Impact Word : less @Position : 16
Hence the main objective behind applying a one-plus-one template reference strategy is to reduce the inevitable biases associated with assessing  JAK2  V617F  AB to approximately 50% considering that this value is of major clinical significance 
Mutation Word : V617F @Position : 23
Function Word : associated @Position : 17
Impact Word : reduce @Position : 13
Immunoblotting for phospho-AKT was performed after successful transfection and weaning of IL3-dependent growth true autoactivating TK mutations result in IL3-independent growth and found that AKT activation increases after transfection of plasmid vectors encoding for a  FLT3  ITD  FLT3  D835V  KIT  D816Y or  BCR-ABL1  isoform 
Mutation Word : D816Y @Position : 46
Function Word : activity @Position : 25
Impact Word : increase @Position : 26
NVP-BEZ235 inhibited proliferation of both cytokine-independent WT BCR-ABL  and mutant  BCR-ABL  E255K and T315I overexpressing cells whereas parental cytokine-dependent Ba/F3 cells were much less sensitive 
Mutation Word : T315I @Position : 16
Function Word : sensitivity @Position : 27
Impact Word : less @Position : 26
We observe that the G375C mutation increases FGFR3 phosphorylation in the absence of ligands and at low but not at high ligand concentrations similarly to the G380R mutation 
Mutation Word : G380R @Position : 26
Function Word : phosphorylation @Position : 8
Impact Word : increase @Position : 6
A  L858R mutation in EGFR kinase the circled R causes non-small cell lung cancer NSCLC by constitutively activating its kinase domain [ 175 ] 
Mutation Word : L858R @Position : 2
Function Word : activity @Position : 18
Impact Word : constitutive @Position : 17
Overexpression of LRRK2-WT and all LRRK2 mutants including kinase-active G2019S kinase-dead D1994A and WD-domain G2385R mutants tended to increase basal levels of phosphorylated p38 compared to empty vector-transfected mock cells although the extent of the increase varied depending on the specific LRRK2 variant 
Mutation Word : G2385R @Position : 14
Function Word : phosphorylation @Position : 22
Impact Word : increase @Position : 35
RAS and RAF proteins play a key role in the control of cellular growth proliferation and differentiation  Bos 1989   Wickenden  et al  2008   KRAS -activating mutations reduce or abolish intrinsic GTPase activity of the protein leading to its constitutive activation  Conlin  et al  2005  Similarly  BRAF  V600E mutation induces structural changes in RAF protein which increase its kinase activity  Wan  et al  2004  Activated RAS and RAF are responsible for the disregulation of RAS/RAF/MAPKs signalling pathway 
Mutation Word : V600E @Position : 59
Function Word : activity @Position : 80
Impact Word : abolish @Position : 35
Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells  Carpten  et al  2007  
Mutation Word : E17K @Position : 7
Function Word : phosphorylation @Position : 15
Impact Word : increase @Position : 13
Thus although dasatinib failed to affect activation-specific phosphorylation of STAT5 a well established substrate of Jak2 it is possible that Lyn may modulate the activity of Jak2-V617F in PVTL-1 cells which needs to be addressed in future studies 
Mutation Word : V617F @Position : 26
Function Word : activity @Position : 24
Impact Word : modulates @Position : 22
FLT3  D835V and  KIT  D816Y retained some level of sensitivity with regard to induction of apoptosis 
Mutation Word : D816Y @Position : 7
Function Word : sensitivity @Position : 12
Impact Word : retain @Position : 8
The EphA3 G518L lung cancer mutation enhances  cis  interaction with ephrin-A3 
Mutation Word : G518L @Position : 2
Function Word : interaction @Position : 10
Impact Word : enhance @Position : 6
Consistent with our structural analysis we found that both the Y931C as well as the G935R mutation resulted in the largest increase 33.3-fold and 19 5-fold respectively in EC 50  values compared to native JAK2V617F  Figure 2A  
Mutation Word : Y931C @Position : 10
Function Word : result @Position : 17
Impact Word : increase @Position : 21
In an  in vitro  study these two types of EGFR mutants demonstrated an enhanced TK activity in response to EGF and increased sensitivity to inhibition by TKI although the biological activity between tumours with L858R and those with deletions was different  Paez  et al  2004   Pao  et al  2004  
Mutation Word : L858R @Position : 36
Function Word : activity @Position : 32
Impact Word : enhance @Position : 15
Similar to E884K R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in- cis  with L858R 
Mutation Word : L858R @Position : 20
Function Word : effect @Position : 7
Impact Word : modulates @Position : 4
There is also evidence that siRNA knockdown of AKT3 and  BRAF  V600E leads to the enhanced inhibition of melanoma xenograft growth in nude mice  Cheung  et al  2008   Tran  et al  2008  
Mutation Word : V600E @Position : 13
Function Word : inhibit @Position : 18
Impact Word : enhance @Position : 17
Our method using ARMS-PCR therefore appears to have high sensitivity 0 5% for  BRAF  V600E mutation detection 
Mutation Word : V600E @Position : 16
Function Word : sensitivity @Position : 9
Impact Word : high @Position : 8
Consistently RhoA knockdown by shRNA vectors or siRNA oligos clearly reduced the translocation of endogenous GLUT1  Fig. 5d  and Myc-GLUT1 to the PM  Fig. 5e–g  and reduced the Warburg effect  Fig  5h–j  in H1299 MDA-MB468 and  p53  R172H/R172H   MEF cells 
Mutation Word : R172H @Position : 46
Function Word : effect @Position : 33
Impact Word : reduce @Position : 30
However cells expressing the Y375C mutation responded to FGF1 treatment with a small increase in ERK1/2 activation while phosphorylation levels of FRS2α and PLCγ1 remained unchanged 
Mutation Word : Y375C @Position : 4
Function Word : phosphorylation @Position : 18
Impact Word : unchange @Position : 25
This agent has 325-fold greater activity against unmutated BCR-ABL in vitro  than imatinib and displays activity in all but one of the known imatinib-resistant BCR-ABL mutations i.e  T315I   
Mutation Word : T315I @Position : 29
Function Word : activity @Position : 16
Impact Word : greater @Position : 4
Hence the dynamic control of Mcl-1 levels in cells with wild type JAK2   appears to be maintained in JAK2 V617F  mutant cells 
Mutation Word : V617F @Position : 21
Function Word : dynamics @Position : 2
Impact Word : maintain @Position : 18
By far the most numerous BRAF alteration is a single point mutation resulting in an amino acid exchange in position 600 dubbed V600E 
Mutation Word : V600E @Position : 22
Function Word : result @Position : 12
Impact Word : alter @Position : 6
The FGFR2 S252W  mutation has a positive effect on both proliferation and migration of fibroblasts and a negative effect on MSC proliferation 
Mutation Word : S252W @Position : 2
Function Word : proliferation @Position : 22
Impact Word : negative @Position : 18
Hence the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT downregulated and MAPK-ERK1/2 phosphorylation upregulated 
Mutation Word : L858R @Position : 4
Function Word : phosphorylation @Position : 20
Impact Word : modulates @Position : 5
Compared to wild-type EGFR the ectodomain mutant A289V-EGFR showed a marked increase in receptor autophosphorylation in the absence of ligand or serum 
Mutation Word : A289V @Position : 7
Function Word : autophosphorylation @Position : 14
Impact Word : increase @Position : 11
Our analysis revealed that the T790M mutation significantly increased the distance between the P-loop and activation loop whereas the G719S mutation significantly shortened the distance between the P-loop and activation loop  Supplementary Figure 2  
Mutation Word : G719S @Position : 19
Function Word : activity @Position : 29
Impact Word : increase @Position : 8
In TERT-NHUC abolishing PLCγ1 phosphorylation significantly reduced the increase in saturation density associated with S249C FGFR3 13% vs. 24% p=0 05  Figure 6a  suggesting that PLCγ1 signaling contributes to this phenotype 
Mutation Word : S249C @Position : 14
Function Word : phosphorylation @Position : 4
Impact Word : reduce @Position : 6
Furthermore constitutive activity of a JAK1 mutant homologous to JAK2 V617F JAK1 V658F was also inhibited by the homologous JAK1 F595 mutation F636A suggesting that our results in JAK2 might be relevant for activation of JAK1 mutants recently identified in T-ALL     
Mutation Word : V617F @Position : 10
Function Word : activity @Position : 33
Impact Word : constitutive @Position : 1
The enhanced tyrosine phosphorylation of PECAM-1 by the E255K and T315I mutants may be at least partly due to their enhanced activities  15 – 17  
Mutation Word : E255K @Position : 8
Function Word : phosphorylation @Position : 3
Impact Word : enhance @Position : 20
Intriguingly the imatinib-resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM-1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells  Fig  4  
Mutation Word : E255K @Position : 5
Function Word : ability @Position : 10
Impact Word : increase @Position : 9
Somatic mutations of the JAK2 gene at V617F which leads to constitutive JAK2 phosphorylation and kinase activation occurs in almost all cases of polycythemia vera and approximately 50% of cases of chronic idiopathic myelofibrosis  
Mutation Word : V617F @Position : 7
Function Word : activity @Position : 16
Impact Word : constitutive @Position : 11
This mutation  E17K  increases recruitment of AKT1 to the membrane increases AKT1 phosphorylation and activity transforms Rat1 fibroblasts and induces leukaemia in transgenic mice  Carpten  et al  2007  
Mutation Word : E17K @Position : 3
Function Word : phosphorylation @Position : 14
Impact Word : increase @Position : 12
Treatment with UO126 at the most optimal treatment condition Additional Figure 3  resulted in the decreased activation of RhoA illustrating that mutant BRAF V600E  utilises the MAPK pathway to activate RhoA Figure  5E  upper panel 
Mutation Word : V600E @Position : 24
Function Word : activity @Position : 31
Impact Word : decrease @Position : 16
For 5 REs representative of strong moderate weak and nearly-absent responsiveness to wild type p53 the functional assay was extended to five p53 missense germline mutations of which three retain partial function A138S C141Y R337C and two are loss of function A138P R175H   
Mutation Word : R337C @Position : 34
Function Word : function @Position : 40
Impact Word : retain @Position : 29
The expression of the G719C transcript was high compared to the S768I transcript throughout the tumor section 
Mutation Word : S768I @Position : 11
Function Word : expression @Position : 1
Impact Word : high @Position : 7
In support western blotting of FLT-3 autophosphorylation of these mutants F691L and D835F/Y from the untreated total cell extracts showed reduced autophosphorylation of FLT3 in comparison with FLT3-ITD  Figure 1c  thus supporting the notion that these mutations confer resistance by destabilizing the active state rather than direct steric hindrance to the drug 
Mutation Word : D835F @Position : 12
Function Word : autophosphorylation @Position : 21
Impact Word : reduce @Position : 20
Signaling studies show again that cells expressing the L858R allele have reduced EGFR AKT and ERK phosphorylation in response to increasing concentrations of dasatinib  Figure 5B  
Mutation Word : L858R @Position : 8
Function Word : expression @Position : 6
Impact Word : reduce @Position : 11
Expression of AKT3 E17K in A375 cells increased AKT phosphorylation as compared to transfection with the control vectors or wild-type AKT3 under normal tissue culture conditions  Figure 1  Panel C 
Mutation Word : E17K @Position : 3
Function Word : expression @Position : 0
Impact Word : increase @Position : 7
The specific type of mutation may hold predictive relevance in that some mutations confer higher affinity for certain EGFR TKIs and some confer resistance to certain EGFR TKIs for example mutations in exon 20 and the T790M mutation 
Mutation Word : T790M @Position : 36
Function Word : affinity @Position : 15
Impact Word : higher @Position : 14
Ba/F3 cells with ITD-A848P FLT3 were resistant to both sunitinib and sorafenib but maintained sensitivity to midostaurin 
Mutation Word : A848P @Position : 3
Function Word : sensitivity @Position : 14
Impact Word : maintain @Position : 13
Patients with Apert syndrome with the S252W mutation in the FGFR2  gene enhanced osteoblastic marker gene expression and ALP activity  
Mutation Word : S252W @Position : 6
Function Word : expression @Position : 17
Impact Word : enhance @Position : 13
As seen in  Fig  4E  the expression of BRAF V600E  completely abolished MST1 kinase activity 
Mutation Word : V600E @Position : 12
Function Word : activity @Position : 18
Impact Word : abolish @Position : 15
Several resistance mechanisms such as EGFR T790M secondary mutation that leads to a higher ATP binding capacity and MET amplification resulting in an aberrantly activated alternative pathway that bypasses the inhibited EGF receptors had been discovered 
Mutation Word : T790M @Position : 6
Function Word : inhibit @Position : 30
Impact Word : higher @Position : 13
PLX4032 was recently demonstrated to reduce the uptake of 218Ffluoro-2-deoxy-D-glucose 18F-FDG in melanoma cells whereas inducible expression of V600E BRAF increased the glucose uptake rate and decreased O 2  consumption in thyroid cancer cells   
Mutation Word : V600E @Position : 18
Function Word : expression @Position : 16
Impact Word : decrease @Position : 26
EGFR mutation-positive NSCLCs which also test positive for mutations associated with primary or most frequently secondary resistance to first-generation TKIs first of all the T790M substitution may respond better to newer agents like afatinib and dacomitinib which have demonstrated a greater effectiveness in these clinical situations but more clinical data are required      
Mutation Word : T790M @Position : 24
Function Word : effect @Position : 41
Impact Word : better @Position : 28
Enhancement by PDGFRα-I of the  in vivo  anti-tumor activity of BRAF-I in BRAF-I sensitive and resistant BRAFV600E melanoma cell lines
Mutation Word : V600E @Position : 18
Function Word : resistance @Position : 17
Impact Word : enhance @Position : 0
Molecular studies on the receptors harbouring a known L858R mutation demonstrated a decreased affinity of the tyrosine kinase for ATP and an increase in the affinity for the tyrosine kinase inhibitors TKI 
Mutation Word : L858R @Position : 8
Function Word : atp @Position : 19
Impact Word : decrease @Position : 12
The EGFR-L747S-L858R Double Mutant Is Less Sensitive to Inhibition by Gefitinib and Erlotinib
Mutation Word : L858R @Position : 1
Function Word : sensitivity @Position : 6
Impact Word : less @Position : 5
The T790M  EGFR  mutant exhibited higher level of tyrosine phosphorylation than wild type  EGFR  and the T790M/L858R double mutant exhibited a substantial increase in phosphorylation levels compared with the L858R mutant alone  
Mutation Word : T790M @Position : 20
Function Word : phosphorylation @Position : 28
Impact Word : higher @Position : 7
Hence E884K in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 1
Function Word : inhibit @Position : 18
Impact Word : alter @Position : 29
Transformation induced by each of the three oncogenes  KRAS G12V   Caco-K cells  BRAF V600E   Caco-BR cells and  HRAS G12V   Caco-H cells managed to increase the ability of Caco-2 cells to migrate and invade  in vitro  independently of their proliferating ability which has been previously analyzed in   
Mutation Word : V600E @Position : 17
Function Word : ability @Position : 50
Impact Word : increase @Position : 32
Now recent work from the Rosen lab at Memorial Sloan-Kettering Cancer Center has uncovered data that vemurafenib reduces feedback inhibition in BRAF V600E -expressing cells such that these cells become sensitized to extracellular growth factors like hepatocyte and epidermal growth factors 
Mutation Word : V600E @Position : 22
Function Word : sensitivity @Position : 30
Impact Word : reduce @Position : 17
The results of this system evaluation suggest that in III-IV NSCLC patients with EGFR mutations patients with the exon 19 deletion have a better response rate and a significantly longer progression-free survival and overall survival than patients with the L858R mutation 
Mutation Word : L858R @Position : 39
Function Word : survival @Position : 34
Impact Word : better @Position : 23
V600E was distributed equally between tumors that lost vs  retained expression of HLA class I in the sporadic MSI-H cases 
Mutation Word : V600E @Position : 0
Function Word : expression @Position : 11
Impact Word : retain @Position : 10
T875N is located in the kinase domain of JAK2 in a loop predicted to be within interaction distance of the linker region between the kinase and pseudokinase domains  Figure 4C right panel  and could induce constitutive activity of JAK2 by triggering a conformational change of the pseudokinase domain 
Mutation Word : T875N @Position : 0
Function Word : activity @Position : 38
Impact Word : constitutive @Position : 37
NFAT transcriptional activity was approximately 10-fold higher in A375 cells and approximately 70-fold higher in WM266-4 cells compared with  BRAF  wild-type CHL-1 cells  Figure 1A  consistent with increased B-RAF activity of BRAF V600D  compared with BRAF V600E   Wan  et al  2004  
Mutation Word : V600E @Position : 41
Function Word : activity @Position : 33
Impact Word : increase @Position : 31
We found that SOCS3  and  SPI1  expression were significantly elevated in  JAK2  V617F-positive patients 
Mutation Word : V617F @Position : 17
Function Word : expression @Position : 9
Impact Word : elevate @Position : 12
Alterations in ATP-dependent reaction rates and inhibitor binding affinities are probably the mechanism for acquired resistance by the T790M mutation   
Mutation Word : T790M @Position : 18
Function Word : binding @Position : 7
Impact Word : alter @Position : 0
JAK2 K539L T875N and R683G were shown to exhibit constitutive STAT5 activation and to transform Ba/F3 cells expressing the EpoR to cytokine-independence     
Mutation Word : K539L @Position : 1
Function Word : activity @Position : 11
Impact Word : constitutive @Position : 9
E884K is activating and can work cooperatively with L858R to differentially modulate downstream signal transduction
Mutation Word : E884K @Position : 0
Function Word : transduction @Position : 14
Impact Word : modulates @Position : 11
The result is the disruption of the I-1 interactions indicating that H587N is a deleterious mutation 
Mutation Word : H587N @Position : 11
Function Word : interaction @Position : 8
Impact Word : disrupt @Position : 4
Here we test the hypothesis that E1271K mutation of MET analogous to E884K-EGFR can also differentially alter inhibitory sensitivity towards selective MET inhibitors  Figure 6  
Mutation Word : E884K @Position : 12
Function Word : sensitivity @Position : 18
Impact Word : alter @Position : 16
In human thyroid cancers it has recently been reported that BRAF V600E is highly associated with 1 overexpression of VEGF and that overexpression of VEGF was highly associated with increasing tumour stage and invasion  Jo  et al  2006  and 2 reduced membrane expression of NIS  Riesco-Eizaguirre  et al  2006  
Mutation Word : V600E @Position : 11
Function Word : expression @Position : 46
Impact Word : increase @Position : 29
Regarding BCR-ABL kinase mutations the multi-resistant T315I one remains a crucial clinical challenge since until recently there is no effective treatment for the patients carrying this particular type of mutation 
Mutation Word : T315I @Position : 6
Function Word : effect @Position : 19
Impact Word : remain @Position : 8
The T790M mutation abrogated the effect of erlotinib on L858R and the L858R/T790M double mutant readily induced Akt phosphorylation even in the presence of 10 μM erlotinib 
Mutation Word : L858R @Position : 12
Function Word : effect @Position : 5
Impact Word : abrogate @Position : 3
Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells  Carpten  et al  2007  
Mutation Word : E17K @Position : 7
Function Word : phosphorylation @Position : 15
Impact Word : increase @Position : 13
To further test our hypothesis that the kinetochore localization of Mps1 may be negatively regulated by its kinase activity we examined the localization of these mutants Mps1 T676A  Mps1 T676E  Mps1 T686A  and Mps1 T686E  
Mutation Word : T676A @Position : 30
Function Word : regulation @Position : 14
Impact Word : negative @Position : 13
Substitution of S252W and P253R alter the ligand binding specificities of FGFR2b and FGFR2c but retain the ligand-dependent activation properties   whereas K659N causes receptor hyperactivation   
Mutation Word : P253R @Position : 4
Function Word : binding @Position : 8
Impact Word : alter @Position : 5
Here we provide the first evidence that  V600E BRAF causes the upregulation of genes involved in glycolysis whereas knock-down of  V600E BRAF in melanoma cells conversely reduces the expression of these genes lowers the rate of glycolysis and causes the reversal of the Warburg phenotype 
Mutation Word : V600E @Position : 22
Function Word : phenotype @Position : 46
Impact Word : lower @Position : 34
Taken together these data provide support that cooperative enhanced inhibition using dual TKIs against MET and EGFR pathways may be an effective treatment strategy to inhibit lung cancer with intrinsic or acquired T790M-EGFR-mediated TKI resistance 
Mutation Word : T790M @Position : 32
Function Word : inhibit @Position : 25
Impact Word : enhance @Position : 8
Synergy is particularly important as it may permit lower doses of PLX4720 to be used potentially translating to a benefit in the clinic by reducing side effects associated with BRAF V600E -inhibition including squamous cell carcinoma [ 54 - 56 ] 
Mutation Word : V600E @Position : 30
Function Word : inhibit @Position : 31
Impact Word : reduce @Position : 24
The enhanced tyrosine phosphorylation of PECAM-1 by the E255K and T315I mutants may be at least partly due to their enhanced activities  15 – 17  
Mutation Word : E255K @Position : 8
Function Word : activity @Position : 21
Impact Word : enhance @Position : 20
We find that PACSIN1 shows significantly increased phosphorylation when co-transfected with the P52L mutant compared to the wild-type PAK6   Fig 2F and G   suggesting that the melanoma-associated mutation indeed functions to increase kinase activity 
Mutation Word : P52L @Position : 12
Function Word : function @Position : 33
Impact Word : increase @Position : 35
Consistent with these results luciferase reporter analysis showed that BRAF-K601E CT with K483R or K578R mutation failed to induce AP-1-dependent luciferase reporter gene expression whereas BRAF-K601E CT and other mutants induced a higher level of AP-1 reporter activity in HEK-293T cells  Fig  S1B  
Mutation Word : K601E @Position : 25
Function Word : activity @Position : 37
Impact Word : higher @Position : 32
The high potency of afatinib to inhibit the tyrosine kinase activity of wild-type EGFR was fully maintained on EGFR with the activating L858R mutation Solca et al.  Sos et al   
Mutation Word : L858R @Position : 22
Function Word : inhibit @Position : 6
Impact Word : maintain @Position : 16
In comparison the activity of some FOP mutants was generally increased to a level similar to caALK2 revealing an inherent gain of function in their catalytic domain in the absence of added BMP ligand  Fig. 1  B . Significantly the signaling by R206H was increased by FK506 to a far greater extent than other GS domain mutants such as L196P  Fig  1  B  
Mutation Word : R206H @Position : 44
Function Word : ligand @Position : 33
Impact Word : increase @Position : 46
Overall H2A values were greater than H2A.Z and that A2B1 H2A > H2A.Z was lesser than A2C12 H2A > H2A Z   Figure S12C   in agreement with nucleosome depletion associated with gene expression 
Mutation Word : S12C @Position : 24
Function Word : associated @Position : 32
Impact Word : greater @Position : 4
In human thyroid cancers it has recently been reported that BRAF V600E is highly associated with 1 overexpression of VEGF and that overexpression of VEGF was highly associated with increasing tumour stage and invasion  Jo  et al  2006  and 2 reduced membrane expression of NIS  Riesco-Eizaguirre  et al  2006  
Mutation Word : V600E @Position : 11
Function Word : expression @Position : 46
Impact Word : reduce @Position : 44
However imatinib is less effective against the D816V KIT mutation in vitro    and in the clinic   
Mutation Word : D816V @Position : 7
Function Word : effect @Position : 4
Impact Word : less @Position : 3
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : T315I @Position : 7
Function Word : induce @Position : 22
Impact Word : increase @Position : 19
Survival for CML-CP patients with the T315I point mutation treated with TKIs is estimated to be reduced by 50% compared with patients without the T315I mutation median survival of 22 months vs. more than 10 years for TKI-responsive CML patients Nicolini et al  2009 
Mutation Word : T315I @Position : 24
Function Word : survival @Position : 27
Impact Word : reduce @Position : 16
F1174L may therefore stabilize an active conformation that is both more oncogenic and less favored for crizotinib binding 
Mutation Word : F1174L @Position : 0
Function Word : activity @Position : 5
Impact Word : stability @Position : 3
We find that PACSIN1 shows significantly increased phosphorylation when co-transfected with the P52L mutant compared to the wild-type PAK6   Fig 2F and G   suggesting that the melanoma-associated mutation indeed functions to increase kinase activity 
Mutation Word : P52L @Position : 12
Function Word : phosphorylation @Position : 7
Impact Word : increase @Position : 35
We see that in the absence of ligand the phosphorylation of both the FGFR3/G375C and the FGFR3/G380R mutants is about 2 5 times higher than that of the wild type 
Mutation Word : G380R @Position : 16
Function Word : phosphorylation @Position : 9
Impact Word : higher @Position : 23
The addition of c-MET siRNA to either EGFR wild type or T790M-specific siRNAs resulted in an increased effect on cell growth inhibition and caspase−3/7 activity induction 
Mutation Word : T790M @Position : 11
Function Word : inhibit @Position : 21
Impact Word : increase @Position : 16
Phosphorylation of Ser 910 /Ser 935  and 14-3-3 binding were significantly reduced in six other mutants M712V R1441H R1441C A1442P L1795F and G2385R  Figure 5  lower panel 
Mutation Word : G2385R @Position : 23
Function Word : binding @Position : 9
Impact Word : reduce @Position : 12
Combined BRAF V600E - and SRC-inhibition induces apoptosis evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer
Mutation Word : V600E @Position : 2
Function Word : induce @Position : 6
Impact Word : reduce @Position : 13
The S252W mutation increased cell proliferation in fibroblasts at all times of culture 24 h  p  < 0 001
Mutation Word : S252W @Position : 1
Function Word : proliferation @Position : 5
Impact Word : increase @Position : 3
Consistent with our hierarchical clustering analysis introduction of the R164Q mutation led to relatively few changes in gene expression or showed reduced pathway activation compared with the other mutants studied 
Mutation Word : R164Q @Position : 9
Function Word : activity @Position : 23
Impact Word : reduce @Position : 21
The gene expression domain of  dlx3  is altered for both expression pattern and intensity of signal such that there is no  dlx3  detected in the BRAF V600E  expressing embryos 
Mutation Word : V600E @Position : 30
Function Word : expression @Position : 32
Impact Word : alter @Position : 9
An accumulation of alternative mutations including a T790M-insensitive mutation in addition to the primary activating mutation could modulate the sensitivity to EGFR-TKI 
Mutation Word : T790M @Position : 7
Function Word : activity @Position : 14
Impact Word : modulates @Position : 17
The mutations E255V M244V T315A Y253H experience increased vdW interactions with Met290 and the mutation M244V experiences increased vdW interactions with Ile293 
Mutation Word : M244V @Position : 15
Function Word : interaction @Position : 19
Impact Word : increase @Position : 17
Furthermore although the gold standard for detection of BRAF V600E mutation is PCR a recently developed monoclonal antibody VE1 shows high sensitivity and specificity for this mutation and has been widely used in replace of PCR for research purpose 
Mutation Word : V600E @Position : 9
Function Word : sensitivity @Position : 21
Impact Word : high @Position : 20
In IFN-β primed cells all NS1 mutants with the exception of V226I exhibited enhanced yield and/or replication kinetics  Fig  6   Table 1  
Mutation Word : V226I @Position : 11
Function Word : exhibit @Position : 12
Impact Word : enhance @Position : 13
Regarding the interference with the ERK signaling cell lines with BRAF V600D/R  mutations presented a faster and stronger inhibition of phosphorylated ERK as compared to control cells with a wild-type  BRAF  Figure  1 C 
Mutation Word : V600D @Position : 11
Function Word : inhibit @Position : 19
Impact Word : stronger @Position : 18
Immune-complexes kinase assays showed as expected high BRAF activity in YULAC-BRAF V600E  and YUMAC-BRAF V600K  cells that was suppressed after treatment with PLX4032 for 30 min  Figure 3A  YULAC and YUMAC 
Mutation Word : V600E @Position : 15
Function Word : activity @Position : 8
Impact Word : high @Position : 6
In contrast G2385R variant within the WD40 domain results in a loss-of-function mutation associated with the reduced kinase activity and is a common susceptibility allele in Asian populations but absent in Caucasians  
Mutation Word : G2385R @Position : 2
Function Word : activity @Position : 18
Impact Word : reduce @Position : 16
Panitumumab remained active in a patient with S492R mutation which abrogated cetuximab binding 
Mutation Word : S492R @Position : 7
Function Word : activity @Position : 2
Impact Word : remain @Position : 1
FLT3  D835V and  KIT  D816Y retained some level of sensitivity with regard to induction of apoptosis 
Mutation Word : D835V @Position : 2
Function Word : apoptosis @Position : 18
Impact Word : retain @Position : 8
This group recently published that human naevi benign tumors of melanocytic origin that can remain in unaltered state for decades and often express BRAF V600E  display senescence-like growth arrest   
Mutation Word : V600E @Position : 24
Function Word : expression @Position : 22
Impact Word : remain @Position : 14
From  Table 2  we observed that Leu298 has stable interactions with CF 3  throughout MD simulations in all mutations while Leu354 experiences increased vdW interactions with mutations E255K and T315A 
Mutation Word : T315A @Position : 32
Function Word : interaction @Position : 27
Impact Word : increase @Position : 25
JAK2 K539L T875N and R683G were shown to exhibit constitutive STAT5 activation and to transform Ba/F3 cells expressing the EpoR to cytokine-independence     
Mutation Word : R683G @Position : 4
Function Word : activity @Position : 11
Impact Word : constitutive @Position : 9
The results showed increased phosphorylation of Erk1/2 and p38 in  Fgfr2 +/S252W   mice BMSCs which indicated that Erk1/2 and p38 signaling may participate in the regulation of endochondral bone formation by FGFR2 
Mutation Word : S252W @Position : 12
Function Word : regulation @Position : 28
Impact Word : increase @Position : 3
The presence of R164Q in cluster 2 rather than in cluster 1 with wt  K-Ras  was therefore initially surprising but suggests that the R164Q mutation also has an activating phenotype albeit attenuated relative to the other mutations studied 
Mutation Word : R164Q @Position : 25
Function Word : activity @Position : 30
Impact Word : attenuate @Position : 33
Indeed as shown in Figure 3a  Tbx3 was significantly upregulated ~10-fold in melanocytes with B-RAF V600E  signaling while no other known E-cadherin regulator in our Illumina dataset was significantly altered 
Mutation Word : V600E @Position : 16
Function Word : regulation @Position : 24
Impact Word : alter @Position : 31
Since the depletion of KLF2 causes enhanced apoptosis of HMC-1V560G c-Kit KLF2 may play a role in the NGF mediated survival signal 
Mutation Word : V560G @Position : 9
Function Word : apoptosis @Position : 7
Impact Word : enhance @Position : 6
BRAF  cDNA from syndromic SSA/Ps hyperplastic polyps HPs and normal colon was amplified by PCR and sequenced since T to A mutations in codon 600 resulting in a valine to glutamic acid V600E amino acid change with increased kinase activity have been reported in SSA/Ps Materials and Methods  [14]  
Mutation Word : V600E @Position : 33
Function Word : activity @Position : 40
Impact Word : increase @Position : 38
Some studies that investigated human periosteal fibroblasts   murine osteoblasts   murine stem cells   or calvarial cells during embryonic sutures formation in murine AS models   point to the FGFR2 S252W  mutation as responsible for increasing cell proliferation 
Mutation Word : S252W @Position : 35
Function Word : proliferation @Position : 43
Impact Word : increase @Position : 41
JAK2 inhibitors such as pacritinib SB1518 an oral inhibitor currently in Phase II clinical studies as well as other JAK2 inhibitors show significant efficacy in treating MPNs reducing the JAK-STAT signal transducer and activator of transcription signaling spleen size JAK2 V617F  mutation burden as well as levels of certain cytokines/growth factors relevant in MPNs 
Mutation Word : V617F @Position : 40
Function Word : activity @Position : 33
Impact Word : reduce @Position : 27
Our results showed diminished expression of  MLH1  in patients harbouring BRAF V600E mutations RET/PTC rearrangements and transitions  IDH1  and  NRAS   
Mutation Word : V600E @Position : 13
Function Word : expression @Position : 4
Impact Word : diminish @Position : 3
It is noteworthy that the Tbx3 primers used in these experiments amplified both splice variants of Tbx3   and expression of both variants was elevated by B-RAF V600E   Figure 3c  
Mutation Word : V600E @Position : 28
Function Word : expression @Position : 20
Impact Word : elevate @Position : 25
Motesanib and imatinib have much diminished activity against the activation loop mutant D816V 
Mutation Word : D816V @Position : 12
Function Word : activity @Position : 9
Impact Word : diminish @Position : 5
In preclinical studies T-cell viability and function was preserved when peripheral blood mononuclear cells and BRAF V600E  mutant melanoma cells were exposed to clinically relevant concentrations of vemurafenib  in vitro    
Mutation Word : V600E @Position : 16
Function Word : function @Position : 6
Impact Word : preserve @Position : 8
However the most prevalent  KIT  mutation in CBF AML substituting valine for aspartic acid at codon 816 KIT D816V was demonstrated to be basically insensitive towards quizartinib in  in vitro  and  ex vivo  leukemia cell lines primary myeloblasts and in an isogenic Ba/F3 cell model – while substitution of a tyrosine residue D816Y retained some sensitivity to quizartinib 
Mutation Word : D816Y @Position : 58
Function Word : sensitivity @Position : 61
Impact Word : retain @Position : 59
Surprisingly we found that expression of each activated KRAS ED  lead to a substantial decrease in Braf V600E  induced tumors relative to the EGFP control suggesting the existence of a KRAS activated negative regulator of tumorigenesis 
Mutation Word : V600E @Position : 18
Function Word : induce @Position : 20
Impact Word : decrease @Position : 15
The mutation Y253F −0.22 kcal/mol experiences increased electrostatic interactions Y253H experiences increased electrostatic interactions −0.3 kcal/mol and decreased vdW −1 31 kcal/mol when binding to ponatinib 
Mutation Word : Y253H @Position : 9
Function Word : interaction @Position : 13
Impact Word : increase @Position : 11
The BRAF V600E  mutation is the most prevalent genetic alteration greater than 50% in papillary thyroid cancer PTC and is implicated in the progression of PTC to ATC  4 – 6  a crucial challenge in thyroid cancer 
Mutation Word : V600E @Position : 2
Function Word : implicated @Position : 21
Impact Word : alter @Position : 10
The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation and to a large degree mutations affecting the residue 317 F317L F317V 
Mutation Word : F317L @Position : 34
Function Word : activity @Position : 1
Impact Word : maintain @Position : 5
Furthermore from a gefitinib-resistant patient carrying the activating L858R mutation we identified a novel secondary resistant mutation L747S in cis to the activating mutation which attenuated the up-regulation of BIM and reduced apoptosis 
Mutation Word : L858R @Position : 8
Function Word : apoptosis @Position : 32
Impact Word : reduce @Position : 31
An acquired T790M mutation was found in a NSLCL patient resistant to the drug Gefitnib by increasing the affinity to ATP   
Mutation Word : T790M @Position : 2
Function Word : atp @Position : 20
Impact Word : increase @Position : 16
E255K and T315I are the most predominant mutations of BCR/ABL causing imatinib resistance in patients and may increase the kinase activity or change the substrate preferences of BCR/ABL  15  18  
Mutation Word : E255K @Position : 0
Function Word : activity @Position : 20
Impact Word : increase @Position : 17
Furthermore from a gefitinib-resistant patient carrying the activating L858R mutation we identified a novel secondary resistant mutation L747S in cis to the activating mutation which attenuated the up-regulation of BIM and reduced apoptosis 
Mutation Word : L858R @Position : 8
Function Word : apoptosis @Position : 32
Impact Word : attenuate @Position : 25
Correcting the results for the variables that could have influence on BT  JAK2 V617F wt and homozygous genotypes remained independently associated with BT 
Mutation Word : V617F @Position : 14
Function Word : associated @Position : 21
Impact Word : remain @Position : 19
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : T315I @Position : 7
Function Word : phosphorylation @Position : 23
Impact Word : increase @Position : 19
However the overall lower IC50 and preserved activity against a wide spectrum of BCR–ABL1 mutations including T315I can be appreciated  
Mutation Word : T315I @Position : 16
Function Word : activity @Position : 7
Impact Word : preserve @Position : 6
F1174L may therefore stabilize an active conformation that is both more oncogenic and less favored for crizotinib binding 
Mutation Word : F1174L @Position : 0
Function Word : binding @Position : 17
Impact Word : favorable @Position : 14
The JAK2 V617F mutation present in over 95% of Polycythemia Vera patients and in 50% of Essential Thrombocythemia and Primary Myelofibrosis patients renders the kinase constitutively active 
Mutation Word : V617F @Position : 2
Function Word : activity @Position : 26
Impact Word : constitutive @Position : 25
When using a higher sensitive approach the ARMS assay which may detect this allele variant with a sensitivity close to 3% persistent cells harbouring KIT M541L  allele variant occurred only in one patient #4 Fig   1B  
Mutation Word : M541L @Position : 25
Function Word : sensitivity @Position : 17
Impact Word : higher @Position : 3
At Days 3 and 5 the cell proliferation rate as determined by % viable cells increase during the assay period was 1.46-fold Day 3 and 1.40-fold  P =0 0013 higher Day 5 in L858R+E884K than L858R alone 
Mutation Word : L858R @Position : 36
Function Word : proliferation @Position : 7
Impact Word : higher @Position : 30
Increased activation of Akt1 by E17K L52R C77F and Q79K mutants led as expected to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
Mutation Word : E17K @Position : 5
Function Word : activity @Position : 1
Impact Word : increase @Position : 15
ERK1/2 phosphorylation decreased ~92% in cells treated with either 0.5 μM SB-590885 a potent inhibitor of total BRAF   or 0 5 μM PLX-4720 the BRAF V600E  selective inhibitor Figure  1B  
Mutation Word : V600E @Position : 27
Function Word : phosphorylation @Position : 1
Impact Word : decrease @Position : 2
All inhibitors reduced the relative level of Mek 1/2 phosphorylation in clones carrying the V600E mutation by more than 90% with dabrafenib showing the strongest effect 
Mutation Word : V600E @Position : 14
Function Word : effect @Position : 25
Impact Word : reduce @Position : 2
Mutating the BRAF dimerization motif R509H abolishes resistance conferred by N-terminal truncated BRAF moieties Poulikakos et al   2011  however it has no effect on  BRAF   V600E/L505H   Figure  4 D 
Mutation Word : V600E @Position : 31
Function Word : resistance @Position : 7
Impact Word : abolish @Position : 6
Research into the molecular mechanisms of BRAF V600E -positive tumors has revealed that the missense valine to glutamic acid mutation increases kinase activity promoting the constitutive activation of MEK-ERK signaling and enhancing ERK-dependent transcriptional output  
Mutation Word : V600E @Position : 7
Function Word : activity @Position : 26
Impact Word : increase @Position : 20
Previous studies in other cellular contexts have demonstrated that the S252W FGFR2 mutant receptor exhibits decreased ligand dissociation  Anderson et al  1998  
Mutation Word : S252W @Position : 10
Function Word : ligand @Position : 16
Impact Word : decrease @Position : 15
Our biochemical studies here now show that E884K mutation in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : L858R @Position : 21
Function Word : associated @Position : 34
Impact Word : alter @Position : 36
Two of these missense mutants V689M and L703F are constitutively active possibly because they stabilize acceptor/donor interactions   
Mutation Word : L703F @Position : 7
Function Word : activity @Position : 10
Impact Word : stability @Position : 14
Figure 1A  shows that both catalytic mutations rescued the temperature sensitivity of the  gcn5 Δ  sas3  mutant with  isw1-K227R  having the stronger effect 
Mutation Word : K227R @Position : 23
Function Word : effect @Position : 28
Impact Word : stronger @Position : 27
Thus certain P loop mutations Y253F E255K and the T315I mutation display a high oncogenic potential which is consistent with the clinical observation of a poor outcome concerning overall and progression-free survival   
Mutation Word : T315I @Position : 9
Function Word : survival @Position : 31
Impact Word : high @Position : 13
Immunoblot analysis revealed that this inhibition was caused by reduced phosphorylation of BCR-ABL and Crk-L and increased activation of PARP in Ba/F3 BCR-ABL T315I cells after treatment with ponatinib  Figure 1D  
Mutation Word : T315I @Position : 23
Function Word : phosphorylation @Position : 10
Impact Word : reduce @Position : 9
In the two cell lines with wt EGFR H460 and A549 we found positive score 3 expression of EGFR D38B1 protein 100% and negative score 0 expression of EGFR E746-A750 deletion specific 6B6 and EGFR L858R mutant-specific 43B2 
Mutation Word : L858R @Position : 35
Function Word : expression @Position : 26
Impact Word : negative @Position : 23
In H3255 cells EGFR L858R  which display impaired EGF-mediated SHP2 phosphorylation relative to cells expressing wild-type EGFR   7    Supplementary Figure S2  SHP2 knockdown had no substantial effect on ERK phosphorylation at any concentration of gefitinib 
Mutation Word : L858R @Position : 4
Function Word : expression @Position : 15
Impact Word : impair @Position : 8
BCR-ABL mutations respond differently to three tyrosine kinase inhibitors approved for first-line treatment of CML e.g  Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib while some mutations are less sensitive to nilotinib E255K/V and F359V/C or dasatinib F317L and V299L  
Mutation Word : E255V @Position : 50
Function Word : sensitivity @Position : 47
Impact Word : less @Position : 46
Despite achieving correct topology however G85E and G91R still disrupt CFTR folding and trafficking Xiong et al.  Patrick et al   
Mutation Word : G85E @Position : 5
Function Word : trafficking @Position : 13
Impact Word : disrupt @Position : 9
The T790M mutation may result in an alteration of EGFR topology that precludes the binding of reversible EGFR-TKIs through steric hindrance or T790M may increase the affinity of the kinase domain for ATP  
Mutation Word : T790M @Position : 22
Function Word : binding @Position : 14
Impact Word : alter @Position : 7
FGFR3 mRNA expression is higher in tumors with S249C FGFR3 mutation
Mutation Word : S249C @Position : 8
Function Word : expression @Position : 2
Impact Word : higher @Position : 4
In the context of wildtype RAF BRAF or CRAF  and  high Ras activity BRAF V600E -inhibition may “paradoxically” enhance MAPK activity [ 60   61 ] 
Mutation Word : V600E @Position : 16
Function Word : activity @Position : 22
Impact Word : high @Position : 12
Motesanib and imatinib have much diminished activity against the activation loop mutant D816V 
Mutation Word : D816V @Position : 12
Function Word : activity @Position : 9
Impact Word : diminish @Position : 5
Very high response rates and improved survival have been noted with the administration of the type I BRAF inhibitor vemurafenib formerly PLX4032/RG7204 to patients with BRAF V600E  mutant cutaneous metastatic melanoma   
Mutation Word : V600E @Position : 26
Function Word : survival @Position : 6
Impact Word : high @Position : 1
We find an increased activity of SIRT1 in PLX4032 resistant BRAF V600E -mutated melanoma cells compared with their sensitive counterpart thereby linking SIRT1 to drug resistance and poor prognosis in melanoma 
Mutation Word : V600E @Position : 11
Function Word : sensitivity @Position : 18
Impact Word : increase @Position : 3
The enhanced tyrosine phosphorylation of PECAM-1 by the E255K and T315I mutants may be at least partly due to their enhanced activities  15 – 17  
Mutation Word : T315I @Position : 10
Function Word : phosphorylation @Position : 3
Impact Word : enhance @Position : 20
Hence E884K mutation can work in concert with L858R to modulate mutant receptor sensitivity to different targeted inhibitors 
Mutation Word : E884K @Position : 1
Function Word : sensitivity @Position : 13
Impact Word : modulates @Position : 10
Sumimoto et al   15  have shown that BRAF V600E  knock-down decreased phospho-ERK1/2 protein levels and inhibited invasion of melanoma cells accompanied by a decrease of matrix metalloproteinase activity and ITGβ1 expression 
Mutation Word : V600E @Position : 11
Function Word : activity @Position : 31
Impact Word : decrease @Position : 27
The V600E mutation confers an increase in BRAF kinase activity of approximately 480 times compared with wild-type BRAF whereas the V600D mutation increases this by approximately 700 times  Wan  et al  2004  
Mutation Word : V600E @Position : 20
Function Word : activity @Position : 9
Impact Word : increase @Position : 22
34  35  45  On the other hand the affinity of this cleft for adenosine triphosphate is increased by T790M 
Mutation Word : T790M @Position : 21
Function Word : affinity @Position : 11
Impact Word : increase @Position : 19
If exon 19 deletion results in EGFR structural alterations which bind TKIs more tightly than L858R mutation it could support our hypothesis 
Mutation Word : L858R @Position : 15
Function Word : binding @Position : 10
Impact Word : alter @Position : 8
By contrast the T790M mutation confers a higher affinity toward ATP than the L858R mutant such that the combined double mutant L858R/T790M results in an activated enzyme that is resistant to ATP-competitive TKIs   
Mutation Word : T790M @Position : 21
Function Word : affinity @Position : 8
Impact Word : higher @Position : 7
Hence the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT down-regulated CBL and MAPK-ERK1/2 phosphorylation up-regulated 
Mutation Word : E884K @Position : 4
Function Word : phosphorylation @Position : 23
Impact Word : modulates @Position : 5
The T790M mutation affects the gatekeeper residue in the catalytic-kinase domain and confers drug resistance by increasing EGFRs affinity for ATP – thus reducing the potency of the ATP-competitive kinase inhibitors [ 39 ] 
Mutation Word : T790M @Position : 1
Function Word : atp @Position : 20
Impact Word : increase @Position : 16
In colon cancer suppression of BRAF in cell lines with BRAF V600E  showed significant decreased proliferation through cyclin D1 and p27 Kip1  and induces apoptosis by a significant decrease in the levels of anti-apoptotic protein Bcl-2   
Mutation Word : V600E @Position : 11
Function Word : proliferation @Position : 16
Impact Word : decrease @Position : 30
For instance the A391E mutation in FGFR3 increases FGFR3 phosphorylation at low ligand concentration similarly to the G380R and G375C ACH mutations studied here  
Mutation Word : A391E @Position : 3
Function Word : phosphorylation @Position : 9
Impact Word : increase @Position : 7
In vivo  the efficacy of ruxolitinib in a murine  JAK2  V617F -driven malignancy model was demonstrated by the fact that it significantly reduced splenomegaly decreased elevated levels of circulating IL-6 and tumor necrosis factor TNF-α to normal and increased survival without causing anemia or lymphopenia [ 98 ] 
Mutation Word : V617F @Position : 13
Function Word : survival @Position : 42
Impact Word : elevate @Position : 28
Both DP-2976 and DP-4851 decreased the autophosphorylation of both wild type and KIT D816V in a concentration-dependent manner  Figure 2  
Mutation Word : D816V @Position : 13
Function Word : autophosphorylation @Position : 6
Impact Word : decrease @Position : 4
Our analysis revealed that the T790M mutation significantly increased the distance between the P-loop and activation loop whereas the G719S mutation significantly shortened the distance between the P-loop and activation loop  Supplementary Figure 2  
Mutation Word : T790M @Position : 5
Function Word : activity @Position : 29
Impact Word : increase @Position : 8
The effect on the downstream signal mediators p-AKT [S473] and p-STAT3 [Y705] correlated well with the inhibition of EGFR phosphorylation  Figure 1A  E884K in- cis  with L858R decreased erlotinib inhibition of AKT and STAT3 phosphorylation but increased inhibition by gefitinib 
Mutation Word : E884K @Position : 24
Function Word : inhibit @Position : 40
Impact Word : decrease @Position : 30
Elevated  SOCS3  mRNA expression in  JAK2  V617F-positive MPN patients was confirmed by individual quantitative PCR qPCR assay of peripheral blood cDNA samples from the 26 patients and 11 healthy volunteers 
Mutation Word : V617F @Position : 10
Function Word : expression @Position : 5
Impact Word : elevate @Position : 0
We first reported that response rate of gefitinib is higher for patients with deletional  EGFR  mutations than for those with other types of mutations predominantly L858R  Mitsudomi  et al  2005  and others extended this observation by demonstrating survival difference between them  Jackman  et al  2006   Riely  et al  2006  
Mutation Word : L858R @Position : 27
Function Word : survival @Position : 43
Impact Word : higher @Position : 9
Some hematopoietic cell lineages and hematologic diseases have defined miR signatures including abnormally high expression of miR-155 in Hodgkin lymphoma and diffuse large B-cell lymphoma loss of expression of miR-15 and miR-16 in chronic lymphocytic leukemia and aberrant expression of let-7a miR-182 miR-143 miR-145 miR-223 miR-26b miR-30b miR-30c and miR-150 in granulocytes mononuclear cells platelets or reticulocytes of PV patients with correlations between aberrant expression of miR-143 let-7a miR-30c miR-342 and miR-150 and  JAK2  V617F  mutation frequency 
Mutation Word : V617F @Position : 76
Function Word : expression @Position : 64
Impact Word : high @Position : 13
Our data support the potential role of dual TKI combinatorial inhibition using EGFR inhibitors to enhance MET inhibition in T790M-EGFR-mediated therapy resistance 
Mutation Word : T790M @Position : 19
Function Word : inhibit @Position : 17
Impact Word : enhance @Position : 15
In the second case the patient was treated with KW-2449 a T315I-specific inhibitor after losing the CCyR induced by 800 mg per day imatinib 
Mutation Word : T315I @Position : 11
Function Word : induce @Position : 17
Impact Word : lose @Position : 14
In the context of wildtype RAF BRAF or CRAF  and  high Ras activity BRAF V600E -inhibition may “paradoxically” enhance MAPK activity [ 60   61 ] 
Mutation Word : V600E @Position : 16
Function Word : activity @Position : 22
Impact Word : enhance @Position : 20
We employed the human mast cell leukemia cell line -1 HMC-1 model which harbors KIT D816V and V560G mutations and depends on signaling from these constitutively active KIT receptors for growth and survival [ 4 ] 
Mutation Word : V560G @Position : 17
Function Word : activity @Position : 26
Impact Word : constitutive @Position : 25
The T790M mutation may result in an alteration of EGFR topology that precludes the binding of reversible EGFR-TKIs through steric hindrance or T790M may increase the affinity of the kinase domain for ATP  
Mutation Word : T790M @Position : 22
Function Word : affinity @Position : 26
Impact Word : increase @Position : 24
Signaling studies show again that cells expressing the L858R allele have reduced EGFR AKT and ERK phosphorylation in response to increasing concentrations of dasatinib  Figure 5B  
Mutation Word : L858R @Position : 8
Function Word : phosphorylation @Position : 16
Impact Word : reduce @Position : 11
Sixteen days after inoculation compared with mice inoculated with VF/EpoR/sh-control cells the volume and weight of subcutaneous tumors were significantly reduced in mice inoculated with VF/EpoR/sh-c-Myc cells  Fig. 5E G . Furthermore knock down of c-Myc markedly attenuated the enlargement of the liver and spleen induced by JAK2 V617F  Fig  5F G  
Mutation Word : V617F @Position : 49
Function Word : induce @Position : 46
Impact Word : attenuate @Position : 38
Structurally this residue lies in the substrate-binding pocket of the kinase and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP-bound form effectively making RET more active more of the time  48 – 51  
Mutation Word : M918T @Position : 13
Function Word : stability @Position : 23
Impact Word : increase @Position : 17
Finally the specific silencing or inhibition of BRAF V600E  expression in the NM176 and ME1042 melanoma cells decreased Tbx3 protein expression and this correlated with the concomitant increased E-cadherin  Figure 2c  
Mutation Word : V600E @Position : 8
Function Word : expression @Position : 21
Impact Word : decrease @Position : 18
Some mutations P112Q R895C E897K enhance angiotensin II receptor-mediated activation of TRPC6 when expressed in HEK293 cells while neither the S270T nor the N143S missense mutations nor a 57-amino acid truncation mutation K874X altered the channel activity   
Mutation Word : N143S @Position : 23
Function Word : activity @Position : 36
Impact Word : alter @Position : 33
Vikis et al  reported that standalone T790M mutations exhibit increased kinase activity 
Mutation Word : T790M @Position : 7
Function Word : activity @Position : 12
Impact Word : increase @Position : 10
While ERBB2-L755S and ERBB2-L755P mutants remained sensitive to AEE788 at very high concentrations IC90 below 2 µM the gatekeeper ERBB2-T798M mutation is totally resistant IC50>2 µM to AEE788 treatment  Figure 4B  
Mutation Word : L755P @Position : 3
Function Word : sensitivity @Position : 6
Impact Word : remain @Position : 5
HEK293 cells were transfected with expression plasmids for TAK1 and constitutively active K650E FGFR3 
Mutation Word : K650E @Position : 12
Function Word : activity @Position : 11
Impact Word : constitutive @Position : 10
The single mutants with the exception of K112N and K118N exhibited slightly lower thermal stability than the wild type 
Mutation Word : K118N @Position : 9
Function Word : stability @Position : 14
Impact Word : lower @Position : 12
Non-hotspot AKT1 PH domain mutants L52R C77F and Q79K increase Akt1 activation and downstream signaling
Mutation Word : L52R @Position : 5
Function Word : activity @Position : 11
Impact Word : increase @Position : 9
The EphA3 G518L mutation found in lung cancer increases the affinity of the lateral interaction between EphA3 and ephrin-A3 
Mutation Word : G518L @Position : 2
Function Word : affinity @Position : 10
Impact Word : increase @Position : 8
Our studies here using COS-7 transfection model system show that E884K works in concert with L858R in- cis  in a dominant fashion to change downstream signaling differentially induce MAPK-ERK1/2 signaling and associated cell proliferation and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor-specific fashion 
Mutation Word : E884K @Position : 10
Function Word : phosphorylation @Position : 41
Impact Word : alter @Position : 37
In vitro  studies in thyroid cells suggest that BRAF V600E induces invasion via increased expression of matrix metalloproteinases MMP12  Mesa  et al  2006  and that it reduces expression and membrane localisation of the Na I symporter responsible for thyrocyte uptake of iodine  Riesco-Eizaguirre  et al  2006  
Mutation Word : V600E @Position : 10
Function Word : expression @Position : 32
Impact Word : increase @Position : 14
9   Preclinical studies have shown superior activity of afatinib over first-generation TKIs mainly due to 1 irreversible binding which confers stronger binding affinity and potency 2 ability to circumvent first-generation TKI resistance mechanism T790M mutation in exon 20 and 3 effectiveness against multiple HER-endothelial growth factor receptors   10  
Mutation Word : T790M @Position : 35
Function Word : binding @Position : 23
Impact Word : stronger @Position : 22
This led us to question whether in solution perturbation of the autoP trajectory by RET M918T could arise through presentation of a better intermolecular substrate by favoring an “AL-out” conformer presenting Y900 or Y905 as a substrate to an active RET kinase in  trans  
Mutation Word : M918T @Position : 14
Function Word : activity @Position : 38
Impact Word : favorable @Position : 25
Furthermore from a gefitinib-resistant patient carrying the activating L858R mutation we identified a novel secondary resistant mutation L747S in cis to the activating mutation which attenuated the up-regulation of BIM and reduced apoptosis 
Mutation Word : L747S @Position : 17
Function Word : apoptosis @Position : 32
Impact Word : attenuate @Position : 25
Tyrosine phosphorylation of STAT5 was also enhanced though not as significantly as that of PECAM-1 in cells expressing the E255K or T315I mutant  Fig  4C  
Mutation Word : E255K @Position : 19
Function Word : expression @Position : 17
Impact Word : enhance @Position : 6
Our studies here using COS-7 transfection model system show that E884K works in concert with L858R in- cis  in a dominant fashion to change downstream signaling differentially induce MAPK-ERK1/2 signaling and associated cell proliferation and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor-specific fashion 
Mutation Word : E884K @Position : 10
Function Word : inhibit @Position : 42
Impact Word : alter @Position : 37
Therefore the modulation of feed-back loops and alteration of Raf dimerization upon treatment with Raf inhibitors may also have a role in the differential sensitivity to PLX4032 in BRAF  V600E  mutant cell lines 
Mutation Word : V600E @Position : 30
Function Word : dimerization @Position : 10
Impact Word : modulates @Position : 2
We previously demonstrated a high degree of variability in the extent of GSK-3β-Ser 9  phosphorylation among BRAF V600E  + melanoma cell lines and showed that GSK-3β activity in these cells was increased in response to the multikinase inhibitor sorafenib   presumably through an ER stress-dependent mechanism 
Mutation Word : V600E @Position : 18
Function Word : activity @Position : 28
Impact Word : increase @Position : 33
In numerous studies the  JAK2  V617F allele has been variably associated with higher indices of erythropoiesis unchanged or decreased platelet counts greater occurrence of thrombosis increased BM fibrosis or cytoreductive treatments older age longer disease duration or poorer survival in MPN   
Mutation Word : V617F @Position : 7
Function Word : survival @Position : 40
Impact Word : decrease @Position : 20
Briefly wild-type or constitutively active K650E sequences of the human FGFR3 cytoplasmic domain amino acids 399–806 were fused to the LexA DNA-binding domain in the pBTM116 plasmid and used to screen a human chondrocyte library encoding fusion proteins with the Gal4 activation domain BD Biosciences Clontech Palo Alto CA in the L40 strain of Saccharomyces cerevisiae  
Mutation Word : K650E @Position : 5
Function Word : activity @Position : 41
Impact Word : constitutive @Position : 3
ERK-dependent resistance mechanisms can occur via activating MEK1  mutations   activating NRAS  mutations   COT  overexpression   elevated CRAS activity   BRAF  V600E alternative splicing or amplification   
Mutation Word : V600E @Position : 30
Function Word : activity @Position : 25
Impact Word : elevate @Position : 23
BCR-ABL1   FLT3  D835V and  KIT  D816Y transfectants displayed an intermediate sensitivity pattern estimated IC50s for NVP-BEZ235 ~10-130 nM and ~65-180 nM for NVP-BGT226 whereas  FLT3  ITD demonstrated high sensitivity for both agents with IC50s below 10 nM 
Mutation Word : D816Y @Position : 10
Function Word : sensitivity @Position : 35
Impact Word : high @Position : 34
Vemurafenib metformin or the combination resulted in decreased phosphorylation of AKT in BRAF V600E  and BRAF WT  cell lines Additional File  3  
Mutation Word : V600E @Position : 13
Function Word : phosphorylation @Position : 8
Impact Word : decrease @Position : 7
FLT3-ITD and FLT3 with an activating amino acid substitution in the tyrosine kinase domain such as FLT3-D835Y also constitutively activate the PI3K/Akt and MEK/Erk signaling pathways as well as STAT5 to stimulate proliferation and enhance survival of hematopoietic cells 
Mutation Word : D835Y @Position : 16
Function Word : activity @Position : 19
Impact Word : constitutive @Position : 18
Regarding the interference with the ERK signaling cell lines with BRAF V600D/R  mutations presented a faster and stronger inhibition of phosphorylated ERK as compared to control cells with a wild-type  BRAF  Figure  1 C 
Mutation Word : V600R @Position : 11
Function Word : inhibit @Position : 19
Impact Word : faster @Position : 16
We noted that the autophosphorylation level pY1092 of YFP-EGFR-ICD T790M was indeed higher than that of the wild type protein at lower expression levels compare graphs in Figure 1D  and Figure  4B  as reported by Vikis et al   
Mutation Word : T790M @Position : 9
Function Word : expression @Position : 22
Impact Word : higher @Position : 12
Notably inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
Mutation Word : D816Y @Position : 16
Function Word : inhibit @Position : 1
Impact Word : reduce @Position : 10
One Akt mutant E17K found in a subset of human cancers displays higher PIP3 binding membrane localization and activation Brazil et al.  Varnai et al   
Mutation Word : E17K @Position : 3
Function Word : activity @Position : 18
Impact Word : higher @Position : 12
Both mutations lead to ALK constitutive activation by autophosphorylation although ALK-F1174L displays a higher degree of phosphorylation and an increased tumorigenic potential compared to other ALK mutations [ 10   13   20 - 22   26 ] 
Mutation Word : F1174L @Position : 10
Function Word : activity @Position : 6
Impact Word : constitutive @Position : 5
The role of  BRAF  and  KRAS  oncogenes in altering cytoskeletal properties was further emphasized following depletion of BRAF V600E  by shRNA in HT29 cells where migration ability of HT-ShBR3 cells with downregulated expression of mt BRAF  gene was significantly impaired as compared to the empty vector control HT-ps cells 
Mutation Word : V600E @Position : 22
Function Word : migration @Position : 30
Impact Word : impair @Position : 45
In vitro studies by Guo and colleagues suggested that Nilotinib in cell lines transfected with a KIT gene containing an exon 9 or 11 mutation with an exon 17 mutation D820Y and N822 K demonstrated significant kinase inhibition as well as decreased cell proliferation The Japanese study also documented a partial response in patients whose GIST contained a KIT exon 11 dup 567–576 and exon 17 D820G mutation   
Mutation Word : D820Y @Position : 65
Function Word : proliferation @Position : 42
Impact Word : decrease @Position : 40
Consistent with this differential signaling effect the L858R+E884K-COS-7 cells had a significantly higher cell proliferation rate than that of the L858R-COS-7 cells in the MTS cell proliferation assay for 5 days  Figure 3B  
Mutation Word : L858R @Position : 20
Function Word : proliferation @Position : 26
Impact Word : higher @Position : 12
This mutation  E17K  increases recruitment of AKT1 to the membrane increases AKT1 phosphorylation and activity transforms Rat1 fibroblasts and induces leukaemia in transgenic mice  Carpten  et al  2007  
Mutation Word : E17K @Position : 3
Function Word : induce @Position : 21
Impact Word : increase @Position : 12
The increase in BIM expression and apoptosis are inhibited by the secondary resistant mutation T790M 
Mutation Word : T790M @Position : 14
Function Word : apoptosis @Position : 6
Impact Word : increase @Position : 1
The data suggest that low BRCA1 level may neutralize the negative effects of the EGFR T790M mutation on erlotinib sensitivity and that high BRCA1 expression may lead to de novo EGFR TKI resistance potentially through increased DNA damage repair capacity   
Mutation Word : T790M @Position : 15
Function Word : expression @Position : 24
Impact Word : high @Position : 22
This led us to question whether in solution perturbation of the autoP trajectory by RET M918T could arise through presentation of a better intermolecular substrate by favoring an “AL-out” conformer presenting Y900 or Y905 as a substrate to an active RET kinase in  trans  
Mutation Word : M918T @Position : 14
Function Word : substrate @Position : 35
Impact Word : better @Position : 21
Conversely E884K worked in concert with L858R in- cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition  Fig  1A B  
Mutation Word : E884K @Position : 1
Function Word : inhibit @Position : 21
Impact Word : enhance @Position : 12
BCR-ABL mutations respond differently to three tyrosine kinase inhibitors approved for first-line treatment of CML e.g  Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib while some mutations are less sensitive to nilotinib E255K/V and F359V/C or dasatinib F317L and V299L  
Mutation Word : F359C @Position : 52
Function Word : sensitivity @Position : 47
Impact Word : less @Position : 46
These two mutations resulting in L1198F and G1201E amino acid changes respectively both reside within the ALK tyrosine kinase domain where they dramatically increased tyrosine kinase activities 
Mutation Word : L1198F @Position : 5
Function Word : activity @Position : 26
Impact Word : increase @Position : 23
In summary we have demonstrated that targeting the switch pocket of KIT offers a novel and selective method to effectively suppress KIT D816V neoplastic proliferation and SCF enhanced mast cell activation 
Mutation Word : D816V @Position : 22
Function Word : activity @Position : 30
Impact Word : enhance @Position : 27
FP-1039 is currently in a Phase II trial for endometrial cancers with the S252W FGFR2  mutation which confers increased affinity and altered specificity of FGF binding   
Mutation Word : S252W @Position : 13
Function Word : binding @Position : 26
Impact Word : alter @Position : 22
In pathological LCH cells constitutive activity of the mutant BRAF V600E protein may lead to a deregulated signaling through this pathway thereby resulting in increased cell survival   
Mutation Word : V600E @Position : 10
Function Word : survival @Position : 26
Impact Word : increase @Position : 24
Our results indicate that lentiviral driven KRAS V12  expression concomitant with Braf V600E  expression reduces tumor number by over 100-fold compared to Braf V600E  expression alone 
Mutation Word : V600E @Position : 25
Function Word : expression @Position : 27
Impact Word : reduce @Position : 16
Notably melanomas that have the V600E  BRAF  mutation exhibit increased HIF-1α expression 
Mutation Word : V600E @Position : 5
Function Word : exhibit @Position : 10
Impact Word : increase @Position : 11
Instead the T790M mutation induces resistance by increasing the binding affinity of ATP by one order of magnitude which is near the affinity for wild-type  EGFR  thus enabling ATP to compete effectively with the kinase inhibitors   
Mutation Word : T790M @Position : 2
Function Word : induce @Position : 4
Impact Word : increase @Position : 7
Inhibition of RAF/MEK/ERK signaling is beneficial for many patients with BRAF V600E –mutated melanoma 
Mutation Word : V600E @Position : 11
Function Word : inhibit @Position : 0
Impact Word : beneficial @Position : 5
Therefore  BRAF  V600E increases the kinase activity that provides cancer cells with both proliferation and survival signals and promotes them to become tumors in the model system 
Mutation Word : V600E @Position : 4
Function Word : activity @Position : 8
Impact Word : increase @Position : 5
Sorafenib induces inhibition of proliferation in all cell lines and induces a significant increase in apoptosis in the cell line harbouring BRAF V600E  mutation Figure  3  
Mutation Word : V600E @Position : 22
Function Word : induce @Position : 10
Impact Word : increase @Position : 13
Cells expressing the L747_E749del A750P and D770_N771insNPG  EGFR  mutants also exhibited a greater degree of loss of contact inhibition than was observed in cells expressing the L858R or G719S EGFR mutants in a primary focus formation assay unpublished data 
Mutation Word : L858R @Position : 28
Function Word : inhibit @Position : 20
Impact Word : greater @Position : 14
Jak2-V617F is constitutively activated without cytokine stimulation and stimulates the various downstream signaling pathways that are normally activated by cytokine-stimulated Jak2 such as the STAT5 MEK/Erk and PI3K/Akt pathways thus leading to cytokine-independent cell survival and proliferation when expressed in cytokine-dependent hematopoietic cell lines  
Mutation Word : V617F @Position : 0
Function Word : activity @Position : 17
Impact Word : constitutive @Position : 2
Notably inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
Mutation Word : D816Y @Position : 16
Function Word : phosphorylation @Position : 3
Impact Word : reduce @Position : 10
There is no longer an indication for these investigations in patients positive for the JAK2  V617F mutation since it has been demonstrated that this mutation induces activation of the JAK2 kinase directly involved in the intracellular signaling following the exposure to EPO or thrombopoietin TPO in the elevated expression of mRNA for PRV-1 or NF-E2 in granulocytes or in processes involving MPL maturation and trafficking 
Mutation Word : V617F @Position : 16
Function Word : expression @Position : 49
Impact Word : elevate @Position : 48
The phosphorylation of ERK1/2 in cells expressing C121S MEK1 was elevated and this variant was permissive for growth in vemurafenib-treated mutant BRAF cell lines 
Mutation Word : C121S @Position : 7
Function Word : expression @Position : 6
Impact Word : elevate @Position : 10
Enforced expression of Stat3C increased miR-92a expression in H460 cells that could be inhibited by S3I-201  Figure 3D  
Mutation Word : S3I @Position : 15
Function Word : inhibit @Position : 13
Impact Word : increase @Position : 4
In comparison the activity of some FOP mutants was generally increased to a level similar to caALK2 revealing an inherent gain of function in their catalytic domain in the absence of added BMP ligand  Fig. 1  B . Significantly the signaling by R206H was increased by FK506 to a far greater extent than other GS domain mutants such as L196P  Fig  1  B  
Mutation Word : R206H @Position : 44
Function Word : activity @Position : 3
Impact Word : increase @Position : 46
Thus in in vitro  assays carried out using metformin MPP +  or TEA as prototypical substrates a reduced or even abolished OCT1-mediated transport activity was observed for R61C C88R S189L G220V P341L G401S M420del G465R P283L R287G P117L Q97K R206C R61S fs∗10 and C88A fs∗16  Table 4  
Mutation Word : G465R @Position : 36
Function Word : activity @Position : 25
Impact Word : reduce @Position : 19
Dyn1T141A-mCherry a mutant with reduced affinity for GTP but greater rate of GTP hydrolysis was surprisingly similar to dyn1S61D/T65D/T65H  Figure 2D  
Mutation Word : T141A @Position : 0
Function Word : affinity @Position : 5
Impact Word : reduce @Position : 4
As expected   single agent vemurafenib induced significant levels of apoptosis in all the BRAF V600E  mutant cell lines that are sensitive to this agent with a much less effect in the resistant ones Figure  3b  
Mutation Word : V600E @Position : 16
Function Word : effect @Position : 31
Impact Word : less @Position : 30
Here we observed that expression of both Snail sixfold and Slug twofold was increased in BRAF V600E  murine thyroid tumor tissue compared to normal thyroid Figure  3 C 
Mutation Word : V600E @Position : 16
Function Word : expression @Position : 4
Impact Word : increase @Position : 13
Consistent with this differential signaling effect the L858R+E884K-COS-7 cells had a significantly higher cell proliferation rate than that of the L858R-COS-7 cells in the MTS cell proliferation assay for 5 days  Figure 3B  
Mutation Word : E884K @Position : 7
Function Word : proliferation @Position : 26
Impact Word : higher @Position : 12
Under restrictive media conditions only S252W fibroblasts showed enhanced migration 
Mutation Word : S252W @Position : 5
Function Word : migration @Position : 9
Impact Word : enhance @Position : 8
In an  in vitro  study these two types of EGFR mutants demonstrated an enhanced TK activity in response to EGF and increased sensitivity to inhibition by TKI although the biological activity between tumours with L858R and those with deletions was different  Paez  et al  2004   Pao  et al  2004  
Mutation Word : L858R @Position : 36
Function Word : inhibit @Position : 26
Impact Word : increase @Position : 23
In  BRAF  V600D  WM266 4 human melanoma xenografts selumetinib induced tumour growth inhibition concomitant with reduced ERK1/2 phosphorylation thus confirming the inhibitory effects of the drug on MEK1/2 
Mutation Word : V600D @Position : 4
Function Word : phosphorylation @Position : 20
Impact Word : reduce @Position : 18
We found high levels of active Caspase-3 in the regressing tumors compared with  BRAF   V600E   mitf  melanomas at <26 °C  n =5 in each group  Figure 5c  
Mutation Word : V600E @Position : 17
Function Word : activity @Position : 5
Impact Word : high @Position : 2
Our previous data suggested that the amount of HGF bound to c-Met-N375S was much lower when compared with c-Met-WT thereby demonstrating a loss of affinity for HGF in the case of c-Met-N375S mutant  
Mutation Word : N375S @Position : 31
Function Word : affinity @Position : 24
Impact Word : lower @Position : 14
Previous  in vivo  analyses of the Fgfr2 P253R/+  and Fgfr2 S252W/+  mouse models of Apert syndrome revealed increased osteoblastic gene expression around the coronal suture   
Mutation Word : P253R @Position : 9
Function Word : expression @Position : 24
Impact Word : increase @Position : 21
Here we show for the first time that activation of FGFR3 is associated with an increase in FGFR3b expression in S249C mutated tumors 
Mutation Word : S249C @Position : 20
Function Word : expression @Position : 18
Impact Word : increase @Position : 15
The Th- ALK F1174L   mutation leads to the constitutive activation of the  ALK  protein in neuroblastoma  [29] – [32]  and the vascular phenotype associated with amplified or wild-type WT  ALK  expression is currently unknown 
Mutation Word : F1174L @Position : 3
Function Word : activity @Position : 11
Impact Word : constitutive @Position : 10
This result indicates that the secondary T790M mutation retains the active conformation of the binding site as proved by Yoshikawa et al  2013 
Mutation Word : T790M @Position : 6
Function Word : binding @Position : 14
Impact Word : retain @Position : 8
NFAT transcriptional activity was approximately 10-fold higher in A375 cells and approximately 70-fold higher in WM266-4 cells compared with  BRAF  wild-type CHL-1 cells  Figure 1A  consistent with increased B-RAF activity of BRAF V600D  compared with BRAF V600E   Wan  et al  2004  
Mutation Word : V600E @Position : 41
Function Word : activity @Position : 33
Impact Word : higher @Position : 13
BA/F3 cells expressing empty vector control BCR/ABL wild-type or imatinib-resistant mutations BCR/ABL E255K and T315I were a kind gift of Dr Brian Druker Oregon Health Science University Portland OR USA and maintained as described 
Mutation Word : T315I @Position : 14
Function Word : expression @Position : 2
Impact Word : maintain @Position : 31
BCR-ABL1   FLT3  D835V and  KIT  D816Y transfectants displayed an intermediate sensitivity pattern estimated IC50s for NVP-BEZ235 ~10-130 nM and ~65-180 nM for NVP-BGT226 whereas  FLT3  ITD demonstrated high sensitivity for both agents with IC50s below 10 nM 
Mutation Word : D835V @Position : 5
Function Word : sensitivity @Position : 35
Impact Word : high @Position : 34
We find an increased activity of SIRT1 in PLX4032 resistant BRAF V600E -mutated melanoma cells compared with their sensitive counterpart thereby linking SIRT1 to drug resistance and poor prognosis in melanoma 
Mutation Word : V600E @Position : 11
Function Word : resistance @Position : 25
Impact Word : increase @Position : 3
Activation by the Gal4-PPARγ-LBD-K365R mutant however was much lower in the absence and presence of ligands  Figure 5B  
Mutation Word : K365R @Position : 3
Function Word : activity @Position : 0
Impact Word : lower @Position : 8
On the contrary when F595 was replaced by an aromatic residue Tyr or Trp in the context of V617F the constitutive activity was maintained 
Mutation Word : V617F @Position : 18
Function Word : activity @Position : 21
Impact Word : maintain @Position : 23
The use of recombinant IFN-α rIFN-α-2b or PEG-IFN-α-2a in the treatment of PV can result in a significant reduction in the phlebotomy rate and is effective in inducing hematologic remission and in some cases reducing expression of  JAK2  V617F  [ 33 ] 
Mutation Word : V617F @Position : 40
Function Word : expression @Position : 35
Impact Word : reduce @Position : 34
The mutations Y253F E255V and H396P experience decreased vdW interactions with Phe382 
Mutation Word : E255V @Position : 3
Function Word : interaction @Position : 9
Impact Word : decrease @Position : 7
This is consistent with data indicating that high levels of ERK activation causes cell-cycle arrest and senescence   and that oncogene-induced senescence is potently induced by V600E BRAF   
Mutation Word : V600E @Position : 27
Function Word : activity @Position : 11
Impact Word : high @Position : 7
Here we present evidence that BRAF V600E  enhances migration and invasion properties in colon carcinoma cells through RhoA activation while KRAS G12V  induces these properties less efficiently as compared to BRAF V600E  albeit through Cdc42 activation and filopodia formation 
Mutation Word : V600E @Position : 33
Function Word : migration @Position : 9
Impact Word : enhance @Position : 8
We note that M918T also has increased activity toward exogenous substrates and is itself phosphorylated to a greater degree by exogenous kinases such as FAK  Figure S7  
Mutation Word : M918T @Position : 3
Function Word : substrate @Position : 10
Impact Word : increase @Position : 6
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : E255K @Position : 5
Function Word : expression @Position : 31
Impact Word : increase @Position : 19
However a comparison of expression arrays from human BRAF V600E  + PTC and ATC identified 1943 genes that were differentially regulated in the ATC compared to PTC which included increased expression of TGFβI and decreased expression of Smad6 a negative regulator of TGFβ signaling 
Mutation Word : V600E @Position : 9
Function Word : expression @Position : 36
Impact Word : decrease @Position : 35
For instance the A391E mutation in FGFR3 increases FGFR3 phosphorylation at low ligand concentration similarly to the G380R and G375C ACH mutations studied here  
Mutation Word : G380R @Position : 17
Function Word : ligand @Position : 12
Impact Word : increase @Position : 7
The most characterized resistance mutation is the T790M-point mutation in exon 20 which increases the affinity of the EGFR for ATP thus reducing the binding of EGFR TKIs to the ATP pocket 
Mutation Word : T790M @Position : 7
Function Word : atp @Position : 30
Impact Word : increase @Position : 13
Preliminary studies by transfection of cell lines with EGFR  mutant constructs revealed that in the absence of ligand EGF an enhanced tyrosine autophosphorylation can be observed in cells harbouring the plasmid containing EGFR-R776G when compared with wild-type EGFR providing biochemical evidence of the functional relevance of this mutation 
Mutation Word : R776G @Position : 33
Function Word : autophosphorylation @Position : 23
Impact Word : enhance @Position : 21
The level of activation of the K652E receptor was higher than the S249C and Y375C mutants  Figure 3a   Supplementary Figure 4a  
Mutation Word : S249C @Position : 12
Function Word : activity @Position : 3
Impact Word : higher @Position : 9
We find an increased activity of SIRT1 in PLX4032 resistant BRAF V600E -mutated melanoma cells compared with their sensitive counterpart thereby linking SIRT1 to drug resistance and poor prognosis in melanoma 
Mutation Word : V600E @Position : 11
Function Word : activity @Position : 4
Impact Word : increase @Position : 3
In summary the BRAF V600E -inhibitor PLX4720 and the SRC-inhibitor dasatinib synergize to inhibit proliferation reduce cellular migration and induce apoptosis in a variety of BRAF V600E -positive PTC and ATC cell lines 
Mutation Word : V600E @Position : 26
Function Word : inhibit @Position : 13
Impact Word : reduce @Position : 15
To further delineate whether these gene expression circuitry modifications were consequence of altered ligand binding affinity of FGFR2 or of constitutively active intracellular signaling by the receptor we sought for BAT3 BDP1 CYP51A1 TCF19 and RFC3 DEGs in S252W fibroblasts treated with FGF2 expression levels in a C342Y fibroblast through qRT-PCR 
Mutation Word : S252W @Position : 38
Function Word : affinity @Position : 15
Impact Word : alter @Position : 12
On the contrary when F595 was replaced by an aromatic residue Tyr or Trp in the context of V617F the constitutive activity was maintained 
Mutation Word : V617F @Position : 18
Function Word : activity @Position : 21
Impact Word : constitutive @Position : 20
In colorectal cancer patients a mutation in the extracellular domain of EGFR S492R which abrogates cetuximab binding but retains panitumumab sensitivity has been recently described as a mechanism of acquired resistance   Fig   2c  
Mutation Word : S492R @Position : 12
Function Word : binding @Position : 16
Impact Word : abrogate @Position : 14
The role of  BRAF  and  KRAS  oncogenes in altering cytoskeletal properties was further emphasized following depletion of BRAF V600E  by shRNA in HT29 cells where migration ability of HT-ShBR3 cells with downregulated expression of mt BRAF  gene was significantly impaired as compared to the empty vector control HT-ps cells 
Mutation Word : V600E @Position : 22
Function Word : expression @Position : 37
Impact Word : impair @Position : 45
These results suggest that the G518L mutation enhances EphA3-ephrin binding in  cis  and supports the involvement in the  cis  interface of the conserved glycine in the second fibronectin type III domain   
Mutation Word : G518L @Position : 5
Function Word : binding @Position : 9
Impact Word : enhance @Position : 7
Furthermore expression of CDK1 was increased in S249C and Y375C cells and the difference was particularly pronounced when the cells were starved in depleted medium to block stimulation by other growth factors 
Mutation Word : S249C @Position : 7
Function Word : expression @Position : 1
Impact Word : increase @Position : 5
The mutations F317V Y253F Y253H and E255K experience increased vdW interactions with residue Leu248 
Mutation Word : Y253H @Position : 4
Function Word : interaction @Position : 10
Impact Word : increase @Position : 8
Of patients with EGFR  mutant lung cancer 26-40% had tumors with high HGF expression and  EGFR -T790M secondary mutation 5-33% had tumors with  Met  gene amplification and  EGFR -T790M secondary mutation and 4-7% had tumors with high HGF expression and  Met  gene amplification suggesting that dual targeting of HGF/Met and the  EGFR -T790M mutation may overcome resistance to EGFR-TKIs   
Mutation Word : T790M @Position : 60
Function Word : expression @Position : 43
Impact Word : high @Position : 41
RNAi against  JAK2  reduced  SPI1  expression in  JAK2  V617F-positive HEL cells 
Mutation Word : V617F @Position : 14
Function Word : expression @Position : 9
Impact Word : reduce @Position : 5
Intriguingly the imatinib-resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM-1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells  Fig  4  
Mutation Word : E255K @Position : 5
Function Word : expression @Position : 23
Impact Word : increase @Position : 9
We verified that oncogenic RET M918T increases enzymatic activity and ATP affinity analogous to the T790M mutation of the EGFR  Yun et al  2008  
Mutation Word : M918T @Position : 5
Function Word : activity @Position : 8
Impact Word : increase @Position : 6
Expression of BRAF V600E  in BRAF mutant naïve cells resulted in increased expression and activation of Usp5 suggesting that pathway activation or phospho-regulation underlie Usp5 activation 
Mutation Word : V600E @Position : 3
Function Word : expression @Position : 13
Impact Word : increase @Position : 12
With molecular testing as a standard the delE746–A750 mutation-specific antibody 6B6 could detect 69 of the 86 cases with an E746–A750 deletion mutation 40 with score 2+ and 29 with score 3+ whereas it was negative in the remaining 17 cases 4 with score 0 and 14 with score 1+ κ = 0.584 sensitivity 80.23% specificity 85.3% PPV 60% NPV 94.01% the L858R mutation-specific antibody 43B2 could identify 53 of 70 cases with a L858R point mutation 31 with score 2+ and 22 with 3+ whereas it was negative in the remaining 17 cases 7 with score 0 and 10 with score 1+ κ = 0.639 sensitivity 75.71% specificity 91.79% PPV 66.25% NPV 94 67% 
Mutation Word : L858R @Position : 72
Function Word : sensitivity @Position : 102
Impact Word : negative @Position : 86
In the 29 patients with exon 19 deletions high expression of EGFR E746-A750 deletion-specific 6B6 protein score 2 or 3 was observed in 17/17 cases 100% with 15-bp deletion 16 with ELREA and 1 with ELREA + T751I 
Mutation Word : T751I @Position : 37
Function Word : expression @Position : 9
Impact Word : high @Position : 8
Other mutations outside the active site secondary mutations can increase resistance in the presence of major primary mutations like L10I/V K20M/L/T and I54V as well as additional primary mutations such as M46I and V82A/F/L/T 
Mutation Word : V82A @Position : 33
Function Word : activity @Position : 4
Impact Word : increase @Position : 9
Specifically BRAF V600E  alters the typical epithelial morphology of Caco-2 cells the distribution of E-cadherin and reduces its expression at the mRNA level 
Mutation Word : V600E @Position : 2
Function Word : expression @Position : 19
Impact Word : reduce @Position : 17
A B and C pro-apoptotic genes  BAX BIK  and  BAD  showed lower expression in ET JAK2 V617F positive patients compared to negative patients D E and F  BAX BIK  and  BAD  expression in ET leukocytes also negatively correlated with the patients JAK2 V617F allele burden 
Mutation Word : V617F @Position : 50
Function Word : expression @Position : 39
Impact Word : lower @Position : 15
Consistent with this we observed a substantially higher ALK phosphorylation in Karpas299 cells carrying I1171T and F1174C mutations 
Mutation Word : F1174C @Position : 16
Function Word : phosphorylation @Position : 9
Impact Word : higher @Position : 7
As expected BRAF V600E  inhibited MST1-induced 3XIRS reporter activation in a dose-dependent manner and MST1 abolished the inhibitory effect of BRAF V600E  on FoxO3 transactivation  Fig  3B & 3C  
Mutation Word : V600E @Position : 22
Function Word : effect @Position : 19
Impact Word : abolish @Position : 16
Other mutations outside the active site secondary mutations can increase resistance in the presence of major primary mutations like L10I/V K20M/L/T and I54V as well as additional primary mutations such as M46I and V82A/F/L/T 
Mutation Word : V82A @Position : 33
Function Word : resistance @Position : 10
Impact Word : increase @Position : 9
Conversely E884K worked in concert with L858R in- cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition  Fig  1A B  
Mutation Word : E884K @Position : 1
Function Word : inhibit @Position : 21
Impact Word : enhance @Position : 12
A AUC for the logistic regression model based on L858R Q score and total EGFR expression Q score was higher than that for L858R intensity only 0.891 vs. 0.853  p  = 0 036 
Mutation Word : L858R @Position : 23
Function Word : expression @Position : 15
Impact Word : higher @Position : 19
In most of adult forms of indolent systemic mastocytosis KIT is constitutively activated as a consequence of D816V mutation whereas in pediatric forms of mastocytosis extracellular and juxtamembrane mutations are more common    
Mutation Word : D816V @Position : 17
Function Word : activity @Position : 12
Impact Word : constitutive @Position : 11
In a dose-response experiment  Figure 3 B left panel the best inhibitor D4 was effective at a concentration of 200 nM to inhibit RET C634Y  autophosphorylation up to 70% and to drastically reduce ERK phosphorylation 
Mutation Word : C634Y @Position : 25
Function Word : phosphorylation @Position : 36
Impact Word : reduce @Position : 34
The addition of EGFR siRNA whether wild type or T790M-specificto c-MET siRNAs enhanced growth inhibition in H358 and H1650 cells compared to EGFR siRNA alone but much less so in H1975 cells  Figure 2A  
Mutation Word : T790M @Position : 9
Function Word : inhibit @Position : 14
Impact Word : enhance @Position : 12
We see that in the absence of ligand the phosphorylation of both the FGFR3/G375C and the FGFR3/G380R mutants is about 2 5 times higher than that of the wild type 
Mutation Word : G380R @Position : 16
Function Word : ligand @Position : 7
Impact Word : higher @Position : 23
In contrast MEN2B is almost always caused by the same M918T mutation and causes ganglioneuromas to form within the ENS impairing bowel function 
Mutation Word : M918T @Position : 10
Function Word : function @Position : 22
Impact Word : impair @Position : 20
The T790M EGFR mutant has increased affinity for ATP which is the primary mechanism responsible for the development of resistance to small molecule tyrosine kinase inhibitors TKIs such as gefitinib and erlotinib  [36]  
Mutation Word : T790M @Position : 1
Function Word : affinity @Position : 6
Impact Word : increase @Position : 5
To avoid the influence of mutant  BRAF V600E   in the ERK phosphorylation assay we used EpoR siRNA for transient transfection in WM3211 melanoma cells which have wild type BRAF and NRAS proteins 
Mutation Word : V600E @Position : 8
Function Word : phosphorylation @Position : 14
Impact Word : avoid @Position : 1
F1174L may therefore stabilize an active conformation that is both more oncogenic and less favored for crizotinib binding 
Mutation Word : F1174L @Position : 0
Function Word : binding @Position : 17
Impact Word : stability @Position : 3
In the cases of mutation M918T constitutive RET activation probably results from disruption of an auto-inhibited head-to-tail RET tyrosine kinase homodimer   
Mutation Word : M918T @Position : 5
Function Word : result @Position : 10
Impact Word : disrupt @Position : 12
Similar to E884K R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in- cis  with L858R 
Mutation Word : E884K @Position : 2
Function Word : sensitivity @Position : 6
Impact Word : modulates @Position : 4
One Akt mutant E17K found in a subset of human cancers displays higher PIP3 binding membrane localization and activation Brazil et al.  Varnai et al   
Mutation Word : E17K @Position : 3
Function Word : binding @Position : 14
Impact Word : higher @Position : 12
Compared to L858R alone the L858R+E884K dual mutant was less sensitive to erlotinib in the inhibition of tyrosine phosphorylation of EGFR 
Mutation Word : E884K @Position : 5
Function Word : sensitivity @Position : 10
Impact Word : less @Position : 9
The EGFR  T790M variant changes the structural conformation of the ATP-binding site thereby increasing the affinity of ATP to EGFR while the affinity of gefitinib to ATP is unchanged 
Mutation Word : T790M @Position : 3
Function Word : affinity @Position : 23
Impact Word : increase @Position : 14
Co-expression of Braf V600E  and activated KRAS significantly reduced tumor formation with this very low tumor burden precluding our ability to observe progression to the adenocarcinoma stage as would be predicted 
Mutation Word : V600E @Position : 3
Function Word : activity @Position : 6
Impact Word : reduce @Position : 9
The PNAcqPCR detects the  BRAF  V600E  mutation with high sensitivity 
Mutation Word : V600E @Position : 7
Function Word : sensitivity @Position : 12
Impact Word : high @Position : 11
Hence E884K in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 1
Function Word : sensitivity @Position : 10
Impact Word : alter @Position : 29
Moreover mutations L755S L755P V777L T798M and T862A displayed enhanced activation of JNK/SAPK and to a lesser extent of ERK1/2 compared to wt-ERBB2  Figure 2A  
Mutation Word : L755S @Position : 3
Function Word : activity @Position : 10
Impact Word : enhance @Position : 9
We also find that a melanoma-associated mutation within the pseudosubstrate sequence P52L disrupts PAK6 autoinhibition enhancing its kinase activity potentially correlating with increased expression of PAK6 in prostate cancer and implied alterations in kinase activity  
Mutation Word : P52L @Position : 11
Function Word : expression @Position : 23
Impact Word : disrupt @Position : 12
For instance the A391E mutation in FGFR3 increases FGFR3 phosphorylation at low ligand concentration similarly to the G380R and G375C ACH mutations studied here  
Mutation Word : A391E @Position : 3
Function Word : ligand @Position : 12
Impact Word : increase @Position : 7
The other possibility is that the presence of the EGFR T790M mutation could increase the affinity of the EGFR-L858R for ATP and thus reduce the potency of an ATP-competitive kinase inhibitor   
Mutation Word : T790M @Position : 10
Function Word : atp @Position : 20
Impact Word : increase @Position : 13
Stimulation of GTL16-L858R cells with a physiological concentration of EGF 1 ng/ml resulted in further increase of anchorage-independent growth only in the absence of MET signaling 
Mutation Word : L858R @Position : 2
Function Word : result @Position : 12
Impact Word : increase @Position : 15
In vitro studies show that T790M confers resistance to gefitinib possibly by increasing EGFR’s affinity for ATP thus decreasing the binding of the ATP-competitive TKI 
Mutation Word : T790M @Position : 5
Function Word : affinity @Position : 14
Impact Word : increase @Position : 12
Mutating the BRAF dimerization motif R509H abolishes resistance conferred by N-terminal truncated BRAF moieties Poulikakos et al   2011  however it has no effect on  BRAF   V600E/L505H   Figure  4 D 
Mutation Word : L505H @Position : 31
Function Word : effect @Position : 25
Impact Word : abolish @Position : 6
As previously reported   levels of phosphorylated RET and ERK were constitutively high in untreated PC12/MEN2A cells due to the presence of the active RET C634Y  allele 
Mutation Word : C634Y @Position : 26
Function Word : phosphorylation @Position : 7
Impact Word : high @Position : 13
Ki67 labeling revealed an enhanced proliferation index in JoMa1-ALK-F1174L-derived tumors 48% compared to JoMa1-ALK-R1275Q- 40% and JoMa1-ALK-wt-derived tumors 38% Figure  3b  suggesting that the accelerated tumor growth of JoMa1-ALK-F1174L tumors may partly result from their increased proliferation capacity 
Mutation Word : F1174L @Position : 30
Function Word : proliferation @Position : 38
Impact Word : increase @Position : 37
Colorectal cancer has been analyzed with the BRAF V600E mutation specific antibody and most studies find high sensitivities and specificities 98 8–100% in comparison with PCR-based methods or sequencing   
Mutation Word : V600E @Position : 8
Function Word : sensitivity @Position : 17
Impact Word : high @Position : 16
The result is the disruption of the I-1 interactions indicating that H587N is a deleterious mutation 
Mutation Word : H587N @Position : 11
Function Word : result @Position : 1
Impact Word : disrupt @Position : 4
Similar to  Figure 1B  STAT3 Akt and Erk phosphorylation in EGFR L858R-and more significantly Δ746-750-expressing cells remained relatively high when compared to vector and wtEGFR-expressing cells upon serum-deprivation  Figure 7A  
Mutation Word : L858R @Position : 13
Function Word : phosphorylation @Position : 10
Impact Word : high @Position : 20
R958D mutation when in- cis  with L858R decreased the sensitivity of the mutant receptor to erlotinib inhibition while increasing the sensitivity to gefitinib in a dominant fashion  Figure 5A B  
Mutation Word : L858R @Position : 7
Function Word : sensitivity @Position : 21
Impact Word : increase @Position : 19
Both mutations lead to ALK constitutive activation by autophosphorylation although ALK-F1174L displays a higher degree of phosphorylation and an increased tumorigenic potential compared to other ALK mutations [ 10   13   20 - 22   26 ] 
Mutation Word : F1174L @Position : 10
Function Word : phosphorylation @Position : 16
Impact Word : higher @Position : 13
MST1 expression significantly increased apoptosis which is reduced by expression of BRAF V600E  
Mutation Word : V600E @Position : 12
Function Word : apoptosis @Position : 4
Impact Word : increase @Position : 3
Since this initial report Xing has shown that the BRAF activating mutation is the most common genetic alteration in thyroid cancer   occurring in 18% to 87% of thyroid cancers   importantly the BRAF V600E   mutation occurs in nearly 45% of sporadic cases of PTC   and 24% of cases of anaplastic carcinoma   
Mutation Word : V600E @Position : 36
Function Word : activity @Position : 10
Impact Word : alter @Position : 17
In an  in vitro  study these two types of EGFR mutants demonstrated an enhanced TK activity in response to EGF and increased sensitivity to inhibition by TKI although the biological activity between tumours with L858R and those with deletions was different  Paez  et al  2004   Pao  et al  2004  
Mutation Word : L858R @Position : 36
Function Word : sensitivity @Position : 24
Impact Word : increase @Position : 23
TBP-3868 exhibits high basal Ras activity relative to the PLX4720 sensitive line TBP-3743 suggesting that the resistance to BRAF V600E -inhibition in TBP-3868 may be attributed to Ras-dependent transactivation of RAF dimers 
Mutation Word : V600E @Position : 19
Function Word : dimerization @Position : 31
Impact Word : high @Position : 2
Treatment of melanoma cells with BRAF V600E-specific shRNA or MEK inhibitors resulted in decreased immunosuppressive activity of melanoma cells on DCs suggesting that MAPK signaling pathway in cancer is associated with impaired DC function in melanoma patients 
Mutation Word : V600E @Position : 6
Function Word : activity @Position : 15
Impact Word : decrease @Position : 13
A JAK2 K539L T875N and R683G all induce constitutive activation of JAK2 however all three mutants display a marked decrease in STAT5 transcriptional activity in γ-2A cells when the F595A mutation is also introduced 
Mutation Word : K539L @Position : 2
Function Word : activity @Position : 23
Impact Word : constitutive @Position : 8
The Y931C mutation might disrupt the π–π interaction between tyrosine ring and the inhibitor ring structure thus weakening the inhibitor binding and resulting in easy expulsion from the pocket 
Mutation Word : Y931C @Position : 1
Function Word : interaction @Position : 7
Impact Word : disrupt @Position : 4
We found that the suppressor of cytokine signaling 3  SOCS3  expression was significantly elevated in MPN patients with a  JAK2  V617F mutation suggesting that  SOCS3  mRNA in peripheral blood can be used as a biomarker for diagnosis and assessment of MPN patients 
Mutation Word : V617F @Position : 24
Function Word : expression @Position : 12
Impact Word : elevate @Position : 15
The goals of these methods are to increase sensitivity specificity and to accurately quantify mutations of B-Raf V600E 
Mutation Word : V600E @Position : 17
Function Word : sensitivity @Position : 8
Impact Word : increase @Position : 7
Previous studies in other cellular contexts have demonstrated that the S252W FGFR2 mutant receptor exhibits decreased ligand dissociation  Anderson et al  1998  
Mutation Word : S252W @Position : 10
Function Word : exhibit @Position : 14
Impact Word : decrease @Position : 15
Co-expression of Braf V600E  and activated KRAS significantly reduced tumor formation with this very low tumor burden precluding our ability to observe progression to the adenocarcinoma stage as would be predicted 
Mutation Word : V600E @Position : 3
Function Word : ability @Position : 20
Impact Word : reduce @Position : 9
Some variants seem to consistently decrease kinase activity including the G2385R variant   that is a genetic risk factor for PD in some populations 
Mutation Word : G2385R @Position : 10
Function Word : activity @Position : 7
Impact Word : decrease @Position : 5
In this regard there has been some controversy regarding the enhanced kinase activity of T790M-mutant EGFR   
Mutation Word : T790M @Position : 14
Function Word : activity @Position : 12
Impact Word : enhance @Position : 10
It is also possible that binding of the drug to one p61B-RAF V600E  monomer inhibits drug binding to the other resulting in one active monomer per dimer and abolishing drug resistance 
Mutation Word : V600E @Position : 12
Function Word : resistance @Position : 31
Impact Word : abolish @Position : 29
However in the case of the two NS1 mutants that induced the greatest mortality D2N †  and M106I + L98S viral yield in the lung was 12 and 8 fold greater than rHK-wt 1 dpi while the corresponding level of IFN-β concentration was significantly increased but only by 50% p<0 01
Mutation Word : D2N @Position : 14
Function Word : induce @Position : 10
Impact Word : greater @Position : 31
Interestingly expression of p16 was significantly elevated in cultures transfected with   V600E   BRAF  but not   WT   BRAF  especially in individual cells expressing   V600E  BRAF relative to those expressing   WT  BRAF  Figure 5A–C  whereas p21 expression was no higher with   V600E  BRAF than   WT  BRAF or the empty vector  Figure 5A  
Mutation Word : V600E @Position : 59
Function Word : expression @Position : 52
Impact Word : elevate @Position : 6
Notably inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
Mutation Word : D816V @Position : 16
Function Word : phosphorylation @Position : 3
Impact Word : reduce @Position : 10
Graph shows that the common L858R mutation confers higher autophosphorylation levels to YFP-EGFR-ICD than P848L and A859T 
Mutation Word : L858R @Position : 5
Function Word : autophosphorylation @Position : 9
Impact Word : higher @Position : 8
In fact it is well established that gefitinib is more active in some patient subgroups such as Asians females never smokers and adenocarcinoma histotypes which have a higher probability of harbouring activating mutations in the tyrosine kinase domain the most frequent being L858R in exon 21 and Del 746-750 in exon 19   
Mutation Word : L858R @Position : 42
Function Word : activity @Position : 31
Impact Word : higher @Position : 27
We identified 25-fold increased expression of MMP-1 mRNA in melanoma cells possessing BRAF V600E  compared to wildtype while HPMs expressed similar transcript levels with BRAF wildtype melanoma cell  Figure 2a  suggesting that increased BRAF kinase activity may be associated with elevated MMP-1 expression in melanomas 
Mutation Word : V600E @Position : 13
Function Word : activity @Position : 38
Impact Word : increase @Position : 35
RAS and RAF proteins play a key role in the control of cellular growth proliferation and differentiation  Bos 1989   Wickenden  et al  2008   KRAS -activating mutations reduce or abolish intrinsic GTPase activity of the protein leading to its constitutive activation  Conlin  et al  2005  Similarly  BRAF  V600E mutation induces structural changes in RAF protein which increase its kinase activity  Wan  et al  2004  Activated RAS and RAF are responsible for the disregulation of RAS/RAF/MAPKs signalling pathway 
Mutation Word : V600E @Position : 59
Function Word : activity @Position : 80
Impact Word : increase @Position : 68
Similarly E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor CL-387785 
Mutation Word : E884K @Position : 1
Function Word : inhibit @Position : 10
Impact Word : enhance @Position : 3
9   Preclinical studies have shown superior activity of afatinib over first-generation TKIs mainly due to 1 irreversible binding which confers stronger binding affinity and potency 2 ability to circumvent first-generation TKI resistance mechanism T790M mutation in exon 20 and 3 effectiveness against multiple HER-endothelial growth factor receptors   10  
Mutation Word : T790M @Position : 35
Function Word : effect @Position : 42
Impact Word : stronger @Position : 22
At Days 3 and 5 the cell proliferation rate as determined by % viable cells increase during the assay period was 1.46-fold Day 3 and 1.40-fold  P =0 0013 higher Day 5 in L858R+E884K than L858R alone 
Mutation Word : E884K @Position : 34
Function Word : proliferation @Position : 7
Impact Word : higher @Position : 30
However this resistance to EGFR TKI has been many times lower than the resistance in cells harbouring both the L858R and T790M mutations 
Mutation Word : T790M @Position : 21
Function Word : resistance @Position : 13
Impact Word : lower @Position : 10
The potency of afatinib on the L858R/T790M double mutation of EGFR known to be resistant to erlotinib gefitinib and lapatinib was reduced but still in the nanomolar range Table  1  Cha et al.  Solca et al.  Sos et al   
Mutation Word : L858R @Position : 6
Function Word : resistance @Position : 14
Impact Word : reduce @Position : 21
Here we test the hypothesis that E1271K mutation of MET analogous to E884K-EGFR can also differentially alter inhibitory sensitivity towards selective MET inhibitors  Figure 6  
Mutation Word : E884K @Position : 12
Function Word : sensitivity @Position : 18
Impact Word : alter @Position : 16
The D816V mutant destabilizes the inactivated form of Kit in a way that the ability of the protein to adopt the "DFG out" inactive conformation is much reduced or even eliminated thus the mutation prevents both motesanib and imatinib from binding to the ATP pocket   
Mutation Word : D816V @Position : 1
Function Word : ability @Position : 14
Impact Word : eliminate @Position : 30
Similar to oncogenic Ras the BRAF V600E  mutant induces an increase in the number of senescent cells in melanoma  92  
Mutation Word : V600E @Position : 6
Function Word : induce @Position : 9
Impact Word : increase @Position : 11
In normal B-cells the wild type BRAF activation loop T 599 VKS 602  induces kinase activity by conformational changes  [27]  whereas the V600E mutation intrinsically achieves a constitutively active conformation by mimicking the loop leading to chronic MEK/ERK signaling and transformation  [28]  
Mutation Word : V600E @Position : 25
Function Word : activity @Position : 31
Impact Word : constitutive @Position : 30
A  PRV1  expression was higher in ET JAK2 V617F positive patients than in JAK2 V617F negative patients B a positive correlation between  PRV1  expression in ET leukocytes and JAK2 V617F allele burden percentage was detected 
Mutation Word : V617F @Position : 33
Function Word : expression @Position : 27
Impact Word : higher @Position : 6
Taken together these data suggest that BRAF V600E  is able to relax cell-cell junctions by reducing E-cadherin expression and may drive colon epithelial cells to a more aggressive phenotype while KRAS G12V  reserves their epithelial characteristics 
Mutation Word : V600E @Position : 7
Function Word : expression @Position : 18
Impact Word : reduce @Position : 16
Indeed we found that TAK1 was tyrosine phosphorylated in HEK293 cells transiently expressing constitutively active FGFR3 K650E but not the kinase-dead receptor K508M indicating that activated FGFR3 can either directly or indirectly tyrosine phosphorylate TAK1  Figure 2A  
Mutation Word : K650E @Position : 16
Function Word : activity @Position : 25
Impact Word : constitutive @Position : 13
The V600E mutation confers an increase in BRAF kinase activity of approximately 480 times compared with wild-type BRAF whereas the V600D mutation increases this by approximately 700 times  Wan  et al  2004  
Mutation Word : V600D @Position : 20
Function Word : activity @Position : 9
Impact Word : increase @Position : 22
It may be that there is preferential MAPK pathway-addiction in sensitive cell lines and cells with lower sensitivity are less dependent on the  BRAF  V600E  oncogenic signaling relying on the co-activation of other signaling pathways including the PI3K/Akt pathway 
Mutation Word : V600E @Position : 26
Function Word : sensitivity @Position : 17
Impact Word : lower @Position : 16
BRAF  V600E has been associated with more aggressive tumors and lower rates of patient survival   
Mutation Word : V600E @Position : 2
Function Word : survival @Position : 15
Impact Word : lower @Position : 11
It is certainly possible that our  BRAF   V600E   mutant cutaneous melanoma panel is skewed for cell lines with natural resistance to inhibition of the MAPK pathway since we have previously reported a similar greater than expected frequency of cutaneous cell lines resistant to the type I BRAF inhibitor vemurafenib   
Mutation Word : V600E @Position : 10
Function Word : resistance @Position : 46
Impact Word : greater @Position : 38
In comparison to the S252W mutation that enhances signaling with a limited subset of Fgfs the P253R mutation enhances signaling with many Fgfs and one hypothesis is that the P253R mutation may respond to many more signals that can have overlapping redundant and/or counteracting effects resulting in a more moderate increase of MI 
Mutation Word : S252W @Position : 4
Function Word : effect @Position : 44
Impact Word : enhance @Position : 18
Because aberrant activation of FGFR2 S252W  is related primarily to its broadened ligand-binding specificity and increased ligand-binding affinity its pathological activities must necessarily be linked to local or cell-intrinsic ligand levels 
Mutation Word : S252W @Position : 5
Function Word : affinity @Position : 18
Impact Word : increase @Position : 16
The V617F mutation disrupts the inhibitory activity of the JAK2 pseudokinase domain leading to constitutive JAK2 kinase activity and hyperactivation of multiple downstream targets  James et al  2005  
Mutation Word : V617F @Position : 1
Function Word : activity @Position : 17
Impact Word : disrupt @Position : 3
The E17K mutation constitutively activates Akt1 by altering the kinetics and specificity of phospholipid binding increasing the binding to PIP2 the more abundant plasma membrane phospholipid in the absence of PI3-kinase activation  
Mutation Word : E17K @Position : 1
Function Word : activity @Position : 31
Impact Word : alter @Position : 7
Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells  Carpten  et al  2007  
Mutation Word : E17K @Position : 7
Function Word : expression @Position : 4
Impact Word : increase @Position : 13
The S252W mutation enhanced cell proliferation in fibroblasts even in critical culture conditions such as 0 5% FBS medium but it had a negative effect on MSCs in 20% FBS culture environment 
Mutation Word : S252W @Position : 1
Function Word : proliferation @Position : 5
Impact Word : enhance @Position : 3
Likewise the T790M-specific-siRNA could knock down T790M mRNA and also suppress cell proliferation and enhance cell caspase activity in H1975 cells containing the T790M mutation 
Mutation Word : T790M @Position : 23
Function Word : activity @Position : 17
Impact Word : enhance @Position : 14
The data suggest that low BRCA1 level may neutralize the negative effects of the EGFR T790M mutation on erlotinib sensitivity and that high BRCA1 expression may lead to de novo EGFR TKI resistance potentially through increased DNA damage repair capacity   
Mutation Word : T790M @Position : 15
Function Word : sensitivity @Position : 19
Impact Word : neutral @Position : 8
JAK2 inhibition in JAK2 V617F  cells modulates the post-translational modification of Bim and levels of Mcl-1
Mutation Word : V617F @Position : 4
Function Word : inhibit @Position : 1
Impact Word : modulates @Position : 7
Moreover E884K had a dominant effect over L858R when in- cis  in these signaling modulatory effects 
Mutation Word : L858R @Position : 7
Function Word : effect @Position : 16
Impact Word : dominant @Position : 4
A mutant form of E17K which has increased phosphorylation is located at the plasma membrane in response to growth factor stimulation 
Mutation Word : E17K @Position : 4
Function Word : phosphorylation @Position : 8
Impact Word : increase @Position : 7
In V617Y Figure  4  and Figure  5  Y617 also interacts with F595 and blocks the contacts between the JH1 activation loop and JH2 C-helix in a way very similar to V617F in that the I-2 interactions vdw [JH1A JH2C] are severely damaged 
Mutation Word : V617F @Position : 34
Function Word : interaction @Position : 39
Impact Word : damage @Position : 45
Furthermore from a gefitinib-resistant patient carrying the activating L858R mutation we identified a novel secondary resistant mutation L747S in cis to the activating mutation which attenuated the up-regulation of BIM and reduced apoptosis 
Mutation Word : L858R @Position : 8
Function Word : activity @Position : 22
Impact Word : attenuate @Position : 25
E884K-EGFR modulates inhibitor sensitivity effects in an inhibitor-specific fashion
Mutation Word : E884K @Position : 0
Function Word : effect @Position : 4
Impact Word : modulates @Position : 1
This mutation  E17K  increases recruitment of AKT1 to the membrane increases AKT1 phosphorylation and activity transforms Rat1 fibroblasts and induces leukaemia in transgenic mice  Carpten  et al  2007  
Mutation Word : E17K @Position : 3
Function Word : activity @Position : 16
Impact Word : increase @Position : 12
Moreover E884K had a dominant effect over L858R when in- cis  in these signaling modulatory effects 
Mutation Word : E884K @Position : 1
Function Word : effect @Position : 16
Impact Word : dominant @Position : 4
These data demonstrate that intermittent dosing of MRLB-11055 at a dose level that was effective at reducing hematocrit and normalizing spleen weight in JAK2 V617F  mice was sparing of lymphocyte populations in normal C57BL/6 mice 
Mutation Word : V617F @Position : 24
Function Word : effect @Position : 14
Impact Word : reduce @Position : 16
The role of BRAF inhibitors targeting non-BRAF V600E cancers remains to be elucidated although promising activity has been reported   
Mutation Word : V600E @Position : 7
Function Word : activity @Position : 15
Impact Word : remain @Position : 9
In numerous studies the  JAK2  V617F allele has been variably associated with higher indices of erythropoiesis unchanged or decreased platelet counts greater occurrence of thrombosis increased BM fibrosis or cytoreductive treatments older age longer disease duration or poorer survival in MPN   
Mutation Word : V617F @Position : 7
Function Word : associated @Position : 12
Impact Word : unchange @Position : 18
Webster and Donoghue proposed that the G380R mutation enhances FGFR3 dimerization likely due to hydrogen bonding of the mutant R380 to the neighboring receptor in the dimer  
Mutation Word : G380R @Position : 6
Function Word : dimerization @Position : 26
Impact Word : enhance @Position : 8
The mutational status of these two lines is particularly relevant to interpretation of the data since BRAF in both A375 and LOX-IMVI is constitutively activated by the V600E mutation  
Mutation Word : V600E @Position : 27
Function Word : activity @Position : 24
Impact Word : constitutive @Position : 23
In fact the T141A and L153A mutations appeared to increase binding slightly  Fig  2J  
Mutation Word : T141A @Position : 3
Function Word : binding @Position : 10
Impact Word : increase @Position : 9
We verified that oncogenic RET M918T increases enzymatic activity and ATP affinity analogous to the T790M mutation of the EGFR  Yun et al  2008  
Mutation Word : T790M @Position : 15
Function Word : activity @Position : 8
Impact Word : increase @Position : 6
19 ] In addition vemurafenib a v-raf murine sarcoma viral oncogene homolog B BRAF kinase inhibitor significantly increased rates of survival over dacarbazine in patients with previously untreated BRAF V600E-mutated metastatic melanoma 40-60% of melanomas [
Mutation Word : V600E @Position : 29
Function Word : survival @Position : 20
Impact Word : increase @Position : 17
R958D mutation when in- cis  with L858R decreased the sensitivity of the mutant receptor to erlotinib inhibition while increasing the sensitivity to gefitinib in a dominant fashion  Figure 5A B  
Mutation Word : L858R @Position : 7
Function Word : inhibit @Position : 17
Impact Word : decrease @Position : 8
The activity against the resistance mutation T790M and cell lines with downstream resistance mechanisms was however only slightly better than the reversible TKIs 
Mutation Word : T790M @Position : 6
Function Word : activity @Position : 1
Impact Word : better @Position : 18
We observe that the G375C mutation increases FGFR3 phosphorylation in the absence of ligands and at low but not at high ligand concentrations similarly to the G380R mutation 
Mutation Word : G380R @Position : 26
Function Word : ligand @Position : 21
Impact Word : increase @Position : 6
As a whole these findings show that SkE also exhibited high activity against the B-Raf V600E mutation 
Mutation Word : V600E @Position : 15
Function Word : activity @Position : 11
Impact Word : high @Position : 10
Complicating this interpretation Ocm1 cells have been shown to carry the common V600E BRAF mutation that constitutively activates the MAPK pathway  
Mutation Word : V600E @Position : 12
Function Word : activity @Position : 17
Impact Word : constitutive @Position : 16
Strongly reduced activity of the PPARγ K365R mutant contradicts the results of Pascual  et al  who reported similar activation of the Aox-tk  luciferase construct by wild type PPARγ and by the PPARγ K365R mutant 
Mutation Word : K365R @Position : 35
Function Word : result @Position : 10
Impact Word : reduce @Position : 1
This V600E BRAF variant possesses a markedly higher dimerization property irrespective of RAS status and strongly activates MEK and ERK1/2 in the presence of vemurafenib 
Mutation Word : V600E @Position : 1
Function Word : dimerization @Position : 8
Impact Word : higher @Position : 7
We show that PAK6 kinase activity is regulated by its N-terminal pseudosubstrate  in vitro  and that a melanoma-associated mutation P52L in the pseudosubstrate sequence displays reduced inhibition 
Mutation Word : P52L @Position : 21
Function Word : inhibit @Position : 28
Impact Word : reduce @Position : 27
The coexistent mutations of  AKT3  and  PIK3CA  in one sample suggest that some types of  AKT  mutations non-E17K might coexist with  PIK3CA  mutations to enhance the activation of the PI3 kinase–AKT pathway 
Mutation Word : E17K @Position : 23
Function Word : activity @Position : 34
Impact Word : enhance @Position : 32
The mutation of arginine at position 24 into cysteine CDK4 R24C  or histidine CDK4 R24C  renders the protein insensitive to regulation by p16 INK4a  but preserves interaction between CDK4 and cyclin D1 leading to constitutive activation of the complex and aberrant proliferation through retinoblastoma protein inactivation and E2F activation 
Mutation Word : R24C @Position : 15
Function Word : activity @Position : 51
Impact Word : preserve @Position : 28
Overexpression of the  JAK2  V617F mutant but not the wild-type  JAK2  in K562 cells also resulted in increased  SPI1  expression 
Mutation Word : V617F @Position : 6
Function Word : expression @Position : 25
Impact Word : increase @Position : 21
Compared to L858R alone the L858R+E884K dual mutant was less sensitive to erlotinib in the inhibition of tyrosine phosphorylation of EGFR 
Mutation Word : E884K @Position : 5
Function Word : sensitivity @Position : 10
Impact Word : less @Position : 9
Synergy is particularly important as it may permit lower doses of PLX4720 to be used potentially translating to a benefit in the clinic by reducing side effects associated with BRAF V600E -inhibition including squamous cell carcinoma [ 54 - 56 ] 
Mutation Word : V600E @Position : 30
Function Word : associated @Position : 27
Impact Word : reduce @Position : 24
Nevertheless preliminary analysis of the overall survival based on the CMC counts within our tested cohort of patients indicated a negative trend between survival and CMC counts in all patients p = 0.12 and particularly for  BRAF V600E   cutaneous melanoma patients p = 0 06 
Mutation Word : V600E @Position : 38
Function Word : survival @Position : 23
Impact Word : negative @Position : 20
Over time however the WT-GARS- and Empt-expressing mice exhibited significantly improved PWT compared with the G240R- and L129P-expressing mice and the allodynia behavior in G240R- and L129P-expressing mice was unchanged for 7 days after adenovirus infection  Fig  3C  
Mutation Word : G240R @Position : 24
Function Word : exhibit @Position : 8
Impact Word : unchange @Position : 29
Mutant BRAFV600E represents a constitutively active protein serine kinase that leads to the sustained activation of the BRAF→MEK1/2→ERK1/2 MAP kinase pathway[ 3   4 ] 
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 14
Impact Word : constitutive @Position : 4
The T790M mutation may result in an alteration of EGFR topology that precludes the binding of reversible EGFR-TKIs through steric hindrance or T790M may increase the affinity of the kinase domain for ATP  
Mutation Word : T790M @Position : 22
Function Word : atp @Position : 32
Impact Word : increase @Position : 24
These data in concert with the evidence described above that BRAF V600E overexpression increases proliferation and DNA instability of thyroid cells and the central role of BRAF as a critical signalling node in RET/PTC-induced thyroid cell proliferation suggest BRAF as an appropriate therapeutic target for thyroid cancer 
Mutation Word : V600E @Position : 11
Function Word : proliferation @Position : 36
Impact Word : increase @Position : 13
Moreover upon IBR2 treatment the HR activity in T315I was reduced to a level comparable to that in parental cells while the latter was relatively insensitive to the treatment suggesting a potential therapeutic window Supporting Information  Fig S9  
Mutation Word : T315I @Position : 8
Function Word : activity @Position : 6
Impact Word : reduce @Position : 10
Hence E884K mutation can work in concert with L858R to modulate mutant receptor sensitivity to different targeted inhibitors 
Mutation Word : L858R @Position : 8
Function Word : sensitivity @Position : 13
Impact Word : modulates @Position : 10
For example crizotinib maintains activity against the R1275Q mutant but drastically loses activity against F1174L another frequently occurring mutant Wood et al.  Sakamoto et al.  Schönherr et al   
Mutation Word : R1275Q @Position : 7
Function Word : activity @Position : 12
Impact Word : lose @Position : 11
Second the constitutive activation of ERK by BRAF V600E  could inhibit FoxO3 activation via the ubiquitin-proteasome pathway  
Mutation Word : V600E @Position : 8
Function Word : activity @Position : 13
Impact Word : constitutive @Position : 2
Structurally this residue lies in the substrate-binding pocket of the kinase and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP-bound form effectively making RET more active more of the time  48 – 51  
Mutation Word : M918T @Position : 13
Function Word : affinity @Position : 20
Impact Word : increase @Position : 17
This series represents preliminary results from our population and indicates a higher  JAK2  V617F  allele burden and RNA expression in patients with PMF than in those with PV or ET 
Mutation Word : V617F @Position : 15
Function Word : expression @Position : 21
Impact Word : higher @Position : 11
This is consistent with our observations that T315I cells have elevated basal level HR activity over parental cells  Fig 3B and C  
Mutation Word : T315I @Position : 7
Function Word : activity @Position : 14
Impact Word : elevate @Position : 10
Therefore  BRAF  V600E increases the kinase activity that provides cancer cells with both proliferation and survival signals and promotes them to become tumors in the model system 
Mutation Word : V600E @Position : 4
Function Word : proliferation @Position : 15
Impact Word : increase @Position : 5
In the presence of the S252W mutation FGFR2 shows enhanced ligand-binding affinity to FGF2 and loses isoform-ligand specificity for most of the other ligands   
Mutation Word : S252W @Position : 5
Function Word : affinity @Position : 11
Impact Word : enhance @Position : 9
Another study found uncoupling in rare TnC variants identified in DCM cTnC Y5H M103I and I148V either decreased or abolished the effects of PKA phosphorylation on Ca 2+ -sensitivity Pinto et al   2011  
Mutation Word : I148V @Position : 15
Function Word : phosphorylation @Position : 24
Impact Word : abolish @Position : 19
Hence the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT downregulated and MAPK-ERK1/2 phosphorylation upregulated 
Mutation Word : E884K @Position : 4
Function Word : phosphorylation @Position : 20
Impact Word : modulates @Position : 5
BCR-ABL mutations respond differently to three tyrosine kinase inhibitors approved for first-line treatment of CML e.g  Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib while some mutations are less sensitive to nilotinib E255K/V and F359V/C or dasatinib F317L and V299L  
Mutation Word : T315A @Position : 30
Function Word : sensitivity @Position : 47
Impact Word : less @Position : 46
Recent studies have demonstrated an approximately 10-fold higher tumor burden with Braf V600E  expression in mouse lung compared to Kras G12D  while adenocarcinoma formation was exclusively observed with Kras G12D  but not Braf V600E  expression  [56]   [57]  
Mutation Word : V600E @Position : 36
Function Word : expression @Position : 38
Impact Word : higher @Position : 7
E884K and L858R+E884K mutants remained sensitive to EGF and were activated by the ligand to a level comparable to L858R  Figure 3A  
Mutation Word : E884K @Position : 2
Function Word : sensitivity @Position : 5
Impact Word : remain @Position : 4
Consistent with published studies our findings reveal that gefitinib-resistant PC9 cells acquired a T790M gate-keeper mutation and gefitinib-resistant HCC827 cells exhibited markedly increased MET expression levels  13   14   15   17    Supplementary Figures S2 and S3  
Mutation Word : T790M @Position : 13
Function Word : exhibit @Position : 20
Impact Word : increase @Position : 22
Furthermore the nuclear activation of YAP1 was maintained in 8505C and K1 cells and resistant to RAF BRAF V600E  and MEK inhibitors 
Mutation Word : V600E @Position : 18
Function Word : activity @Position : 3
Impact Word : maintain @Position : 7
It is believed that V617F mutation enables JAK2 to be constitutively active by reliving the negative regulatory interaction between its kinase and pseudo-kinase domains 
Mutation Word : V617F @Position : 4
Function Word : activity @Position : 11
Impact Word : constitutive @Position : 10
The most common BRAF mutation is a substitution of valine with glutamic acid at amino acid position 600 V600E which locks BRAF into its active conformation resulting in a ten-fold increase in activity over wild-type BRAF  
Mutation Word : V600E @Position : 18
Function Word : activity @Position : 32
Impact Word : increase @Position : 30
Hence the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT downregulated and MAPK-ERK1/2 phosphorylation upregulated 
Mutation Word : E884K @Position : 4
Function Word : effect @Position : 13
Impact Word : modulates @Position : 5
On the other hand YFP-EGFR-ICD proteins bearing the uncommon exon 21 mutation P848L and A859T showed markedly lower autophosphorylation levels than YFP-EGFR-ICD L858R Figure  4C  
Mutation Word : A859T @Position : 14
Function Word : autophosphorylation @Position : 18
Impact Word : lower @Position : 17
Furthermore expression of CDK1 was increased in S249C and Y375C cells and the difference was particularly pronounced when the cells were starved in depleted medium to block stimulation by other growth factors 
Mutation Word : Y375C @Position : 9
Function Word : expression @Position : 1
Impact Word : increase @Position : 5
In vitro  Y791F mutations have been shown to enhance signal transducer and activator of transcription 3 STAT3 signaling  74  
Mutation Word : Y791F @Position : 3
Function Word : activity @Position : 13
Impact Word : enhance @Position : 9
The T315I cells exhibit increased proliferation rate Supporting Information Fig S8  elevated basal expressions of Rad51 and γ-H2AX  Fig 5A  and display increased endogenous DNA damage response indicated by increased Rad51 and γ-H2AX foci  Fig 5B and C  when compared with parental cells 
Mutation Word : T315I @Position : 1
Function Word : proliferation @Position : 5
Impact Word : increase @Position : 32
One important question that emerged was whether the higher aggregation propensity of the R248Q mutant was related to the negative dominance effect observed  in vivo  
Mutation Word : R248Q @Position : 13
Function Word : effect @Position : 21
Impact Word : negative @Position : 19
A change at residue 600 in the BRAF gene V600E leads to 500-fold increased activation of BRAF V600E -MEK-ERK signaling in tumor cells a signaling pathway that is frequently mutated in melanoma Cantwell-Dorris et al   2011  
Mutation Word : V600E @Position : 17
Function Word : activity @Position : 14
Impact Word : increase @Position : 13
Our data support the potential role of dual TKI combinatorial inhibition using EGFR inhibitors to enhance MET inhibition in T790M-EGFR-mediated therapy resistance 
Mutation Word : T790M @Position : 19
Function Word : resistance @Position : 21
Impact Word : enhance @Position : 15
Indeed dual blockade of MEK/BRAF V600E  with PD184352 PLX4720 or vemurafenib and MET with crizotinib SU11274 or MET-specific siRNA resulted in reversal of drug resistance and reduced the proliferation of melanoma cell lines which was restored by exogenous HGF  29  109  
Mutation Word : V600E @Position : 5
Function Word : result @Position : 20
Impact Word : reduce @Position : 27
To confirm DUB regulation through BRAF activation mutant BRAF V600E was expressed in HEK293T cells and DUB activity assessments were used to demonstrate increased Usp5 activity in cells expressing BRAF V600E  Fig   1F  
Mutation Word : V600E @Position : 30
Function Word : expression @Position : 28
Impact Word : increase @Position : 23
These studies demonstrate that by targeting the switch pocket this class of KIT inhibitors possesses a novel mechanism of inhibition whose dual suppression of KIT D816V neoplastic proliferation and SCF enhanced mast cell activation advocate future clinical development 
Mutation Word : D816V @Position : 25
Function Word : activity @Position : 33
Impact Word : enhance @Position : 30
This unexpected facet of oncogenic RET M918T is in addition to increasing RET enzymatic activity and ATP affinity  Figures 5  and  7  
Mutation Word : M918T @Position : 6
Function Word : activity @Position : 14
Impact Word : increase @Position : 11
Some of these mutations alter specifically the configuration of the ATP-binding kinase pocket V654A and T670I inhibiting imatinib binding 
Mutation Word : V654A @Position : 13
Function Word : inhibit @Position : 16
Impact Word : alter @Position : 4
We identified 25-fold increased expression of MMP-1 mRNA in melanoma cells possessing BRAF V600E  compared to wildtype while HPMs expressed similar transcript levels with BRAF wildtype melanoma cell  Figure 2a  suggesting that increased BRAF kinase activity may be associated with elevated MMP-1 expression in melanomas 
Mutation Word : V600E @Position : 13
Function Word : expression @Position : 45
Impact Word : increase @Position : 35
The T790M mutation may result in an alteration of EGFR topology that precludes the binding of reversible EGFR-TKIs through steric hindrance or T790M may increase the affinity of the kinase domain for ATP  
Mutation Word : T790M @Position : 22
Function Word : result @Position : 4
Impact Word : alter @Position : 7
Cells expressing S249C and Y375C FGFR3 displayed an increased saturation density related to increased proliferation and viability 
Mutation Word : Y375C @Position : 4
Function Word : proliferation @Position : 14
Impact Word : increase @Position : 13
62  Mutated ALK at F1174L led to increased proliferation and decreased apoptosis of neuroblastoma cell lines 
Mutation Word : F1174L @Position : 5
Function Word : apoptosis @Position : 12
Impact Word : decrease @Position : 11
We used S3I-201 and found that STAT3 inhibition disrupted p53-RELA- GIS association Figure 6a b  and inhibited mir-21 upregulation Figure  6c  without altering p53 and RELA nuclear abundance Figure  6d  
Mutation Word : S3I @Position : 10
Function Word : inhibit @Position : 17
Impact Word : disrupt @Position : 8
The most notable change was seen in F1174L mutation which was well supported by an increase in binding energy and loss of hydrogen bond interaction with the neighboring protein when compared to the native protein 
Mutation Word : F1174L @Position : 7
Function Word : interaction @Position : 24
Impact Word : increase @Position : 15
Surprisingly we found that expression of each activated KRAS ED  lead to a substantial decrease in Braf V600E  induced tumors relative to the EGFP control suggesting the existence of a KRAS activated negative regulator of tumorigenesis 
Mutation Word : V600E @Position : 18
Function Word : regulation @Position : 35
Impact Word : negative @Position : 34
Expression of BRAF V600E  in the well-differentiated thyroid cell line PCCL3 was recently reported to increase secretion of TGFβ1   
Mutation Word : V600E @Position : 3
Function Word : expression @Position : 0
Impact Word : increase @Position : 16
SIRT1 inhibition decreases melanoma cell growth and rescues the sensibility to PLX4032 of PLX4032-resistant BRAF V600E -mutated melanoma cells 
Mutation Word : V600E @Position : 15
Function Word : inhibit @Position : 1
Impact Word : decrease @Position : 2
Similar to E884K R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in- cis  with L858R 
Mutation Word : L858R @Position : 20
Function Word : sensitivity @Position : 6
Impact Word : modulates @Position : 4
The mutation of arginine at position 24 into cysteine CDK4 R24C  or histidine CDK4 R24C  renders the protein insensitive to regulation by p16 INK4a  but preserves interaction between CDK4 and cyclin D1 leading to constitutive activation of the complex and aberrant proliferation through retinoblastoma protein inactivation and E2F activation 
Mutation Word : R24C @Position : 15
Function Word : interaction @Position : 29
Impact Word : preserve @Position : 28
In the analyses of clinical specimens obtained from patients who acquired resistance to EGFR-TKIs high expression of HGF was identified in 61% patients overlapping with T790M mutation and MET amplification 
Mutation Word : T790M @Position : 25
Function Word : expression @Position : 15
Impact Word : high @Position : 14
The T315I cells exhibit increased proliferation rate Supporting Information Fig S8  elevated basal expressions of Rad51 and γ-H2AX  Fig 5A  and display increased endogenous DNA damage response indicated by increased Rad51 and γ-H2AX foci  Fig 5B and C  when compared with parental cells 
Mutation Word : T315I @Position : 1
Function Word : exhibit @Position : 3
Impact Word : increase @Position : 32
Similarly E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor CL-387785 
Mutation Word : L858R @Position : 7
Function Word : sensitivity @Position : 5
Impact Word : enhance @Position : 3
In pre-clinical studies JAK2 inhibitors reduced the proliferation of JAK2 V617F  and MPL W515L  mutant cells and attenuated disease development in murine models of MPN  40 - 43  
Mutation Word : V617F @Position : 10
Function Word : proliferation @Position : 7
Impact Word : reduce @Position : 5
However this resistance to EGFR TKI has been many times lower than the resistance in cells harbouring both the L858R and T790M mutations 
Mutation Word : L858R @Position : 19
Function Word : resistance @Position : 13
Impact Word : lower @Position : 10
While FLT3-ITD red and FLT3-D835Y blue displayed very high sensitivity towards 17-AAG treatment the efficacy was slightly lower against FLT3-ITD-N676K and FLT3-ITD-F691L at 1 µM  Figure 3B  
Mutation Word : F691L @Position : 21
Function Word : sensitivity @Position : 9
Impact Word : lower @Position : 17
While both compounds differ from reversible inhibitors and show greater inhibitory potency—as ATP competitors—they will face the increased affinity for ATP of T790M EGFR mutants albeit at a much lesser extent 
Mutation Word : T790M @Position : 22
Function Word : atp @Position : 20
Impact Word : greater @Position : 9
Notably GLUT1 knockdown largely abolished the stimulating effect of mutp53 on the Warburg effect in H1299 cells and in  p53  R172H/R172H   MEF cells  Fig  4a & b  
Mutation Word : R172H @Position : 22
Function Word : effect @Position : 13
Impact Word : abolish @Position : 4
The most characterized resistance mutation is the T790M-point mutation in exon 20 which increases the affinity of the EGFR for ATP thus reducing the binding of EGFR TKIs to the ATP pocket 
Mutation Word : T790M @Position : 7
Function Word : atp @Position : 30
Impact Word : reduce @Position : 22
Patients with Apert syndrome with the S252W mutation in the FGFR2  gene enhanced osteoblastic marker gene expression and ALP activity  
Mutation Word : S252W @Position : 6
Function Word : activity @Position : 20
Impact Word : enhance @Position : 13
NFAT transcriptional activity was approximately 10-fold higher in A375 cells and approximately 70-fold higher in WM266-4 cells compared with  BRAF  wild-type CHL-1 cells  Figure 1A  consistent with increased B-RAF activity of BRAF V600D  compared with BRAF V600E   Wan  et al  2004  
Mutation Word : V600D @Position : 41
Function Word : activity @Position : 33
Impact Word : increase @Position : 31
A Constitutively active  KRAS V12    BRAF V600E   or  MEK1 S218DS222D   mutants confer resistance to ALK inhibitors 
Mutation Word : V600E @Position : 10
Function Word : activity @Position : 2
Impact Word : constitutive @Position : 1
A somatic mutation of JAK2  coding for constitutively activated Jak2-V617F is frequently observed in  BCR/ABL1 -negative myeloproliferative neoplasms MPNs 96% in polycythemia vera PV 55% in essential thrombocythemia ET and 65% in primary myelofibrosis PMF  
Mutation Word : V617F @Position : 10
Function Word : activity @Position : 9
Impact Word : constitutive @Position : 8
Hence E884K in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 1
Function Word : inhibit @Position : 18
Impact Word : alter @Position : 29
To gain insight into the mechanism of E884K modulation of EGFR tyrosine kinase inhibitor TKI sensitivity we further studied its effect on downstream AKT and STAT3 signaling pathways with TKI inhibition 
Mutation Word : E884K @Position : 7
Function Word : sensitivity @Position : 15
Impact Word : modulates @Position : 8
Previous studies showed that Mps1 T676A  has less active kinase activity than Mps1 WT  [29] – [30]  
Mutation Word : T676A @Position : 5
Function Word : activity @Position : 11
Impact Word : less @Position : 8
Some mutations P112Q R895C E897K enhance angiotensin II receptor-mediated activation of TRPC6 when expressed in HEK293 cells while neither the S270T nor the N143S missense mutations nor a 57-amino acid truncation mutation K874X altered the channel activity   
Mutation Word : N143S @Position : 23
Function Word : expression @Position : 13
Impact Word : enhance @Position : 5
Substitution of S252W and P253R alter the ligand binding specificities of FGFR2b and FGFR2c but retain the ligand-dependent activation properties   whereas K659N causes receptor hyperactivation   
Mutation Word : P253R @Position : 4
Function Word : activity @Position : 18
Impact Word : retain @Position : 15
R958D mutation when in- cis  with L858R decreased the sensitivity of the mutant receptor to erlotinib inhibition while increasing the sensitivity to gefitinib in a dominant fashion  Figure 5A B  
Mutation Word : L858R @Position : 7
Function Word : sensitivity @Position : 21
Impact Word : decrease @Position : 8
Among the exon 20 mutations tested Ins770SVD showed an intermediate level of autophosphorylation lower than S768I but higher than T790M Figure  4B  
Mutation Word : T790M @Position : 19
Function Word : autophosphorylation @Position : 12
Impact Word : higher @Position : 17
TBP-3868 exhibits high basal Ras activity relative to the PLX4720 sensitive line TBP-3743 suggesting that the resistance to BRAF V600E -inhibition in TBP-3868 may be attributed to Ras-dependent transactivation of RAF dimers 
Mutation Word : V600E @Position : 19
Function Word : sensitivity @Position : 10
Impact Word : high @Position : 2
Hence the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT down-regulated CBL and MAPK-ERK1/2 phosphorylation up-regulated 
Mutation Word : E884K @Position : 4
Function Word : phosphorylation @Position : 23
Impact Word : modulates @Position : 5
Therefore in this study we explored the retained antitumor activity of gefitinib in resistant HCC827-GR5 and NCI-H1975 NSCLC cells carrying  MET  amplification and T790M mutation respectively 
Mutation Word : T790M @Position : 25
Function Word : activity @Position : 9
Impact Word : retain @Position : 7
Most recently MITF-dependent BCL2A1 was identified as an oncogene restricted to melanoma  versus  normal tissues and the co-treatment of  V600E BRAF melanomas with BRAF inhibitors and obatoclax an inhibitor of BCL2A1 reduced the resistance to BRAF inhibitors in  BCL2A1 -amplified melanoma cells  in vitro  and  in vivo  [55]  
Mutation Word : V600E @Position : 22
Function Word : resistance @Position : 36
Impact Word : reduce @Position : 34
BRAF V600E  has elevated kinase activity when compared with wild type  BRAF  1  and it induces constitutive ERK signaling through hyperactivation of the RAS/RAF/MEK/ERK pathway stimulating proliferation survival and transformation 
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 6
Impact Word : elevate @Position : 4
Transformation induced by each of the three oncogenes  KRAS G12V   Caco-K cells  BRAF V600E   Caco-BR cells and  HRAS G12V   Caco-H cells managed to increase the ability of Caco-2 cells to migrate and invade  in vitro  independently of their proliferating ability which has been previously analyzed in   
Mutation Word : V600E @Position : 17
Function Word : induce @Position : 1
Impact Word : increase @Position : 32
Patient  # 1 lacked the KIT D816V mutation and mast cells from this patient exhibited a dose dependent decrease in survival in response to the SP inhibitors  Figure 5A  
Mutation Word : D816V @Position : 7
Function Word : survival @Position : 21
Impact Word : decrease @Position : 19
The mutations F317V Y253F Y253H and E255K experience increased vdW interactions with residue Leu248 
Mutation Word : E255K @Position : 6
Function Word : interaction @Position : 10
Impact Word : increase @Position : 8
Our biochemical studies here now show that E884K mutation in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 7
Function Word : associated @Position : 34
Impact Word : alter @Position : 36
Notably the M918T mutant protein also shows constitutively high levels of tyrosine phosphorylation especially at Y1062 the docking site that influences SSC self-renewal in mice 
Mutation Word : M918T @Position : 2
Function Word : phosphorylation @Position : 12
Impact Word : high @Position : 8
Although the frequency of HGF expression among cases of acquired resistance is unclear because of scarcity of reports the frequency of coexistence of HGF expression with T790M mutations could possibly be high   
Mutation Word : T790M @Position : 26
Function Word : resistance @Position : 10
Impact Word : high @Position : 31
The M918T mutation appears to increase the stability of monomeric active forms of RET but activation of these mutants can also be further enhanced by binding of GDNF–GFRα complexes suggesting that these mutant RET forms may induce signal transduction from both within and outside the lipid rafts perhaps via distinct signaling complexes  Figure 2B  
Mutation Word : M918T @Position : 1
Function Word : stability @Position : 7
Impact Word : increase @Position : 5
Thus certain P loop mutations Y253F E255K and the T315I mutation display a high oncogenic potential which is consistent with the clinical observation of a poor outcome concerning overall and progression-free survival   
Mutation Word : Y253F @Position : 5
Function Word : survival @Position : 31
Impact Word : high @Position : 13
The effect on the downstream signal mediators p-AKT [S473] and p-STAT3 [Y705] correlated well with the inhibition of EGFR phosphorylation  Figure 1A  E884K in- cis  with L858R decreased erlotinib inhibition of AKT and STAT3 phosphorylation but increased inhibition by gefitinib 
Mutation Word : E884K @Position : 24
Function Word : inhibit @Position : 40
Impact Word : increase @Position : 39
Additional genetic alterations within the target oncogene itself which prevent drug binding and lead to kinase activation even in the presence of the inhibitor are a common mechanism of both primary and acquired resistance in cancer a paradigmatic example is provided by the T790M “gatekeeper” secondary mutation in the  EGFR  gene which installs resistance to reversible EGFR inhibitors in  EGFR -mutant NSCLC   
Mutation Word : T790M @Position : 43
Function Word : binding @Position : 11
Impact Word : alter @Position : 2
Nonetheless recent work in a L858R/T790M- EGFR  transgenic mouse model suggests that the double mutant- EGFR  responds only partially to HKI-272 alone  Li  et al  2007  and enhanced inhibition was seen in combination with mammalian target of rapamycin inhibitor 
Mutation Word : T790M @Position : 5
Function Word : inhibit @Position : 34
Impact Word : enhance @Position : 33
However the ability of crizotinib to inhibit ALK phosphorylation was substantially reduced in all mutants tested with IC 50 s >1000 n m  for L1196M and G1269S  Table 2  
Mutation Word : L1196M @Position : 25
Function Word : phosphorylation @Position : 8
Impact Word : reduce @Position : 11
RAS and RAF proteins play a key role in the control of cellular growth proliferation and differentiation  Bos 1989   Wickenden  et al  2008   KRAS -activating mutations reduce or abolish intrinsic GTPase activity of the protein leading to its constitutive activation  Conlin  et al  2005  Similarly  BRAF  V600E mutation induces structural changes in RAF protein which increase its kinase activity  Wan  et al  2004  Activated RAS and RAF are responsible for the disregulation of RAS/RAF/MAPKs signalling pathway 
Mutation Word : V600E @Position : 59
Function Word : activity @Position : 80
Impact Word : increase @Position : 68
These studies variably identified those patients who were JAK2 V617F-positive to have a higher risk of thrombotic complications a result that has been confirmed in a recent meta-analysis 
Mutation Word : V617F @Position : 9
Function Word : result @Position : 19
Impact Word : higher @Position : 13
Furthermore MEK inhibition alone caused regression of xenografted and orthotopically transplanted tumors and reduced proliferation in tumors of Braf LSL-V637E/   +  mice orthologous to human  BRAF  V600E mutation   
Mutation Word : V600E @Position : 31
Function Word : proliferation @Position : 14
Impact Word : reduce @Position : 13
Time-activity studies showed that the treatment of PC12/MEN2A cells at 200 nM for 1 h was sufficient to significantly inhibit RET C634Y  autophosphorylation and to drastically reduce ERK phosphorylation  Figure 3 B right panel 
Mutation Word : C634Y @Position : 21
Function Word : phosphorylation @Position : 29
Impact Word : reduce @Position : 27
Enhancement by PDGFRα-I of the  in vivo  anti-tumor activity of BRAF-I in BRAF-I sensitive and resistant BRAFV600E melanoma cell lines
Mutation Word : V600E @Position : 18
Function Word : sensitivity @Position : 15
Impact Word : enhance @Position : 0
BRAF V600E   mutations are found in 60% of benign nevi and are thought to result in the initial increase in proliferation of melanocytic cells followed by induction of cell cycle arrest and senescence   
Mutation Word : V600E @Position : 1
Function Word : proliferation @Position : 22
Impact Word : increase @Position : 20
Interestingly S252W mutation had opposite effects on different cell types S252W MSCs proliferated less than WT MSCs while S252W fibroblasts proliferated more than WT fibroblasts 
Mutation Word : S252W @Position : 18
Function Word : proliferation @Position : 20
Impact Word : less @Position : 13
The most frequent somatic alteration in  BRAF  is a point mutation T1799A encoding BRAF V600E  which results in a several hundred-fold increased activity of the protein’s kinase domain 
Mutation Word : V600E @Position : 16
Function Word : activity @Position : 25
Impact Word : increase @Position : 24
This mutant form of  BRAF  V600E elicits enhanced dimerization in cells which contain low levels of active Ras in comparison to cells containing the full-length  BRAF  V600E mutation 
Mutation Word : V600E @Position : 30
Function Word : dimerization @Position : 10
Impact Word : enhance @Position : 9
BRAF V600E  is a dominant activating mutation in melanoma resulting in a constitutive activation of the mitogen-activated protein kinase MAPK pathway and uncontrolled cell growth  
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 14
Impact Word : constitutive @Position : 13
E255K and T315I are the most predominant mutations of BCR/ABL causing imatinib resistance in patients and may increase the kinase activity or change the substrate preferences of BCR/ABL  15  18  
Mutation Word : T315I @Position : 2
Function Word : activity @Position : 20
Impact Word : increase @Position : 17
Hence E884K in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 1
Function Word : associated @Position : 27
Impact Word : alter @Position : 29
Intriguingly the imatinib-resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM-1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells  Fig  4  
Mutation Word : E255K @Position : 5
Function Word : induce @Position : 17
Impact Word : increase @Position : 9
The T790M mutation abrogated the effect of erlotinib on L858R and the L858R/T790M double mutant readily induced Akt phosphorylation even in the presence of 10 μM erlotinib 
Mutation Word : T790M @Position : 12
Function Word : effect @Position : 5
Impact Word : abrogate @Position : 3
D Transient re-expression of KT3-tagged wild-type PTP-PEST cDNA but not the C231S mutant in PTP-PEST knockdown cells suppresses enhanced tyrosine phosphorylation of p120 
Mutation Word : C231S @Position : 11
Function Word : phosphorylation @Position : 20
Impact Word : enhance @Position : 18
BRAF V600E  is a constitutively active onco-kinase and is the most common genetic alteration in papillary thyroid carcinoma PTC and in anaplastic thyroid carcinoma as well albeit at a lower frequency 
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 6
Impact Word : constitutive @Position : 5
When expressed in MCF-7 PIK3CAWT  the E17K mutant led to increased activation of Akt under low serum conditions as measured by phosphorylation of serine 473 and threonine 308 when compared to empty vector control Figure  1  and  Supplemental Figure 1A  
Mutation Word : E17K @Position : 7
Function Word : activity @Position : 12
Impact Word : increase @Position : 11
The other possibility is that the presence of the EGFR T790M mutation could increase the affinity of the EGFR-L858R for ATP and thus reduce the potency of an ATP-competitive kinase inhibitor   
Mutation Word : L858R @Position : 18
Function Word : atp @Position : 20
Impact Word : increase @Position : 13
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : E255K @Position : 5
Function Word : phosphorylation @Position : 23
Impact Word : increase @Position : 19
The patient remained on this regimen for 7 mo with an excellent performance status exceeding the expected survival of a patient expressing B-RAF V600E colon cancer 
Mutation Word : V600E @Position : 23
Function Word : survival @Position : 17
Impact Word : remain @Position : 2
The mutations E255V M244V T315A Y253H experience increased vdW interactions with Met290 and the mutation M244V experiences increased vdW interactions with Ile293 
Mutation Word : T315A @Position : 4
Function Word : interaction @Position : 19
Impact Word : increase @Position : 17
The former is the case of the S492R mutant which confers resistance to cetuximab since the mutation is located in its binding epitope on the EGFR external domain   whereas the later is the case of the T790M mutant mutation in the kinase domain which confers resistance to gefitinib or erlotinib in lung adenocarcinomas   by stabilizing the active tyrosine kinase conformation and enhancing aTP binding   
Mutation Word : S492R @Position : 7
Function Word : atp @Position : 66
Impact Word : enhance @Position : 65
Moreover we showed that the expression of genes encoding three inflammation-related genes CCL20 CXCL8 and l-selectin was enhanced either in  BRAF  V600E  or in  RET / PTC  tumors compared with normal samples 
Mutation Word : V600E @Position : 23
Function Word : expression @Position : 5
Impact Word : enhance @Position : 17
One hypothesis may state that induction of apoptosis is mediated via Thr308 We observed a particular high phosphorylation pattern of Thr308 in cells transfected with the tyrosine kinase domain TKD-mutated  FLT3  D835V and  KIT  D816Y isoforms in our assays see Figure  6  
Mutation Word : D835V @Position : 33
Function Word : phosphorylation @Position : 17
Impact Word : high @Position : 16
Cell proliferation Ki67 labelling was significantly reduced in melanocytes transfected with   V600E   BRAF  but not   WT   BRAF   Figure 5B  
Mutation Word : V600E @Position : 13
Function Word : proliferation @Position : 1
Impact Word : reduce @Position : 6
TBP-3868 exhibits high basal Ras activity relative to the PLX4720 sensitive line TBP-3743 suggesting that the resistance to BRAF V600E -inhibition in TBP-3868 may be attributed to Ras-dependent transactivation of RAF dimers 
Mutation Word : V600E @Position : 19
Function Word : activity @Position : 5
Impact Word : high @Position : 2
The mutant proteins K216A and E118A also had high expression yield and were purified by similar procedures 
Mutation Word : E118A @Position : 5
Function Word : expression @Position : 9
Impact Word : high @Position : 8
In addition the T1799A alteration can rather be associated with a second nucleotide mutation G1798A and leads to a V600K mutation in an additional ~6% to 29% of patients with a BRAF mutation   
Mutation Word : V600K @Position : 19
Function Word : associated @Position : 8
Impact Word : alter @Position : 4
Our observation that NFAT activity was higher in V600D-mutated WM266-4 cells compared with V600E-mutated A375 cells which correlated with the amount of BRAF kinase activity evoked by each mutant is particularly noteworthy 
Mutation Word : V600E @Position : 13
Function Word : activity @Position : 24
Impact Word : higher @Position : 6
Furthermore we show that proliferation of cells derived from  JAK2 V617F   patients is increased when they were co-cultured with macrophages 
Mutation Word : V617F @Position : 11
Function Word : proliferation @Position : 4
Impact Word : increase @Position : 16
By contrast the T790M mutation confers a higher affinity toward ATP than the L858R mutant such that the combined double mutant L858R/T790M results in an activated enzyme that is resistant to ATP-competitive TKIs   
Mutation Word : L858R @Position : 21
Function Word : affinity @Position : 8
Impact Word : higher @Position : 7
The prevalent  BRAF  c.1799 T > A V600E mutation characterizing 4.7% to 8.7% of CRC demonstrated a negative prognostic effect compared to  BRAF  wild-type pts in MCRC pts treated with doublet chemotherapy alone or added to cetuximab BEV and cetuximab plus BEV with a median PFS of 5.6 to 8 months and median OS of 10.3 to 15 9 months   
Mutation Word : V600E @Position : 9
Function Word : effect @Position : 21
Impact Word : negative @Position : 19
The high potency of afatinib to inhibit the tyrosine kinase activity of wild-type EGFR was fully maintained on EGFR with the activating L858R mutation Solca et al.  Sos et al   
Mutation Word : L858R @Position : 22
Function Word : activity @Position : 21
Impact Word : maintain @Position : 16
The mutation F359V experiences decreased vdW −2.13 kcal/mol and electrostatic interactions −0.16 kcal/mol while decreased electrostatic interactions are experienced due to mutations E255K 0.35 kcal/mol and E255V −0 09 kcal/mol 
Mutation Word : F359V @Position : 2
Function Word : interaction @Position : 16
Impact Word : decrease @Position : 14
The other possibility is that the presence of the EGFR T790M mutation could increase the affinity of the EGFR-L858R for ATP and thus reduce the potency of an ATP-competitive kinase inhibitor   
Mutation Word : T790M @Position : 10
Function Word : affinity @Position : 15
Impact Word : increase @Position : 13
While FLT3-ITD red and FLT3-D835Y blue displayed very high sensitivity towards 17-AAG treatment the efficacy was slightly lower against FLT3-ITD-N676K and FLT3-ITD-F691L at 1 µM  Figure 3B  
Mutation Word : F691L @Position : 21
Function Word : sensitivity @Position : 9
Impact Word : high @Position : 8
Simultaneously we have applied the increase of sensitivity of COLD-PCR assay approach combined with HRM analysis for the non-invasive prenatal diagnosis of C634Y fetal mutations using pregnant women serum 
Mutation Word : C634Y @Position : 22
Function Word : sensitivity @Position : 7
Impact Word : increase @Position : 5
The JAK2 V617F mutation can induce constitutive activation regardless of the dimeric conformation of the receptor it is bound to while JAK2 wild-type requires a ligand-activated EpoR dimer in order to signal 
Mutation Word : V617F @Position : 2
Function Word : activity @Position : 7
Impact Word : constitutive @Position : 6
Our biochemical studies here now show that E884K mutation in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : L858R @Position : 21
Function Word : inhibit @Position : 25
Impact Word : alter @Position : 36
We recently reported that the activity of the tumour suppressor protein phosphatase 2A PP2A is markedly inhibited in blast crisis CML patient cells and that molecular or pharmacologic re-activation of PP2A phosphatase led to growth suppression enhanced apoptosis impaired clonogenic potential and decreased  in vivo  leukaemogenesis of imatinib-sensitive and -resistant T315I included CML-BC patient cells and/or BCR/ABL +  myeloid progenitor cell lines 
Mutation Word : T315I @Position : 52
Function Word : apoptosis @Position : 37
Impact Word : enhance @Position : 36
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : E255K @Position : 5
Function Word : activity @Position : 16
Impact Word : increase @Position : 19
Hence the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT downregulated and MAPK-ERK1/2 phosphorylation upregulated 
Mutation Word : L858R @Position : 4
Function Word : effect @Position : 13
Impact Word : modulates @Position : 5
Expression of the deletion mutant was comparable to that of L858R EGFR whereas expression of the insertion mutant was lower as reflected in the  EGFR  expression levels of the clonal cell lines  Figure 2 A and unpublished data 
Mutation Word : L858R @Position : 10
Function Word : expression @Position : 27
Impact Word : lower @Position : 19
Consistent with this we found that the introduction of R1275Q into EML4-ALK had no negative impact on sensitivity to crizotinib IC 50  47 ± 8 n m  
Mutation Word : R1275Q @Position : 9
Function Word : sensitivity @Position : 17
Impact Word : negative @Position : 14
Similarly E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor CL-387785 
Mutation Word : E884K @Position : 1
Function Word : inhibit @Position : 10
Impact Word : enhance @Position : 3
Time-activity studies showed that the treatment of PC12/MEN2A cells at 200 nM for 1 h was sufficient to significantly inhibit RET C634Y  autophosphorylation and to drastically reduce ERK phosphorylation  Figure 3 B right panel 
Mutation Word : C634Y @Position : 21
Function Word : inhibit @Position : 19
Impact Word : reduce @Position : 27
In that context we demonstrate that inhibition of SIRT1 with genetic or pharmacological approaches additively enhances the efficacy of PLX4032 of melanoma cells but more importantly that it rescues the sensitivity to PLX4032 of the resistant BRAF V600E -mutated melanoma cells 
Mutation Word : V600E @Position : 37
Function Word : sensitivity @Position : 30
Impact Word : enhance @Position : 15
Indeed upon the addition of NN hTMSC chemotactic migration was significantly reduced compared with the control condition as well as to N C -stimulated cells  Fig. 3  A . Furthermore in NSCLC line H1975 which expresses EGFR with the double mutation L858R and T790M as well as HER2 and HER3   NN stimulation reduced chemokinesis relative to NRG-stimulated and untreated control cells  Fig  3   B  and  C  
Mutation Word : T790M @Position : 45
Function Word : expression @Position : 37
Impact Word : reduce @Position : 56
Of note is that same epitopes are also exposed in the constitutively active L858R EGFR mutant and therefore such a mutant also binds efficiently the α4-2 mAb   
Mutation Word : L858R @Position : 13
Function Word : activity @Position : 12
Impact Word : constitutive @Position : 11
Selumetinib induces an increase in ADC in BRAF V600E  Colo205 colon tumour xenografts concomitant with inhibition of ERK1/2 signalling and tumour growth
Mutation Word : V600E @Position : 8
Function Word : induce @Position : 1
Impact Word : increase @Position : 3
Activation by the Gal4-PPARγ-LBD-K365R mutant however was much lower in the absence and presence of ligands  Figure 5B  
Mutation Word : K365R @Position : 3
Function Word : ligand @Position : 15
Impact Word : lower @Position : 8
However when any of the phosphorylation deficient-mutants were tested p19S76A p19T141A p19S76A/T141A DNA repair levels were significantly diminished after UV light or β-amyloid treatment reaching those values obtained for control cells  Figure 7A  and  Figure S6A  
Mutation Word : T141A @Position : 11
Function Word : phosphorylation @Position : 5
Impact Word : diminish @Position : 17
Enhancement by PDGFRα-I of the  in vitro  anti-proliferative and pro-apoptotic activity of BRAF-I in BRAF-I sensitive and resistant melanoma cell lines harboring BRAFV600E
Mutation Word : V600E @Position : 24
Function Word : activity @Position : 12
Impact Word : enhance @Position : 0
Similar to E884K R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in- cis  with L858R 
Mutation Word : E884K @Position : 2
Function Word : sensitivity @Position : 6
Impact Word : modulates @Position : 4
In an overlay assay using ERK4 peptides with wild-type sequence or single amino-acid substitutions bound to cellulose membrane the authors showed that D336N but not E331D reduced  in vitro  binding of recombinant MK5 
Mutation Word : D336N @Position : 22
Function Word : binding @Position : 31
Impact Word : reduce @Position : 26
The somatic E884K substitution appears to be relatively infrequent and resulted in a mutant lysine residue that disrupts an ion pair with residue R958 in the EGFR kinase domain C-lobe an interaction that is highly conserved within the human kinome as demonstrated by our sequence analysis and structure analysis 
Mutation Word : E884K @Position : 2
Function Word : interaction @Position : 31
Impact Word : disrupt @Position : 17
Among the investigated melanoma cell lines three display constitutive activation of the Ras/Raf/MEK/ERK pathway through activating V600E BRAF mutation or NRAS mutations Colo-679 BRAF V600E mut Nras wt IGR-39 BRAF V600E mut Nras wt IPC298 Braf wt Nras Q61K mut  
Mutation Word : V600E @Position : 30
Function Word : activity @Position : 15
Impact Word : constitutive @Position : 8
In our recent studies on the effects of PLX4032 we demonstrated that the high enzymatic activity of both V600E and V600K BRAF mutants in melanoma cells is suppressed by treatment with PLX4032   
Mutation Word : V600E @Position : 20
Function Word : activity @Position : 15
Impact Word : high @Position : 13
Graph shows that autophosphorylation levels are lower for T790M white diamonds than for S768I white squares or Ins770SVD black triangles 
Mutation Word : S768I @Position : 13
Function Word : autophosphorylation @Position : 3
Impact Word : lower @Position : 6
The mutation of arginine at position 24 into cysteine CDK4 R24C  or histidine CDK4 R24C  renders the protein insensitive to regulation by p16 INK4a  but preserves interaction between CDK4 and cyclin D1 leading to constitutive activation of the complex and aberrant proliferation through retinoblastoma protein inactivation and E2F activation 
Mutation Word : R24C @Position : 15
Function Word : proliferation @Position : 44
Impact Word : preserve @Position : 28
The mutants T316A K323A and R326A which were engineered to abrogate the hydrophilic interactions also moderately impaired the kinase activity 
Mutation Word : T316A @Position : 2
Function Word : interaction @Position : 13
Impact Word : abrogate @Position : 10
These two cases illustrate the importance of high assay sensitivity of our ARMS-PCR assay to detect low  BRAF  V600E allele burdens in tumor samples 
Mutation Word : V600E @Position : 20
Function Word : sensitivity @Position : 9
Impact Word : high @Position : 7
Moreover high expression of the glucose transporter type 1 gene supports the use of PET with specific tracers in the clinical management of such cancers and BRAF-V600E point mutations may lead to less differentiated phenotypes and lower expression of NIS suggesting a worse prognosis [ 15 ] 
Mutation Word : V600E @Position : 26
Function Word : expression @Position : 37
Impact Word : high @Position : 1
Structurally this residue lies in the substrate-binding pocket of the kinase and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP-bound form effectively making RET more active more of the time  48 – 51  
Mutation Word : M918T @Position : 13
Function Word : atp @Position : -2
Impact Word : increase @Position : 17
In this critical step BsaXI removes from the wild type PCR product a 30 bp fragment containing the V617F mutation site which effectively eliminates the chance that the full-length wild type product is re-generated in the subsequent PCR 
Mutation Word : V617F @Position : 18
Function Word : effect @Position : 22
Impact Word : eliminate @Position : 23
Binding of DACH1 to the R273H mutant was reduced 60% and the R248Q mutant was incapable of binding DACH1  S  3AB  
Mutation Word : R248Q @Position : 12
Function Word : binding @Position : 17
Impact Word : reduce @Position : 8
The data demonstrated that while E-cadherin was well expressed in normal thyroid tissue its expression was markedly decreased and vimentin expression up-regulated in the thyroid carcinomas from the transgenic mice over-expressing BRAF V600E   25  
Mutation Word : V600E @Position : 32
Function Word : expression @Position : 20
Impact Word : decrease @Position : 17
Our biochemical studies here now show that E884K mutation in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 7
Function Word : associated @Position : 34
Impact Word : alter @Position : 36
However when used in combination NAC enhanced the inhibitory effect of PLX4032 BRAF V600E inhibitor and Gefitinib EGFR inhibitor on FO-1 and PT4 cell survival 
Mutation Word : V600E @Position : 13
Function Word : survival @Position : 24
Impact Word : enhance @Position : 6
Consistent with the results of Y27632 treatments knockdown of ROCK1/2 greatly reduced the GLUT1 translocation and the Warburg effect in cells and furthermore largely abolished the stimulating effects of mutp53 on GLUT1 translocation and the Warburg effect in H1299  Fig. 6c & d   p53  R172H/R172H   MEF  Fig. 6e & f  and MDA-MB468 cells  Supplementary Fig  S6c & e  
Mutation Word : R172H @Position : 48
Function Word : result @Position : 3
Impact Word : reduce @Position : 11
We note that M918T also has increased activity toward exogenous substrates and is itself phosphorylated to a greater degree by exogenous kinases such as FAK  Figure S7  
Mutation Word : M918T @Position : 3
Function Word : activity @Position : 7
Impact Word : increase @Position : 6
The analysis of dasatinib complexed with native and T315I mutant BCR-ABL kinases revealed that native complex has relatively higher SIE free energy −9.53 kcal/mol than when complexed with T315I −8 44 kcal/mol that signifies the greater affinity of dasatinib for native compared to mutant BCR-ABL kinase 
Mutation Word : T315I @Position : 28
Function Word : affinity @Position : 36
Impact Word : greater @Position : 35
In addition the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
Mutation Word : V617F @Position : 39
Function Word : stability @Position : 12
Impact Word : increase @Position : 33
By contrast both ALK F1174I  and ALK F1174L  displayed robust foci formation although ALK M1166R  showed rather weak foci formation ability in comparison with ALK F1174S   Fig  5A  
Mutation Word : F1174S @Position : 28
Function Word : ability @Position : 23
Impact Word : weak @Position : 20
In the current study Liu and colleagues show that mutant V600E BRAF enhances STAT3 phosphorylation and increases PAX3 expression in melanocytes 
Mutation Word : V600E @Position : 10
Function Word : phosphorylation @Position : 14
Impact Word : enhance @Position : 12
Hence the E884K mutation when in- cis  with L858R modulates the sensitivity of the mutant receptor towards ERBB family kinase inhibitors in an inhibitor-specific fashion 
Mutation Word : E884K @Position : 2
Function Word : sensitivity @Position : 12
Impact Word : modulates @Position : 10
The mutations F317V Y253F Y253H and E255K experience increased vdW interactions with residue Leu248 
Mutation Word : Y253F @Position : 4
Function Word : interaction @Position : 10
Impact Word : increase @Position : 8
The most common mutation is V600E which dramatically enhances BRAF enzyme activity and thus induces tumorous transformation 
Mutation Word : V600E @Position : 5
Function Word : induce @Position : 14
Impact Word : enhance @Position : 8
Moreover high expression of the glucose transporter type 1 gene supports the use of PET with specific tracers in the clinical management of such cancers and BRAF-V600E point mutations may lead to less differentiated phenotypes and lower expression of NIS suggesting a worse prognosis [ 15 ] 
Mutation Word : V600E @Position : 26
Function Word : expression @Position : 37
Impact Word : lower @Position : 36
It was noted that PLX4720 also reduced pRB protein phosphorylation increased p27 expression suppressed cyclin D1 expression and induced cleavage of PARP only in melanoma cell lines harbouring the  BRAF -V600E mutation  Figure 1D  
Mutation Word : V600E @Position : 31
Function Word : phosphorylation @Position : 9
Impact Word : reduce @Position : 6
 B  Endogenous TAK1 interacts with kinase-dead K508M wild-type and constitutively active K650E FGFR3 in HeLa cells 
Mutation Word : K650E @Position : 13
Function Word : activity @Position : 12
Impact Word : constitutive @Position : 11
RAS and RAF proteins play a key role in the control of cellular growth proliferation and differentiation  Bos 1989   Wickenden  et al  2008   KRAS -activating mutations reduce or abolish intrinsic GTPase activity of the protein leading to its constitutive activation  Conlin  et al  2005  Similarly  BRAF  V600E mutation induces structural changes in RAF protein which increase its kinase activity  Wan  et al  2004  Activated RAS and RAF are responsible for the disregulation of RAS/RAF/MAPKs signalling pathway 
Mutation Word : V600E @Position : 59
Function Word : activity @Position : 80
Impact Word : abolish @Position : 35
The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation and to a large degree mutations affecting the residue 317 F317L F317V 
Mutation Word : F317V @Position : 34
Function Word : resistance @Position : 13
Impact Word : maintain @Position : 5
Interestingly SIRT1 level and activity are enhanced in the PLX4032-resistant BRAF V600E -mutated melanoma cells compared with their sensitive counterpart 
Mutation Word : V600E @Position : 11
Function Word : sensitivity @Position : 18
Impact Word : enhance @Position : 6
The T315I cells exhibit increased proliferation rate Supporting Information Fig S8  elevated basal expressions of Rad51 and γ-H2AX  Fig 5A  and display increased endogenous DNA damage response indicated by increased Rad51 and γ-H2AX foci  Fig 5B and C  when compared with parental cells 
Mutation Word : T315I @Position : 1
Function Word : expression @Position : 14
Impact Word : elevate @Position : 12
Constitutive activation of the FLT3 receptor kinase due to internal tandem duplication ITD or point mutation D835Y is detected in almost 30% of AML patients  [1]  
Mutation Word : D835Y @Position : 16
Function Word : activity @Position : 1
Impact Word : constitutive @Position : 0
Even the few LT-sensitive human tumor cells having the BRAF V600E mutation such as melanoma SK-MEL-28 HT29 and colon carcinoma Colo205 are less sensitive to LT than to PA/FP59  Figure 1  
Mutation Word : V600E @Position : 10
Function Word : sensitivity @Position : 23
Impact Word : less @Position : 22
Intriguingly tyrosine phosphorylation of PECAM-1 as well as its physical association with SHP2 was enhanced by the imatinib-resistance E255K or T315I mutation 
Mutation Word : E255K @Position : 18
Function Word : associated @Position : 10
Impact Word : enhance @Position : 14
Synergy is particularly important as it may permit lower doses of PLX4720 to be used potentially translating to a benefit in the clinic by reducing side effects associated with BRAF V600E -inhibition including squamous cell carcinoma [ 54 - 56 ] 
Mutation Word : V600E @Position : 30
Function Word : effect @Position : 26
Impact Word : reduce @Position : 24
Remarkably abrogating MITF activity in  BRAF V600E mitf  melanoma leads to dramatic tumor regression marked by melanophage infiltration and increased apoptosis 
Mutation Word : V600E @Position : 7
Function Word : apoptosis @Position : 22
Impact Word : increase @Position : 21
Notably melanomas that have the V600E  BRAF  mutation exhibit increased HIF-1α expression 
Mutation Word : V600E @Position : 5
Function Word : exhibit @Position : 10
Impact Word : increase @Position : 11
The most common mutation is V600E which dramatically enhances BRAF enzyme activity and thus induces tumorous transformation 
Mutation Word : V600E @Position : 5
Function Word : activity @Position : 11
Impact Word : enhance @Position : 8
EGFR mutation-positive NSCLCs which also test positive for mutations associated with primary or most frequently secondary resistance to first-generation TKIs first of all the T790M substitution may respond better to newer agents like afatinib and dacomitinib which have demonstrated a greater effectiveness in these clinical situations but more clinical data are required      
Mutation Word : T790M @Position : 24
Function Word : effect @Position : 41
Impact Word : greater @Position : 40
Notably inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
Mutation Word : D816F @Position : 16
Function Word : inhibit @Position : 1
Impact Word : reduce @Position : 10
Recently WZ4002 a new inhibitor specifically targeting T790M gatekeeper mutation was developed and found to induce greater growth inhibition in vitro and in vivo against T790M than against wild-type EGFR    Figure 1  
Mutation Word : T790M @Position : 25
Function Word : inhibit @Position : 18
Impact Word : greater @Position : 16
The T315I cells exhibit increased proliferation rate Supporting Information Fig S8  elevated basal expressions of Rad51 and γ-H2AX  Fig 5A  and display increased endogenous DNA damage response indicated by increased Rad51 and γ-H2AX foci  Fig 5B and C  when compared with parental cells 
Mutation Word : T315I @Position : 1
Function Word : expression @Position : 14
Impact Word : increase @Position : 32
We hypothesized that the R958D substitution would disrupt the ion pair with E884 through electrostatic repulsion in a way similar to the effect of the E884K substitution 
Mutation Word : E884K @Position : 25
Function Word : effect @Position : 22
Impact Word : disrupt @Position : 7
Strongly reduced activity of the PPARγ K365R mutant contradicts the results of Pascual  et al  who reported similar activation of the Aox-tk  luciferase construct by wild type PPARγ and by the PPARγ K365R mutant 
Mutation Word : K365R @Position : 35
Function Word : activity @Position : 20
Impact Word : reduce @Position : 1
Webster and Donoghue proposed that the G380R mutation enhances FGFR3 dimerization likely due to hydrogen bonding of the mutant R380 to the neighboring receptor in the dimer  
Mutation Word : G380R @Position : 6
Function Word : dimerization @Position : 26
Impact Word : enhance @Position : 8
The results showed increased phosphorylation of Erk1/2 and p38 in  Fgfr2 +/S252W   mice BMSCs which indicated that Erk1/2 and p38 signaling may participate in the regulation of endochondral bone formation by FGFR2 
Mutation Word : S252W @Position : 12
Function Word : phosphorylation @Position : 4
Impact Word : increase @Position : 3
Our studies here using COS-7 transfection model system show that E884K works in concert with L858R in- cis  in a dominant fashion to change downstream signaling differentially induce MAPK-ERK1/2 signaling and associated cell proliferation and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor-specific fashion 
Mutation Word : L858R @Position : 15
Function Word : phosphorylation @Position : 41
Impact Word : alter @Position : 37
A Treatment of BaF3-JAK3 V674A  cells with NSC114792 results in a decrease in phosphorylated JAK3 and STAT5 levels in a dose-dependent manner 
Mutation Word : V674A @Position : 4
Function Word : phosphorylation @Position : 14
Impact Word : decrease @Position : 12
The mutations E255V M244V T315A Y253H experience increased vdW interactions with Met290 and the mutation M244V experiences increased vdW interactions with Ile293 
Mutation Word : Y253H @Position : 5
Function Word : interaction @Position : 19
Impact Word : increase @Position : 17
In the absence of a three-dimensional structure for the full-length protein the mechanism of activation of JAK2 V617F has remained elusive 
Mutation Word : V617F @Position : 17
Function Word : activity @Position : 14
Impact Word : remain @Position : 19
Our studies here using COS-7 transfection model system show that E884K works in concert with L858R in- cis  in a dominant fashion to change downstream signaling differentially induce MAPK-ERK1/2 signaling and associated cell proliferation and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor-specific fashion 
Mutation Word : L858R @Position : 15
Function Word : inhibit @Position : 42
Impact Word : alter @Position : 37
In an effort to enhance the efficacy of BRAF V600E -inhibition in thyroid cancer we chose to target additional signaling pathways chiefly SRC signaling 
Mutation Word : V600E @Position : 9
Function Word : inhibit @Position : 10
Impact Word : enhance @Position : 4
In vitro  the V617F substitution increases JAK2 kinase activity thus causing cytokine-independent growth of cell lines and cultured bone marrow cells 
Mutation Word : V617F @Position : 4
Function Word : activity @Position : 9
Impact Word : increase @Position : 6
BA/F3 cells expressing empty vector control BCR/ABL wild-type or imatinib-resistant mutations BCR/ABL E255K and T315I were a kind gift of Dr Brian Druker Oregon Health Science University Portland OR USA and maintained as described 
Mutation Word : E255K @Position : 12
Function Word : expression @Position : 2
Impact Word : maintain @Position : 31
Levels of L858R EGFR expression necessary to achieve transformation in this model cell culture system were no higher than expression levels observed in the human lung adenocarcinoma cell line H3255 bearing the L858R mutation  Figure 1 C 
Mutation Word : L858R @Position : 32
Function Word : expression @Position : 19
Impact Word : higher @Position : 17
Moreover  Fgfr2 +/S252W   BMSCs developed fewer mineralized colonies and exhibited reduced alizarin red staining  Fig  5 B  
Mutation Word : S252W @Position : 3
Function Word : exhibit @Position : 12
Impact Word : reduce @Position : 13
Interestingly further  V600E B-RAF over-expression at a much greater level as in the case of M395 R relative to M395 P increase in RNA/cDNA level shown in  Supplementary Fig. S3c and S5  increase in protein level shown in  Fig. 2c  conferred enhanced drug resistance mainly at 1 μM vemurafenib but not 10 μM vemurafenib  Fig  2d  
Mutation Word : V600E @Position : 3
Function Word : resistance @Position : 48
Impact Word : enhance @Position : 46
The analysis of dasatinib complexed with native and T315I mutant BCR-ABL kinases revealed that native complex has relatively higher SIE free energy −9.53 kcal/mol than when complexed with T315I −8 44 kcal/mol that signifies the greater affinity of dasatinib for native compared to mutant BCR-ABL kinase 
Mutation Word : T315I @Position : 28
Function Word : affinity @Position : 36
Impact Word : higher @Position : 18
The coexistent mutations of  AKT3  and  PIK3CA  in one sample suggest that some types of  AKT  mutations non-E17K might coexist with  PIK3CA  mutations to enhance the activation of the PI3 kinase–AKT pathway 
Mutation Word : E17K @Position : 23
Function Word : activity @Position : 34
Impact Word : enhance @Position : 32
Intriguingly the imatinib-resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM-1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells  Fig  4  
Mutation Word : T315I @Position : 7
Function Word : expression @Position : 23
Impact Word : increase @Position : 9
Conversely E884K worked in concert with L858R in- cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition  Fig  1A B  
Mutation Word : L858R @Position : 6
Function Word : sensitivity @Position : 14
Impact Word : enhance @Position : 12
However the most prevalent  KIT  mutation in CBF AML substituting valine for aspartic acid at codon 816 KIT D816V was demonstrated to be basically insensitive towards quizartinib in  in vitro  and  ex vivo  leukemia cell lines primary myeloblasts and in an isogenic Ba/F3 cell model – while substitution of a tyrosine residue D816Y retained some sensitivity to quizartinib 
Mutation Word : D816V @Position : 58
Function Word : sensitivity @Position : 61
Impact Word : retain @Position : 59
Similarly E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor CL-387785 
Mutation Word : E884K @Position : 1
Function Word : sensitivity @Position : 5
Impact Word : enhance @Position : 3
Research into the molecular mechanisms of BRAF V600E -positive tumors has revealed that the missense valine to glutamic acid mutation increases kinase activity promoting the constitutive activation of MEK-ERK signaling and enhancing ERK-dependent transcriptional output  
Mutation Word : V600E @Position : 7
Function Word : activity @Position : 26
Impact Word : constitutive @Position : 25
Given this scenario we expected that when appended to a dimeric cytokine receptor JAK2 V617F would signal irrespective of the particular dimeric orientation of the receptor and that other less active mutants V617M V617L V617I might still depend on a conformational change of a dimeric receptor 
Mutation Word : V617I @Position : 34
Function Word : activity @Position : 30
Impact Word : less @Position : 29
The two substitutions V600E and V600K represent 95% of all BRAF mutations in melanoma and both create a constitutively active kinase that is independent of receptor tyrosine kinase or RAS 
Mutation Word : V600E @Position : 5
Function Word : activity @Position : 19
Impact Word : constitutive @Position : 18
Our biochemical studies here now show that E884K mutation in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 7
Function Word : sensitivity @Position : 17
Impact Word : alter @Position : 36
Other possibilities are that the associated haplotype causes the JAK2  gene to be more susceptible to mutation or allows increased survival of  JAK2  V617F  alleles 
Mutation Word : V617F @Position : 26
Function Word : survival @Position : 21
Impact Word : increase @Position : 20
Several resistance mechanisms such as EGFR T790M secondary mutation that leads to a higher ATP binding capacity and MET amplification resulting in an aberrantly activated alternative pathway that bypasses the inhibited EGF receptors had been discovered 
Mutation Word : T790M @Position : 6
Function Word : binding @Position : 15
Impact Word : higher @Position : 13
To gain insight into the mechanism of E884K modulation of EGFR tyrosine kinase inhibitor TKI sensitivity we further studied its effect on downstream AKT and STAT3 signaling pathways with TKI inhibition 
Mutation Word : E884K @Position : 7
Function Word : sensitivity @Position : 15
Impact Word : modulates @Position : 8
While phosphorylation is reversible under nilotinib treatment in Ba/F3p210 cells the TKI-resistant mutant Ba/F3p210 T315I  cells showed an impaired phosphorylation status Figure  4  right panel suggesting that LASP1 is a direct substrate of BCR-ABL 
Mutation Word : T315I @Position : 14
Function Word : phosphorylation @Position : 20
Impact Word : impair @Position : 19
PDGFRA  exon 18 mutations D842V which affect the activation loop of the PDGFRα kinase are biochemically less sensitive to imatinib than the more common KIT exon 11 mutations 
Mutation Word : D842V @Position : 5
Function Word : sensitivity @Position : 18
Impact Word : less @Position : 17
To confirm DUB regulation through BRAF activation mutant BRAF V600E was expressed in HEK293T cells and DUB activity assessments were used to demonstrate increased Usp5 activity in cells expressing BRAF V600E  Fig   1F  
Mutation Word : V600E @Position : 30
Function Word : activity @Position : 25
Impact Word : increase @Position : 23
Mulloy et al  showed that the T790M mutant exhibits tyrosine phosphorylation levels comparable to those of wild-type EGFR whereas the T790M/L858R double mutant exhibits a substantial increase in phosphorylation compared with the L858R mutant alone   
Mutation Word : T790M @Position : 21
Function Word : exhibit @Position : 24
Impact Word : increase @Position : 27
In an  EGFR -vIII-based method of overexpression L861Q mutation reportedly enhances EGFR kinase activity and transforms activity without an increase in sensitivity to EGFR-TKI but with an increase in sensitivity to irreversible second-generation EGFR-TKI  26  
Mutation Word : L861Q @Position : 8
Function Word : sensitivity @Position : 30
Impact Word : enhance @Position : 11
This latter type of resistance mechanism is highly reminiscent of that previously described for resistance of EGFR to gefitinib Iressa and erlotinib Tarceva in NSCLC patients as a result of the T790M secondary mutation in EGFR Yun et al   and by analogy all ALK inhibitors with an ATP-competitive binding mechanism may be destined to display decreased inhibitory activity when the F1174L mutation appears 
Mutation Word : T790M @Position : 31
Function Word : activity @Position : 59
Impact Word : decrease @Position : 57
Sumimoto et al   15  have shown that BRAF V600E  knock-down decreased phospho-ERK1/2 protein levels and inhibited invasion of melanoma cells accompanied by a decrease of matrix metalloproteinase activity and ITGβ1 expression 
Mutation Word : V600E @Position : 11
Function Word : expression @Position : 34
Impact Word : decrease @Position : 27
Furthermore the nuclear activation of YAP1 was maintained in 8505C and K1 cells and resistant to RAF BRAF V600E  and MEK inhibitors 
Mutation Word : V600E @Position : 18
Function Word : resistance @Position : 14
Impact Word : maintain @Position : 7
This uncoupling of the LKB1-AMPK complex allows BRAF V600E  oncogene-driven cancer cells to become resistant to energy stress and avoid apoptosis   
Mutation Word : V600E @Position : 8
Function Word : resistance @Position : 15
Impact Word : avoid @Position : 20
At a later time point in pancreas development S33Y mutant β-cat expression enhanced islet cell proliferation and increased the size of pancreas [ 49 ] 
Mutation Word : S33Y @Position : 8
Function Word : expression @Position : 11
Impact Word : increase @Position : 17
Upon FGF2 stimulation S252W fibroblasts significantly altered expression of 55 DEGs up-regulating 21 genes and down regulating 34 genes  Table S3  
Mutation Word : S252W @Position : 3
Function Word : expression @Position : 7
Impact Word : alter @Position : 6
BRAF V600E  elicits a strong kinase activity increased phosphorylation PO4− compared with wild type wt BRAF and activates MEK1/2 to phospho-MEK1/2 and ERK1/2 to phospho-ERK1/2 which may be involved in the up-regulation of some ECM remodeling genes i e 
Mutation Word : V600E @Position : 1
Function Word : phosphorylation @Position : 9
Impact Word : increase @Position : 8
An accumulation of alternative mutations including a T790M-insensitive mutation in addition to the primary activating mutation could modulate the sensitivity to EGFR-TKI 
Mutation Word : T790M @Position : 7
Function Word : sensitivity @Position : 19
Impact Word : modulates @Position : 17
Whether resistance to BRAF V600E inhibitors also arises in gliomas where EGFR and PI3K/mTOR pathways are often over-activated remains to be seen in neuro-oncology patients treated with BRAF V600E inhibitors 
Mutation Word : V600E @Position : 28
Function Word : resistance @Position : 1
Impact Word : remain @Position : 18
Molecular studies on the receptors harbouring a known L858R mutation demonstrated a decreased affinity of the tyrosine kinase for ATP and an increase in the affinity for the tyrosine kinase inhibitors TKI 
Mutation Word : L858R @Position : 8
Function Word : affinity @Position : 25
Impact Word : decrease @Position : 12
In vitro  studies have demonstrated that  JAK2  V617F  leads to a specific phosphorylation associated with the constitutive activation of the tyrosine kinase function  [3]  
Mutation Word : V617F @Position : 10
Function Word : activity @Position : 21
Impact Word : constitutive @Position : 20
Here we present evidence that BRAF V600E  enhances migration and invasion properties in colon carcinoma cells through RhoA activation while KRAS G12V  induces these properties less efficiently as compared to BRAF V600E  albeit through Cdc42 activation and filopodia formation 
Mutation Word : V600E @Position : 33
Function Word : induce @Position : 24
Impact Word : enhance @Position : 8
In fact rare divergent results between BRAF DNA sequencing and V600E immunohistochemistry usually resolve in favor of the antibody based results 
Mutation Word : V600E @Position : 10
Function Word : result @Position : 20
Impact Word : favorable @Position : 15
One Akt mutant E17K found in a subset of human cancers displays higher PIP3 binding membrane localization and activation Brazil et al.  Varnai et al   
Mutation Word : E17K @Position : 3
Function Word : activity @Position : 18
Impact Word : higher @Position : 12
In H3255 cells EGFR L858R  which display impaired EGF-mediated SHP2 phosphorylation relative to cells expressing wild-type EGFR   7    Supplementary Figure S2  SHP2 knockdown had no substantial effect on ERK phosphorylation at any concentration of gefitinib 
Mutation Word : L858R @Position : 4
Function Word : phosphorylation @Position : 36
Impact Word : impair @Position : 8
The BRAF V600E  mutation results in the constitutive activation of the Ras/Raf/MEK/ERK signaling pathway   
Mutation Word : V600E @Position : 2
Function Word : activity @Position : 9
Impact Word : constitutive @Position : 8
The mutations E255V M244V T315A Y253H experience increased vdW interactions with Met290 and the mutation M244V experiences increased vdW interactions with Ile293 
Mutation Word : E255V @Position : 2
Function Word : interaction @Position : 19
Impact Word : increase @Position : 17
Hence E884K in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : L858R @Position : 14
Function Word : sensitivity @Position : 10
Impact Word : alter @Position : 29
The up-regulation of BIM was also attenuated in a similar dose–response manner as seen in the apoptosis assay  Figure 6 A bottom with L858R-T790M completely abrogating the induction of BIM and L858R-L747S attenuating both the up-regulation of BIM and apoptosis 
Mutation Word : L747S @Position : 32
Function Word : apoptosis @Position : 40
Impact Word : attenuate @Position : 33
The AKT1 E17K mutant can cause increases in the protein levels of Bcl-2 and the phosphorylation of the pro-apoptotic protein BAD resulting in enhanced resistance to apoptosis 
Mutation Word : E17K @Position : 2
Function Word : phosphorylation @Position : 15
Impact Word : increase @Position : 6
Intriguingly the imatinib-resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM-1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells  Fig  4  
Mutation Word : E255K @Position : 5
Function Word : phosphorylation @Position : 19
Impact Word : increase @Position : 9
We hypothesised that patients with low or heterogeneous expression of mutant BRAF V600E  protein would have a poor response to treatment with BRAF inhibitors and reduced survival compared with patients with high and homogeneous expression 
Mutation Word : V600E @Position : 12
Function Word : expression @Position : 35
Impact Word : high @Position : 32
One Akt mutant E17K found in a subset of human cancers displays higher PIP3 binding membrane localization and activation Brazil et al.  Varnai et al   
Mutation Word : E17K @Position : 3
Function Word : binding @Position : 14
Impact Word : higher @Position : 12
Increased mitotic activity in  BRAF   V600E   p53  melanomas compared with  BRAF   V600E   mitf  melanoma cells was confirmed by immunostaining for phospho-histone H3 a marker of late-G2/M phase  Figure 2f and g  
Mutation Word : V600E @Position : 20
Function Word : activity @Position : 2
Impact Word : increase @Position : 0
Similar to E884K R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in- cis  with L858R 
Mutation Word : E884K @Position : 2
Function Word : effect @Position : 7
Impact Word : modulates @Position : 4
For 4557W reversible dual TKI of EGFR/ERBB2 the E884K mutation modulated the L858R mutation in- cis  again in a dominant fashion rendering the double mutant receptor more sensitive to the dual inhibitor  Figure 2  
Mutation Word : E884K @Position : 8
Function Word : sensitivity @Position : 28
Impact Word : modulates @Position : 10
One hypothesis may state that induction of apoptosis is mediated via Thr308 We observed a particular high phosphorylation pattern of Thr308 in cells transfected with the tyrosine kinase domain TKD-mutated  FLT3  D835V and  KIT  D816Y isoforms in our assays see Figure  6  
Mutation Word : D816Y @Position : 38
Function Word : phosphorylation @Position : 17
Impact Word : high @Position : 16
Interestingly all LRRK2 mutants R1441C G2019S G2385R and D1994A significantly increased NF-κB activity indicating that the increase was independent of mutations in ROC kinase and WD domains  Fig  6C  
Mutation Word : G2385R @Position : 6
Function Word : activity @Position : 12
Impact Word : increase @Position : 16
Here we demonstrate that a human FLT3 -ITD +  AML cell line harbouring a secondary D835Y mutation has high relative resistance to the FLT3 inhibitors AC220 MLN518 and Sorafenib but not to CCT137690 
Mutation Word : D835Y @Position : 16
Function Word : resistance @Position : 21
Impact Word : high @Position : 19
Graph shows that the common L858R mutation confers higher autophosphorylation levels to YFP-EGFR-ICD than P848L and A859T 
Mutation Word : P848L @Position : 14
Function Word : autophosphorylation @Position : 9
Impact Word : higher @Position : 8
Interestingly GSK-3β was inactivated in transformed Ba/F3 cells by JAK2 V617F and this enhanced the protein expression of c-Myc 
Mutation Word : V617F @Position : 10
Function Word : expression @Position : 16
Impact Word : enhance @Position : 13
E884K and L858R+E884K mutants remained sensitive to EGF and were activated by the ligand to a level comparable to L858R  Figure 3A  
Mutation Word : L858R @Position : 19
Function Word : sensitivity @Position : 5
Impact Word : remain @Position : 4
The counterselection necessary to avoid selecting for aptamers that nonspecifically recognized the cell surface included a first step against parental PC12 cells in order to eliminate nonspecific binders of the PC12 cell surface followed by a second counterselection step against PC12/MEN2B cells that expressed an allele of RET RET M918T  mutated in the intracellular tyrosine kinase domain 
Mutation Word : M918T @Position : 49
Function Word : expression @Position : 43
Impact Word : avoid @Position : 4
The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation and to a large degree mutations affecting the residue 317 F317L F317V 
Mutation Word : T315I @Position : 21
Function Word : resistance @Position : 13
Impact Word : maintain @Position : 5
However tyrosine phosphorylation on the EGFR mutants could be further increased by EGF stimulation  Figure 2 B suggesting that the mutant EGFRs exhibit both ligand-independent and ligand-dependent activation similar to that observed upon EGF stimulation of the L858R mutant H3255 lung adenocarcinoma cell line   
Mutation Word : L858R @Position : 38
Function Word : exhibit @Position : 23
Impact Word : increase @Position : 10
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : E255K @Position : 5
Function Word : substrate @Position : 29
Impact Word : increase @Position : 19
It is striking that several of the variants with reduced activity had altered evolutionarily conserved glycine residues that is G220V G401S and G465R suggesting that these residues may be particularly important for OCT1 function   
Mutation Word : G465R @Position : 22
Function Word : activity @Position : 10
Impact Word : reduce @Position : 9
Two of these missense mutants V689M and L703F are constitutively active possibly because they stabilize acceptor/donor interactions   
Mutation Word : V689M @Position : 5
Function Word : activity @Position : 10
Impact Word : constitutive @Position : 9
In MPN it has been shown that the JAK2 V617F mutation induces an increase in spontaneous homologous recombination leading to a hyperrecombination state 
Mutation Word : V617F @Position : 9
Function Word : induce @Position : 11
Impact Word : increase @Position : 13
The mutations G250E Y253H and T315I experience decreased vdW interactions with Phe359 
Mutation Word : Y253H @Position : 3
Function Word : interaction @Position : 9
Impact Word : decrease @Position : 7
The H878Y missense mutation occurring in the activation domain of  ERBB2  alters a basic hydrophilic residue to an acidic hydrophilic residue and so is predicted to affect function 
Mutation Word : H878Y @Position : 1
Function Word : activity @Position : 7
Impact Word : alter @Position : 13
Introduction  of a melanoma-associated mutation P52L into this peptide reduces pseudosubstrate autoinhibition of PAK6 and increases phosphorylation of its substrate PACSIN1 Syndapin I in cells 
Mutation Word : P52L @Position : 6
Function Word : phosphorylation @Position : 17
Impact Word : increase @Position : 16
On the contrary the initial status of the  JAK2 V617F genotype was significantly associated with the risk of incurring into BT P<0.001 it resulted higher in patients who had either wt or homozygous V617F genotype with respect to those who had heterozygous genotype HR 1.98 95% CI 1.11 to 3.53 P = 0.019 and HR 2.04 95% CI 1.12 to 3.71 P = 0 018 respectively  Figure 1  
Mutation Word : V617F @Position : 34
Function Word : result @Position : 24
Impact Word : higher @Position : 25
However when cells expressing that mutant were exposed to ox-stress GO the affinity of the L858R EGFR for the α4-2 Ab was reduced ∼70% in comparison to the untreated or EGF-treated cells  Fig  6D–E  
Mutation Word : L858R @Position : 15
Function Word : expression @Position : 3
Impact Word : reduce @Position : 22
Results  There was decreased expression of thyroid-specific genes such as Tg and NIS and increased expression of stemness markers such as Oct4 Rex1 CD15 and Sox2 in the thyroid carcinoma tissue from 6-week-old BRAF V600E  mice indicating the dedifferentiated status of the cells and the fact that stemness was derived in this model from differentiated thyroid cells 
Mutation Word : V600E @Position : 35
Function Word : expression @Position : 16
Impact Word : decrease @Position : 4
E884K is activating and can work cooperatively with L858R to differentially modulate downstream signal transduction
Mutation Word : E884K @Position : 0
Function Word : transduction @Position : 14
Impact Word : modulates @Position : 11
Although inhibition of MEK and ERK phosphorylation was achieved in BRAF V600E/K  mutant melanoma significantly increased tumour growth was seen in BRAF wild-type melanomas with upstream RAS mutations 
Mutation Word : V600E @Position : 11
Function Word : inhibit @Position : 1
Impact Word : increase @Position : 16
Accordingly there was higher Congo red binding of aggregated R248Q p53C than aggregated WT p53C at pH 7.2  Fig  2  A  
Mutation Word : R248Q @Position : 9
Function Word : binding @Position : 6
Impact Word : higher @Position : 3
Moreover mutations L755S L755P V777L T798M and T862A displayed enhanced activation of JNK/SAPK and to a lesser extent of ERK1/2 compared to wt-ERBB2  Figure 2A  
Mutation Word : L755P @Position : 3
Function Word : activity @Position : 10
Impact Word : enhance @Position : 9
Although T315I BCR-ABL is sufficient to confer resistance to TKIs in CML cells surprisingly we found that multiple drug resistance pathways were activated in KCL-22M cells along with reduced expression of a set of myeloid differentiation genes 
Mutation Word : T315I @Position : 1
Function Word : expression @Position : 29
Impact Word : reduce @Position : 28
The Ba/F3-EpoR cells expressing JAK2 V617F previously selected for autonomous growth show a typical increase in STAT5 transcriptional activity both in the presence and absence of Epo 
Mutation Word : V617F @Position : 5
Function Word : activity @Position : 18
Impact Word : increase @Position : 14
The Y931C mutation might disrupt the π–π interaction between tyrosine ring and the inhibitor ring structure thus weakening the inhibitor binding and resulting in easy expulsion from the pocket 
Mutation Word : Y931C @Position : 1
Function Word : binding @Position : 20
Impact Word : disrupt @Position : 4
Some mutations P112Q R895C E897K enhance angiotensin II receptor-mediated activation of TRPC6 when expressed in HEK293 cells while neither the S270T nor the N143S missense mutations nor a 57-amino acid truncation mutation K874X altered the channel activity   
Mutation Word : N143S @Position : 23
Function Word : expression @Position : 13
Impact Word : alter @Position : 33
E884K-EGFR modulates inhibitor sensitivity effects in an inhibitor-specific fashion
Mutation Word : E884K @Position : 0
Function Word : sensitivity @Position : 3
Impact Word : modulates @Position : 1
It has been shown that the A391E mutation increases FGFR3 dimerization  unlike the G380R and G375C mutations 
Mutation Word : G380R @Position : 14
Function Word : dimerization @Position : 10
Impact Word : increase @Position : 8
Moreover treatment of mice carrying BRAF V600E  PTC with BRAF inhibitors reduced tumor proliferative index and partially restored thyroid-specific gene expression Chakravarty et al   2011  
Mutation Word : V600E @Position : 6
Function Word : expression @Position : 21
Impact Word : reduce @Position : 12
The G370C and S371C mutants produced higher levels of constitutive activation of MAPK in L8 cells and c- fos  transcription in RCJ cells than the G375C mutant consistent with the fact that TD1 is much more severe than ACH 
Mutation Word : G370C @Position : 26
Function Word : activity @Position : 10
Impact Word : higher @Position : 6
7  Death receptor stimulated apoptotic pathways also appear disrupted in JAK2 V617F PV derived erythroblasts with deregulated expression of the short isoform of c-FLIP  21  which fundamentally plays an essential role in the normal homeostatic apoptotic cascade 
Mutation Word : V617F @Position : 12
Function Word : expression @Position : 18
Impact Word : disrupt @Position : 9
Somatic mutations of the EGFR gene most commonly L858R exon 21 and short in-frame exon 19 deletions have been found to confer enhanced sensitivity towards the inhibitors gefitinib and erlotinib 
Mutation Word : L858R @Position : 8
Function Word : sensitivity @Position : 23
Impact Word : enhance @Position : 22
F1174L may therefore stabilize an active conformation that is both more oncogenic and less favored for crizotinib binding 
Mutation Word : F1174L @Position : 0
Function Word : activity @Position : 5
Impact Word : favorable @Position : 14
It has been reported that BRAF V600E inhibitor improves recognition of human melanoma cells by antigen-specific T lymphocytes through increased expression of melanoma differentiation antigens MDAs   
Mutation Word : V600E @Position : 6
Function Word : expression @Position : 20
Impact Word : increase @Position : 19
In that context we demonstrate that inhibition of SIRT1 with genetic or pharmacological approaches additively enhances the efficacy of PLX4032 of melanoma cells but more importantly that it rescues the sensitivity to PLX4032 of the resistant BRAF V600E -mutated melanoma cells 
Mutation Word : V600E @Position : 37
Function Word : resistance @Position : 35
Impact Word : enhance @Position : 15
One of the putative passenger variants G831E although negative in the BaF3 assay was also predicted to alter function 
Mutation Word : G831E @Position : 6
Function Word : function @Position : 18
Impact Word : alter @Position : 17
In TERT-NHUC abolishing PLCγ1 phosphorylation significantly reduced the increase in saturation density associated with S249C FGFR3 13% vs. 24% p=0 05  Figure 6a  suggesting that PLCγ1 signaling contributes to this phenotype 
Mutation Word : S249C @Position : 14
Function Word : associated @Position : 12
Impact Word : reduce @Position : 6
A gain of function JAK2  JAK2 V617F   mutation leads to enhanced GATA-1 expression whereas morpholino knock-down of  jak2a  or a specific JAK2 inhibitor TG101209 significantly suppresses GATA-1 expression in zebrafish embryos   
Mutation Word : V617F @Position : 7
Function Word : expression @Position : 32
Impact Word : enhance @Position : 13
The T315I mutation is the most resistant to inhibition because of a combination of several factors including steric hindrance of drug binding loss of a key hydrogen-bonding interaction with the T315 side-chain hydroxyl group exploited by Imatinib Nilotinib and Dasatinib and potentially through increasing aberrant intrinsic kinase activity accompanied by aberrant substrate phosphorylation   
Mutation Word : T315I @Position : 30
Function Word : activity @Position : 47
Impact Word : increase @Position : 43
Vikis et al  reported that standalone T790M mutations exhibit increased kinase activity 
Mutation Word : T790M @Position : 7
Function Word : exhibit @Position : 9
Impact Word : increase @Position : 10
A JAK2 K539L T875N and R683G all induce constitutive activation of JAK2 however all three mutants display a marked decrease in STAT5 transcriptional activity in γ-2A cells when the F595A mutation is also introduced 
Mutation Word : T875N @Position : 3
Function Word : activity @Position : 23
Impact Word : constitutive @Position : 8
In a conclusion our findings offer preclinical proof of principle for combined inhibition as a promising treatment strategy for NSCLC especially for patients in whom current EGFR-targeted treatments fail due to the presence of the T790M-EGFR-mutation or high c-MET expression 
Mutation Word : T790M @Position : 35
Function Word : expression @Position : 39
Impact Word : high @Position : 37
The mutations E255K and T315A experience increased vdW interactions with Leu354 
Mutation Word : T315A @Position : 4
Function Word : interaction @Position : 8
Impact Word : increase @Position : 6
The G370C and S371C mutants produced higher levels of constitutive activation of MAPK in L8 cells and c- fos  transcription in RCJ cells than the G375C mutant consistent with the fact that TD1 is much more severe than ACH 
Mutation Word : S371C @Position : 3
Function Word : activity @Position : 10
Impact Word : higher @Position : 6
These data indicate that BRAF V600E  increases NFAT transcriptional activity via MEK/ERK-dependent signalling  Figure 2C  
Mutation Word : V600E @Position : 5
Function Word : activity @Position : 10
Impact Word : increase @Position : 7
The striking stability of our gene expression results on  PDGFRA  mutated tumors could be explained by the D842V mutation found on 4/5 samples 
Mutation Word : D842V @Position : 19
Function Word : expression @Position : 6
Impact Word : stability @Position : 2
However we failed to detect new co-occurring mutations in the  EGFR  gene including the gatekeeper EGFR- T790M  mutation in the tumors generated by the PC-9/Erl-R cells which maintained the same expression level of EGFR Δ E746-A750  as the PC-9 cells  Supplementary Fig  1  
Mutation Word : T790M @Position : 18
Function Word : expression @Position : 33
Impact Word : maintain @Position : 30
Intriguingly tyrosine phosphorylation of PECAM-1 as well as its physical association with SHP2 was enhanced by the imatinib-resistance E255K or T315I mutation 
Mutation Word : T315I @Position : 20
Function Word : associated @Position : 10
Impact Word : enhance @Position : 14
However Yun et al  2008 showed that both the single T790M mutant and the double-mutant L858R/T790M maintain the same low nanomolar affinity for gefitinib as the L858R mutant 
Mutation Word : L858R @Position : 27
Function Word : affinity @Position : 22
Impact Word : maintain @Position : 17
MEK inhibition resulted in increase in pMEK more prominently in  NRAS   Q61L   mutant and  GNAQ  mutant cell lines than in  BRAF   V600E   mutant cell lines 
Mutation Word : V600E @Position : 31
Function Word : result @Position : 2
Impact Word : increase @Position : 4
Furthermore constitutive activity of a JAK1 mutant homologous to JAK2 V617F JAK1 V658F was also inhibited by the homologous JAK1 F595 mutation F636A suggesting that our results in JAK2 might be relevant for activation of JAK1 mutants recently identified in T-ALL     
Mutation Word : V658F @Position : 12
Function Word : activity @Position : 33
Impact Word : constitutive @Position : 1
The EGFR  T790M variant changes the structural conformation of the ATP-binding site thereby increasing the affinity of ATP to EGFR while the affinity of gefitinib to ATP is unchanged 
Mutation Word : T790M @Position : 3
Function Word : atp @Position : 27
Impact Word : increase @Position : 14
The EGFR-L747S-L858R Double Mutant Is Less Sensitive to Inhibition by Gefitinib and Erlotinib
Mutation Word : L747S @Position : 1
Function Word : sensitivity @Position : 6
Impact Word : less @Position : 5
Cells expressing S249C and Y375C FGFR3 displayed an increased saturation density related to increased proliferation and viability 
Mutation Word : S249C @Position : 2
Function Word : proliferation @Position : 14
Impact Word : increase @Position : 13
This mutation JAK2 V617F is a gain of function mutation and hematopoietic progenitor cells from patients with this mutation have increased sensitivity to hematopoietic growth factors   
Mutation Word : V617F @Position : 3
Function Word : sensitivity @Position : 21
Impact Word : increase @Position : 20
Indeed upon the addition of NN hTMSC chemotactic migration was significantly reduced compared with the control condition as well as to N C -stimulated cells  Fig. 3  A . Furthermore in NSCLC line H1975 which expresses EGFR with the double mutation L858R and T790M as well as HER2 and HER3   NN stimulation reduced chemokinesis relative to NRG-stimulated and untreated control cells  Fig  3   B  and  C  
Mutation Word : L858R @Position : 43
Function Word : migration @Position : 8
Impact Word : reduce @Position : 56
The data demonstrated that while E-cadherin was well expressed in normal thyroid tissue its expression was markedly decreased and vimentin expression up-regulated in the thyroid carcinomas from the transgenic mice over-expressing BRAF V600E   25  
Mutation Word : V600E @Position : 32
Function Word : expression @Position : 20
Impact Word : decrease @Position : 17
E884K is activating and can work cooperatively with L858R to differentially modulate downstream signal transduction
Mutation Word : L858R @Position : 8
Function Word : transduction @Position : 14
Impact Word : modulates @Position : 11
In addition the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
Mutation Word : V617F @Position : 39
Function Word : phosphorylation @Position : 41
Impact Word : increase @Position : 33
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : T315I @Position : 7
Function Word : activity @Position : 16
Impact Word : increase @Position : 19
According to the Ki67 positive cells  BRaf  V600E  expression increased lung cell proliferation index from 33.51% ±2.389% n = 8 20X fields from 3 different mice in 10-days-old WT to 42.56% ±2.861% n = 11 20X fields from 3 different mice in age-matched  Braf  CA  mice each 20X field quantified contained between 2500–5000 nucleus  P  = 0 0345  Figure 1E  
Mutation Word : V600E @Position : 9
Function Word : expression @Position : 11
Impact Word : increase @Position : 12
In addition in PMF JAK2 V617F-positive patients compared to their mutation-negative counterparts were more likely to display higher plasma levels of IL-1RA IL-2R IL-6 IL-12 hepatocyte growth factor HGF CXCL10 and monokine induced by interferon IFN-γ other phenotypic correlates included increased levels of i IL-6 and IL-8 with constitutional symptoms ii HGF with marked splenomegaly iii IL-2R IL-8 IL-10 macrophage inflammatory protein MIP-1α and monocyte chemotactic protein-1 with red cell transfusion dependency iv IL-2R HGF and CXCL10 with leukocytosis and v CXCL10 with thrombocytopenia 
Mutation Word : V617F @Position : 5
Function Word : induce @Position : 32
Impact Word : higher @Position : 17
Some mutations P112Q R895C E897K enhance angiotensin II receptor-mediated activation of TRPC6 when expressed in HEK293 cells while neither the S270T nor the N143S missense mutations nor a 57-amino acid truncation mutation K874X altered the channel activity   
Mutation Word : N143S @Position : 23
Function Word : activity @Position : 36
Impact Word : alter @Position : 33
Increased activation of Akt1 by E17K L52R C77F and Q79K mutants led as expected to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
Mutation Word : L52R @Position : 6
Function Word : phosphorylation @Position : 16
Impact Word : increase @Position : 15
Tyrosine phosphorylation of STAT5 was also enhanced though not as significantly as that of PECAM-1 in cells expressing the E255K or T315I mutant  Fig  4C  
Mutation Word : T315I @Position : 21
Function Word : phosphorylation @Position : 1
Impact Word : enhance @Position : 6
The specific type of mutation may hold predictive relevance in that some mutations confer higher affinity for certain EGFR TKIs and some confer resistance to certain EGFR TKIs for example mutations in exon 20 and the T790M mutation 
Mutation Word : T790M @Position : 36
Function Word : resistance @Position : 23
Impact Word : higher @Position : 14
JAK2 F595A/V617F and F595V/V617F have lost the ability to signal constitutively from active and inactive dimeric conformations suggesting that F595 may play a role in the constitutive activity of JAK2 V617F 
Mutation Word : V617F @Position : 30
Function Word : activity @Position : 27
Impact Word : constitutive @Position : 26
The former is the case of the S492R mutant which confers resistance to cetuximab since the mutation is located in its binding epitope on the EGFR external domain   whereas the later is the case of the T790M mutant mutation in the kinase domain which confers resistance to gefitinib or erlotinib in lung adenocarcinomas   by stabilizing the active tyrosine kinase conformation and enhancing aTP binding   
Mutation Word : T790M @Position : 38
Function Word : binding @Position : 67
Impact Word : enhance @Position : 65
The mutation F359V experiences decreased vdW −2.13 kcal/mol and electrostatic interactions −0.16 kcal/mol while decreased electrostatic interactions are experienced due to mutations E255K 0.35 kcal/mol and E255V −0 09 kcal/mol 
Mutation Word : E255K @Position : 26
Function Word : interaction @Position : 16
Impact Word : decrease @Position : 14
The two major classes of EGFR  mutations are an L858R point mutation and small in-frame deletions in exon 19 both types of mutation enhance the activity and oncogenicity of EGFR compared to the wild-type protein   
Mutation Word : L858R @Position : 10
Function Word : activity @Position : 26
Impact Word : enhance @Position : 24
Tumor responses were dependent on the presence of the BRAF   V600E   oncogene and efficient inhibition of the MAPK pathway as detected by decreased phosphorylation of ERK   
Mutation Word : V600E @Position : 12
Function Word : phosphorylation @Position : 27
Impact Word : decrease @Position : 26
Although Akt was found constitutively activate in  JAK2 V617F mutated cells  in vitro and in V617F transgenic or knock-in mice  the contribution of PI3K/Akt signaling to the pathogenesis of MPN is still poorly characterized 
Mutation Word : V617F @Position : 17
Function Word : activity @Position : 5
Impact Word : constitutive @Position : 4
There was approximately fourfold increase in YUDOSO-BRAF WT  migrating cells compared with control whereas the number of migrating YULAC-BRAF V600E  melanoma cells was reduced by 30%  Figure 6Db  
Mutation Word : V600E @Position : 20
Function Word : migration @Position : 18
Impact Word : reduce @Position : 25
More recently results were published of another phase III trial comparing the BRAF inhibitor dabrafenib a newer-generation reversible kinase inhibitor of V600E-mutant BRAF with a higher affinity than the wildtype enzyme for mutant BRAF to dacarbazine [ 22 ] 
Mutation Word : V600E @Position : 21
Function Word : affinity @Position : 26
Impact Word : higher @Position : 25
Residue Leu573 forms hydrophobic interactions that appear to stabilize the helical segment of the SH2-PK linker and mutation of the corresponding residue in Jak2 from methionine to alanine M535A also reversed V617F-driven proliferation 
Mutation Word : V617F @Position : 31
Function Word : interaction @Position : 4
Impact Word : stability @Position : 8
A positive correlation was observed Spearman r = 0.53 p = 0 02 even with the inclusion of four cases with increased  JAK2  V617F  RNA expression levels outliers  Figure S5  
Mutation Word : V617F @Position : 21
Function Word : expression @Position : 24
Impact Word : increase @Position : 17
Regarding the interference with the ERK signaling cell lines with BRAF V600D/R  mutations presented a faster and stronger inhibition of phosphorylated ERK as compared to control cells with a wild-type  BRAF  Figure  1 C 
Mutation Word : V600D @Position : 11
Function Word : inhibit @Position : 19
Impact Word : faster @Position : 16
This uncoupling of the LKB1-AMPK complex allows BRAF V600E  oncogene-driven cancer cells to become resistant to energy stress and avoid apoptosis   
Mutation Word : V600E @Position : 8
Function Word : apoptosis @Position : 21
Impact Word : avoid @Position : 20
The EGFR  T790M variant changes the structural conformation of the ATP-binding site thereby increasing the affinity of ATP to EGFR while the affinity of gefitinib to ATP is unchanged 
Mutation Word : T790M @Position : 3
Function Word : atp @Position : 27
Impact Word : unchange @Position : 29
Interestingly we found that the ability of mutant FGFR3-expressing cells to reach a higher saturation density was partially dependent on PLCγ1 phosphorylation as this was reduced in cells expressing S249C FGFR3 with a mutation disrupting the PLCγ1-binding site 
Mutation Word : S249C @Position : 29
Function Word : expression @Position : 28
Impact Word : reduce @Position : 25
In numerous studies the  JAK2  V617F allele has been variably associated with higher indices of erythropoiesis unchanged or decreased platelet counts greater occurrence of thrombosis increased BM fibrosis or cytoreductive treatments older age longer disease duration or poorer survival in MPN   
Mutation Word : V617F @Position : 7
Function Word : associated @Position : 12
Impact Word : decrease @Position : 20
We previously demonstrated a high degree of variability in the extent of GSK-3β-Ser 9  phosphorylation among BRAF V600E  + melanoma cell lines and showed that GSK-3β activity in these cells was increased in response to the multikinase inhibitor sorafenib   presumably through an ER stress-dependent mechanism 
Mutation Word : V600E @Position : 18
Function Word : phosphorylation @Position : 15
Impact Word : high @Position : 4
Moreover coexpression of a dominant-negative SENP-1C630S mutant significantly enhanced FOXM1 SUMOylation suggesting that modified FOXM1 is a substrate for endogenous SENP-1  Figure 1f  
Mutation Word : C630S @Position : 5
Function Word : sumoylation @Position : 10
Impact Word : enhance @Position : 8
The role of  BRAF  and  KRAS  oncogenes in altering cytoskeletal properties was further emphasized following depletion of BRAF V600E  by shRNA in HT29 cells where migration ability of HT-ShBR3 cells with downregulated expression of mt BRAF  gene was significantly impaired as compared to the empty vector control HT-ps cells 
Mutation Word : V600E @Position : 22
Function Word : ability @Position : 31
Impact Word : impair @Position : 45
41   The presence of the JAK2 V617F mutation was shown to be prognostically unfavorable in a few cases of t821 leukemia affecting their disease-free survival rate 
Mutation Word : V617F @Position : 8
Function Word : survival @Position : 26
Impact Word : unfavorable @Position : 15
Consistent with our hierarchical clustering analysis introduction of the R164Q mutation led to relatively few changes in gene expression or showed reduced pathway activation compared with the other mutants studied 
Mutation Word : R164Q @Position : 9
Function Word : activity @Position : 23
Impact Word : reduce @Position : 21
By contrast in V600E-mutated melanoma cells IC 50  values were lower than 100 n M  whereas V600E unmutated cells including cells carrying other  BRAF  mutations required more than 1 μ M  to display any sensitivity 
Mutation Word : V600E @Position : 17
Function Word : sensitivity @Position : 37
Impact Word : lower @Position : 11
However tyrosine phosphorylation on the EGFR mutants could be further increased by EGF stimulation  Figure 2 B suggesting that the mutant EGFRs exhibit both ligand-independent and ligand-dependent activation similar to that observed upon EGF stimulation of the L858R mutant H3255 lung adenocarcinoma cell line   
Mutation Word : L858R @Position : 38
Function Word : phosphorylation @Position : 2
Impact Word : increase @Position : 10
PLX4032 was recently demonstrated to reduce the uptake of 218Ffluoro-2-deoxy-D-glucose 18F-FDG in melanoma cells whereas inducible expression of V600E BRAF increased the glucose uptake rate and decreased O 2  consumption in thyroid cancer cells   
Mutation Word : V600E @Position : 18
Function Word : expression @Position : 16
Impact Word : increase @Position : 20
Consistent with the results of Y27632 treatments knockdown of ROCK1/2 greatly reduced the GLUT1 translocation and the Warburg effect in cells and furthermore largely abolished the stimulating effects of mutp53 on GLUT1 translocation and the Warburg effect in H1299  Fig. 6c & d   p53  R172H/R172H   MEF  Fig. 6e & f  and MDA-MB468 cells  Supplementary Fig  S6c & e  
Mutation Word : R172H @Position : 48
Function Word : result @Position : 3
Impact Word : abolish @Position : 24
Indeed upon the addition of NN hTMSC chemotactic migration was significantly reduced compared with the control condition as well as to N C -stimulated cells  Fig. 3  A . Furthermore in NSCLC line H1975 which expresses EGFR with the double mutation L858R and T790M as well as HER2 and HER3   NN stimulation reduced chemokinesis relative to NRG-stimulated and untreated control cells  Fig  3   B  and  C  
Mutation Word : T790M @Position : 45
Function Word : migration @Position : 8
Impact Word : reduce @Position : 56
However cells expressing S249C+Y762F FGFR3 achieved higher cell numbers at confluence compared with K652E and control cells p=0 05  Figures 2a  and  6a  suggesting that other signaling pathways also modulate this phenotype and may be differentially activated between K652E and the other mutants 
Mutation Word : S249C @Position : 3
Function Word : phenotype @Position : 35
Impact Word : modulates @Position : 33
The expression levels of Runx2 were similar in  Fgfr2 +/S252W   mice and unaffected littermates with high expression in osteoblasts and low expression in the intervening mesenchyme but this mesenchyme was more extensive in the mutant suture 
Mutation Word : S252W @Position : 10
Function Word : expression @Position : 24
Impact Word : high @Position : 18
The T790M mutation abrogated the effect of erlotinib on L858R and the L858R/T790M double mutant readily induced Akt phosphorylation even in the presence of 10 μM erlotinib 
Mutation Word : T790M @Position : 12
Function Word : phosphorylation @Position : 18
Impact Word : abrogate @Position : 3
Firstly exon 19 deletions might be more efficiently inhibited by EGFR-TKIs than exon 21 L858R mutations [8]  Mutant forms of exon 19 deletion and L858R mutation had a reduced affinity for its natural substrate ATP but equivalent or increased affinity for reversible EGFR-TKIs which explained why tumors with these EGFR mutations had higher sensitivity to TKIs  [30]   [31]  
Mutation Word : L858R @Position : 25
Function Word : atp @Position : 35
Impact Word : reduce @Position : 29
These results suggest that sorafenib distinctively enhanced apoptosis in these cells by inhibiting the T315I mutant to attenuate the Chk1-mediated checkpoint activation 
Mutation Word : T315I @Position : 14
Function Word : activity @Position : 21
Impact Word : attenuate @Position : 17
These cells express an FGFR3 mutant K650E which has significantly enhanced tyrosine kinase activity   
Mutation Word : K650E @Position : 6
Function Word : activity @Position : 13
Impact Word : enhance @Position : 10
S768I  S768I is a frequently occurring mutation  Table 1  in the C-helix of EGFR that increases basal kinase activity  
Mutation Word : S768I @Position : 2
Function Word : activity @Position : 21
Impact Word : increase @Position : 18
Our biochemical studies here now show that E884K mutation in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 7
Function Word : inhibit @Position : 25
Impact Word : alter @Position : 36
However when used in combination NAC enhanced the inhibitory effect of PLX4032 BRAF V600E inhibitor and Gefitinib EGFR inhibitor on FO-1 and PT4 cell survival 
Mutation Word : V600E @Position : 13
Function Word : effect @Position : 9
Impact Word : enhance @Position : 6
Intriguingly tyrosine phosphorylation of PECAM-1 as well as its physical association with SHP2 was enhanced by the imatinib-resistance E255K or T315I mutation 
Mutation Word : T315I @Position : 20
Function Word : phosphorylation @Position : 2
Impact Word : enhance @Position : 14
Graph shows that autophosphorylation levels are lower for T790M white diamonds than for S768I white squares or Ins770SVD black triangles 
Mutation Word : T790M @Position : 8
Function Word : autophosphorylation @Position : 3
Impact Word : lower @Position : 6
From  Table 2  we observed that Leu298 has stable interactions with CF 3  throughout MD simulations in all mutations while Leu354 experiences increased vdW interactions with mutations E255K and T315A 
Mutation Word : E255K @Position : 30
Function Word : interaction @Position : 27
Impact Word : increase @Position : 25
Interestingly the proliferation of BMSCs of Fgfr2+/S252W mice was decreased in the early days of culturing P4–P8 
Mutation Word : S252W @Position : 6
Function Word : proliferation @Position : 2
Impact Word : decrease @Position : 9
The T790M  EGFR  mutant exhibited higher level of tyrosine phosphorylation than wild type  EGFR  and the T790M/L858R double mutant exhibited a substantial increase in phosphorylation levels compared with the L858R mutant alone  
Mutation Word : T790M @Position : 20
Function Word : exhibit @Position : 23
Impact Word : increase @Position : 26
Here we observe that FGFR3 phosphorylation in the absence of ligand increases 2 5 times due to the G375C and G380R mutations 
Mutation Word : G380R @Position : 20
Function Word : ligand @Position : 10
Impact Word : increase @Position : 11
Furthermore as shown in  Figure 2H  the level of ISG15 was also found induced in proliferating undifferentiated erythroblasts expressing a constitutively activated form of STAT5 STAT5 S710F  an essential effector of EpoR signaling in erythroid development  
Mutation Word : S710F @Position : 28
Function Word : activity @Position : 23
Impact Word : constitutive @Position : 22
To confirm the FGFR3-TAK1 interaction in mammalian cells and specifically FGFR3-associated cancer cell lines human FGFR3 constructs including wild-type kinase-dead and constitutively active K650E sequences were transiently expressed in HeLa cells 
Mutation Word : K650E @Position : 23
Function Word : activity @Position : 22
Impact Word : constitutive @Position : 21
Instead the T790M mutation induces resistance by increasing the binding affinity of ATP by one order of magnitude which is near the affinity for wild-type  EGFR  thus enabling ATP to compete effectively with the kinase inhibitors   
Mutation Word : T790M @Position : 2
Function Word : atp @Position : 30
Impact Word : increase @Position : 7
It was previously reported that FGFR2 S252W  has enhanced affinity to different FGFs   therefore the altered S252W cell proliferation and cell migration in response to different FBS concentrations suggests that FBS contains growth stimulating FGFs to which S252W fibroblasts are more sensitive to and FGFs that in high concentration inhibit migration of S252W fibroblasts 
Mutation Word : S252W @Position : 55
Function Word : proliferation @Position : 21
Impact Word : alter @Position : 18
Our studies here using COS-7 transfection model system show that E884K works in concert with L858R in- cis  in a dominant fashion to change downstream signaling differentially induce MAPK-ERK1/2 signaling and associated cell proliferation and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor-specific fashion 
Mutation Word : E884K @Position : 10
Function Word : phosphorylation @Position : 41
Impact Word : alter @Position : 37
The NS1 mutants D2N †  and V226I bound F2F3-FLAG with comparable affinity to HK-wt NS1 but NS1 mutants V23A and R227K †  demonstrated a 2-fold increase in binding affinity p<0.05 and p<0 01 two-tailed students t-test 
Mutation Word : V226I @Position : 7
Function Word : affinity @Position : 30
Impact Word : increase @Position : 27
The increase in BIM expression and apoptosis are inhibited by the secondary resistant mutation T790M 
Mutation Word : T790M @Position : 14
Function Word : expression @Position : 4
Impact Word : increase @Position : 1
These data suggest that binding to PtsInsP species is enhanced by the E416A mutation in agreement with the MD results reported above 
Mutation Word : E416A @Position : 12
Function Word : binding @Position : 4
Impact Word : enhance @Position : 9
The mutations F317V Y253F Y253H and E255K experience increased vdW interactions with residue Leu248 
Mutation Word : F317V @Position : 2
Function Word : interaction @Position : 10
Impact Word : increase @Position : 8
It can be also postulated when an amino acid is altered for example G691S depending on the genotype could subtly alter the function of the RET protein if located in a critical domain 
Mutation Word : G691S @Position : 13
Function Word : function @Position : 22
Impact Word : alter @Position : 20
Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells  Carpten  et al  2007  
Mutation Word : E17K @Position : 7
Function Word : phosphorylation @Position : 15
Impact Word : increase @Position : 13
As expected we found that the combination of both reduced ATP and V600E BRAF levels caused activation of AMPK as seen from increased phosphorylation at Thr172 of the alpha subunit of AMPK in doxycycline treated samples Figure  6F  
Mutation Word : V600E @Position : 12
Function Word : atp @Position : 10
Impact Word : reduce @Position : 9
NSCLCs harboring a small insertion or duplication in exon 20 observed in ~5% of NSCLCs are less sensitive to EGFR TKIs compared to the exon 19 deletion mutants and L858R mutants in vitro   as well as in patients   
Mutation Word : L858R @Position : 29
Function Word : sensitivity @Position : 17
Impact Word : less @Position : 16
Such an approach has been undertaken whereby inhibitors are selected for potent inhibition of MEK–ERK activation in a BRAF V600E  cell line but decreased potency in the induction of MEK–ERK activation in BRAF wild-type cells   
Mutation Word : V600E @Position : 19
Function Word : activity @Position : 31
Impact Word : decrease @Position : 24
In particular our data are consistent with the identification of ETV1 and ETV5 in screens for mRNAs whose expression was decreased by BRAFV600E/MEK [MAPK mitogen-activated protein kinase/ERK kinase] inhibitors in melanoma cells   
Mutation Word : V600E @Position : 22
Function Word : expression @Position : 18
Impact Word : decrease @Position : 20
In TERT-NHUC abolishing PLCγ1 phosphorylation significantly reduced the increase in saturation density associated with S249C FGFR3 13% vs. 24% p=0 05  Figure 6a  suggesting that PLCγ1 signaling contributes to this phenotype 
Mutation Word : S249C @Position : 14
Function Word : phosphorylation @Position : 4
Impact Word : abolish @Position : 2
demonstrated that the F1174L mutation of ALK enhanced MYCN protein stabilization and found that endogenous  Mycn  mRNA was upregulated in the tumors of  MYCN/ALKF1174L  transgenic mice  
Mutation Word : F1174L @Position : 26
Function Word : stability @Position : 10
Impact Word : enhance @Position : 7
Previously we reported that the V617F mutation caused the constitutive activation of JAK2 when Epo receptor EpoR was coexpressed and JAK2 V617F exhibited cytokine-independent survival and the proliferation of JAK2-deficient erythroid progenitor cells  
Mutation Word : V617F @Position : 21
Function Word : activity @Position : 10
Impact Word : constitutive @Position : 9
The most marked effect was with  γ -mangostin which induced a 6.8-fold decrease of the mRNA level of BRAF V600E relative to the untreated control  P  < 0 01 
Mutation Word : V600E @Position : 20
Function Word : induce @Position : 10
Impact Word : decrease @Position : 13
As expected BRAF V600E  inhibited MST1-induced 3XIRS reporter activation in a dose-dependent manner and MST1 abolished the inhibitory effect of BRAF V600E  on FoxO3 transactivation  Fig  3B & 3C  
Mutation Word : V600E @Position : 22
Function Word : inhibit @Position : 5
Impact Word : abolish @Position : 16
The sensitivity and accuracy of the PNAcqPCR method were both higher than those of DS for the detection of the  BRAF  V600E  mutation 
Mutation Word : V600E @Position : 23
Function Word : sensitivity @Position : 1
Impact Word : higher @Position : 10
The most characterized resistance mutation is the T790M-point mutation in exon 20 which increases the affinity of the EGFR for ATP thus reducing the binding of EGFR TKIs to the ATP pocket 
Mutation Word : T790M @Position : 7
Function Word : binding @Position : 24
Impact Word : reduce @Position : 22
We also found that all of the  NRAS  mutated melanoma lines evaluated or included in our panel had low expression of CDK2 whereas there was some variability within the  BRAF -V600E mutated group with some cell lines harboring high expression of CDK2 and some with low expression 
Mutation Word : V600E @Position : 33
Function Word : expression @Position : 49
Impact Word : high @Position : 41
Given that all cases with  BRAF   V600E  -positive were histologically diagnosed as malignant thyroid neoplasm after thyroidectomy in order to further increase diagnostic sensitivity the cut-off values for each gene were calculated using ROC curves to distinguish the cases with  BRAF   V600E  -negative from benign nodules Figure  2  
Mutation Word : V600E @Position : 48
Function Word : sensitivity @Position : 27
Impact Word : increase @Position : 25
Wnt5a  methylation also remained strongly associated with  BRAF  V600E before OR=25 9
Mutation Word : V600E @Position : 11
Function Word : associated @Position : 6
Impact Word : remain @Position : 4
In vitro analyses showed that in the absence of ligand EGF an enhanced tyrosine autophosphorylation can be observed in cells transfected with the plasmid containing EGFR-R776G when compared to those transfected with wild-type EGFR Figure  2  
Mutation Word : R776G @Position : 25
Function Word : autophosphorylation @Position : 14
Impact Word : enhance @Position : 12
The extent of body weight loss in general correlated with mortality however the M106I mutant virus induced the greatest weight loss but resulted in less mortality than the two most virulent mutants D2N †  and M106I+L98S which both induced the next greatest statistically significant increase in body weight loss compared to rHK-wt p<0 001
Mutation Word : D2N @Position : 32
Function Word : induce @Position : 39
Impact Word : less @Position : 24
In that case it may well be that DAX-1 is independent of SF-1 in the state represented by the NCI-H295R cells or that compensatory mechanisms step in when SF-1 expression is diminished 
Mutation Word : H295R @Position : 19
Function Word : expression @Position : 29
Impact Word : diminish @Position : 31
A375 is a human-derived melanoma cell line harboring a BRAF mutation due to the substitution of valine for glutamic acid at codon 600 termed V600E resulting in constitutive activation aggressive proliferation and high BCL-2 expression 
Mutation Word : V600E @Position : 24
Function Word : expression @Position : 34
Impact Word : high @Position : 32
Mutations to this protein such as G469A E586K V600E and K601E can increase BRAF catalytic activity  
Mutation Word : G469A @Position : 6
Function Word : activity @Position : 15
Impact Word : increase @Position : 12
To understand the role of the c-Met-N375S sequence variant in modulating sensitivity to MET inhibitor we measured the viability of A549 lung cancer cells transfected with the recombinant  c-Met-WT  and  c-Met-N375S  constructs after treatment with the preclinical MET inhibitor SU11274  
Mutation Word : N375S @Position : 33
Function Word : sensitivity @Position : 11
Impact Word : modulates @Position : 10
The classic FOP-associated ACVR1 mutation R206H renders ACVR1 constitutively active and increases the phosphorylation of downstream Smad1 effector proteins 
Mutation Word : R206H @Position : 5
Function Word : phosphorylation @Position : 13
Impact Word : increase @Position : 11
Moreover the introduction of  miR-146b  into PTC mutated cells BRAF V600E  or RET/PTC1 enhances cell invasiveness and migration [ 53 ] 
Mutation Word : V600E @Position : 12
Function Word : migration @Position : 20
Impact Word : enhance @Position : 16
Finally the researchers identified a new TKI resistance mutation L747S substitution of serine for leucine at position 747 in a patient whose TKI-sensitive NSCLC had become resistant to gefitinib and showed that this resistance mutation also reduced TKI-induced apoptosis in cells growing in dishes by interfering with BIM up-regulation 
Mutation Word : L747S @Position : 9
Function Word : resistance @Position : 33
Impact Word : reduce @Position : 36
Sumimoto et al   15  have shown that BRAF V600E  knock-down decreased phospho-ERK1/2 protein levels and inhibited invasion of melanoma cells accompanied by a decrease of matrix metalloproteinase activity and ITGβ1 expression 
Mutation Word : V600E @Position : 11
Function Word : inhibit @Position : 19
Impact Word : decrease @Position : 27
In contrast to the isolated L858R kinase domain results we observe that mutation of residues in the dimer interface in tEGFR dramatically reduces the activity of both the L858R and Δ746–750 tEGFRs indicating that this dimerization event is critical for activation of both of these oncogenic mutants 
Mutation Word : L858R @Position : 28
Function Word : activity @Position : 40
Impact Word : reduce @Position : 22
However an active form of  β -catenin increases the penetrance and incidence of melanoma in mice expressing oncogenic NRAS Q61K  or BRAF V600E  specifically in melanocytes [ 131   216 ] 
Mutation Word : V600E @Position : 24
Function Word : expression @Position : 17
Impact Word : increase @Position : 8
Bone marrow-derived pro-B-cell line BaF3 stably expressing wild type  JAK3  or mutant  JAK3  V674A were obtained from Dr  Hiroyuki Mano   and maintained in RPMI 1640 containing 10% FBS 
Mutation Word : V674A @Position : 17
Function Word : expression @Position : 6
Impact Word : maintain @Position : 28
We noted that the autophosphorylation level pY1092 of YFP-EGFR-ICD T790M was indeed higher than that of the wild type protein at lower expression levels compare graphs in Figure 1D  and Figure  4B  as reported by Vikis et al   
Mutation Word : T790M @Position : 9
Function Word : autophosphorylation @Position : 4
Impact Word : higher @Position : 12
These shape changes lead to palatine bones that are laterally displaced with an associated increase in the width of the inter-palatine suture in  Fgfr2 +/S252W   mice  Fig. 2B  top right relative to  Fgfr2 +/P253R   mutant mice  Fig  2Ba  
Mutation Word : S252W @Position : 25
Function Word : associated @Position : 13
Impact Word : increase @Position : 14
The BRAF  mutations found in CFC can confer either weakly elevated kinase activity mutations of Q257R S467A L485F K499E or impaired kinase activity versus wild-type  BRAF  E501G and G596V     
Mutation Word : L485F @Position : 18
Function Word : activity @Position : 23
Impact Word : impair @Position : 21
These differences in MITF activity may reflect distinct subtypes of melanoma however another possibility is that MITF amplification indicates the need for melanoma cells to maintain sufficient MITF activity for survival in the context of high BRAF V600E  signaling   
Mutation Word : V600E @Position : 37
Function Word : activity @Position : 28
Impact Word : maintain @Position : 25
Gain in   V600E B-RAF  copy number was reflected in corresponding increased gene expression at the protein level  Fig  1b  
Mutation Word : V600E @Position : 4
Function Word : expression @Position : 15
Impact Word : increase @Position : 13
Regarding the interference with the ERK signaling cell lines with BRAF V600D/R  mutations presented a faster and stronger inhibition of phosphorylated ERK as compared to control cells with a wild-type  BRAF  Figure  1 C 
Mutation Word : V600R @Position : 11
Function Word : inhibit @Position : 19
Impact Word : stronger @Position : 18
Our main observation is that residue F595 residing in the middle of the pseudokinase domain αC helix plays a key role in the constitutive activation of JAK2 V617F 
Mutation Word : V617F @Position : 27
Function Word : activity @Position : 24
Impact Word : constitutive @Position : 23
In TERT-NHUC abolishing PLCγ1 phosphorylation significantly reduced the increase in saturation density associated with S249C FGFR3 13% vs. 24% p=0 05  Figure 6a  suggesting that PLCγ1 signaling contributes to this phenotype 
Mutation Word : S249C @Position : 14
Function Word : phenotype @Position : 32
Impact Word : reduce @Position : 6
The G370C and S371C mutants produced higher levels of constitutive activation of MAPK in L8 cells and c- fos  transcription in RCJ cells than the G375C mutant consistent with the fact that TD1 is much more severe than ACH 
Mutation Word : G370C @Position : 26
Function Word : activity @Position : 10
Impact Word : constitutive @Position : 9
CYT387 demonstrated efficacy in a JAK2 V617F mutation-associated animal model where it inhibited constitutively activated JAK2 associated STAT3 function by neutralizing IL-6 by a negative feed-back inhibition   
Mutation Word : V617F @Position : 6
Function Word : inhibit @Position : 26
Impact Word : neutral @Position : 20
Notably melanomas that have the V600E  BRAF  mutation exhibit increased HIF-1α expression 
Mutation Word : V600E @Position : 5
Function Word : expression @Position : 13
Impact Word : increase @Position : 11
NVP-BEZ235 inhibited proliferation of both cytokine-independent WT BCR-ABL  and mutant  BCR-ABL  E255K and T315I overexpressing cells whereas parental cytokine-dependent Ba/F3 cells were much less sensitive 
Mutation Word : E255K @Position : 14
Function Word : sensitivity @Position : 27
Impact Word : less @Position : 26
Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells  Carpten  et al  2007  
Mutation Word : E17K @Position : 7
Function Word : expression @Position : 4
Impact Word : increase @Position : 13
However four mutations E269S S448N K493E and K493Q that had no effect on the sensitivity of PKR to inhibition by vacK3L-H47R or varE3L resulted in increased resistance to varC3L 
Mutation Word : S448N @Position : 4
Function Word : resistance @Position : 26
Impact Word : increase @Position : 25
To challenge the prediction that JAK2V617F alters the balance between proliferation and differentiation at the apex of the stem cell hierarchy we undertook a paired daughter cell analysis to assess the fate outcome of the first division of HSCs from JAK2 V617F  mice and their littermate controls 
Mutation Word : V617F @Position : 41
Function Word : proliferation @Position : 10
Impact Word : alter @Position : 6
Consistent with published data   PLX4032 abolished the ERK1/2 activating phosphorylation in BRAF V600E/K  melanoma cells  Figure 2  pERK YULAC YURIF YUMAC and YUGEN8 
Mutation Word : V600E @Position : 14
Function Word : phosphorylation @Position : 11
Impact Word : abolish @Position : 7
Among the genetic alterations known in thyroid cancer  BRAF V600E   is the most useful to this purpose because of its high sensitivity and its absolute specificity 
Mutation Word : V600E @Position : 10
Function Word : sensitivity @Position : 24
Impact Word : high @Position : 23
Compared with p53−/− mice much higher levels of RhoA-GTP  Fig. 6g  and ROCK activities  Fig. 6h   Supplementary Fig  S9  were observed in different tissues of p53  R172H/R172H  mice including the liver lung and small intestine 
Mutation Word : R172H @Position : 34
Function Word : activity @Position : 15
Impact Word : higher @Position : 5
The mutations G250E Y253H and T315I experience decreased vdW interactions with Phe359 
Mutation Word : G250E @Position : 2
Function Word : interaction @Position : 9
Impact Word : decrease @Position : 7
RET-MEN2B  RET  M918T is more effectively autophosphorylated at RET Y1062 than is RET-MEN2A which subsequently leads to increased constitutive activation of the Ras/mitogen-activated protein kinase MAPK and PI3K/AKT/mTOR signaling cascades   
Mutation Word : M918T @Position : 4
Function Word : activity @Position : 21
Impact Word : increase @Position : 19
Similar to the EGFR T790M mutation alteration of the drug contact residue T854 to a smaller hydrophobic alanine may increase the size of the selectivity pocket and negatively impact erlotinib binding 
Mutation Word : T790M @Position : 4
Function Word : binding @Position : 30
Impact Word : increase @Position : 19
The phosphorylation of Akt induced by S768I was abrogated by 100 nM erlotinib and fibril formation was noted upon treatment with 1 μM or higher concentration of the drug 
Mutation Word : S768I @Position : 6
Function Word : induce @Position : 4
Impact Word : abrogate @Position : 8
RO5424802 treatment inhibited the growth of cells expressing the native and L1196M and C1156Y EML-ALK mutants and inhibited ALK and STAT3 phosphorylation and lowered the levels of the STAT3-regulated proteins BCL3 and NNMT [ 142  143 ] 
Mutation Word : L1196M @Position : 11
Function Word : inhibit @Position : 17
Impact Word : lower @Position : 23
Here we provide the first evidence that  V600E BRAF causes the upregulation of genes involved in glycolysis whereas knock-down of  V600E BRAF in melanoma cells conversely reduces the expression of these genes lowers the rate of glycolysis and causes the reversal of the Warburg phenotype 
Mutation Word : V600E @Position : 22
Function Word : expression @Position : 30
Impact Word : lower @Position : 34
Another study showed that germline polymorphism of fibroblast growth factor receptor 4 FGFR4 at residue 388 G388R correlates with enhancement of LPA 1  expression and more aggressive migratory and invasive responses to LPA in tumors carrying R388 FGFR4   
Mutation Word : G388R @Position : 16
Function Word : expression @Position : 24
Impact Word : enhance @Position : 19
Our studies here using COS-7 transfection model system show that E884K works in concert with L858R in- cis  in a dominant fashion to change downstream signaling differentially induce MAPK-ERK1/2 signaling and associated cell proliferation and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor-specific fashion 
Mutation Word : E884K @Position : 10
Function Word : sensitivity @Position : 38
Impact Word : alter @Position : 37
The level of activation of the K652E receptor was higher than the S249C and Y375C mutants  Figure 3a   Supplementary Figure 4a  
Mutation Word : Y375C @Position : 14
Function Word : activity @Position : 3
Impact Word : higher @Position : 9
G2385R also similarly increased NF-κB activity at 100 ng and 500 ng  Fig  6D  
Mutation Word : G2385R @Position : 0
Function Word : activity @Position : 5
Impact Word : increase @Position : 3
These are autoinhibitory phosphorylation sites and the V617F mutation has been proposed to promote Jak2 activation in part by abrogating pseudokinase catalytic activity and therefore phosphorylation of these sites  15  20   
Mutation Word : V617F @Position : 7
Function Word : activity @Position : 22
Impact Word : abrogate @Position : 19
We have previously shown that the JAK2 V617F homologous mutation in JAK1 V658F induces constitutive activation of JAK1  
Mutation Word : V658F @Position : 12
Function Word : activity @Position : 15
Impact Word : constitutive @Position : 14
Initial data testing MEK inhibitors in melanoma cell lines suggested a high level and selective sensitivity in  BRAF   V600E   mutant melanoma cell lines with low sensitivity in melanoma cell lines with other driver oncogenes   
Mutation Word : V600E @Position : 21
Function Word : sensitivity @Position : 30
Impact Word : high @Position : 11
The T790M  EGFR  mutant exhibited higher level of tyrosine phosphorylation than wild type  EGFR  and the T790M/L858R double mutant exhibited a substantial increase in phosphorylation levels compared with the L858R mutant alone  
Mutation Word : L858R @Position : 33
Function Word : phosphorylation @Position : 28
Impact Word : higher @Position : 7
The T790M EGFR mutant has increased affinity for ATP which is the primary mechanism responsible for the development of resistance to small molecule tyrosine kinase inhibitors TKIs such as gefitinib and erlotinib  [36]  
Mutation Word : T790M @Position : 1
Function Word : resistance @Position : 19
Impact Word : increase @Position : 5
Consistent with published data   PLX4032 abolished the ERK1/2 activating phosphorylation in BRAF V600E/K  melanoma cells  Figure 2  pERK YULAC YURIF YUMAC and YUGEN8 
Mutation Word : V600K @Position : 14
Function Word : phosphorylation @Position : 11
Impact Word : abolish @Position : 7
The T790M  EGFR  mutant exhibited higher level of tyrosine phosphorylation than wild type  EGFR  and the T790M/L858R double mutant exhibited a substantial increase in phosphorylation levels compared with the L858R mutant alone  
Mutation Word : L858R @Position : 33
Function Word : exhibit @Position : 23
Impact Word : increase @Position : 26
Plasmid expression vectors were generated by cloning cDNAs of interest into a Gateway cloning-compatible variant of the vector pCIG as follows PLZF full-length chick clone isolated by PCR from e4 chick cDNA EnR-PLZF and VP16-PLZF were created by respectively fusing either the Drosophila  Engrailed repressor domain or the herpes simplex VP16 transactivation domain to aa 300–665 of chick PLZF FGFR3 WT form of the human FGFR3  caFGFR3 myristoylated and constitutively activated K650E form of the human FGFR3 cytoplasmic domain aa 399–806  STAT3-C mouse STAT3 containing two activating mutations A662C N664C obtained from Addgene and dnSTAT3 was created by incorporating into the mouse STAT3 nonphosphorylatable Y705F mutant  obtained from Addgene an additional H332Y mutation that disrupts DNA binding  
Mutation Word : K650E @Position : 73
Function Word : binding @Position : 120
Impact Word : disrupt @Position : 118
This study finds that the two most common EGFR mutations in non-small cell lung cancer L858R and Δ746–750 result in EGF–independent tEGFR activities comparable to or greater than the activity of EGF–stimulated WT EGFR and that tEGFR activation resulting from these mutations remains strongly coupled to asymmetric kinase dimer formation  Fig  3d  
Mutation Word : L858R @Position : 15
Function Word : result @Position : 38
Impact Word : remain @Position : 42
Indeed upon the addition of NN hTMSC chemotactic migration was significantly reduced compared with the control condition as well as to N C -stimulated cells  Fig. 3  A . Furthermore in NSCLC line H1975 which expresses EGFR with the double mutation L858R and T790M as well as HER2 and HER3   NN stimulation reduced chemokinesis relative to NRG-stimulated and untreated control cells  Fig  3   B  and  C  
Mutation Word : L858R @Position : 43
Function Word : expression @Position : 37
Impact Word : reduce @Position : 56
Mutations to this protein such as G469A E586K V600E and K601E can increase BRAF catalytic activity  
Mutation Word : V600E @Position : 8
Function Word : activity @Position : 15
Impact Word : increase @Position : 12
Furthermore from a gefitinib-resistant patient carrying the activating L858R mutation we identified a novel secondary resistant mutation L747S in cis to the activating mutation which attenuated the up-regulation of BIM and reduced apoptosis 
Mutation Word : L747S @Position : 17
Function Word : apoptosis @Position : 32
Impact Word : reduce @Position : 31
It is also possible that binding of the drug to one p61B-RAF V600E  monomer inhibits drug binding to the other resulting in one active monomer per dimer and abolishing drug resistance 
Mutation Word : V600E @Position : 12
Function Word : inhibit @Position : 15
Impact Word : abolish @Position : 29
BCR-ABL mutations respond differently to three tyrosine kinase inhibitors approved for first-line treatment of CML e.g  Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib while some mutations are less sensitive to nilotinib E255K/V and F359V/C or dasatinib F317L and V299L  
Mutation Word : G250E @Position : 19
Function Word : sensitivity @Position : 47
Impact Word : less @Position : 46
Instead the T790M mutation induces resistance by increasing the binding affinity of ATP by one order of magnitude which is near the affinity for wild-type  EGFR  thus enabling ATP to compete effectively with the kinase inhibitors   
Mutation Word : T790M @Position : 2
Function Word : affinity @Position : 22
Impact Word : increase @Position : 7
The T315I mutation experiences increased −4.11 kcal/mol and T315A mutation experiences decreased electrostatic interactions −2.05 kcal/mol and the mutation G250E contributes increased electrostatic interaction −0 32 kcal/mol while binding to ponatinib 
Mutation Word : T315A @Position : 8
Function Word : interaction @Position : 23
Impact Word : decrease @Position : 11
In case of occurrence of both L858R and T790M mutations the concentration of erlotinib should be three times higher in order to achieve a therapeutic effect 
Mutation Word : T790M @Position : 8
Function Word : effect @Position : 25
Impact Word : higher @Position : 18
Tyrosine phosphorylation of MIG6 appears to be increased in cancer cell lines containing Δ746–750 or L858R EGFRs suggesting that in addition to inhibiting EGFR MIG6 may also be a direct substrate of these mutant receptor EGFRs  
Mutation Word : L858R @Position : 15
Function Word : inhibit @Position : 22
Impact Word : increase @Position : 7
The G380R mutation has been shown to increase FGFR3 phosphorylation and thus shorten the proliferative phase in chondrocyte development but the cause for the increased receptor phosphorylation is under debate 
Mutation Word : G380R @Position : 1
Function Word : phosphorylation @Position : 26
Impact Word : increase @Position : 24
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : E255K @Position : 5
Function Word : induce @Position : 22
Impact Word : increase @Position : 19
Some of these mutations alter specifically the configuration of the ATP-binding kinase pocket V654A and T670I inhibiting imatinib binding 
Mutation Word : T670I @Position : 15
Function Word : inhibit @Position : 16
Impact Word : alter @Position : 4
The striking stability of our gene expression results on  PDGFRA  mutated tumors could be explained by the D842V mutation found on 4/5 samples 
Mutation Word : D842V @Position : 19
Function Word : result @Position : 7
Impact Word : stability @Position : 2
Strongly reduced activity of the PPARγ K365R mutant contradicts the results of Pascual  et al  who reported similar activation of the Aox-tk  luciferase construct by wild type PPARγ and by the PPARγ K365R mutant 
Mutation Word : K365R @Position : 35
Function Word : activity @Position : 20
Impact Word : reduce @Position : 1
In our recent studies on the effects of PLX4032 we demonstrated that the high enzymatic activity of both V600E and V600K BRAF mutants in melanoma cells is suppressed by treatment with PLX4032   
Mutation Word : V600K @Position : 20
Function Word : activity @Position : 15
Impact Word : high @Position : 13
These domains interact when the enzyme is in the inactive conformation and the V600E mutation shifts the kinase into the active conformation suggesting that disrupting this interaction is a primary mechanism for activating the  BRAF  oncogenes 
Mutation Word : V600E @Position : 13
Function Word : interaction @Position : 26
Impact Word : disrupt @Position : 24
Our biochemical studies here now show that E884K mutation in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : L858R @Position : 21
Function Word : sensitivity @Position : 17
Impact Word : alter @Position : 36
The EGFR  T790M variant changes the structural conformation of the ATP-binding site thereby increasing the affinity of ATP to EGFR while the affinity of gefitinib to ATP is unchanged 
Mutation Word : T790M @Position : 3
Function Word : affinity @Position : 23
Impact Word : unchange @Position : 29
Although the Y253H mutation was less sensitive to nilotinib in an  in vitro  cell viability assay IC 50  > 150 nM   the level of BCR-ABL1  transcripts in the Y253H patient in our trial decreased from 8.06% to 0 30% 
Mutation Word : Y253H @Position : 32
Function Word : sensitivity @Position : 6
Impact Word : decrease @Position : 37
Hence we hypothesized that the constitutive activation of the EGFR/RAS/BRAF pathway could be responsible for the lack of sensitivity of FO-1 cells to NAC and therefore treated them with both NAC and PLX4032 a specific inhibitor of BRAF V600E 
Mutation Word : V600E @Position : 38
Function Word : activity @Position : 6
Impact Word : constitutive @Position : 5
FP-1039 is currently in a Phase II trial for endometrial cancers with the S252W FGFR2  mutation which confers increased affinity and altered specificity of FGF binding   
Mutation Word : S252W @Position : 13
Function Word : affinity @Position : 20
Impact Word : increase @Position : 19
Concurrently in a recent study published in the New England Journal of Medicine Flaherty and colleagues provide promising data from an open-label trial   involving over 400 patients that a combination of the BRAF V600E  inhibitor dabrafenib and a MEK inhibitor trametinib GlaxoSmithKline which is near approval   significantly increased progression-free survival when compared to monotherapy 
Mutation Word : V600E @Position : 35
Function Word : survival @Position : 54
Impact Word : increase @Position : 52
In melanomas this mutation gives rise to constitutive signalling through the MEK/ERK cascade and leads to increased proliferation transformation and tumourigenicity characteristics that can all be suppressed by  V600E BRAF inhibition Hingorani et al  Karasarides et al  Wellbrock et al  
Mutation Word : V600E @Position : 29
Function Word : proliferation @Position : 17
Impact Word : increase @Position : 16
Oncogenic mutations S768I and L861Q may alter the canonical interactions at the JM-C-helix interface
Mutation Word : S768I @Position : 2
Function Word : interaction @Position : 9
Impact Word : alter @Position : 6
CCT137690 inhibits FLT3-D835Y kinase with similar potency to FLT3-ITD kinase but MLN518 is much less active against FLT3-D835Y in biochemical assays IC 50  1 8 μM 
Mutation Word : D835Y @Position : 17
Function Word : activity @Position : 15
Impact Word : less @Position : 14
In contrast to the isolated L858R kinase domain results we observe that mutation of residues in the dimer interface in tEGFR dramatically reduces the activity of both the L858R and Δ746–750 tEGFRs indicating that this dimerization event is critical for activation of both of these oncogenic mutants 
Mutation Word : L858R @Position : 28
Function Word : activity @Position : 40
Impact Word : reduce @Position : 22
Interestingly in our hands the cells carrying the G250E mutation seems less sensitive to the effect of ponatinib that the one carrying the T315I mutation 
Mutation Word : T315I @Position : 23
Function Word : sensitivity @Position : 12
Impact Word : less @Position : 11
The  JAK2  V617F allele burden has been associated with disease duration in PV patients such that the allele burden was significantly elevated in patients examined more than 5 years after their initial diagnosis   
Mutation Word : V617F @Position : 4
Function Word : associated @Position : 9
Impact Word : elevate @Position : 23
Moreover the E884K alone and L858R+E884K double mutant EGFR remained sensitive to EGF and the E884K mutation cooperates with L858R when in- cis  to enhance the mutational effects on downstream phosphoprotein activation 
Mutation Word : E884K @Position : 15
Function Word : activity @Position : 32
Impact Word : enhance @Position : 25
Dasatinib treatment of TBP-3743 cells reduced pAKT levels perhaps permitting apoptosis whereas the high basal pAKT levels in the PTEN-null cells were unaffected by dasatinib treatment suggesting that the loss of PTEN and the concomitant increase of AKT signaling may be a factor influencing resistance to apoptosis following BRAF V600E -inhibition as has been demonstrated in melanoma [ 62 ] 
Mutation Word : V600E @Position : 49
Function Word : resistance @Position : 44
Impact Word : increase @Position : 35
BRAF V600E   enhances the migrating and invasive capacity of colon adenocarcinoma cells through RhoA activation  
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 16
Impact Word : enhance @Position : 4
Recently several mechanisms of EGFR-TKI resistance have been identified and classified as follows 1 alteration of the target  EGFR  gene e.g. T790M gatekeeper mutation  6  7   2 activation of bypass resistance signals e.g   Met  gene amplification  8   hepatocyte growth factor [HGF] overexpression  9   and activation of the nuclear factor-kappa B NFkBpathway  10   and Gas6-AXL axis  11   and 3 other mechanisms such as transformation to small-cell lung cancer  12 – 14   epithelial-to-mesenchymal transition  15 – 17   alteration of microRNA  18   and down-regulation of MED12 
Mutation Word : T790M @Position : 23
Function Word : resistance @Position : 36
Impact Word : alter @Position : 102
Another study found uncoupling in rare TnC variants identified in DCM cTnC Y5H M103I and I148V either decreased or abolished the effects of PKA phosphorylation on Ca 2+ -sensitivity Pinto et al   2011  
Mutation Word : I148V @Position : 15
Function Word : effect @Position : 21
Impact Word : decrease @Position : 17
However in the scratch assays performed to determine whether YAP1 affected the migration ability of  BRAF   V600E  -activated 8505C cells shYAP1-8505C showed a remarkably lower migration rate compared with shCTL-8505C 46.2±7.4% vs 22 9±3 9%
Mutation Word : V600E @Position : 19
Function Word : migration @Position : 29
Impact Word : lower @Position : 28
Thus in the proliferative environment of the regenerating tail fin sufficient cellular controls are maintained to prevent tumorigenesis in BRAF V600E - and RAS V12 -expressing melanocytes 
Mutation Word : V600E @Position : 20
Function Word : expression @Position : 25
Impact Word : maintain @Position : 14
In vitro both S249C and K652E or K653M mutations are shown to constitutively increase the FGFR3 kinase activity albeit with different mechanisms  Naski et al. 1996   d’Avis et al  1998  
Mutation Word : S249C @Position : 3
Function Word : activity @Position : 17
Impact Word : increase @Position : 13
Studies on North American patients indicated that those with deletions of exon 19 in the EGFR have a better response rate progression-free survival and overall survival after EGFR tyrosine kinase inhibitor treatment than do those with the L858R mutation in exon 21 Jackman et al.  Riely et al   
Mutation Word : L858R @Position : 37
Function Word : survival @Position : 25
Impact Word : better @Position : 18
Molecular studies on the receptors harbouring a known L858R mutation demonstrated a decreased affinity of the tyrosine kinase for ATP and an increase in the affinity for the tyrosine kinase inhibitors TKI 
Mutation Word : L858R @Position : 8
Function Word : affinity @Position : 25
Impact Word : increase @Position : 22
The D816V mutant destabilizes the inactivated form of Kit in a way that the ability of the protein to adopt the "DFG out" inactive conformation is much reduced or even eliminated thus the mutation prevents both motesanib and imatinib from binding to the ATP pocket   
Mutation Word : D816V @Position : 1
Function Word : ability @Position : 14
Impact Word : reduce @Position : 27
The mutations E255K F317L and F317V experience increased electrostatic interactions with Tyr253 
Mutation Word : F317L @Position : 5
Function Word : interaction @Position : 9
Impact Word : increase @Position : 7
These data suggest that BRAF V600E  can negatively regulate MST1 kinase through direct interaction with its C-terminus 
Mutation Word : V600E @Position : 5
Function Word : regulation @Position : 9
Impact Word : negative @Position : 8
The effects of ruxolitinib were attenuated when cells expressing JAK2 V617F  were cocultured with primary or immortalized human bone marrow mesenchymal stromal cells probably owing to paracrine activity of the mesenchymal stromal cells 
Mutation Word : V617F @Position : 10
Function Word : effect @Position : 1
Impact Word : attenuate @Position : 5
E255K and T315I are the most predominant mutations of BCR/ABL causing imatinib resistance in patients and may increase the kinase activity or change the substrate preferences of BCR/ABL  15  18  
Mutation Word : T315I @Position : 2
Function Word : substrate @Position : 24
Impact Word : increase @Position : 17
Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells  Carpten  et al  2007  
Mutation Word : E17K @Position : 7
Function Word : expression @Position : 4
Impact Word : increase @Position : 13
More recently several groups have demonstrated that dasatinib treatment reduces tumor growth and inhibits metastasis in various mouse models of BRAF WT  and BRAF V600E -positive thyroid cancer [ 23   27   31 ] 
Mutation Word : V600E @Position : 25
Function Word : inhibit @Position : 13
Impact Word : reduce @Position : 9
Two of these missense mutants V689M and L703F are constitutively active possibly because they stabilize acceptor/donor interactions   
Mutation Word : V689M @Position : 5
Function Word : activity @Position : 10
Impact Word : stability @Position : 14
JAK2 V617F as well as exon 12 mutant alleles seen in  JAK2V617F -negative MPN lead to enhanced JAK2 kinase activity and cytokine-independent growth of primary cells and cell lines 
Mutation Word : V617F @Position : 12
Function Word : activity @Position : 20
Impact Word : enhance @Position : 17
F1174L which recapitulates the primary mutation found in neuroblastoma previously shown to render the enzyme insensitive to crizotinib appears instead to induce a conformational change in the protein which results in increased affinity for ATP itself 
Mutation Word : F1174L @Position : 0
Function Word : affinity @Position : 32
Impact Word : increase @Position : 31
Simultaneously we have applied the increase of sensitivity of COLD-PCR assay approach combined with HRM genotyping analysis for the NIPD of a C634Y fetal mutation using pregnant woman serum 
Mutation Word : C634Y @Position : 22
Function Word : sensitivity @Position : 7
Impact Word : increase @Position : 5
This mutation  E17K  increases recruitment of AKT1 to the membrane increases AKT1 phosphorylation and activity transforms Rat1 fibroblasts and induces leukaemia in transgenic mice  Carpten  et al  2007  
Mutation Word : E17K @Position : 3
Function Word : phosphorylation @Position : 14
Impact Word : increase @Position : 12
In colon cancer suppression of BRAF in cell lines with BRAF V600E  showed significant decreased proliferation through cyclin D1 and p27 Kip1  and induces apoptosis by a significant decrease in the levels of anti-apoptotic protein Bcl-2   
Mutation Word : V600E @Position : 11
Function Word : induce @Position : 25
Impact Word : decrease @Position : 30
S252W mutation alters the gene expression in response to FGFR2 activation
Mutation Word : S252W @Position : 0
Function Word : expression @Position : 5
Impact Word : alter @Position : 2
In support western blotting of FLT-3 autophosphorylation of these mutants F691L and D835F/Y from the untreated total cell extracts showed reduced autophosphorylation of FLT3 in comparison with FLT3-ITD  Figure 1c  thus supporting the notion that these mutations confer resistance by destabilizing the active state rather than direct steric hindrance to the drug 
Mutation Word : D835Y @Position : 12
Function Word : autophosphorylation @Position : 21
Impact Word : reduce @Position : 20
This mutation  E17K  increases recruitment of AKT1 to the membrane increases AKT1 phosphorylation and activity transforms Rat1 fibroblasts and induces leukaemia in transgenic mice  Carpten  et al  2007  
Mutation Word : E17K @Position : 3
Function Word : induce @Position : 21
Impact Word : increase @Position : 12
Surprisingly we found that expression of each activated KRAS ED  lead to a substantial decrease in Braf V600E  induced tumors relative to the EGFP control suggesting the existence of a KRAS activated negative regulator of tumorigenesis 
Mutation Word : V600E @Position : 18
Function Word : activity @Position : 33
Impact Word : decrease @Position : 15
The former is the case of the S492R mutant which confers resistance to cetuximab since the mutation is located in its binding epitope on the EGFR external domain   whereas the later is the case of the T790M mutant mutation in the kinase domain which confers resistance to gefitinib or erlotinib in lung adenocarcinomas   by stabilizing the active tyrosine kinase conformation and enhancing aTP binding   
Mutation Word : S492R @Position : 7
Function Word : binding @Position : 67
Impact Word : enhance @Position : 65
However Yun et al  2008 showed that both the single T790M mutant and the double-mutant L858R/T790M maintain the same low nanomolar affinity for gefitinib as the L858R mutant 
Mutation Word : T790M @Position : 16
Function Word : affinity @Position : 22
Impact Word : maintain @Position : 17
BCR-ABL mutations respond differently to three tyrosine kinase inhibitors approved for first-line treatment of CML e.g  Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib while some mutations are less sensitive to nilotinib E255K/V and F359V/C or dasatinib F317L and V299L  
Mutation Word : E255K @Position : 50
Function Word : sensitivity @Position : 47
Impact Word : less @Position : 46
This is perhaps best exemplified by  BRAF  V600E  mutations which are predictive of response to Vemurafenib in melanoma however colorectal cancer patients harboring oncogenic  BRAF  V600E  mutations derive limited if any benefit from this drug due to increased EGFR expression Prahallad et al   
Mutation Word : V600E @Position : 30
Function Word : expression @Position : 45
Impact Word : increase @Position : 43
If a lack of predictive power of the BRAF V600E  antibody or additional measures of BRAF protein expression is confirmed it suggests there may be other strong modulators of BRAF inhibitor response over and above BRAF V600E  protein expression and these may be readily targeted with drugs 
Mutation Word : V600E @Position : 37
Function Word : expression @Position : 40
Impact Word : modulates @Position : 28
It was previously reported that FGFR2 S252W  has enhanced affinity to different FGFs   therefore the altered S252W cell proliferation and cell migration in response to different FBS concentrations suggests that FBS contains growth stimulating FGFs to which S252W fibroblasts are more sensitive to and FGFs that in high concentration inhibit migration of S252W fibroblasts 
Mutation Word : S252W @Position : 55
Function Word : affinity @Position : 10
Impact Word : enhance @Position : 9
BRAF inhibition by RNAi strongly reduces ERK activation in the cell line harbouring the BRAF V600E  mutation is also effective in the cell line with RAS G13R  but has no effect in ERK activation in the cell line with RET/PTC rearrangement 
Mutation Word : V600E @Position : 15
Function Word : activity @Position : 35
Impact Word : reduce @Position : 5
Ki67 labeling revealed an enhanced proliferation index in JoMa1-ALK-F1174L-derived tumors 48% compared to JoMa1-ALK-R1275Q- 40% and JoMa1-ALK-wt-derived tumors 38% Figure  3b  suggesting that the accelerated tumor growth of JoMa1-ALK-F1174L tumors may partly result from their increased proliferation capacity 
Mutation Word : F1174L @Position : 30
Function Word : proliferation @Position : 38
Impact Word : enhance @Position : 4
Compared to wild type BRAF BRAF V600E  shows around 500-fold higher activity causing sustained activation of ERK signaling  Hingorani et al 2003   Houben et al 2004   Ikenoue et al 2003   Ikenoue et al 2004   Karasarides et al 2004  
Mutation Word : V600E @Position : 6
Function Word : activity @Position : 15
Impact Word : higher @Position : 11
The activity against the resistance mutation T790M and cell lines with downstream resistance mechanisms was however only slightly better than the reversible TKIs 
Mutation Word : T790M @Position : 6
Function Word : resistance @Position : 12
Impact Word : better @Position : 18
In colorectal cancer patients a mutation in the extracellular domain of EGFR S492R which abrogates cetuximab binding but retains panitumumab sensitivity has been recently described as a mechanism of acquired resistance   Fig   2c  
Mutation Word : S492R @Position : 12
Function Word : sensitivity @Position : 20
Impact Word : abrogate @Position : 14
Consistent with that result BRAF CT V600E and K601E induced a stronger ERK activation compared with BRAF CT wild-type 
Mutation Word : V600E @Position : 6
Function Word : activity @Position : 13
Impact Word : stronger @Position : 11
Mutating the BRAF dimerization motif R509H abolishes resistance conferred by N-terminal truncated BRAF moieties Poulikakos et al   2011  however it has no effect on  BRAF   V600E/L505H   Figure  4 D 
Mutation Word : L505H @Position : 31
Function Word : resistance @Position : 7
Impact Word : abolish @Position : 6
As expected based on prior data   MEK inhibition resulted in increase of pMEK in non- BRAF   V600E   mutant cell lines Figure  3  
Mutation Word : V600E @Position : 20
Function Word : result @Position : 10
Impact Word : increase @Position : 12
Instead the T790M mutation induces resistance by increasing the binding affinity of ATP by one order of magnitude which is near the affinity for wild-type  EGFR  thus enabling ATP to compete effectively with the kinase inhibitors   
Mutation Word : T790M @Position : 2
Function Word : binding @Position : 9
Impact Word : increase @Position : 7
Our results reveal that SIRT1 activity is higher in PLX4032-resistant BRAF V600E -mutated melanoma cells compared with their sensitive counterpart 
Mutation Word : V600E @Position : 11
Function Word : activity @Position : 5
Impact Word : higher @Position : 7
Actually our  in vitro  kinase assay clearly showed that MST1 kinase activity on histone H2B was markedly decreased by BRAF V600E  
Mutation Word : V600E @Position : 22
Function Word : activity @Position : 13
Impact Word : decrease @Position : 19
How M918T mutation perturbs the GRL  cis -inhibition in solution and increases ATP affinity is unclear from the DFG-in conformer crystal structure 
Mutation Word : M918T @Position : 1
Function Word : affinity @Position : 14
Impact Word : increase @Position : 12
FDG could furthermore be used to distinguish between  BRAF  V600E  mutant melanomas with high or low sensitivity to PLX4032 
Mutation Word : V600E @Position : 11
Function Word : sensitivity @Position : 19
Impact Word : high @Position : 16
Overall SP inhibitors represent an innovative mechanism of KIT inhibition whose dual suppression of KIT D816V neoplastic mast cell proliferation and SCF enhanced mast cell activation may provide significant therapeutic benefits 
Mutation Word : D816V @Position : 15
Function Word : inhibit @Position : 9
Impact Word : enhance @Position : 22
Hence the E884K mutation when in- cis  with L858R modulates the sensitivity of the mutant receptor towards ERBB family kinase inhibitors in an inhibitor-specific fashion 
Mutation Word : E884K @Position : 2
Function Word : sensitivity @Position : 12
Impact Word : modulates @Position : 10
The T315I mutation experiences increased −4.11 kcal/mol and T315A mutation experiences decreased electrostatic interactions −2.05 kcal/mol and the mutation G250E contributes increased electrostatic interaction −0 32 kcal/mol while binding to ponatinib 
Mutation Word : T315I @Position : 8
Function Word : interaction @Position : 23
Impact Word : increase @Position : 21
Under chondrocyte induction conditions the already reduced gene expression in  Fgfr2 +/S252W   mice was recovered after inhibition of p38 signaling 
Mutation Word : S252W @Position : 12
Function Word : expression @Position : 8
Impact Word : reduce @Position : 6
We also find that a melanoma-associated mutation within the pseudosubstrate sequence P52L disrupts PAK6 autoinhibition enhancing its kinase activity potentially correlating with increased expression of PAK6 in prostate cancer and implied alterations in kinase activity  
Mutation Word : P52L @Position : 11
Function Word : expression @Position : 23
Impact Word : increase @Position : 22
Ectopic expression of  V600E BRAF or  Q61L NRAS increases the expression of metabolic genes
Mutation Word : V600E @Position : 4
Function Word : expression @Position : 12
Impact Word : increase @Position : 10
This result indicates that the secondary T790M mutation retains the active conformation of the binding site as proved by Yoshikawa et al  2013 
Mutation Word : T790M @Position : 6
Function Word : activity @Position : 10
Impact Word : retain @Position : 8
In light of the reports of c-Met signaling as the target for lung cancer treatment  it is of interest to study whether c-Met-N375S cells are less sensitive to SU11275 in the presence of HGF 
Mutation Word : N375S @Position : 23
Function Word : sensitivity @Position : 27
Impact Word : less @Position : 26
E884K-EGFR modulates inhibitor sensitivity effects in an inhibitor-specific fashion
Mutation Word : E884K @Position : 0
Function Word : sensitivity @Position : 3
Impact Word : modulates @Position : 1
The T315I mutation experiences increased −4.11 kcal/mol and T315A mutation experiences decreased electrostatic interactions −2.05 kcal/mol and the mutation G250E contributes increased electrostatic interaction −0 32 kcal/mol while binding to ponatinib 
Mutation Word : G250E @Position : 19
Function Word : interaction @Position : 23
Impact Word : increase @Position : 21
They demonstrated that panobinostat treatment depletes the auto-phosphorylation expression and downstream signaling of JAK2 V617F and disrupted the chaperone association of JAK2 V617F with heat shock protein 90 thus promoting proteasomal degradation of JAK2 V617F 
Mutation Word : V617F @Position : 34
Function Word : associated @Position : 19
Impact Word : disrupt @Position : 16
The free energy of BCR-ABL T315I  complexed with imatinib is −9 89 kcal/mol indicating that ponatinib has higher binding towards T315I mutation compared to imatinib 
Mutation Word : T315I @Position : 21
Function Word : binding @Position : 19
Impact Word : higher @Position : 18
The T790M mutation abrogated the effect of erlotinib on L858R and the L858R/T790M double mutant readily induced Akt phosphorylation even in the presence of 10 μM erlotinib 
Mutation Word : L858R @Position : 12
Function Word : induce @Position : 16
Impact Word : abrogate @Position : 3
Our lab previously demonstrated that the inhibition of oncogenic BRAF results in dramatic tumor reduction in a model of human ATC and several other groups have shown that dasatinib treatment effectively reduces tumor growth in mice implanted with human BRAF V600E -positive thyroid cancer cells [ 6   8   23   31 ] 
Mutation Word : V600E @Position : 40
Function Word : effect @Position : 30
Impact Word : reduce @Position : 31
Furthermore in some leukemias and myeloproliferative neoplasms constitutive JAK2 activation V617F mutation drives malignant transformation [ 27 ] and this prompted a significant effort in targeting JAK2 inhibition as a potential therapeutic strategy 
Mutation Word : V617F @Position : 10
Function Word : activity @Position : 9
Impact Word : constitutive @Position : 7
The T790M mutation abrogated the effect of erlotinib on L858R and the L858R/T790M double mutant readily induced Akt phosphorylation even in the presence of 10 μM erlotinib 
Mutation Word : T790M @Position : 12
Function Word : induce @Position : 16
Impact Word : abrogate @Position : 3
In a dose-response experiment  Figure 3 B left panel the best inhibitor D4 was effective at a concentration of 200 nM to inhibit RET C634Y  autophosphorylation up to 70% and to drastically reduce ERK phosphorylation 
Mutation Word : C634Y @Position : 25
Function Word : inhibit @Position : 23
Impact Word : reduce @Position : 34
This suggests that MAPK pathway activation by BRAF V600E  as in A375 and by NRAS Q61K  as in Mel Juso is important in maintaining FOSL1 expression 
Mutation Word : V600E @Position : 8
Function Word : expression @Position : 27
Impact Word : maintain @Position : 25
The T790M EGFR mutant has increased affinity for ATP which is the primary mechanism responsible for the development of resistance to small molecule tyrosine kinase inhibitors TKIs such as gefitinib and erlotinib  [36]  
Mutation Word : T790M @Position : 1
Function Word : atp @Position : 8
Impact Word : increase @Position : 5
The mutations E255K F317L and F317V experience increased electrostatic interactions with Tyr253 
Mutation Word : F317V @Position : 5
Function Word : interaction @Position : 9
Impact Word : increase @Position : 7
The calculated free energies correlate with experimentally measured IC50 values and comparably ponatinib has better binding towards the mutation T315A −10.44 kcal/mol than T315I −10 35 kcal/mol 
Mutation Word : T315I @Position : 23
Function Word : binding @Position : 15
Impact Word : better @Position : 14
Structurally this residue lies in the substrate-binding pocket of the kinase and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP-bound form effectively making RET more active more of the time  48 – 51  
Mutation Word : M918T @Position : 13
Function Word : activity @Position : 33
Impact Word : increase @Position : 17
Consistent with that result BRAF CT V600E and K601E induced a stronger ERK activation compared with BRAF CT wild-type 
Mutation Word : K601E @Position : 8
Function Word : activity @Position : 13
Impact Word : stronger @Position : 11
Thus certain P loop mutations Y253F E255K and the T315I mutation display a high oncogenic potential which is consistent with the clinical observation of a poor outcome concerning overall and progression-free survival   
Mutation Word : E255K @Position : 6
Function Word : survival @Position : 31
Impact Word : high @Position : 13
These results indicate that despite the reduced levels of MITF activity in  BRAF   V600E   mitf  melanomas there is sufficient MITF activity to control MITF target genes involved in cell proliferation and survival 
Mutation Word : V600E @Position : 16
Function Word : activity @Position : 26
Impact Word : reduce @Position : 6
At a later time point in pancreas development S33Y mutant β-cat expression enhanced islet cell proliferation and increased the size of pancreas [ 49 ] 
Mutation Word : S33Y @Position : 8
Function Word : proliferation @Position : 15
Impact Word : enhance @Position : 12
If exon 19 deletion results in EGFR structural alterations which bind TKIs more tightly than L858R mutation it could support our hypothesis 
Mutation Word : L858R @Position : 15
Function Word : result @Position : 4
Impact Word : alter @Position : 8
Consistent with the results of Y27632 treatments knockdown of ROCK1/2 greatly reduced the GLUT1 translocation and the Warburg effect in cells and furthermore largely abolished the stimulating effects of mutp53 on GLUT1 translocation and the Warburg effect in H1299  Fig. 6c & d   p53  R172H/R172H   MEF  Fig. 6e & f  and MDA-MB468 cells  Supplementary Fig  S6c & e  
Mutation Word : R172H @Position : 48
Function Word : effect @Position : 36
Impact Word : reduce @Position : 11
Enhancement by PDGFRα-I of the signaling pathway inhibition by BRAF-I in BRAF-I sensitive and resistant melanoma cell lines harboring BRAFV600E
Mutation Word : V600E @Position : 19
Function Word : sensitivity @Position : 12
Impact Word : enhance @Position : 0
Another possibility is that PLX4032-resistant  BRAF  V600E  mutants have alternative signaling at the level of Raf as has been described for cell lines with acquired resistance to a different Raf-inhibitor AZ628 which show increased signaling through C-Raf   
Mutation Word : V600E @Position : 8
Function Word : resistance @Position : 28
Impact Word : increase @Position : 36
We identified 25-fold increased expression of MMP-1 mRNA in melanoma cells possessing BRAF V600E  compared to wildtype while HPMs expressed similar transcript levels with BRAF wildtype melanoma cell  Figure 2a  suggesting that increased BRAF kinase activity may be associated with elevated MMP-1 expression in melanomas 
Mutation Word : V600E @Position : 13
Function Word : expression @Position : 45
Impact Word : elevate @Position : 43
Enhancement by PDGFRα-I of the  in vivo  anti-tumor activity of BRAF-I in BRAF-I sensitive and resistant BRAFV600E melanoma cell lines
Mutation Word : V600E @Position : 18
Function Word : activity @Position : 10
Impact Word : enhance @Position : 0
The data they collected using cell lines of colon adenocarcinoma shows that  BRAF -V600E induces migration and enhances the invasive potential of these cells 
Mutation Word : V600E @Position : 14
Function Word : induce @Position : 15
Impact Word : enhance @Position : 18
The Doghman study also showed that RNAi-mediated SF-1 knockdown decreased proliferation in NCI-H295R cells 
Mutation Word : H295R @Position : 12
Function Word : proliferation @Position : 10
Impact Word : decrease @Position : 9
Similarly E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor CL-387785 
Mutation Word : E884K @Position : 1
Function Word : sensitivity @Position : 5
Impact Word : enhance @Position : 3
The most characterized resistance mutation is the T790M-point mutation in exon 20 which increases the affinity of the EGFR for ATP thus reducing the binding of EGFR TKIs to the ATP pocket 
Mutation Word : T790M @Position : 7
Function Word : affinity @Position : 15
Impact Word : increase @Position : 13
In case of occurrence of both L858R and T790M mutations the concentration of erlotinib should be three times higher in order to achieve a therapeutic effect 
Mutation Word : L858R @Position : 6
Function Word : effect @Position : 25
Impact Word : higher @Position : 18
Hence E884K in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : L858R @Position : 14
Function Word : inhibit @Position : 18
Impact Word : alter @Position : 29
Moreover PHA-739358 reportedly has a higher affinity for the T315I form 5 nM than the Abl wild type 21 nM   which may prove advantageous for clinical treatment 
Mutation Word : T315I @Position : 9
Function Word : affinity @Position : 6
Impact Word : higher @Position : 5
This stepwise enhancement of PtdIns binding is confirmed by the estimated free energies of binding predicted by AutoDock which suggest that docking to the E416A mutant open PH domain is more favorable than docking to the wild type open which in turn is an improvement over the wild type closed PH domain 
Mutation Word : E416A @Position : 24
Function Word : binding @Position : 14
Impact Word : enhance @Position : 2
Following mutant BRAF V600E  overexpression the phosphorylation of both BRAF/ CRAF kinases was significantly increased which resulted in the downstream activation of MEK but not ERK signalling  Figure 9 -upper panel lanes 3–4 
Mutation Word : V600E @Position : 3
Function Word : result @Position : 17
Impact Word : increase @Position : 15
Although inhibition of MEK and ERK phosphorylation was achieved in BRAF V600E/K  mutant melanoma significantly increased tumour growth was seen in BRAF wild-type melanomas with upstream RAS mutations 
Mutation Word : V600E @Position : 11
Function Word : phosphorylation @Position : 6
Impact Word : increase @Position : 16
Nonetheless recent work in a L858R/T790M- EGFR  transgenic mouse model suggests that the double mutant- EGFR  responds only partially to HKI-272 alone  Li  et al  2007  and enhanced inhibition was seen in combination with mammalian target of rapamycin inhibitor 
Mutation Word : L858R @Position : 5
Function Word : inhibit @Position : 34
Impact Word : enhance @Position : 33
Our studies here using COS-7 transfection model system show that E884K works in concert with L858R in- cis  in a dominant fashion to change downstream signaling differentially induce MAPK-ERK1/2 signaling and associated cell proliferation and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor-specific fashion 
Mutation Word : E884K @Position : 10
Function Word : inhibit @Position : 42
Impact Word : alter @Position : 37
FP-1039 is currently in a Phase II trial for endometrial cancers with the S252W FGFR2  mutation which confers increased affinity and altered specificity of FGF binding   
Mutation Word : S252W @Position : 13
Function Word : binding @Position : 26
Impact Word : increase @Position : 19
Remarkably abrogating MITF activity in  BRAF V600E mitf  melanoma leads to dramatic tumor regression marked by melanophage infiltration and increased apoptosis 
Mutation Word : V600E @Position : 7
Function Word : activity @Position : 3
Impact Word : abrogate @Position : 1
Furthermore some activating mutations in EGFR mainly deletion mutations in exon 19 and the single L858R point mutation in exon 21 are associated with increased response and survival after tyrosine kinase inhibitor therapy whereas the T790M point mutation or insertion mutations in exon 20 of EGFR are associated with failure to respond   
Mutation Word : T790M @Position : 35
Function Word : survival @Position : 27
Impact Word : increase @Position : 24
Similarly E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor CL-387785 
Mutation Word : L858R @Position : 7
Function Word : inhibit @Position : 10
Impact Word : enhance @Position : 3
Phe636 in the C-helix forms the platform for the observed rearrangement and we found that mutation of the corresponding residue in Jak2 Phe595 to alanine also abrogated the transforming effect of V617F  Fig  2c  as previously observed  17  18   
Mutation Word : V617F @Position : 31
Function Word : effect @Position : 29
Impact Word : abrogate @Position : 26
The T790M mutation affects the gatekeeper residue in the catalytic-kinase domain and confers drug resistance by increasing EGFRs affinity for ATP – thus reducing the potency of the ATP-competitive kinase inhibitors [ 39 ] 
Mutation Word : T790M @Position : 1
Function Word : affinity @Position : 18
Impact Word : increase @Position : 16
For example  hsf1  knockout dramatically delayed overall development of various tumors and increased survival of  p53  knock-in mutant R172H mice  1  
Mutation Word : R172H @Position : 22
Function Word : survival @Position : 15
Impact Word : increase @Position : 14
Ganetespib effectively targets the upstream regulator JAK2 including the constitutively active JAK2 V617F  mutant for degradation in a range of hematological and solid tumor types with subsequent prolonged loss of STAT3 and STAT5 signaling 
Mutation Word : V617F @Position : 12
Function Word : activity @Position : 10
Impact Word : constitutive @Position : 9
Our model suggests that the enhanced sensitivity of SAR302503 for the variants D839G and Y842H is due to the destabilization of the inactive conformation by these mutations that in effect would stabilize the open and active conformation to which the drug preferentially binds thus conferring hypersensitive response  Figures 2d and e  
Mutation Word : D839G @Position : 12
Function Word : effect @Position : 29
Impact Word : stability @Position : 31
While many JAK2 inhibitors are able to achieve normalization of leukocytosis and thrombocytosis as well as improve symptoms in cancer patients [ 15   16 ] they are less effective in achieving consistent hematologic remissions and reducing JAK2V617F allelic burden [ 15   17 - 20 ] 
Mutation Word : V617F @Position : 38
Function Word : effect @Position : 30
Impact Word : reduce @Position : 37
All mutations experience variations in electrostatic interactions ranging from −4.95 to −6 71 kcal/mol with Glu286 in particular Q252H Y253H T315I and F317L experience increased electrostatic interactions with Glu286 
Mutation Word : Y253H @Position : 19
Function Word : interaction @Position : 26
Impact Word : increase @Position : 24
The EphA3 G518L lung cancer mutation enhances cis interaction with coexpressed ephrin-A3
Mutation Word : G518L @Position : 2
Function Word : interaction @Position : 8
Impact Word : enhance @Position : 6
In comparison the activity of some FOP mutants was generally increased to a level similar to caALK2 revealing an inherent gain of function in their catalytic domain in the absence of added BMP ligand  Fig. 1  B . Significantly the signaling by R206H was increased by FK506 to a far greater extent than other GS domain mutants such as L196P  Fig  1  B  
Mutation Word : R206H @Position : 44
Function Word : function @Position : 22
Impact Word : increase @Position : 46
Since residue V617 is located in the pseudokinase domain of JAK2 this lack of information has hindered a detailed understanding of the mechanism of activation of JAK2 V617F 
Mutation Word : V617F @Position : 27
Function Word : activity @Position : 24
Impact Word : hinder @Position : 16
Several resistance mechanisms such as EGFR T790M secondary mutation that leads to a higher ATP binding capacity and MET amplification resulting in an aberrantly activated alternative pathway that bypasses the inhibited EGF receptors had been discovered 
Mutation Word : T790M @Position : 6
Function Word : activity @Position : 24
Impact Word : higher @Position : 13
CNP and meclozine increased the Alcian blue staining of ATDC5 cells expressing FGFR3-G380R and –K650E in micromass culture 
Mutation Word : K650E @Position : 14
Function Word : expression @Position : 11
Impact Word : increase @Position : 3
The constitutive increase in EGFR activity appears to be ligand-independent as a combination of neutralizing antibodies against EGF TGFα and EGFR failed to inhibit elevated basal levels of L858R autophosphorylation  Figure 2 B 
Mutation Word : L858R @Position : 28
Function Word : autophosphorylation @Position : 29
Impact Word : elevate @Position : 24
JAK2  wt Ba/F3 cells engineered to express the erythropoietin receptor Ba/F3-EPOR wt and the cytokine-independent counterpart with ectopic expression of  JAK2 V617F Ba/F3-EPOR VF were exposed to increasing drug concentrations in proliferation 48 h  Figure 1A  and clonogenic 7 days  Figure 1B  assay 
Mutation Word : V617F @Position : 23
Function Word : proliferation @Position : 33
Impact Word : increase @Position : 29
Mcl-1 depletion in JAK2 V617F  mutant SET-2 cells increases apoptosis and sensitizes the cells to NVP-BSK805-induced cell death  
Mutation Word : V617F @Position : 4
Function Word : apoptosis @Position : 10
Impact Word : increase @Position : 9
Although these antagonistic roles offset in the steady state we demonstrate that the supportive role of macrophages in RBC development is dominant in recovery from hemolytic anemia acute blood loss myeloablation and also JAK2 V617F -induced polycythemia vera 
Mutation Word : V617F @Position : 34
Function Word : induce @Position : 35
Impact Word : dominant @Position : 21
Results  There was decreased expression of thyroid-specific genes such as Tg and NIS and increased expression of stemness markers such as Oct4 Rex1 CD15 and Sox2 in the thyroid carcinoma tissue from 6-week-old BRAF V600E  mice indicating the dedifferentiated status of the cells and the fact that stemness was derived in this model from differentiated thyroid cells 
Mutation Word : V600E @Position : 35
Function Word : result @Position : 0
Impact Word : decrease @Position : 4
These features stem from elevated activation of JAK2 downstream of EPOR arising from the  JAK2 V617F   mutation in Polycythemia vera or elevated EPO levels in β-thalassemia and can be limited by the administration of JAK2 inhibitors  39  40  42 – 45   
Mutation Word : V617F @Position : 16
Function Word : activity @Position : 5
Impact Word : elevate @Position : 24
The presence of R164Q in cluster 2 rather than in cluster 1 with wt  K-Ras  was therefore initially surprising but suggests that the R164Q mutation also has an activating phenotype albeit attenuated relative to the other mutations studied 
Mutation Word : R164Q @Position : 25
Function Word : phenotype @Position : 31
Impact Word : attenuate @Position : 33
MST1 expression significantly increased apoptosis which is reduced by expression of BRAF V600E  
Mutation Word : V600E @Position : 12
Function Word : apoptosis @Position : 4
Impact Word : reduce @Position : 7
Some mutations P112Q R895C E897K enhance angiotensin II receptor-mediated activation of TRPC6 when expressed in HEK293 cells while neither the S270T nor the N143S missense mutations nor a 57-amino acid truncation mutation K874X altered the channel activity   
Mutation Word : N143S @Position : 23
Function Word : activity @Position : 36
Impact Word : enhance @Position : 5
The somatic E884K substitution appears to be relatively infrequent and resulted in a mutant lysine residue that disrupts an ion pair with residue R958 in the EGFR kinase domain C-lobe an interaction that is highly conserved within the human kinome as demonstrated by our sequence analysis and structure analysis 
Mutation Word : E884K @Position : 2
Function Word : interaction @Position : 31
Impact Word : disrupt @Position : 17
This led us to question whether in solution perturbation of the autoP trajectory by RET M918T could arise through presentation of a better intermolecular substrate by favoring an “AL-out” conformer presenting Y900 or Y905 as a substrate to an active RET kinase in  trans  
Mutation Word : M918T @Position : 14
Function Word : substrate @Position : 35
Impact Word : favorable @Position : 25
This mutation  E17K  increases recruitment of AKT1 to the membrane increases AKT1 phosphorylation and activity transforms Rat1 fibroblasts and induces leukaemia in transgenic mice  Carpten  et al  2007  
Mutation Word : E17K @Position : 3
Function Word : activity @Position : 16
Impact Word : increase @Position : 12
Consistent with the results of Y27632 treatments knockdown of ROCK1/2 greatly reduced the GLUT1 translocation and the Warburg effect in cells and furthermore largely abolished the stimulating effects of mutp53 on GLUT1 translocation and the Warburg effect in H1299  Fig. 6c & d   p53  R172H/R172H   MEF  Fig. 6e & f  and MDA-MB468 cells  Supplementary Fig  S6c & e  
Mutation Word : R172H @Position : 48
Function Word : effect @Position : 36
Impact Word : abolish @Position : 24
MST1 expression significantly increased apoptosis which is reduced by expression of BRAF V600E  
Mutation Word : V600E @Position : 12
Function Word : expression @Position : 9
Impact Word : reduce @Position : 7
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : E255K @Position : 5
Function Word : ability @Position : 20
Impact Word : increase @Position : 19
Tyrosine phosphorylation of STAT5 was also enhanced though not as significantly as that of PECAM-1 in cells expressing the E255K or T315I mutant  Fig  4C  
Mutation Word : E255K @Position : 19
Function Word : phosphorylation @Position : 1
Impact Word : enhance @Position : 6
BRAF V600E  induced transforming properties are further enhanced through cooperation with TGFβ-1 suggesting that synergism between oncogene and growth factor is essential for induction of further migration properties in colon adenocarcinoma cells 
Mutation Word : V600E @Position : 1
Function Word : induce @Position : 3
Impact Word : enhance @Position : 8
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : T315I @Position : 7
Function Word : ability @Position : 20
Impact Word : increase @Position : 19
In H606Q the interactions between the H606 side chain and the L604/L609 backbones are disrupted and the conformation of the loop 604 to 609 is changed 
Mutation Word : H606Q @Position : 6
Function Word : interaction @Position : 3
Impact Word : disrupt @Position : 14
The mutations G250E Y253H and T315I experience decreased vdW interactions with Phe359 
Mutation Word : T315I @Position : 5
Function Word : interaction @Position : 9
Impact Word : decrease @Position : 7
BRAF V600E  constitutively activates the MEK-ERK signaling pathway promoting ERK-dependent transcriptional activity which regulates cell growth cell proliferation apoptosis evasion replicative potential angiogenesis and tissue invasion  
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 12
Impact Word : constitutive @Position : 3
These differences in MITF activity may reflect distinct subtypes of melanoma however another possibility is that MITF amplification indicates the need for melanoma cells to maintain sufficient MITF activity for survival in the context of high BRAF V600E  signaling   
Mutation Word : V600E @Position : 37
Function Word : survival @Position : 30
Impact Word : maintain @Position : 25
For 4557W reversible dual TKI of EGFR/ERBB2 the E884K mutation modulated the L858R mutation in- cis  again in a dominant fashion rendering the double mutant receptor more sensitive to the dual inhibitor  Figure 2  
Mutation Word : L858R @Position : 12
Function Word : sensitivity @Position : 28
Impact Word : modulates @Position : 10
We have shown previously that co-treatment of several melanoma cell lines with WNT3A and with a targeted BRAF-V600E inhibitor synergistically increases Wnt/β-catenin signaling and apoptosis   
Mutation Word : V600E @Position : 17
Function Word : apoptosis @Position : 24
Impact Word : increase @Position : 20
As a whole these data indicate that blocking mTOR signalling pathway is effective in reducing proliferation and clonogenic potential of cells expressing the  JAK2 V617F mutation however mTOR inhibitors appeared to exert mainly a cytostatic rather than an apoptotic effect when compared with JAK2 inhibitors 
Mutation Word : V617F @Position : 25
Function Word : proliferation @Position : 15
Impact Word : reduce @Position : 14
The combination of vemurafenib and metformin tended to have stronger anti-proliferative effects on BRAF V600E  mutant cell lines 
Mutation Word : V600E @Position : 14
Function Word : effect @Position : 11
Impact Word : stronger @Position : 9
The results show that only BRAF carrying the L505H amino acid substitution significantly increased resistance to PLX4032 [IC 50  from 0.18 to 4.58  μ M for YUMAC P-value < 0.0001 and 0.1 to 1.0  μ M for YUGEN8 P-value < 0 0001] and activated the MAPK cascade Figure  3 C–E  Figure S4  
Mutation Word : L505H @Position : 8
Function Word : resistance @Position : 14
Impact Word : increase @Position : 13
It is possible that the elevated expression of KRAS V12  coupled with Braf V600E  induces senescence at an early stage in tumor development precluding detection 
Mutation Word : V600E @Position : 14
Function Word : expression @Position : 6
Impact Word : elevate @Position : 5
This agent has demonstrated 325-fold greater activity against native BCR-ABL in vitro as compared with imatinib and is active against all imatinib-resistant BCR-ABL mutations with the exception of T315I   
Mutation Word : T315I @Position : 28
Function Word : activity @Position : 18
Impact Word : greater @Position : 5
Despite the decreased expression observed BRAF V600E-mutated samples had a hypomethylated pattern  p  = 0 048 
Mutation Word : V600E @Position : 6
Function Word : expression @Position : 3
Impact Word : decrease @Position : 2
In addition the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
Mutation Word : V617F @Position : 39
Function Word : binding @Position : 26
Impact Word : increase @Position : 33
Mutating the BRAF dimerization motif R509H abolishes resistance conferred by N-terminal truncated BRAF moieties Poulikakos et al   2011  however it has no effect on  BRAF   V600E/L505H   Figure  4 D 
Mutation Word : V600E @Position : 31
Function Word : effect @Position : 25
Impact Word : abolish @Position : 6
 H  Mock and mscv-puro-STAT5 S710F  transduced p53 -/-  erythroid cell line maintained under proliferation conditions were lyzed and analyzed for ISG15 expression using anti-ISG15 antibody on a 10% acrylamide gel Top panel 
Mutation Word : S710F @Position : 6
Function Word : proliferation @Position : 17
Impact Word : maintain @Position : 15
Structurally this residue lies in the substrate-binding pocket of the kinase and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP-bound form effectively making RET more active more of the time  48 – 51  
Mutation Word : M918T @Position : 13
Function Word : effect @Position : 29
Impact Word : increase @Position : 17
Moreover significant suppression of pERK following BRAF degradation by 17-AAG has also contributed to a MEK dependent DR4 downregulation in the presence of attenuated BRAF V600E  activity 
Mutation Word : V600E @Position : 25
Function Word : activity @Position : 27
Impact Word : attenuate @Position : 23
JAK2 K539L T875N and R683G were shown to exhibit constitutive STAT5 activation and to transform Ba/F3 cells expressing the EpoR to cytokine-independence     
Mutation Word : T875N @Position : 2
Function Word : activity @Position : 11
Impact Word : constitutive @Position : 9
We hypothesised that patients with low or heterogeneous expression of mutant BRAF V600E  protein would have a poor response to treatment with BRAF inhibitors and reduced survival compared with patients with high and homogeneous expression 
Mutation Word : V600E @Position : 12
Function Word : survival @Position : 27
Impact Word : reduce @Position : 26
Importantly whereas mice receiving 10 6  JAK2 V617F  cells retained a balanced production of myeloid and lymphoid lineages those receiving 10 5  JAK2 V617F  cells exhibited marked lineage skewing  Figure 1B  as determined by the relative production of myeloid and lymphoid elements by donor and competitor cells 
Mutation Word : V617F @Position : 26
Function Word : exhibit @Position : 29
Impact Word : retain @Position : 11
Ba/F3 cells with D835H/Y demonstrate IL-3-independent growth and increased STAT5 phosphorylation consistent with reports that D835 mutations are primary transforming events  173  
Mutation Word : D835H @Position : 15
Function Word : phosphorylation @Position : 10
Impact Word : increase @Position : 8
Increased activation of Akt1 by E17K L52R C77F and Q79K mutants led as expected to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
Mutation Word : Q79K @Position : 9
Function Word : phosphorylation @Position : 16
Impact Word : increase @Position : 15
LGX818 treatment at oral doses as low as 6 mg/kg in human melanoma xenograft models BRAF V600E  resulted in strong and sustained >24 hours decrease in pMEK   
Mutation Word : V600E @Position : 15
Function Word : result @Position : 17
Impact Word : decrease @Position : 23
BRAF V600E  mutations in malignant melanoma are associated with increased expressions of BAALC
Mutation Word : V600E @Position : 1
Function Word : expression @Position : 11
Impact Word : increase @Position : 10
This is probably because COLO 205 cells harbor a BRAF V600E  mutation  www.sanger.ac uk/genetics/CGP/cosmic  which is constitutively active and stimulates MAPK signaling  
Mutation Word : V600E @Position : 10
Function Word : activity @Position : 20
Impact Word : constitutive @Position : 19
Immediately after introduction of EphA2 into non-transformed immortalized melanocytes there was a notable increase in the subG1 fraction which was additive with ectopic Braf V600E  expression  Figure 5A  
Mutation Word : V600E @Position : 24
Function Word : expression @Position : 26
Impact Word : increase @Position : 13
The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation and to a large degree mutations affecting the residue 317 F317L F317V 
Mutation Word : F317V @Position : 34
Function Word : activity @Position : 1
Impact Word : maintain @Position : 5
The T790M mutation abrogated the effect of erlotinib on L858R and the L858R/T790M double mutant readily induced Akt phosphorylation even in the presence of 10 μM erlotinib 
Mutation Word : L858R @Position : 12
Function Word : phosphorylation @Position : 18
Impact Word : abrogate @Position : 3
BCR-ABL mutations respond differently to three tyrosine kinase inhibitors approved for first-line treatment of CML e.g  Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib while some mutations are less sensitive to nilotinib E255K/V and F359V/C or dasatinib F317L and V299L  
Mutation Word : F317L @Position : 55
Function Word : sensitivity @Position : 47
Impact Word : less @Position : 46
We found that tumors expressing Braf V600E  and either KRAS V12  or KRAS V12/C40  were significantly larger than those expressing Braf V600E  alone or Braf V600E  and the other KRAS ED  mutants 
Mutation Word : V600E @Position : 29
Function Word : expression @Position : 22
Impact Word : larger @Position : 19
Some of these mutations alter specifically the configuration of the ATP-binding kinase pocket V654A and T670I inhibiting imatinib binding 
Mutation Word : T670I @Position : 15
Function Word : binding @Position : 18
Impact Word : alter @Position : 4
Expression of AKT3 E17K in A375 cells increased AKT phosphorylation as compared to transfection with the control vectors or wild-type AKT3 under normal tissue culture conditions  Figure 1  Panel C 
Mutation Word : E17K @Position : 3
Function Word : expression @Position : 0
Impact Word : increase @Position : 7
Genetic variations that directly affect ATP sensitivity I182V ABCC8  do so by decreasing K ATP  channel affinity for ATP which causes the K ATP  channel to remain open that translates to a reduction in insulin secretion 
Mutation Word : I182V @Position : 7
Function Word : affinity @Position : 18
Impact Word : decrease @Position : 13
Survival for CML-CP patients with the T315I point mutation treated with TKIs is estimated to be reduced by 50% compared with patients without the T315I mutation median survival of 22 months vs. more than 10 years for TKI-responsive CML patients Nicolini et al  2009 
Mutation Word : T315I @Position : 24
Function Word : survival @Position : 27
Impact Word : reduce @Position : 16
In numerous studies the  JAK2  V617F allele has been variably associated with higher indices of erythropoiesis unchanged or decreased platelet counts greater occurrence of thrombosis increased BM fibrosis or cytoreductive treatments older age longer disease duration or poorer survival in MPN   
Mutation Word : V617F @Position : 7
Function Word : survival @Position : 40
Impact Word : increase @Position : 27
These results suggest that execution of apoptosis may be impaired by the presence of T790M and to a lesser extent L747S 
Mutation Word : L747S @Position : 20
Function Word : apoptosis @Position : 6
Impact Word : impair @Position : 9
The presence of R164Q in cluster 2 rather than in cluster 1 with wt  K-Ras  was therefore initially surprising but suggests that the R164Q mutation also has an activating phenotype albeit attenuated relative to the other mutations studied 
Mutation Word : R164Q @Position : 25
Function Word : phenotype @Position : 31
Impact Word : attenuate @Position : 33
A E-SLAM HSCs were increased in frequency in wild type ∼2-fold see  Figure 1E  but not JAK2 V617F  marrow in 18–24-mo-old mice  n  = 10 compared to 6–10-mo-old mice resulting in a 3-fold overall reduction in E-SLAM HSCs compared to wild-type  p  = 0 002 in three independent experiments 
Mutation Word : V617F @Position : 19
Function Word : result @Position : 32
Impact Word : increase @Position : 4
Cells expressing the L747_E749del A750P and D770_N771insNPG  EGFR  mutants also exhibited a greater degree of loss of contact inhibition than was observed in cells expressing the L858R or G719S EGFR mutants in a primary focus formation assay unpublished data 
Mutation Word : A750P @Position : 4
Function Word : inhibit @Position : 20
Impact Word : greater @Position : 14
In colorectal cancer patients a mutation in the extracellular domain of EGFR S492R which abrogates cetuximab binding but retains panitumumab sensitivity has been recently described as a mechanism of acquired resistance   Fig   2c  
Mutation Word : S492R @Position : 12
Function Word : binding @Position : 16
Impact Word : retain @Position : 18
Kinase activation in the clinically benign mutant L196P is far weaker than R206H but yields equivalent signals due to the stronger interaction of FKBP12 with R206H 
Mutation Word : R206H @Position : 25
Function Word : interaction @Position : 21
Impact Word : stronger @Position : 20
In the current study Liu and colleagues show that mutant V600E BRAF enhances STAT3 phosphorylation and increases PAX3 expression in melanocytes 
Mutation Word : V600E @Position : 10
Function Word : expression @Position : 18
Impact Word : enhance @Position : 12
ALK-F1174L expression in murine NCPC MONC-1 impairs differentiation of NC cell-derived tumors
Mutation Word : F1174L @Position : 0
Function Word : expression @Position : 1
Impact Word : impair @Position : 6
This analysis also indicates that the magnitude of MI within and between regions is increased in mice carrying the  Fgfr2  mutations especially the S252W mutation  Fig  4  confirming all previous results and supporting H 1B  
Mutation Word : S252W @Position : 25
Function Word : result @Position : 35
Impact Word : increase @Position : 14
BRAF V600E  is the most prevalent genetic alteration implicated in the initiation and progression of PTC especially in aggressive subtypes such as the tall cell variant of PTC and in those with extra-thyroidal extension and lymph node or distant metastases 
Mutation Word : V600E @Position : 1
Function Word : implicated @Position : 9
Impact Word : alter @Position : 8
We have evaluated the role of mutant BRAF V600E in human melanoma cells by using mutant BRAF V600E-specific lentiviral shRNAs and found that BRAF mutation was involved in enhanced cell proliferation and invasion Sumimoto et al   
Mutation Word : V600E @Position : 17
Function Word : proliferation @Position : 30
Impact Word : enhance @Position : 28
The increase in BIM expression and apoptosis are inhibited by the secondary resistant mutation T790M 
Mutation Word : T790M @Position : 14
Function Word : inhibit @Position : 8
Impact Word : increase @Position : 1
The sensitivity of mass spectrometric genotyping technologies such as OncoMap or Asan-Panel is known to be approximately 1–5%   and so detection of the T790M mutation could be increased if more sensitive techniqueswere used 
Mutation Word : T790M @Position : 25
Function Word : sensitivity @Position : 32
Impact Word : increase @Position : 29
S252W fibroblasts showed 6-fold increase in ALP activity in comparison to WT fibroblasts  p  < 0.001 Fig.  2a  while S252W MSCs had 3-fold increase in comparison to WT MSCs  p  < 0.001 Fig   2b  
Mutation Word : S252W @Position : 20
Function Word : activity @Position : 7
Impact Word : increase @Position : 24
To ascertain whether E-SLAM HSCs from JAK2 V617F  mice were less functional than normal controls 10 donor E-SLAM HSCs were transplanted alongside competitor BM cells and secondary transplantations were performed using BM from all the primary recipients showing even trace amounts of donor-derived repopulation 
Mutation Word : V617F @Position : 7
Function Word : function @Position : 12
Impact Word : less @Position : 11
Intriguingly a recent study indicates that the G2385R risk variant causes a partial loss of kinase activity highlighting the possibility that both too much or too little LRRK2 kinase activity may be detrimental   
Mutation Word : G2385R @Position : 7
Function Word : activity @Position : 29
Impact Word : detrimental @Position : 32
This study also showed that endogenous expression or ectopic induction of p61B-Raf V600E induced ERK signaling resistant to vemurafenib where disruption of p61B-Raf V600E dimerization by site-directed mutation restored its sensitivity to vemurafenib 
Mutation Word : V600E @Position : 23
Function Word : dimerization @Position : 24
Impact Word : disrupt @Position : 20
In this last study the JAK2  V617F mutation was found associated with the increased platelet activation 
Mutation Word : V617F @Position : 7
Function Word : activity @Position : 16
Impact Word : increase @Position : 14
At Days 3 and 5 the cell proliferation rate as determined by % viable cells increase during the assay period was 1.46-fold Day 3 and 1.40-fold  P =0 0013 higher Day 5 in L858R+E884K than L858R alone 
Mutation Word : E884K @Position : 34
Function Word : proliferation @Position : 7
Impact Word : higher @Position : 30
Hence the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT down-regulated CBL and MAPK-ERK1/2 phosphorylation up-regulated 
Mutation Word : E884K @Position : 4
Function Word : effect @Position : 15
Impact Word : modulates @Position : 5
As shown in  Figure 3a–b  the kinase activities of L858R/V948R tEGFR in its EGF– and Cetuximab–bound forms were reduced substantially compared to that of L858R tEGFR indicating that mutation of either the N-lobe or C-lobe face of the dimer interface of L858R results in a 10- to 30-fold decrease in catalytic rate 
Mutation Word : L858R @Position : 43
Function Word : result @Position : 44
Impact Word : reduce @Position : 20
This mutation  E17K  increases recruitment of AKT1 to the membrane increases AKT1 phosphorylation and activity transforms Rat1 fibroblasts and induces leukaemia in transgenic mice  Carpten  et al  2007  
Mutation Word : E17K @Position : 3
Function Word : induce @Position : 21
Impact Word : increase @Position : 12
In a recent study   we found a significantly increased MVD and VEGF expression in MPN compared to controls particularly in cases with high JAK2-V617F  mutant allele burdens 
Mutation Word : V617F @Position : 25
Function Word : expression @Position : 14
Impact Word : increase @Position : 10
TBP-3868 exhibits high basal Ras activity relative to the PLX4720 sensitive line TBP-3743 suggesting that the resistance to BRAF V600E -inhibition in TBP-3868 may be attributed to Ras-dependent transactivation of RAF dimers 
Mutation Word : V600E @Position : 19
Function Word : resistance @Position : 16
Impact Word : high @Position : 2
In contrast to these compounds the B-Raf V600E  inhibitor dabrafenib selectively decreased proliferation of  BRAF -mutant cell clones Figure  4 D 
Mutation Word : V600E @Position : 7
Function Word : proliferation @Position : 13
Impact Word : decrease @Position : 12
Enhancement by PDGFRα-I of the  in vitro  anti-proliferative and pro-apoptotic activity of BRAF-I in BRAF-I sensitive and resistant melanoma cell lines harboring BRAFV600E
Mutation Word : V600E @Position : 24
Function Word : resistance @Position : 19
Impact Word : enhance @Position : 0
Therefore even with a higher sensitivity permitting detection of 1% mutant DNA as is reached with SARMS and PNA-based PCR clamping detection of the T790M mutation in cfDNA remains difficult 
Mutation Word : T790M @Position : 24
Function Word : sensitivity @Position : 5
Impact Word : higher @Position : 4
In an  EGFR -vIII-based method of overexpression L861Q mutation reportedly enhances EGFR kinase activity and transforms activity without an increase in sensitivity to EGFR-TKI but with an increase in sensitivity to irreversible second-generation EGFR-TKI  26  
Mutation Word : L861Q @Position : 8
Function Word : sensitivity @Position : 30
Impact Word : increase @Position : 28
Oncogenic mutations S768I and L861Q may alter the canonical interactions at the JM-C-helix interface
Mutation Word : L861Q @Position : 4
Function Word : interaction @Position : 9
Impact Word : alter @Position : 6
Phosphorylation of Ser 910 /Ser 935  and 14-3-3 binding were significantly reduced in six other mutants M712V R1441H R1441C A1442P L1795F and G2385R  Figure 5  lower panel 
Mutation Word : G2385R @Position : 23
Function Word : phosphorylation @Position : 0
Impact Word : reduce @Position : 12
Now recent work from the Rosen lab at Memorial Sloan-Kettering Cancer Center has uncovered data that vemurafenib reduces feedback inhibition in BRAF V600E -expressing cells such that these cells become sensitized to extracellular growth factors like hepatocyte and epidermal growth factors 
Mutation Word : V600E @Position : 22
Function Word : inhibit @Position : 19
Impact Word : reduce @Position : 17
In vitro  studies in thyroid cells suggest that BRAF V600E induces invasion via increased expression of matrix metalloproteinases MMP12  Mesa  et al  2006  and that it reduces expression and membrane localisation of the Na I symporter responsible for thyrocyte uptake of iodine  Riesco-Eizaguirre  et al  2006  
Mutation Word : V600E @Position : 10
Function Word : expression @Position : 32
Impact Word : reduce @Position : 31
Is Follow-up BRAF V600E  Mutation Analysis Helpful in the Differential Diagnosis of Thyroid Nodules with Negative Results on Initial Analysis?
Mutation Word : V600E @Position : 3
Function Word : result @Position : 17
Impact Word : negative @Position : 16
In terms of EGFR-TKI sensitivity Kancha et al  have identified 4 sets of mutations based on their drug sensitivity profiles a mutations that are very sensitive to all 3 drugs tested with IC50 values in the low nanomolar range L858R and Del 747-753insS b mutations that are less sensitive to gefitinib IC50 >100 nmol/l but sensitive to both erlotinib and AEE788 G719S V742A and R776C IC50 < 100 nmol/l c mutations that are less sensitive to both gefitinib and erlotinib but sensitive to AEE788 D761N S768I S784F L838V and L861Q and d mutations that are resistant to all three drugs tested N826S and T790M   
Mutation Word : N826S @Position : 102
Function Word : sensitivity @Position : 82
Impact Word : less @Position : 74
Hence E884K mutation can work in concert with L858R to modulate mutant receptor sensitivity to different targeted inhibitors 
Mutation Word : E884K @Position : 1
Function Word : sensitivity @Position : 13
Impact Word : modulates @Position : 10
The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation and to a large degree mutations affecting the residue 317 F317L F317V 
Mutation Word : F317L @Position : 34
Function Word : resistance @Position : 13
Impact Word : maintain @Position : 5
BRAF V600E mutation leads to constitutive activation of the MEK/ERK pathway promoting cancer cell survival and proliferation   
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 6
Impact Word : constitutive @Position : 5
The former is the case of the S492R mutant which confers resistance to cetuximab since the mutation is located in its binding epitope on the EGFR external domain   whereas the later is the case of the T790M mutant mutation in the kinase domain which confers resistance to gefitinib or erlotinib in lung adenocarcinomas   by stabilizing the active tyrosine kinase conformation and enhancing aTP binding   
Mutation Word : T790M @Position : 38
Function Word : activity @Position : 60
Impact Word : stability @Position : 58
Similar to E884K R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in- cis  with L858R 
Mutation Word : E884K @Position : 2
Function Word : effect @Position : 7
Impact Word : modulates @Position : 4
The mutation F359V experiences decreased vdW −2.13 kcal/mol and electrostatic interactions −0.16 kcal/mol while decreased electrostatic interactions are experienced due to mutations E255K 0.35 kcal/mol and E255V −0 09 kcal/mol 
Mutation Word : E255V @Position : 26
Function Word : interaction @Position : 16
Impact Word : decrease @Position : 14
Partial degradation of mutant BRAF and insufficient MAPK pathway inhibition in Caco-BR cells overexpressing mutant BRAF V600E  appear to preclude cell sensitivity to 17-AAG  Figure S10  regardless of the interaction between mutant BRAF and Hsp90 in the Caco-BR cells  Figure 8B  
Mutation Word : V600E @Position : 16
Function Word : inhibit @Position : 9
Impact Word : degrade @Position : 1
For example prolonged treatment of BRAF V600E -expressing melanoma cells with the BRAF inhibitor AZ628 leads to the development of clones that maintain high levels of phosphorylated ERK which continue to proliferate in the presence of drug  Montagut  et al  2008  
Mutation Word : V600E @Position : 6
Function Word : phosphorylation @Position : 26
Impact Word : maintain @Position : 22
These NB tumors expressed reduced levels of CD44 but increased levels of Ncam1 compared to undifferentiated tumors derived either from MONC-1 or MONC-1-ALK-F1174L cells Figure  1C  
Mutation Word : F1174L @Position : 22
Function Word : expression @Position : 3
Impact Word : increase @Position : 9
In comparison to the S252W mutation that enhances signaling with a limited subset of Fgfs the P253R mutation enhances signaling with many Fgfs and one hypothesis is that the P253R mutation may respond to many more signals that can have overlapping redundant and/or counteracting effects resulting in a more moderate increase of MI 
Mutation Word : P253R @Position : 29
Function Word : effect @Position : 44
Impact Word : enhance @Position : 18
Later Nehs et al  [ 78 ] elegantly demonstrated the remarkable efficacy of PLX4720 compound which is an ATP analog that selectively inhibits B-Raf V600E  by stabilizing it in an inactive conformation [ 79 ] to induce significant regression in an orthotopic mouse model of ATC even when administered at a very late therapeutic intervention stage 
Mutation Word : V600E @Position : 25
Function Word : inhibit @Position : 23
Impact Word : stability @Position : 28
It appears that PtdIns binding is enhanced in the E416A mutant for two reasons i the Arg 380 –Glu 416  salt bridge which otherwise blocks the entrance to the binding pocket is broken and ii the sentry glutamate residue Glu 416  is replaced by an alanine in this open state which further increases the accessibility of the binding site for negatively charged lipid headgroups 
Mutation Word : E416A @Position : 9
Function Word : binding @Position : 59
Impact Word : enhance @Position : 6
The mutation Y253F −0.22 kcal/mol experiences increased electrostatic interactions Y253H experiences increased electrostatic interactions −0.3 kcal/mol and decreased vdW −1 31 kcal/mol when binding to ponatinib 
Mutation Word : Y253F @Position : 9
Function Word : interaction @Position : 13
Impact Word : increase @Position : 11
The EphA3 G518L mutation found in lung cancer increases the affinity of the lateral interaction between EphA3 and ephrin-A3 
Mutation Word : G518L @Position : 2
Function Word : interaction @Position : 14
Impact Word : increase @Position : 8
We also find that a melanoma-associated mutation within the pseudosubstrate sequence P52L disrupts PAK6 autoinhibition enhancing its kinase activity potentially correlating with increased expression of PAK6 in prostate cancer and implied alterations in kinase activity  
Mutation Word : P52L @Position : 11
Function Word : activity @Position : 34
Impact Word : disrupt @Position : 12
Our data suggest that exon 20 insertions may disrupt these interactions to a greater extent than the T790M point mutation 
Mutation Word : T790M @Position : 17
Function Word : interaction @Position : 10
Impact Word : disrupt @Position : 8
While RalB-GTP levels were generally difficult to detect with only one cell line exhibiting detectable RalB-GTP either the amount of RalA-GTP normalized to actin or the ratio of RalA-GTP to total RalA normalized to control cells was higher in one of three  NRAS/BRAF  three of four  NRAS Q61L/R /BRAF  and two of five  NRAS/BRAF   V600E   human melanoma cell lines compared to the control melanocytes  Figure 1  
Mutation Word : V600E @Position : 61
Function Word : exhibit @Position : 13
Impact Word : higher @Position : 37
BRAF V600E   mutation is the most frequent genetic alteration in papillary thyroid carcinoma PTC its high prevalence makes this oncogene a useful marker to refine inconclusive FNC results 
Mutation Word : V600E @Position : 1
Function Word : result @Position : 29
Impact Word : alter @Position : 10
We have previously shown that BRAF V600E  plays an important role in the aggressive behavior of thyroid cancer cells  in vitro  and that treatment with the selective BRAF V600E -inhibitor PLX4720 results in impressive decreases in tumor volume and metastasis in an orthotopic mouse model of ATC [ 5 - 8   10 ] 
Mutation Word : V600E @Position : 31
Function Word : result @Position : 34
Impact Word : decrease @Position : 37
When we first verified the expression level of genes up-regulated by FGFR2 +/S252W  similar significant alterations in these genes in FGF2 induced control fibroblasts was only observed after 24 h    
Mutation Word : S252W @Position : 12
Function Word : induce @Position : 22
Impact Word : alter @Position : 16
Although inhibition of MEK and ERK phosphorylation was achieved in BRAF V600E/K  mutant melanoma significantly increased tumour growth was seen in BRAF wild-type melanomas with upstream RAS mutations 
Mutation Word : V600K @Position : 11
Function Word : phosphorylation @Position : 6
Impact Word : increase @Position : 16
In summary the BRAF V600E -inhibitor PLX4720 and the SRC-inhibitor dasatinib synergize to inhibit proliferation reduce cellular migration and induce apoptosis in a variety of BRAF V600E -positive PTC and ATC cell lines 
Mutation Word : V600E @Position : 26
Function Word : migration @Position : 17
Impact Word : reduce @Position : 15
Hence the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT downregulated and MAPK-ERK1/2 phosphorylation upregulated 
Mutation Word : E884K @Position : 4
Function Word : effect @Position : 13
Impact Word : modulates @Position : 5
In preclinical studies T-cell viability and function was preserved when peripheral blood mononuclear cells and BRAF V600E  mutant melanoma cells were exposed to clinically relevant concentrations of vemurafenib in vitro   
Mutation Word : V600E @Position : 16
Function Word : function @Position : 6
Impact Word : preserve @Position : 8
The mutation Y253H experiences decreased vdW interactions with Phe317 while structurally these two side chains are located on either side of imidazo [12b] pyridazine ring 
Mutation Word : Y253H @Position : 2
Function Word : interaction @Position : 6
Impact Word : decrease @Position : 4
BRAF V600E results in elevated kinase activity compared with BRAF wild type and stimulated phosphorylation of downstream endogenous ERK   
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 6
Impact Word : elevate @Position : 4
The R611Q R611W A614D C696Y and V769E substitutions   disrupted the tuberin–hamartin interaction and prevented the phosphorylation of tuberin by PKB  the inhibition of S6 and S6K phosphorylation and the stimulation of Rheb GTPase activity cause TSC because they result in major conformational changes to tuberin 
Mutation Word : R611W @Position : 2
Function Word : interaction @Position : 13
Impact Word : disrupt @Position : 10
Increased activation of Akt1 by E17K L52R C77F and Q79K mutants led as expected to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
Mutation Word : Q79K @Position : 9
Function Word : activity @Position : 1
Impact Word : increase @Position : 15
The Y931C mutation might disrupt the π–π interaction between tyrosine ring and the inhibitor ring structure thus weakening the inhibitor binding and resulting in easy expulsion from the pocket 
Mutation Word : Y931C @Position : 1
Function Word : result @Position : 22
Impact Word : disrupt @Position : 4
Furthermore we show that the R728L variant decreases overall receptor levels and cellular receptor activity 
Mutation Word : R728L @Position : 5
Function Word : activity @Position : 14
Impact Word : decrease @Position : 7
Notably melanomas that have the V600E  BRAF  mutation exhibit increased HIF-1α expression 
Mutation Word : V600E @Position : 5
Function Word : expression @Position : 13
Impact Word : increase @Position : 11
It has been postulated that FGFR2 S252W  enhances cell proliferation which would account for the higher ossification rate at the sutures   
Mutation Word : S252W @Position : 6
Function Word : proliferation @Position : 10
Impact Word : enhance @Position : 8
Recently several mechanisms of EGFR-TKI resistance have been identified and classified as follows 1 alteration of the target  EGFR  gene e.g. T790M gatekeeper mutation  6  7   2 activation of bypass resistance signals e.g   Met  gene amplification  8   hepatocyte growth factor [HGF] overexpression  9   and activation of the nuclear factor-kappa B NFkBpathway  10   and Gas6-AXL axis  11   and 3 other mechanisms such as transformation to small-cell lung cancer  12 – 14   epithelial-to-mesenchymal transition  15 – 17   alteration of microRNA  18   and down-regulation of MED12 
Mutation Word : T790M @Position : 23
Function Word : activity @Position : 59
Impact Word : alter @Position : 102
To further delineate whether these gene expression circuitry modifications were consequence of altered ligand binding affinity of FGFR2 or of constitutively active intracellular signaling by the receptor we sought for BAT3 BDP1 CYP51A1 TCF19 and RFC3 DEGs in S252W fibroblasts treated with FGF2 expression levels in a C342Y fibroblast through qRT-PCR 
Mutation Word : S252W @Position : 38
Function Word : activity @Position : 21
Impact Word : constitutive @Position : 20
The G380R mutation has been shown to increase FGFR3 phosphorylation and thus shorten the proliferative phase in chondrocyte development but the cause for the increased receptor phosphorylation is under debate 
Mutation Word : G380R @Position : 1
Function Word : phosphorylation @Position : 26
Impact Word : increase @Position : 24
For instance the A391E mutation in FGFR3 increases FGFR3 phosphorylation at low ligand concentration similarly to the G380R and G375C ACH mutations studied here  
Mutation Word : G380R @Position : 17
Function Word : phosphorylation @Position : 9
Impact Word : increase @Position : 7
In conclusion our study indicates that the antiproliferative and apoptotic effects of these three xanthones on human melanoma SK-MEL-28 cell line are via modulation of the genes involved in the cell cycle and apoptosis pathway together with downregulation of the mRNA expression of Akt1 NF κ B and BRAF V600E 
Mutation Word : V600E @Position : 49
Function Word : apoptosis @Position : 33
Impact Word : modulates @Position : 23
E442G V279A F284S V445A E442G V410A I302V and S414P which confer or otherwise were strongly associated with increased resistance to interferon ribavirin cyclosporine and/or Debio 025 could also be identified  Table 2  
Mutation Word : V410A @Position : 5
Function Word : resistance @Position : 18
Impact Word : increase @Position : 17
The second incidentally found during study of the pathogenic Sec23A-F382L mutation  56  is that Sar1B-Sec23-Sec24 pre-budding complexes have lower affinity for Sec13/Sec31A than equivalent Sar1A-Sec23-Sec24 complexes reducing Sec23-mediated hydrolysis of GTP on Sar1 
Mutation Word : F382L @Position : 9
Function Word : affinity @Position : 21
Impact Word : lower @Position : 20
Of relevance BRAF V600E  oncoprotein elicits elevated kinase activity that leads to activation of the MAPK i e 
Mutation Word : V600E @Position : 3
Function Word : activity @Position : 13
Impact Word : elevate @Position : 7
This discrepancy might be a result of modulation of other genes besides JAK2 V617F  and FLT3-ITD by HDAC inhibition 
Mutation Word : V617F @Position : 13
Function Word : result @Position : 5
Impact Word : modulates @Position : 7
When using a higher sensitive approach the ARMS assay which may detect this allele variant with a sensitivity close to 3% persistent cells harbouring KIT M541L  allele variant occurred only in one patient #4 Fig   1B  
Mutation Word : M541L @Position : 25
Function Word : sensitivity @Position : 17
Impact Word : higher @Position : 3
Further combined treatment with these inhibitors results in a robust cytotoxic response and decreased tumor volume in a preclinical model of aggressive BRAF V600E -positive ATC 
Mutation Word : V600E @Position : 23
Function Word : result @Position : 6
Impact Word : decrease @Position : 13
Moreover coexpression of a dominant-negative SENP-1C630S mutant significantly enhanced FOXM1 SUMOylation suggesting that modified FOXM1 is a substrate for endogenous SENP-1  Figure 1f  
Mutation Word : C630S @Position : 5
Function Word : substrate @Position : 17
Impact Word : enhance @Position : 8
The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation and to a large degree mutations affecting the residue 317 F317L F317V 
Mutation Word : T315I @Position : 21
Function Word : activity @Position : 1
Impact Word : maintain @Position : 5
AP26113 has a fivefold greater potency than does crizotinib in inhibiting ALK as well as the L1196M gatekeeper mutation Katayama et al  2011 
Mutation Word : L1196M @Position : 16
Function Word : inhibit @Position : 10
Impact Word : greater @Position : 4
Our results imply that higher activity of Jak2-related pathways as observed in cases with higher  JAK2-V617F  mutant allele burdens may influence angiogenesis in MPN 
Mutation Word : V617F @Position : 16
Function Word : activity @Position : 5
Impact Word : higher @Position : 14
Moreover E-cadherin protein levels were significantly diminished in B-RAF V600E  transduced normal melanocytes derived from three individuals  Figure 2b  and E-cadherin protein levels increased when B-RAF V600E  was specifically silenced by shRNA or inhibited using the targeted B-RAF inhibitor Vemurafenib PLX4032 in two B-RAF V600E -positive melanoma cell lines NM176 and ME1042  Figure 2c  
Mutation Word : V600E @Position : 48
Function Word : inhibit @Position : 37
Impact Word : diminish @Position : 6
The two substitutions V600E and V600K represent 95% of all BRAF mutations in melanoma and both create a constitutively active kinase that is independent of receptor tyrosine kinase or RAS 
Mutation Word : V600K @Position : 5
Function Word : activity @Position : 19
Impact Word : constitutive @Position : 18
Our observation that the completely inactive mutants Mps1 T686A  and Mps1 T686E  showed stronger kinetochore signals than the less-active mutants Mps1 T676A  and Mps1 T676E  suggests that the kinetochore localization of Mps1 is negatively regulated by its own kinase activity 
Mutation Word : T676A @Position : 27
Function Word : regulation @Position : 38
Impact Word : negative @Position : 37
We show that B-RAF induces the transcriptional repressor Tbx3 which results in diminished E-cadherin expression in human melanocytes and increased invasiveness of B-RAF V600E -mutant melanoma cells 
Mutation Word : V600E @Position : 23
Function Word : expression @Position : 14
Impact Word : diminish @Position : 12
To test whether functional interactions between NF1 and ALK exist in human cells we used the SK-SY5Y and Kelly neuroblastoma cells both of which harbor constitutively active F1174L  ALK  alleles and both of which are highly sensitive to pharmacological ALK inhibition  
Mutation Word : F1174L @Position : 27
Function Word : activity @Position : 26
Impact Word : constitutive @Position : 25
In a study of four categories of imatinib- and dasatinib-treated patients imatinib resistant/dasatinib-responsive dasatinib-resistant blast crisis or CML progression and T315I or F317L mutated patient receiving omacetaxine treatment   transcriptional and translational levels of HCK LYN and another SFK-related gene BTK were elevated in more than 50% of resistant CML patients 
Mutation Word : T315I @Position : 20
Function Word : resistance @Position : 49
Impact Word : elevate @Position : 43
In such a case although she died of progressive disease of T790M mutated tumor cells in her thorax EGFR-TKI which was effective in the brain metastases was beneficial for her to improve her quality of life 
Mutation Word : T790M @Position : 11
Function Word : effect @Position : 21
Impact Word : beneficial @Position : 27
Hence the E884K mutation when in- cis  with L858R modulates the sensitivity of the mutant receptor towards ERBB family kinase inhibitors in an inhibitor-specific fashion 
Mutation Word : L858R @Position : 9
Function Word : sensitivity @Position : 12
Impact Word : modulates @Position : 10
Further elevated CDK4 levels in the embryonic pancreas through the CDK4 R24C  mutant showed increased proliferation of early mesenchymal endocrine precursors   
Mutation Word : R24C @Position : 11
Function Word : proliferation @Position : 16
Impact Word : elevate @Position : 1
This test was reported to have a very high sensitivity when the V600E mutant allele content was greater than 10%  
Mutation Word : V600E @Position : 12
Function Word : sensitivity @Position : 9
Impact Word : high @Position : 8
RNase L R462Q has reduced enzyme activity and doubles the risk of prostate cancer when homozygous   
Mutation Word : R462Q @Position : 2
Function Word : activity @Position : 6
Impact Word : reduce @Position : 4
Intriguingly tyrosine phosphorylation of PECAM-1 as well as its physical association with SHP2 was enhanced by the imatinib-resistance E255K or T315I mutation 
Mutation Word : E255K @Position : 18
Function Word : phosphorylation @Position : 2
Impact Word : enhance @Position : 14
Clinical results from phase I II and III trials showed that vemurafenib treatment caused complete or partial tumor regression in 80% of patients carrying BRAF V600E  tumors as well as an increased progression-free survival rate   
Mutation Word : V600E @Position : 25
Function Word : survival @Position : 34
Impact Word : increase @Position : 32
Our biochemical studies here now show that E884K mutation in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 7
Function Word : sensitivity @Position : 17
Impact Word : alter @Position : 36
The Y931C mutation may disrupt hydrophobic interactions between Y931 and the ring structures of the inhibitor along with other hydrophobic interactions which are likely required to hold the inhibitor in the binding pocket eventually weakening the inhibitor binding 
Mutation Word : Y931C @Position : 8
Function Word : interaction @Position : 20
Impact Word : disrupt @Position : 4
Afatinib BIBW 2992 Boehringer Ingelheim GmbH is an irreversible inhibitor of both EGFR HER2 and HER4 kinases and retains some activity in tumors with T790M mutations but at doses that are a log higher than what is needed for cancers harboring sensitizing mutations         
Mutation Word : T790M @Position : 24
Function Word : activity @Position : 20
Impact Word : retain @Position : 18
The G370C and S371C mutants produced higher levels of constitutive activation of MAPK in L8 cells and c- fos  transcription in RCJ cells than the G375C mutant consistent with the fact that TD1 is much more severe than ACH 
Mutation Word : S371C @Position : 3
Function Word : activity @Position : 10
Impact Word : constitutive @Position : 9
In agreement with the effects on EGFR phosphorylation and AKT/ERK signaling cells expressing the T790M form of L858R EGFR had less apoptosis when exposed to dasatinib  Figure 5C  
Mutation Word : T790M @Position : 14
Function Word : apoptosis @Position : 21
Impact Word : less @Position : 20
The convincing clinical response observed in the patient with the L576P mutation in exon 11 Case 3 is interesting to note in the context of  in vitro  data demonstrating reduced sensitivity to imatinib compared with other exon 11 mutations  Antonescu  et al  2007  
Mutation Word : L576P @Position : 10
Function Word : sensitivity @Position : 32
Impact Word : reduce @Position : 31
Substitution of S252W and P253R alter the ligand binding specificities of FGFR2b and FGFR2c but retain the ligand-dependent activation properties   whereas K659N causes receptor hyperactivation   
Mutation Word : S252W @Position : 2
Function Word : ligand @Position : 7
Impact Word : alter @Position : 5
Another study found uncoupling in rare TnC variants identified in DCM cTnC Y5H M103I and I148V either decreased or abolished the effects of PKA phosphorylation on Ca 2+ -sensitivity Pinto et al   2011  
Mutation Word : I148V @Position : 15
Function Word : phosphorylation @Position : 24
Impact Word : decrease @Position : 17
Indeed dual blockade of MEK/BRAF V600E  with PD184352 PLX4720 or vemurafenib and MET with crizotinib SU11274 or MET-specific siRNA resulted in reversal of drug resistance and reduced the proliferation of melanoma cell lines which was restored by exogenous HGF  29  109  
Mutation Word : V600E @Position : 5
Function Word : proliferation @Position : 29
Impact Word : reduce @Position : 27
Tyrosine phosphorylation of MIG6 appears to be increased in cancer cell lines containing Δ746–750 or L858R EGFRs suggesting that in addition to inhibiting EGFR MIG6 may also be a direct substrate of these mutant receptor EGFRs  
Mutation Word : L858R @Position : 15
Function Word : phosphorylation @Position : 1
Impact Word : increase @Position : 7
BCR-ABL mutations respond differently to three tyrosine kinase inhibitors approved for first-line treatment of CML e.g  Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib while some mutations are less sensitive to nilotinib E255K/V and F359V/C or dasatinib F317L and V299L  
Mutation Word : V299L @Position : 57
Function Word : sensitivity @Position : 47
Impact Word : less @Position : 46
Intriguingly the imatinib-resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM-1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells  Fig  4  
Mutation Word : T315I @Position : 7
Function Word : ability @Position : 10
Impact Word : increase @Position : 9
Intriguingly the imatinib-resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM-1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells  Fig  4  
Mutation Word : T315I @Position : 7
Function Word : induce @Position : 17
Impact Word : increase @Position : 9
Non-hotspot AKT1 PH domain mutants L52R C77F and Q79K increase Akt1 activation and downstream signaling
Mutation Word : Q79K @Position : 8
Function Word : activity @Position : 11
Impact Word : increase @Position : 9
Moreover mutations L755S L755P V777L T798M and T862A displayed enhanced activation of JNK/SAPK and to a lesser extent of ERK1/2 compared to wt-ERBB2  Figure 2A  
Mutation Word : V777L @Position : 4
Function Word : activity @Position : 10
Impact Word : enhance @Position : 9
However this EGFR mutant carrying D761Y or L747S was 100-fold less resistant to EGFR-TKIs than the mutant carrying T790M in vitro 
Mutation Word : L747S @Position : 7
Function Word : resistance @Position : 11
Impact Word : less @Position : 10
Hence the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT downregulated and MAPK-ERK1/2 phosphorylation upregulated 
Mutation Word : E884K @Position : 4
Function Word : phosphorylation @Position : 20
Impact Word : modulates @Position : 5
We now show in an animal that a low level of wild-type MITF activity is oncogenic with BRAF V600E  and that abrogating MITF activity in melanoma leads to tumor regression 
Mutation Word : V600E @Position : 18
Function Word : activity @Position : 24
Impact Word : abrogate @Position : 22
Contrarily mutation of F595 to Tyr or Trp supported a level of constitutive activity of V617F similar to non-mutated F595 indicating the presence of an aromatic residue at position 595 is required to maintain the constitutive activity of JAK2 V617F  Figure 2A  
Mutation Word : V617F @Position : 39
Function Word : activity @Position : 36
Impact Word : constitutive @Position : 35
The results showed an increase in phospho-FAK S910 the ERK1/2 phosphorylation site in YUDOSO-BRAF WT  and a reduction in YULAC-BRAF V600E  melanoma cells  Figure 6B  pFAK S910 
Mutation Word : V600E @Position : 21
Function Word : phosphorylation @Position : 10
Impact Word : increase @Position : 4
Moreover E-cadherin protein levels were significantly diminished in B-RAF V600E  transduced normal melanocytes derived from three individuals  Figure 2b  and E-cadherin protein levels increased when B-RAF V600E  was specifically silenced by shRNA or inhibited using the targeted B-RAF inhibitor Vemurafenib PLX4032 in two B-RAF V600E -positive melanoma cell lines NM176 and ME1042  Figure 2c  
Mutation Word : V600E @Position : 48
Function Word : inhibit @Position : 37
Impact Word : increase @Position : 26
Here we present evidence that BRAF V600E  enhances migration and invasion properties in colon carcinoma cells through RhoA activation while KRAS G12V  induces these properties less efficiently as compared to BRAF V600E  albeit through Cdc42 activation and filopodia formation 
Mutation Word : V600E @Position : 33
Function Word : activity @Position : 38
Impact Word : enhance @Position : 8
Genetic variations that directly affect ATP sensitivity I182V ABCC8  do so by decreasing K ATP  channel affinity for ATP which causes the K ATP  channel to remain open that translates to a reduction in insulin secretion 
Mutation Word : I182V @Position : 7
Function Word : atp @Position : 25
Impact Word : decrease @Position : 13
A JAK2 K539L T875N and R683G all induce constitutive activation of JAK2 however all three mutants display a marked decrease in STAT5 transcriptional activity in γ-2A cells when the F595A mutation is also introduced 
Mutation Word : R683G @Position : 5
Function Word : activity @Position : 23
Impact Word : constitutive @Position : 8
Importantly Mcl-1 depletion increased apoptosis in JAK2 V617F  mutant SET-2 cells and sensitized the cells to NVP-BSK805-induced cell death as assessed by Western blot analysis and measuring the sub-G1 cell fraction by flow cytometry Figure  7B  and  7C  
Mutation Word : V617F @Position : 7
Function Word : apoptosis @Position : 4
Impact Word : increase @Position : 3
It is also interesting that the apparent K  m  of L858R tEGFR for substrate peptide is ~4-fold greater than for WT and Δ746–750 tEGFRs 
Mutation Word : L858R @Position : 12
Function Word : substrate @Position : 15
Impact Word : greater @Position : 19
This study finds that the two most common EGFR mutations in non-small cell lung cancer L858R and Δ746–750 result in EGF–independent tEGFR activities comparable to or greater than the activity of EGF–stimulated WT EGFR and that tEGFR activation resulting from these mutations remains strongly coupled to asymmetric kinase dimer formation  Fig  3d  
Mutation Word : L858R @Position : 15
Function Word : activity @Position : 37
Impact Word : remain @Position : 42
These observations indicate that activation by the L858R substitution is coupled to kinase dimer formation and that inhibiting dimer formation by mutation increases accessibility of the inactive kinase conformation 
Mutation Word : L858R @Position : 7
Function Word : inhibit @Position : 17
Impact Word : increase @Position : 22
The NS1 mutants D2N †  and V226I bound F2F3-FLAG with comparable affinity to HK-wt NS1 but NS1 mutants V23A and R227K †  demonstrated a 2-fold increase in binding affinity p<0.05 and p<0 01 two-tailed students t-test 
Mutation Word : D2N @Position : 3
Function Word : affinity @Position : 30
Impact Word : increase @Position : 27
Among the exon 20 mutations tested Ins770SVD showed an intermediate level of autophosphorylation lower than S768I but higher than T790M Figure  4B  
Mutation Word : S768I @Position : 15
Function Word : autophosphorylation @Position : 12
Impact Word : higher @Position : 17
However tyrosine phosphorylation on the EGFR mutants could be further increased by EGF stimulation  Figure 2 B suggesting that the mutant EGFRs exhibit both ligand-independent and ligand-dependent activation similar to that observed upon EGF stimulation of the L858R mutant H3255 lung adenocarcinoma cell line   
Mutation Word : L858R @Position : 38
Function Word : activity @Position : 28
Impact Word : increase @Position : 10
It was noted that PLX4720 also reduced pRB protein phosphorylation increased p27 expression suppressed cyclin D1 expression and induced cleavage of PARP only in melanoma cell lines harbouring the  BRAF -V600E mutation  Figure 1D  
Mutation Word : V600E @Position : 31
Function Word : expression @Position : 16
Impact Word : reduce @Position : 6
T790M in the context of either transiently expressed wild-type EGFR or the mutant alleles del L474–E749A750P or L858R impairs inhibition by gefitinib or erlotinib as assessed by autophosphorylation 
Mutation Word : A750P @Position : 15
Function Word : inhibit @Position : 19
Impact Word : impair @Position : 18
Although inhibition of MEK and ERK phosphorylation was achieved in BRAF V600E/K  mutant melanoma significantly increased tumour growth was seen in BRAF wild-type melanomas with upstream RAS mutations 
Mutation Word : V600K @Position : 11
Function Word : inhibit @Position : 1
Impact Word : increase @Position : 16
Early experiments suggested that the T790M mutation sterically hindered the binding of TKIs to the EGFR kinase domain Kobayashi et al.  Pao et al   
Mutation Word : T790M @Position : 5
Function Word : binding @Position : 10
Impact Word : hinder @Position : 8
This becomes important because it may help to explain the surprisingly low or normal blood counts observed in BCS JAK2 V617F -positive patients the subsequent hemodilution and hypersplenism resulting from the portal hypertension may decrease the actual hemoglobin and other blood cell counts making the diagnosis of MPN quite challenging in many cases   
Mutation Word : V617F @Position : 20
Function Word : result @Position : 28
Impact Word : decrease @Position : 34
Conversely E884K worked in concert with L858R in- cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition  Fig  1A B  
Mutation Word : L858R @Position : 6
Function Word : inhibit @Position : 21
Impact Word : enhance @Position : 12
E884K and L858R+E884K mutants remained sensitive to EGF and were activated by the ligand to a level comparable to L858R  Figure 3A  
Mutation Word : E884K @Position : 2
Function Word : sensitivity @Position : 5
Impact Word : remain @Position : 4
In terms of EGFR-TKI sensitivity Kancha et al  have identified 4 sets of mutations based on their drug sensitivity profiles a mutations that are very sensitive to all 3 drugs tested with IC50 values in the low nanomolar range L858R and Del 747-753insS b mutations that are less sensitive to gefitinib IC50 >100 nmol/l but sensitive to both erlotinib and AEE788 G719S V742A and R776C IC50 < 100 nmol/l c mutations that are less sensitive to both gefitinib and erlotinib but sensitive to AEE788 D761N S768I S784F L838V and L861Q and d mutations that are resistant to all three drugs tested N826S and T790M   
Mutation Word : L858R @Position : 40
Function Word : sensitivity @Position : 82
Impact Word : less @Position : 74
The potency of afatinib on the L858R/T790M double mutation of EGFR known to be resistant to erlotinib gefitinib and lapatinib was reduced but still in the nanomolar range Table  1  Cha et al.  Solca et al.  Sos et al   
Mutation Word : T790M @Position : 6
Function Word : resistance @Position : 14
Impact Word : reduce @Position : 21
The majority of mutations in BRAF  are accounted for by a single nucleotide transversion from thymidine to adenosine leading to a substitution of valine by glutamic acid at position 600 termed  BRAF  V600E    which leads to a 500-fold increase in activity compared to the wild type protein kinase   
Mutation Word : V600E @Position : 35
Function Word : activity @Position : 46
Impact Word : increase @Position : 44
In order to determine the effect of the FGFR2 S252W  mutation in periosteal cells we first accessed whether the presence of the mutation altered the proliferation rates of S252W fibroblasts and S252W MSCs 
Mutation Word : S252W @Position : 32
Function Word : proliferation @Position : 26
Impact Word : alter @Position : 24
In contrast the silencing of  BRAF   V600E   by transfecting siBRAF resulted in an increase in the inactivating phosphorylation S127 and cytosolic translocation of YAP1  Figures 3c and d  
Mutation Word : V600E @Position : 9
Function Word : result @Position : 15
Impact Word : increase @Position : 18
Thus we asked next whether the Apert S252W mutation confers higher functional stem cell activity and a selective advantage that enables mutants to outcompete WT counterparts 
Mutation Word : S252W @Position : 7
Function Word : function @Position : 11
Impact Word : higher @Position : 10
The mutations T315I E255V F317L and F317V contribute to decreased vdW interactions with Ala269 
Mutation Word : F317V @Position : 6
Function Word : interaction @Position : 11
Impact Word : decrease @Position : 9
The mutations T315I E255V F317L and F317V contribute to decreased vdW interactions with Ala269 
Mutation Word : F317L @Position : 6
Function Word : interaction @Position : 11
Impact Word : decrease @Position : 9
Enforced expression of Stat3C increased miR-92a expression in H460 cells that could be inhibited by S3I-201  Figure 3D  
Mutation Word : S3I @Position : 15
Function Word : expression @Position : 6
Impact Word : increase @Position : 4
Based on these results and on a molecular model of FGFR3 TM domain created with the program CHI  it has been proposed that the G380R mutation introduces a structural change in the unliganded FGFR3 dimers thus altering their phosphorylation efficiencies and ultimately increasing FGFR3 phosphorylation in the absence of ligand 
Mutation Word : G380R @Position : 25
Function Word : phosphorylation @Position : 45
Impact Word : alter @Position : 37
Ba/F3 cells with D835H/Y demonstrate IL-3-independent growth and increased STAT5 phosphorylation consistent with reports that D835 mutations are primary transforming events  173  
Mutation Word : D835Y @Position : 15
Function Word : phosphorylation @Position : 10
Impact Word : increase @Position : 8
All inhibitors reduced the relative level of Mek 1/2 phosphorylation in clones carrying the V600E mutation by more than 90% with dabrafenib showing the strongest effect 
Mutation Word : V600E @Position : 14
Function Word : phosphorylation @Position : 9
Impact Word : reduce @Position : 2
The V600E mutation is an acquired activating mutation that results in constitutively active  BRAF  kinase activity leading to activation of the  MAPK  pathway 
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 20
Impact Word : constitutive @Position : 11
In particular an activating point mutation in JAK2 JAK2 V617F  has been described with high frequency in chronic myeloproliferative disorders MPD and constitutive JAK2 activation caused by chromosomal translocations has been reported in various types of leukemia     
Mutation Word : V617F @Position : 9
Function Word : activity @Position : 25
Impact Word : constitutive @Position : 23
Another study found uncoupling in rare TnC variants identified in DCM cTnC Y5H M103I and I148V either decreased or abolished the effects of PKA phosphorylation on Ca 2+ -sensitivity Pinto et al   2011  
Mutation Word : I148V @Position : 15
Function Word : effect @Position : 21
Impact Word : abolish @Position : 19
E255K and T315I are the most predominant mutations of BCR/ABL causing imatinib resistance in patients and may increase the kinase activity or change the substrate preferences of BCR/ABL  15  18  
Mutation Word : E255K @Position : 0
Function Word : substrate @Position : 24
Impact Word : increase @Position : 17
As shown in  Figure 3a–b  the kinase activities of L858R/V948R tEGFR in its EGF– and Cetuximab–bound forms were reduced substantially compared to that of L858R tEGFR indicating that mutation of either the N-lobe or C-lobe face of the dimer interface of L858R results in a 10- to 30-fold decrease in catalytic rate 
Mutation Word : L858R @Position : 43
Function Word : activity @Position : 9
Impact Word : reduce @Position : 20
Onitsuka et al  examined clinical specimens of the acquired resistance cases and found that certain lung adenocarcinoma tissues have the T790M mutation and high levels of HGF expression 
Mutation Word : T790M @Position : 21
Function Word : expression @Position : 28
Impact Word : high @Position : 24
We verified that oncogenic RET M918T increases enzymatic activity and ATP affinity analogous to the T790M mutation of the EGFR  Yun et al  2008  
Mutation Word : T790M @Position : 15
Function Word : atp @Position : 10
Impact Word : increase @Position : 6
Although B-RAF appears to be a plausible target in N-RAS mutated melanoma preclinical studies have consistently shown that selective B-RAF V600E  inhibitors can actually stimulate cell growth and have detrimental effects in N-RAS mutated melanoma   
Mutation Word : V600E @Position : 20
Function Word : effect @Position : 31
Impact Word : detrimental @Position : 30
It has been shown that the A391E mutation increases FGFR3 dimerization  unlike the G380R and G375C mutations 
Mutation Word : A391E @Position : 6
Function Word : dimerization @Position : 10
Impact Word : increase @Position : 8
EGFR knock-down by siRNA enhanced the growth inhibitory effect of afatinib or cetuximab in a panel of five NSCLC cell lines including those with T790M mutation Chen et al   
Mutation Word : T790M @Position : 24
Function Word : effect @Position : 8
Impact Word : enhance @Position : 4
P61BRAF V600E  expressing cells remained sensitive to the MEK inhibitor Selumetinib 
Mutation Word : V600E @Position : 1
Function Word : sensitivity @Position : 6
Impact Word : remain @Position : 5
Increased activation of Akt1 by E17K L52R C77F and Q79K mutants led as expected to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
Mutation Word : L52R @Position : 6
Function Word : activity @Position : 1
Impact Word : increase @Position : 15
Expression of the p61 BRAF V600E  splice variant shows enhanced dimerization rendering a subset of melanoma patients resistant to vemurafenib  
Mutation Word : V600E @Position : 5
Function Word : resistance @Position : 18
Impact Word : enhance @Position : 10
Two sensitive transfectants harboring a  FLT3  D835V or  KIT  D816Y mutation were immunoblotted – and showed higher elevated threonine 308 phosphorylation levels compared to  FLT3  ITD or  BCR-ABL1  transfected cells 
Mutation Word : D835V @Position : 8
Function Word : phosphorylation @Position : 24
Impact Word : elevate @Position : 21
The presence of R164Q in cluster 2 rather than in cluster 1 with wt  K-Ras  was therefore initially surprising but suggests that the R164Q mutation also has an activating phenotype albeit attenuated relative to the other mutations studied 
Mutation Word : R164Q @Position : 25
Function Word : activity @Position : 30
Impact Word : attenuate @Position : 33
9   Preclinical studies have shown superior activity of afatinib over first-generation TKIs mainly due to 1 irreversible binding which confers stronger binding affinity and potency 2 ability to circumvent first-generation TKI resistance mechanism T790M mutation in exon 20 and 3 effectiveness against multiple HER-endothelial growth factor receptors   10  
Mutation Word : T790M @Position : 35
Function Word : resistance @Position : 33
Impact Word : stronger @Position : 22
Approximately 90% of all identified BRAF mutations that occur in human cancer are a T1799A transversion mutation in exon 15 which results in a V600E amino acid substitution   T1799A alteration V600E mutation accounts for 70 to 90% of BRAF mutant melanoma patients   
Mutation Word : V600E @Position : 32
Function Word : result @Position : 21
Impact Word : alter @Position : 31
For instance Das Thakur and colleagues argued that vemurafenib-resistant melanoma cells exhibit similar resistance to the MEK inhibitor AZD6244 due to elevated BRAF V600E expression  7  
Mutation Word : V600E @Position : 23
Function Word : expression @Position : 24
Impact Word : elevate @Position : 21
Our biochemical studies here now show that E884K mutation in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : E884K @Position : 7
Function Word : inhibit @Position : 25
Impact Word : alter @Position : 36
In the two cell lines with exon 19 deletion 15 bp H1650 and PC9 expression of EGFR D38B1 protein and EGFR E746-A750 deletion specific 6B6 was positive score 3 100% and expression of EGFR L858R mutant-specific 43B2 was negative score 0 
Mutation Word : L858R @Position : 34
Function Word : expression @Position : 31
Impact Word : negative @Position : 38
The up-regulation of BIM was also attenuated in a similar dose–response manner as seen in the apoptosis assay  Figure 6 A bottom with L858R-T790M completely abrogating the induction of BIM and L858R-L747S attenuating both the up-regulation of BIM and apoptosis 
Mutation Word : T790M @Position : 24
Function Word : apoptosis @Position : 40
Impact Word : attenuate @Position : 33
Hence an effect of PLX4032 was recently demonstrated on the uptake of 18F-FDG in melanoma cells whereas inducible expression of  V600E BRAF increased the glucose uptake rate and decreased O 2  consumption in thyroid cancer cells   
Mutation Word : V600E @Position : 21
Function Word : induce @Position : 17
Impact Word : decrease @Position : 29
In summary our data demonstrate that MEK inhibition of BRAF V600E -positive melanoma cells can lead to AKT-dependent enhanced apoptosis resistance towards genotoxic stress implying a careful choice of pathway inhibitors in combination therapies 
Mutation Word : V600E @Position : 10
Function Word : resistance @Position : 20
Impact Word : enhance @Position : 18
Previously we reported that constitutive activation of STAT5 induced by JAK2 V617F conferred growth-factor independence on Ba/F3 cells and assumed that a wide range of genes induced by STAT5 activation seems to play important roles in cellular transformation induced by JAK2 V617F therefore by performing DNA array analysis the alteration of the gene expression was examined between cells expressing wild-type JAK2 with EpoR WT/EpoR cells and cells expressing JAK2 V617F with EpoR VF/EpoR cells 
Mutation Word : V617F @Position : 69
Function Word : activity @Position : 29
Impact Word : constitutive @Position : 4
However response to the EGFR TKIs may be short lived due possibly to a secondary mutation in the EGFR T790M or increased signaling through pathways downstream to the EGFR without its activation   
Mutation Word : T790M @Position : 19
Function Word : activity @Position : 31
Impact Word : increase @Position : 21
The mutations T315I E255V F317L and F317V contribute to decreased vdW interactions with Ala269 
Mutation Word : T315I @Position : 2
Function Word : interaction @Position : 11
Impact Word : decrease @Position : 9
FLT3  D835V and  KIT  D816Y retained some level of sensitivity with regard to induction of apoptosis 
Mutation Word : D816Y @Position : 7
Function Word : apoptosis @Position : 18
Impact Word : retain @Position : 8
The favorable clinical response of tumors harboring the common exon 19 deletions or the L858R mutation correlates with the high TKI sensitivity of these EGFR mutant proteins at the molecular level 
Mutation Word : L858R @Position : 14
Function Word : sensitivity @Position : 21
Impact Word : high @Position : 19
33  34  Overall dabrafenib has markedly higher response rates and progression-free survival along with a well-tolerated toxicity profile compared with dacarbazine in patients with  V600E BRAF -mutated metastatic melanoma 
Mutation Word : V600E @Position : 27
Function Word : survival @Position : 13
Impact Word : higher @Position : 8
These results suggest that acquired resistance to adjuvant imatinib was infrequent especially since both arms included patients with mutations known to be less sensitive or resistant to imatinib e.g  platelet-derived growth factor receptor alpha [PDGFRA] D842V   
Mutation Word : D842V @Position : 36
Function Word : sensitivity @Position : 23
Impact Word : less @Position : 22
In vitro studies show that T790M confers resistance to gefitinib possibly by increasing EGFR’s affinity for ATP thus decreasing the binding of the ATP-competitive TKI 
Mutation Word : T790M @Position : 5
Function Word : atp @Position : 16
Impact Word : increase @Position : 12
The single mutants with the exception of K112N and K118N exhibited slightly lower thermal stability than the wild type 
Mutation Word : K118N @Position : 9
Function Word : exhibit @Position : 10
Impact Word : stability @Position : 14
Several resistance mechanisms such as EGFR T790M secondary mutation that leads to a higher ATP binding capacity and MET amplification resulting in an aberrantly activated alternative pathway that bypasses the inhibited EGF receptors had been discovered 
Mutation Word : T790M @Position : 6
Function Word : atp @Position : 14
Impact Word : higher @Position : 13
In this study a high sensitivity DHPLC-based method as well as conventional direct sequencing were performed to screen deletions in exon 19 and L858R mutation in exon 21 of the  EGFR  gene in 127 Chinese ESCC patients respectively 
Mutation Word : L858R @Position : 23
Function Word : sensitivity @Position : 5
Impact Word : high @Position : 4
In an  EGFR -vIII-based method of overexpression L861Q mutation reportedly enhances EGFR kinase activity and transforms activity without an increase in sensitivity to EGFR-TKI but with an increase in sensitivity to irreversible second-generation EGFR-TKI  26  
Mutation Word : L861Q @Position : 8
Function Word : activity @Position : 17
Impact Word : enhance @Position : 11
While BRAF V600E -inhibition has been previously shown to increase tumor infiltrating lymphocytes it has also been shown to induce the expression of T cell exhaustion markers including PD-L1 TIM3 and PD1 in melanoma patients [ 53 ] 
Mutation Word : V600E @Position : 2
Function Word : inhibit @Position : 3
Impact Word : increase @Position : 9
Another genetic aberration in BRAF in addition to BRAF V600E point mutations that leads to increased kinase activity in low- and high-grade pediatric brain tumors is a fusion protein of KIAA1549BRAF that is found in the majority of pilocytic astrocytomas 
Mutation Word : V600E @Position : 9
Function Word : activity @Position : 17
Impact Word : increase @Position : 15
AMN107 maintains activity against 32/33 imatinib-resistant  BCR-ABL  mutants but has no significant activity against the T315I mutant  Table 1   Manley  et al  2005   OHare  et al  2005   Weisberg  et al  2005  
Mutation Word : T315I @Position : 17
Function Word : activity @Position : 14
Impact Word : maintain @Position : 1
BRAF V600E  which accounts for more than 90% of BRAF mutations leads to constitutive activation of downstream signaling via the MAPK cascade a pathway that is critical in cell cycle regulation and proliferation  
Mutation Word : V600E @Position : 1
Function Word : activity @Position : 15
Impact Word : constitutive @Position : 14
S252W mutation alters the gene expression in response to FGFR2 activation
Mutation Word : S252W @Position : 0
Function Word : activity @Position : 10
Impact Word : alter @Position : 2
Our studies here using COS-7 transfection model system show that E884K works in concert with L858R in- cis  in a dominant fashion to change downstream signaling differentially induce MAPK-ERK1/2 signaling and associated cell proliferation and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor-specific fashion 
Mutation Word : E884K @Position : 10
Function Word : sensitivity @Position : 38
Impact Word : alter @Position : 37
On the other hand YFP-EGFR-ICD proteins bearing the uncommon exon 21 mutation P848L and A859T showed markedly lower autophosphorylation levels than YFP-EGFR-ICD L858R Figure  4C  
Mutation Word : L858R @Position : 22
Function Word : autophosphorylation @Position : 18
Impact Word : lower @Position : 17
Furthermore from a gefitinib-resistant patient carrying the activating L858R mutation we identified a novel secondary resistant mutation L747S in cis to the activating mutation which attenuated the up-regulation of BIM and reduced apoptosis 
Mutation Word : L747S @Position : 17
Function Word : activity @Position : 22
Impact Word : attenuate @Position : 25
In non-small lung cancer a missense mutation  T790M  within the EGFR kinase domain has been shown to emerge in lesions that progress while on TKIs yielding a protein with reduced binding to drug  
Mutation Word : T790M @Position : 8
Function Word : binding @Position : 32
Impact Word : reduce @Position : 31
Based on these results and on a molecular model of FGFR3 TM domain created with the program CHI  it has been proposed that the G380R mutation introduces a structural change in the unliganded FGFR3 dimers thus altering their phosphorylation efficiencies and ultimately increasing FGFR3 phosphorylation in the absence of ligand 
Mutation Word : G380R @Position : 25
Function Word : phosphorylation @Position : 45
Impact Word : increase @Position : 43
Now recent work from the Rosen lab at Memorial Sloan-Kettering Cancer Center has uncovered data that vemurafenib reduces feedback inhibition in BRAF V600E -expressing cells such that these cells become sensitized to extracellular growth factors like hepatocyte and epidermal growth factors 
Mutation Word : V600E @Position : 22
Function Word : expression @Position : 23
Impact Word : reduce @Position : 17
Expression of the p61 BRAF V600E  splice variant shows enhanced dimerization rendering a subset of melanoma patients resistant to vemurafenib  
Mutation Word : V600E @Position : 5
Function Word : dimerization @Position : 11
Impact Word : enhance @Position : 10
The other possibility is that the presence of the EGFR T790M mutation could increase the affinity of the EGFR-L858R for ATP and thus reduce the potency of an ATP-competitive kinase inhibitor   
Mutation Word : L858R @Position : 18
Function Word : affinity @Position : 15
Impact Word : increase @Position : 13
Vemurafenib treatment results in deletion mutant p61B-RAF V600E  with enhanced dimerization and activity through a similar allosteric mechanism 
Mutation Word : V600E @Position : 7
Function Word : activity @Position : 13
Impact Word : enhance @Position : 10
Dasatinib is a dual BCR-ABL and Src kinase inhibitor with approximately 325-fold greater activity than IM against BCR-ABL and with activity against most mutations resistant to IM with the exception of T315I but to date it is still unknown whether dasatinib therapy is superior to IM in terms of preventing relapse or inducing longer EFS 
Mutation Word : T315I @Position : 31
Function Word : activity @Position : 20
Impact Word : greater @Position : 12
T315I is a gate-keeper mutation that abrogates inhibitor binding to the BCR-ABL kinase domain 
Mutation Word : T315I @Position : 0
Function Word : binding @Position : 8
Impact Word : abrogate @Position : 6
E884K-EGFR modulates inhibitor sensitivity effects in an inhibitor-specific fashion
Mutation Word : E884K @Position : 0
Function Word : effect @Position : 4
Impact Word : modulates @Position : 1
Notably inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
Mutation Word : D816V @Position : 16
Function Word : inhibit @Position : 1
Impact Word : reduce @Position : 10
In line with previous observations   the T790M mutation abrogated erlotinib sensitivity 
Mutation Word : T790M @Position : 8
Function Word : sensitivity @Position : 12
Impact Word : abrogate @Position : 10
We also find that a melanoma-associated mutation within the pseudosubstrate sequence P52L disrupts PAK6 autoinhibition enhancing its kinase activity potentially correlating with increased expression of PAK6 in prostate cancer and implied alterations in kinase activity  
Mutation Word : P52L @Position : 11
Function Word : activity @Position : 34
Impact Word : alter @Position : 31
In contrast to the lack of change in proliferation and viability in cells expressing the mutant form of BCR-ABL T315I  Supplemental Figure 1a and 1b    higher concentrations of imatinib inhibited cell proliferation and induced cell death in a dose-dependent fashion suggesting that these cells selected for imatinib resistance still rely on BCR-ABL for their survival and proliferation 
Mutation Word : T315I @Position : 19
Function Word : proliferation @Position : 60
Impact Word : higher @Position : 29
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : T315I @Position : 7
Function Word : expression @Position : 31
Impact Word : increase @Position : 19
Research into the molecular mechanisms of BRAF V600E -positive tumors has revealed that the missense valine to glutamic acid mutation increases kinase activity promoting the constitutive activation of MEK-ERK signaling and enhancing ERK-dependent transcriptional output  
Mutation Word : V600E @Position : 7
Function Word : activity @Position : 26
Impact Word : increase @Position : 20
Despite the fact that we have no data concerning the frequency of BRAF V600E  in the present series of tumours NrCAM transcript expression was significantly higher in every analysed cancer 
Mutation Word : V600E @Position : 13
Function Word : expression @Position : 23
Impact Word : higher @Position : 26
Although the frequency of HGF expression among cases of acquired resistance is unclear because of scarcity of reports the frequency of coexistence of HGF expression with T790M mutations could possibly be high   
Mutation Word : T790M @Position : 26
Function Word : expression @Position : 24
Impact Word : high @Position : 31
Since the companion assay COBAS used in the phase 3 vemurafenib study has a high sensitivity for V600E with partial cross-reactivity to V600K  http//www.accessdata.fda.gov/cdrh_docs/pdf11/P110020b pdf  10 patients who were later found to have the BRAF V600K mutation were included in the vemurafenib group 
Mutation Word : V600K @Position : 37
Function Word : sensitivity @Position : 15
Impact Word : high @Position : 14
Here we show for the first time that activation of FGFR3 is associated with an increase in FGFR3b expression in S249C mutated tumors 
Mutation Word : S249C @Position : 20
Function Word : associated @Position : 12
Impact Word : increase @Position : 15
Overall SP inhibitors represent an innovative mechanism of KIT inhibition whose dual suppression of KIT D816V neoplastic mast cell proliferation and SCF enhanced mast cell activation may provide significant therapeutic benefits 
Mutation Word : D816V @Position : 15
Function Word : activity @Position : 25
Impact Word : enhance @Position : 22
Two sensitive transfectants harboring a  FLT3  D835V or  KIT  D816Y mutation were immunoblotted – and showed higher elevated threonine 308 phosphorylation levels compared to  FLT3  ITD or  BCR-ABL1  transfected cells 
Mutation Word : D816Y @Position : 13
Function Word : phosphorylation @Position : 24
Impact Word : elevate @Position : 21
Cell viability was decreased in all mesothelioma cell lines tested in response to ARQ 197 with those harboring the T1010I MET mutation H513 and H2596 showing the greatest sensitivity 
Mutation Word : T1010I @Position : 19
Function Word : sensitivity @Position : 28
Impact Word : decrease @Position : 3
TBP-3868 exhibits high basal Ras activity relative to the PLX4720 sensitive line TBP-3743 suggesting that the resistance to BRAF V600E -inhibition in TBP-3868 may be attributed to Ras-dependent transactivation of RAF dimers 
Mutation Word : V600E @Position : 19
Function Word : inhibit @Position : 20
Impact Word : high @Position : 2
FLT3  D835V and  KIT  D816Y retained some level of sensitivity with regard to induction of apoptosis 
Mutation Word : D835V @Position : 2
Function Word : sensitivity @Position : 12
Impact Word : retain @Position : 8
As shown in  Fig  5a  expression of mutp53 greatly increased the levels of RhoA-GTP but not the total RhoA in H1299 and p53  R172H/R172H  MEF cells and furthermore knockdown of endogenous mutp53 greatly reduced the levels of RhoA-GTP but not the total RhoA in MDA-MB468 and SK-BR3 cells 
Mutation Word : R172H @Position : 27
Function Word : expression @Position : 8
Impact Word : increase @Position : 12
Furthermore transfection of another activated mutant L858R EGFR cDNA also induced enhanced expression  Figure 7C  and restored drug sensitivity to erlotinib in 11–18/ER1-7 cells  Figure 7D  
Mutation Word : L858R @Position : 6
Function Word : activity @Position : 4
Impact Word : enhance @Position : 11
The enhanced tyrosine phosphorylation of PECAM-1 by the E255K and T315I mutants may be at least partly due to their enhanced activities  15 – 17  
Mutation Word : T315I @Position : 10
Function Word : activity @Position : 21
Impact Word : enhance @Position : 20
Alterations in ATP-dependent reaction rates and inhibitor binding affinities are probably the mechanism for acquired resistance by the T790M mutation   
Mutation Word : T790M @Position : 18
Function Word : affinity @Position : 8
Impact Word : alter @Position : 0
We have previously shown that the JAK2 V617F homologous mutation in JAK1 V658F induces constitutive activation of JAK1  
Mutation Word : V617F @Position : 7
Function Word : activity @Position : 15
Impact Word : constitutive @Position : 14
Cells expressing the L747_E749del A750P and D770_N771insNPG  EGFR  mutants also exhibited a greater degree of loss of contact inhibition than was observed in cells expressing the L858R or G719S EGFR mutants in a primary focus formation assay unpublished data 
Mutation Word : G719S @Position : 30
Function Word : inhibit @Position : 20
Impact Word : greater @Position : 14
Hence E884K in- cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone through differential inhibition of the pro-survival AKT and STAT3 signaling pathways associated with altered induction of cleaved-PARPAsp214 
Mutation Word : L858R @Position : 14
Function Word : associated @Position : 27
Impact Word : alter @Position : 29
Although the tumors are heterogeneous the low expression of differentiation genes  tyr  and  dct  coupled with high  c-met  gene expression pattern suggests that hypomorphic MITF activity may maintain melanocytes in a less differentiated state that is more susceptible to BRAF V600E  transformation 
Mutation Word : V600E @Position : 46
Function Word : activity @Position : 31
Impact Word : maintain @Position : 33
We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated native BCR/ABL  15 – 17  
Mutation Word : T315I @Position : 7
Function Word : substrate @Position : 29
Impact Word : increase @Position : 19
This mutation  E17K  increases recruitment of AKT1 to the membrane increases AKT1 phosphorylation and activity transforms Rat1 fibroblasts and induces leukaemia in transgenic mice  Carpten  et al  2007  
Mutation Word : E17K @Position : 3
Function Word : phosphorylation @Position : 14
Impact Word : increase @Position : 12
Enhanced activation of downstream pathways other than JAK/STAT including the phosphatidylinositol 3-kinase PI3K and extracellular signal-regulated kinase ERK pathways has been documented in  JAK2 V617F mutated cells  
Mutation Word : V617F @Position : 25
Function Word : activity @Position : 1
Impact Word : enhance @Position : 0
Further crystallographic data showed that E542K disrupts the inhibitory interaction of p110α with the amino-terminal SH2 domain of p85 thus enhancing its catalytic activity   
Mutation Word : E542K @Position : 5
Function Word : activity @Position : 23
Impact Word : enhance @Position : 20
BUILD SUCCESSFUL (total time: 4 seconds)
